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Abstract 
Despite the advances made since the advent of germ theory, infectious diseases 
still wreak havoc on human societies, not only affecting us directly but impacting the 
crops and livestock upon which we rely. Infectious diseases also have dramatic effects 
on wildlife ecology. Therefore research into infectious diseases could not only directly 
lead to the improvement and saving of human lives, but aid in food security and the 
conservation of many wildlife species. Of vital importance in understanding the ecology 
of infectious diseases are the mechanisms by which they persist in host populations. 
One possible mechanism is vertical transmission: the transmission of a pathogen from a 
parent to its offspring as a result of the process of host reproduction. Another possible 
mechanism is inapparant infections, where an infected host does not display symptoms. 
Focusing on dengue fever and the Plodia interpunctella granulovirus laboratory system, 
this PhD thesis looks at the role these two mechanisms play on the persistence of two 
viral infections and their ecology. Regarding the Plodia interpunctella granulovirus 
(PiGV) low host food quality led to greater detection of vertically transmitted 
inapparant PiGV, but did not lead to its activation to an apparent form. Host inbreeding 
did not lead to vertically transmitted inapparant PiGV’s activation, nor had an effect on 
its vertical transmission. The vertical infection rate of PiGV was very low. I would 
therefore suggest that it may be better to use an insect virus system with a higher rate of 
vertical infection in future research into vertically transmitting inapparent infections. 
Regarding dengue virus I conclude that vertical transmission is not likely to play a role 
in the persistence of this virus. However modelling work found that inapparent 
infections could provide dengue viruses with a means of persistence and should be 
subject to further research.  
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EPIDEMIC STARTED BY THE ARRIVAL OF AN ASYMPTOMATIC INDIVIDUAL. B) MODEL A WITH AN EPIDEMIC STARTED BY 
THE ARRIVAL OF A SYMPTOMATIC INDIVIDUAL. C) MODEL B WITH AN EPIDEMIC STARTED BY THE ARRIVAL OF AN 
ASYMPTOMATIC INDIVIDUAL. D) MODEL B WITH AN EPIDEMIC STARTED BY THE ARRIVAL OF A SYMPTOMATIC 
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FIGURE 5.18: PERCENTAGE OF THE POPULATION RESISTANT AT THE END OF THE EPIDEMIC, AGAINST DIFFERENT DURATIONS OF 
ASYMPTOMATIC INFECTION (D) AND DIFFERENT PROPORTIONS OF INFECTIONS DEVELOPING SYMPTOMS (P), WHEN 
LEVELS OF TRANSMISSION FROM ASYMPTOMATIC AND SYMPTOMATIC INFECTIONS WERE THE SAME (C=1), UNDER MID-
LEVEL TRANSMISSION (ΒI=300/365). EPIDEMICS THAT HAD AN R0 OF LESS THAN 1 OR LAST LESS THAN 20 DAYS ARE IN 
WHITE. A) MODEL A WITH AN EPIDEMIC STARTED BY THE ARRIVAL OF AN ASYMPTOMATIC INDIVIDUAL. B) MODEL A 
WITH AN EPIDEMIC STARTED BY THE ARRIVAL OF A SYMPTOMATIC INDIVIDUAL. C) MODEL B WITH AN EPIDEMIC 
STARTED BY THE ARRIVAL OF AN ASYMPTOMATIC INDIVIDUAL. D) MODEL B WITH AN EPIDEMIC STARTED BY THE 
ARRIVAL OF A SYMPTOMATIC INDIVIDUAL. FOR ALL SUB-FIGURES THE MORE CONSERVATIVE REGION OF PARAMETER 
SPACE IS DISPLAYED THROUGH THE AXIS LABELLED VALUES BEING GREEN. ........................................................ 178 
FIGURE 5.19: PERCENTAGE OF THE POPULATION RESISTANT AT THE END OF THE EPIDEMIC, AGAINST DIFFERENT LEVELS OF 
TRANSMISSION FROM ASYMPTOMATIC INFECTIONS (C) AND DIFFERENT PROPORTIONS OF INFECTIONS DEVELOPING 
SYMPTOMS (P), WHEN DURATIONS OF ASYMPTOMATIC AND SYMPTOMATIC INFECTIONS WERE THE SAME (D=1), UNDER 
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SAME (D=1). B) MODEL B AT DIFFERENT PROPORTIONS OF INFECTIONS DEVELOPING SYMPTOMS (P) AND DIFFERENT 
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ASYMPTOMATIC AND SYMPTOMATIC INFECTIONS IS THE SAME (C=1).  D) MODEL B AT DIFFERENT PROPORTIONS OF 
INFECTIONS DEVELOPING SYMPTOMS (P) AND DIFFERENT DURATIONS OF ASYMPTOMATIC INFECTION (D), WHEN 
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ASYMPTOMATIC AND SYMPTOMATIC INFECTIONS IS THE SAME (C=1).  D) MODEL B AT DIFFERENT PROPORTIONS OF 
INFECTIONS DEVELOPING SYMPTOMS (P) AND DIFFERENT DURATIONS OF ASYMPTOMATIC INFECTION (D), WHEN 
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FIGURE 6.11: DAYS UNTIL EPIDEMIC EXTINCTION AGAINST DIFFERENT LEVELS OF TRANSMISSION FROM ASYMPTOMATIC 
INFECTIONS (C) AND DIFFERENT PROPORTIONS OF INFECTIONS DEVELOPING SYMPTOMS (P), WHEN DURATIONS OF 
ASYMPTOMATIC AND SYMPTOMATIC INFECTIONS WERE THE SAME (D=1), UNDER MID-LEVEL TRANSMISSION (ΒI=0.75 
AND B=0.65). DAYS UNTIL EPIDEMIC EXTINCTION IS DEFINED AS THE FIRST OCCURRENCE OF THE ASYMPTOMATIC AND 
SYMPTOMATIC CLASSES BEING LESS THAN 1 AFTER THE PEAK TOTAL OF SYMPTOMATIC AND ASYMPTOMATIC INFECTIONS. 
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SYMPTOMATIC CLASSES BEING LESS THAN 1 AFTER THE PEAK TOTAL OF SYMPTOMATIC AND ASYMPTOMATIC INFECTIONS. 
EPIDEMICS THAT HAD AN R0 OF LESS THAN 1 OR LAST LESS THAN 20 DAYS ARE IN WHITE, EPIDEMICS WHERE 
ASYMPTOMATIC AND SYMPTOMATIC CLASSES NEVER REACHED LESS THAN 1 IN 30 YEARS ARE IN BLACK. A) MODEL A 
WITH AN EPIDEMIC STARTED BY THE ARRIVAL OF AN ASYMPTOMATIC INDIVIDUAL. B) MODEL A WITH AN EPIDEMIC 
STARTED BY THE ARRIVAL OF A SYMPTOMATIC INDIVIDUAL. C) MODEL B WITH AN EPIDEMIC STARTED BY THE ARRIVAL 
OF AN ASYMPTOMATIC INDIVIDUAL. D) MODEL B WITH AN EPIDEMIC STARTED BY THE ARRIVAL OF A SYMPTOMATIC 
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Chapter 1: Introduction 
1.1 General introduction 
Even today with all the advances in technology and understanding made since 
Koch’s postulates gave clarity to germ theory in 1890 (Goering et al. 2008a), infectious 
diseases still wreak havoc on human societies. HIV and diarrheal diseases were each 
responsible for 1.5 million deaths in 2012, making them the sixth and seventh global 
cause of death that year (WHO 2012a). The WHO using the measure Disability 
Adjusted Life Years (DALY), which combines the number of years lost from the 
standard life expectancy and years lived with disability (WHO 2015e), estimate that 
430,000,000 years of healthy life were lost due to infectious disease in 2012 (WHO 
2012b).  
Infectious diseases have often shaped human history, through the sheer scale of 
lives lost in epidemics. The Black Death of the 1340s, caused by Yersinia pestis, is 
thought to have killed 25 million people in Europe (Goering et al. 2008e). In England 
alone, approximately 35% of the population may have died in the space of two and a 
half years (Goering et al. 2008e). This dramatic loss of life is thought to have either 
brought about or hasten the end of feudalism (Fasulo 2008). Similarly the introduction 
of disease from Europe to the Americas, aided in the European conquest of the 
Americas (Diamond 1997). For example nearly half the population of the Aztecs died 
due to the arrival of smallpox in 1520, aiding the comparably unaffected troops of 
Hernán Cortés in the conquest of the Aztecs (Diamond 1997). Often accompanying 
wars and other such political upheavals, infectious diseases can cause similar 
morbidities and mortalities as the events themselves. For instance the epidemic of 
typhus accompanying the chaos in the aftermath of the Russian revolution was 
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responsible for 30 million cases of illness and 3 million deaths in European Russia 
alone (Fasulo 2008). Supposedly regarding the control of the body louse, the vector of 
typhus, Lenin speculated “Either socialism will defeat the louse or the louse will defeat 
socialism”.  
Moving to the future there are several ways in which infectious diseases may 
become an increasingly important cause of morbidity and mortality. The opening of the 
2011 annual report of the UK chief medical officer, highlighted that in the absence of 
new antibiotics or other treatments the growth of antibiotic resistance could lead to 
minor surgery and routine infections becoming high risk (Davies 2011). Furthermore in 
2013 the same UK chief medical officer went on to publically urge the UK government 
to bring up the issue at the G8, suggesting that antibiotic resistance should be ranked 
alongside terrorism as a threat to the nation (Walsh 2013). It has also been debated that 
climate change may well increase the burden and geographical range of many vector 
borne diseases (Lambrechts et al. 2010; Fan et al. 2014; Campbell-lendrum et al. 2015). 
This is not only due to the increased global distribution of the vectors of these diseases 
(M. Service 2012b; Lambrechts et al. 2010; WHO 2015b) but also the changes in 
extrinsic incubation period within the vector that is associated with temperature change 
(M. Service 2012a; Fan et al. 2014; Campbell-lendrum et al. 2015), as well as the 
effects of temperature and climatic factors on the life cycles of these vectors (M. 
Service 2012a; M. Service 2012b; Campbell-lendrum et al. 2015).   
Infectious diseases not only affect us directly but impact the crops and livestock 
upon which we rely. Phytophthora infestans the causative agent of the Irish potato 
famine of the 1840s (which led to the death of a million people and emigration of 
another million people (Turner 2005)) is reported to cost the EU economy more than €1 
billion per year (Haverkroft et al. 2008). In the semi-arid regions of Africa, infections 
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caused by parasites of the genus Trypanosoma for centuries has prevented an area larger 
than the size of the United States from being used for large scale cattle rearing (Roberts 
& Janovy 2006). If these Trypanosoma diseases were to be eliminated it is estimated 
that it would generate $2.5 billion over the next twenty years (Shaw et al. 2014). Recent 
outbreaks of livestock diseases in the UK have caused tremendous costs to the 
economy. Figures by the UK Audit Office estimated the cost of the Foot and Mouth 
epidemic of 2001 at £3 billion to the UK government and £5 billion to the private sector 
(National Audit Office 2002). A freedom of information request revealed that the UK’s 
Department for Environment Food and Rural Affairs (DEFRA) spent more than £26 
million in compensation and animal slaughter in the programme to control bovine TB, 
for the tax year 2012-2013 (DEFRA TB Programme 2013).  
On a more positive note there has been growing research and a market in the use 
of infectious diseases as biopesticides in the control of crop pests (Wilson et al. 2013). 
Whilst these biopesticides have the advantages of higher target specificity, a capacity 
for secondary cycling and transgenerational transmission over traditional pesticides, 
they have proved so far to have had varying efficacy, a slower speed of kill and greater 
environmental sensitivity (Wilson et al. 2013). 
Infectious diseases not only have dramatic effects on human communities but on 
populations of wildlife. Often having effects on an animal’s ecology that at face value 
do not make intuitive sense until further study reveals the underlying mechanics. A 
study of cowpox infections in bank voles on the Wirral peninsula, North West England 
found that in the summer months an infection with cowpox increased survival at both 
the individual and population level, a similar affect was found in wood mice at the 
population level (Telfer et al. 2002). It was later found that both female wood mice and 
bank voles infected with cowpox are more likely to delay maturation and therefore 
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reproduction, suggesting that these rodents maximise their overall fitness by delaying 
reproduction in order to transfer resources to fight the cowpox infection (Telfer et al. 
2005). This delay in reproduction associated with cowpox infection could lead to an 
increase in survival over the summer months as the rodent would not be playing a role 
within the breeding season which has its own risks and strains on resources (Telfer et al. 
2002; Telfer et al. 2005).  
More notably infectious diseases can cause dramatic wildlife population 
declines. Infectious diseases have been linked to the decline of many amphibian species, 
to levels of critical endangerment, even when the environments in which these 
amphibians live is protected (Stuart et al. 2004; Wake & Vredenburg 2008). The 
infectious agent most linked to this decline is the chytrid fungus Batrachochytrium 
dendrobatidis (Stuart et al. 2004; Wake & Vredenburg 2008), which has rapidly 
expanded across the continents capable of sustaining amphibians (Wake & Vredenburg 
2008; Olson et al. 2013). Many of the viruses found in the honey bee species Apis 
mellifera, some of which are linked to the damage caused by the Varroa mite, have 
been demonstrated to infect many wild pollinating insects (Manley et al. 2015). 
Meaning that these viruses pose a possible risk to the continued pollination of not only 
many crop species but the pollination of wild plants that form the basis of many 
ecological communities (Manley et al. 2015).  
Therefore for the reasons outlined above research into infectious diseases could 
not only directly lead to the improvement and saving of human lives but aid in food 
security and the conservation of many wildlife species. Of vital importance in 
understanding the ecology of infectious diseases are the mechanisms by which they 
persist. 
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1.2 Persistence of infectious agents within host populations 
In order for an infectious agent to invade a population events that allow an 
infectious agent to transmit from an infected host to a susceptible host must on average 
occur at least once before an infected host dies or clears an infection through immunity 
(Anderson & May 1991a). Similarly if these transmission events occur in proportion to 
host population size, as an infectious agent uses up the pool of susceptible hosts it may 
run out of susceptible hosts to infect, unless enough susceptible hosts are quickly added 
to the population through births or immigration (Anderson & May 1991b; Keeling & 
Rohani 2008c). Therefore for a given combined birth and immigration rate there is a 
critical community size (CCS) below which an infectious agent could not persist in a 
population (Anderson & May 1991b; Keeling & Rohani 2008c).  
The most widely known work on critical community size was that of Bartlett’s 
in the late 50s and early 60s (Grenfell 1997), who estimated the CCS required for 
measles to persist in a US city being between 250,000-300,000 (Bartlett 1960). This and 
other work on measles demonstrated that measles was maintained in populations above 
this CCS by being introduced from these larger urban areas to villages or towns, where 
upon measles would spread through the population, use up the pool of susceptible hosts 
and then become extinct (Grenfell 1997). After a period of time births would increase 
the pool of susceptible hosts in these villages or towns, meaning that measles could 
once again be reintroduced by someone infected from a city or town over the CCS 
(Grenfell 1997). The patchiness of resources leading to different thresholds in which an 
organism can survive gives rise to what is called metapopulation dynamics (Grenfell 
1997). In the case of infectious agents hosts can be seen as such a resource (Grenfell 
1997). The example of measles can further illustrate how infectious agents are 
maintained through metapopulation dynamics by the natural experiment that was the 
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UK mass vaccination programme of the late 60s to the late 80s (Grenfell 1997). It was 
expected that there would be an increase to measles’ CCS, due to 60% of those been 
born susceptible to measles quickly acquiring immunity through vaccination 
Surprisingly this did not occur (Grenfell 1997). Before the vaccination programme 
epidemics of measles were synchronised between the major population centres (Grenfell 
1997). However, vaccinations led to desynchronicity in measles incidence between 
those population centres (Grenfell 1997). Such asynchronies can aid disease persistence 
via different patches of population acting as reservoirs of infection for each other. A 
disease becomes extinct in one patch only to be later reseeded from another patch where 
the disease is about to use up its susceptible population, and so on (Grenfell 1997). This 
metapopulation dynamic in measles persistence was ended when the UK vaccination 
rose to 90% in the late 80s (Grenfell 1997).  
An infectious disease being reseeded via metapopulation dynamics is not the 
only mechanism by which an infectious disease may persist. Furthermore reseeding via 
metapopulation dynamics in many situations would not on its own cause a disease to 
persist. Factors such as large seasonal fluctuations in transmission or little connectivity 
between sparse populations of hosts that are all below the CCS, may prevent 
metapopulation dynamics from playing a role. This PhD looks at two other mechanisms 
by which infectious disease may persist, focusing on a moth virus laboratory system and 
a mosquito borne viral infection of humans.  
1.3 Vertical transmission of an infectious agent and its role in disease persistence 
Most pathogens transmit through horizontal transmission between hosts of the 
same or different generations. Vertical transmission is specifically where a pathogen is 
transmitted from parent to offspring as a result of the process of host reproduction, such 
as through an infected egg (transovarial transmission), the surface of an egg (transovum 
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transmission), sperm, seminal fluid, placenta, reproductive tract or breast milk. Vertical 
transmission provides a pathogen with a mechanism of persisting across many 
generations. An example of a retrovirus that infects humans and is thought to persist 
through vertical transmission is Human T-cell Lymphotropic Virus type 1 (HTLV-1) 
(Goering et al. 2008g; Goering et al. 2008c). HTLV-1 is common to certain islands in 
the Caribbean and Japanese archipelago where 5-15% of the population is thought to be 
infected (Goering et al. 2008c). HTLV-1 is mainly transmitted vertically through breast 
milk with some minor horizontal transmission through sexual intercourse and 
intravenous drug use (Goering et al. 2008c). The major issue with HTLV-1 is the 5% 
risk of developing T-cell leukaemia, which has a high and rapid mortality rate (Goering 
et al. 2008c). 
Through the insertion of their genome into the host genome, in the form of a 
provirus, retroviruses can be transmitted vertically if they infect germline cells (Goering 
et al. 2008g; Haig 2012). There is an indication of the widespread past vertical 
transmission of many retroviruses, from the long history of mammalian genomes 
containing ancestral non-functioning retrovirus genomes (Goering et al. 2008g; Haig 
2012). It has been suggested that many parts of these non-functioning retrovirus 
genomes have been co-opted in the evolution of the placenta (Haig 2012). In a like 
fashion vertically transmitting lysogenic bacteriophage often cause many bacterial 
strains to become pathogenic through the encoding of pathogenic genes from the 
integrated prophage genome (Campbell 2003).  
Vertical transmission is not restricted to viral pathogens. For example the 
intracellular symbiotic bacteria of the genus Wolbachia are maintained through vertical 
transmission in populations of their host and depending on circumstances can either 
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have a parasitic or mutualistic relationship with their hosts (terrestrial arthropods and 
filarial nematodes) (Salunkhe et al. 2014).   
1.4 Inapparent (asymptomatic) infections and their role in disease persistence 
Inapparent infections where to the eye of researchers, veterinary and medical 
practitioners, an infected host does not display symptoms can be a common occurrence 
for many pathogens. Such infections are often described as asymptomatic infections, 
with the infecting pathogen being able to horizontally transmit to other hosts. When a 
host does not clear an infection through immunity (chronic infection) and is 
asymptomatic, it can act as a persisting reservoir of infection, continuously transmitting 
an infection horizontally (Goering et al. 2008f). A classic example of this is Mary 
Mallon, A.K.A Typhoid Mary (Goering et al. 2008f). Upon infection with Salmonella 
typhi a human develops typhoid fever, after recovering from typhoid fever 1-3% of the 
population develop a chronic asymptomatic infection, continually transmitting S. typhi 
through faeces and urine (Goering et al. 2008b). From 1901-1914 Marry Mallon 
through her job as a cook and her chronic asymptomatic S. typhi infection is thought to 
have caused 200 cases of typhoid fever, despite frequent warnings from the US 
authorities not to be employed as a cook (Goering et al. 2008f). This led to two spells of 
incarceration, the second of which was from 1914 to 1938 when she died (Goering et al. 
2008f).  
In a like manner, even when chronic infections do not occur if a large proportion 
of infections are asymptomatic, a pathogen can be said to persist through the population 
of hosts that are asymptomatically infected acting as a reservoir of infection. Polio virus 
remains endemic to only a few countries, where it persists through a large proportion of 
asymptomatic infections (72%) acting as a reservoir (Hamborsky et al. 2015). Within 
many animal species infection with certain pathogens is often asymptomatic and thus 
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these asymptomatic infections can act as a reservoir. The already mentioned cowpox 
infection presents as an asymptomatic infection within wood mice and bank voles with 
an infectious period of 4 weeks (Telfer et al. 2005). Another member of the Poxviridae 
family squirrel parapoxvirus causes no signs of infection for the vast majority of 
infections in its natural host grey squirrels (Sainsbury et al. 2000).   
1.5 Inapparent (covert) infections and their role in disease persistence 
Inapparent infections can come in the form of covert infections. This is where 
upon infection a host becomes either overtly infected becoming symptomatic leading to 
the host transmitting the infection horizontally, or the host becomes covertly infected, 
were the host does not display symptoms and does not transmit the infection 
horizontally but may vertically transmit the covert infection. In some forms of this type 
of infection a host first becomes overtly infected followed by being covertly infected. 
This includes many viruses of the family Herpesviridae, such as varicella-zoster virus 
(the causative agent of chickenpox and shingles in its activated form), herpes simplex 1 
and 2 (causative agents of both oral and genital herpes) (Goering et al. 2008d). A key 
feature of covert infections is that at some point the infection may switch to an overt 
form (activation), leading to the horizontal transmission of the infectious agent (Sorrell 
et al. 2009). Covert infections can occur in two forms. In the persistent form the virus is 
actively translating proteins and replicating its genome but does not cause observable 
symptoms. In the latent form a viral infection likewise does not cause observable 
symptoms but the translation of proteins is lacking or reduced and the replication of its 
genome is absent (Hughes et al. 1997; Bonsall et al. 2005; Goering et al. 2008d; Sorrell 
et al. 2009). The circumstances under which a covert infection could be selected and 
allow a pathogen to persist were hypothesised by Sorrell et al. (2009), using 
mathematical models. Sorrell et al. (2009) predicted that highly fecund hosts that go 
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through fluctuating population densities would select for an infectious agent using a 
covert strategy for persistence. Sorrell et al. (2009)  goes on to point to a few studies 
which found insects covertly infected with baculoviruses of which there are many 
examples dating back to the 1950s (Steinhaus 1958; Steinhaus & Dineen 1960; Jaques 
1962; Longworth & Cunningham 1968; Etzel 1976; Biever & Wilkinson 1978; 
Jurkovíčová 1979; Fuxa & Richter 1992; Hughes et al. 1997; Fuxa et al. 1999; Cooper 
et al. 2003; Burden et al. 2003; Burden et al. 2006; Vilaplana et al. 2008; Vilaplana et 
al. 2010; Murillo et al. 2011). 
1.6 Baculoviruses, Plodia interpunctella and its baculovirus Plodia interpunctella 
granulovirus (PiGV) 
Baculoviruses are a widely occurring infection within lepidopteran species 
(Cory & Myers 2003). Many of the host lepidopteran species of baculoviruses are 
agricultural pests, as such the use of baculoviruses as biopesticides has been and is 
being actively researched (Smith & Rivers 1956; Grzywacz et al. 2013). Baculoviruses 
are DNA based viruses which are divided into two groups; nuclear polyhedrosis viruses 
(NPVs) and granuloviruses (GVs) (Cory & Myers 2003). Infection by baculoviruses 
commonly occurs when larvae consume proteinaceous structures known as occlusion 
bodies (OBs). OBs contain either a single virus in the case of GVs or multiple viruses in 
the case of NPVs  (Cory & Myers 2003). Horizontal transmission in the overt form of 
infection occurs when the host body tissue is converted into millions of OBs, causing 
the death of the host and subsequent release of OBs (Cory & Myers 2003). 
In the laboratory the baculovirus of the Indian meal moth (Plodia 
interpunctella), Plodia interpunctella granulovirus (PIGV) has provided a useful tool 
for exploring host-pathogen dynamics (Boots & Begon 1993; S. M. Sait et al. 1994b; S. 
M. Sait et al. 1994a; Boots & Mealor 2007). P. interpunctella is a notable pest of stored 
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grains, nuts and fruits (Mohandass et al. 2007). Found in every habitable continent this 
pest causes not only direct economic costs through lost product but indirect costs 
through consumer complaints, quality loss and the control of this pest (Mohandass et al. 
2007). Depending on diet, temperature and humidity the duration of the life cycle of P. 
interpunctella can vary considerably (Mohandass et al. 2007). The laboratory group I 
work within achieves a generation time of 35-40 days for P. interpunctella, provided P. 
interpunctella is maintained on a mixture 200g Ready Brek (porridge), 120g bran, 80g 
ground rice, 80g brewer’s yeast, 0.8g sorbic acid, 0.8g methyl paraben, 100 ml organic 
honey and 100 ml glycerol, at 27 (+/-1) °C on 16/8 hour light/dark cycle. Other 
academics using P. interpunctella as a model system have achieved similar generation 
times (Begon et al. 1996; Bjornstad et al. 1998). The typical experimental procedure for 
infecting P. interpunctella with PiGV is to place several of the third instar larvae on a 
petri dish along with small droplets of the dosing solution made of 75ml green food dye, 
25ml distilled water and 5g sucrose along with the required concentration of PiGV 
(depending on the type of experiment). The larvae given time will then feed on the 
dosing solution. Larvae are considered dosed when the green food dye is clearly visible 
within the third instar larvae. The ease of maintaining P. interpunctella stocks in the 
laboratory, quick generation time, easy storage of PiGV (-20°C i.e. a domestic freezer), 
simplicity of infecting P. interpunctella with PiGV make this a useful model system for 
exploring the ecology of host-pathogen dynamics. 
1.7 Dengue viruses and the illnesses they cause 
Since cases of dengue haemorrhagic fever (DHF) started appearing the 
Philippines and Thailand in the 1950s, illnesses caused by the four serotypes of dengue 
viruses, have grown to be a leading cause of childhood illness and death within Latin 
America and most Asian countries (WHO 2015b). Dengue viruses are positive-stranded 
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RNA viruses of the Flavivirus genus (Guzman et al. 2010; Rodenhuis-Zybert et al. 
2010), with mosquitoes of the genus Aedes acting as a vector (M. Service 2012b). Aedes 
aegypti is the principal vector of dengue viruses, but also Aedes albopictus may have an 
important role in acting as a vector of dengue viruses (M. Service 2012b; Lambrechts et 
al. 2010). Ae. albopictus has increased its range to include 29 states of the USA, 15 
European countries, Australia and New Zealand (M. Service 2012b; Lambrechts et al. 
2010; WHO 2015b). With the increasing spread of Ae. albopictus there has been a 
growing concern that there could be an increasing risk of outbreaks of dengue fever in 
these countries (Lambrechts et al. 2010). A literature review and meta-analyses of the 
vector competency of Ae. albopictus conducted by Lambrechts et al. (2010) 
demonstrates that as things currently stand Ae. albopictus is an inefficient dengue 
vector. However, Lambrechts et al. (2010) point that other arthropod-borne viruses 
(arboviruses) have adapted to alternative vectors and the expansion of Ae. albopictus to 
islands of the Indian Ocean, Central Africa and Italy did lead to outbreaks of 
chikungunya.  
Dengue viruses are grouped into four immunological serotypes (DENV-1, 
DENV-2, DENV-3 and DENV-4), (Guzman et al. 2010; Rodenhuis-Zybert et al. 2010). 
Infection with one serotype can lead to asymptomatic infection through to dengue fever 
(DF), a severe flu like illness that seldom causes death (Guzman et al. 2010; Andraud et 
al. 2012; Grange et al. 2014; WHO 2015b). Upon recovery from infection with a 
dengue serotype an individual is homotypically immune to that serotype for life 
(Guzman et al. 2010; Rodenhuis-Zybert et al. 2010; Andraud et al. 2012). However 
there is approximately only 1-3 years of heterotypic immunity to other dengue serotypes 
(Reich et al. 2013). After this period of cross protective immunity is over, secondary 
infection with another serotype puts a person at risk of developing DHF (Guzman et al. 
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2010; Rodenhuis-Zybert et al. 2010; Andraud et al. 2012; WHO 2015b). DHF can lead 
to dengue shock syndrome (DSS), both of which are life threatening. Many group DHF 
and DSS into severe dengue, which has been estimated to cause 500,000 cases of 
illness, mostly in children and have a mortality rate of 2.5% (WHO 2015b). 
1.8 Summary of the proceeding chapters 
In Chapter 2 for two reasons I test whether food quality can cause the activation 
of covert vertically transmitted PiGV in P. interpunctella. The first reason being that the 
activation of a virus from a covert vertically transmitted state to an overt horizontally 
transmitted state would be advantageous to the virus at high host densities. Such a 
potential cue for detecting a host’s density may well be the drop in the resource quality 
associated with increased host density. The second reason being that many studies of 
insects demonstrate an association between poor diet quality and a loss of immune 
function. I then build on this work by further developing the molecular methods to 
screen for the presence of the genome of covertly infecting PiGV within P. 
interpunctella larvae. The larvae from Chapter 2 were then tested for covert PiGV using 
these methods. 
In Chapter 3 as inbreeding has been demonstrated to have varying effects on 
different measures of immune function in insects. I use the molecular techniques 
developed in the previous chapter to examine whether there are differences in covert 
vertical transmitted PiGV infections within 3 inbred populations of P. interpunctella 
and 2 outbred populations of P. interpunctella. 
In Chapter 4 as the role of vertical transmission of dengue viruses in mosquitoes 
on the epidemiology of dengue fever has been debated (Angel and Joshi 2008; Joshi et 
al. 2002; Rosen et al. 1983; Adams and Boots 2010; Pinheiro et al. 2005; Zeidler et al. 
2008) and a significant amount of work is still published on this subject (Martínez et al. 
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2014; Sanchez-Rodríguez et al. 2014; Yang et al. 2014; Espinosa et al. 2014). I review 
the literature on vertical transmission and discuss its role in dengue’s epidemiological 
persistence and control. 
In Chapter 5, considering that recent reviews have found asymptomatic dengue 
viral infections to be common, I adapt two frequency dependent SIR type models that 
include an asymptomatic class (SAIR models), to dengue virus dynamics. I then use the 
models to test the role asymptomatic dengue virus infections on the epidemic success 
and persistence of dengue viruses, as well as the population left at risk of developing 
DHF. 
The models from Chapter 5 lacked the explicit inclusion of mosquitoes. The 
length of time an infecting dengue virus takes to produce an infectious mosquito host 
may affect the speed at which an epidemic progresses or uses up the newly born 
susceptible population; this in turn could lead to an epidemic becoming endemic. For 
these reasons in Chapter 6 I modified the two models from Chapter 5 to explicitly 
include mosquitoes in dengue’s transmission. 
The discussion sections of chapters 6 and 7 highlighted the ways in which 
stochasticity may affect the ecology and persistence of dengue viruses. Therefore in 
Chapter 7 one of the SAIR models is modelled stochastically in both the frequency 
transmission dependent and mosquito transmission dependent forms in order to 
ascertain whether stochasticity could affect any of the insights into dengue’s 
epidemiology gained in the previous two chapters. 
Finally in Chapter 8 I start by summarising the key findings of this PhD thesis, 
going on to point to wider conclusions as well as future avenues of research concerning 
inapparent and vertically transmitted infections in arboviruses and insect viruses. As 
discussed above, inapparent infections whether in the form of covert or asymptomatic 
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infections could allow a pathogen to persist by providing a reservoir of infected host, 
whose role would be at first sight hidden from researchers, medics, vets and 
conservationist (see Section 1.4-5). Similarly, vertical transmission could provide a 
pathogen with a persisting infecting reservoir across generations (see Section 1.3). The 
main aim of this thesis therefore is to see if broad trends or parallels in how inapparent 
and vertically transmitted infections relate to pathogen persistence can be found by 
looking at these forms of infection in dengue viruses and PiGV. The last section of the 
discussion chapter returns to this theme by putting what this thesis has found out about 
pathogen persistence through looking at inapparent and vertically transmitted infections 
in these two viruses in a broader ecological context. 
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Chapter 2: The impact of host food resource level on  vertically 
transmitted covert PiGV within its host Plodia interpunctella 
Abstract 
Covert baculovirus infections can be transmitted vertically within their 
Lepidopteran hosts; this may be how such pathogens persist in fluctuating host 
populations. Quality of the host’s food resources could impact covert infections in a 
number of ways. Baculoviruses may be directly selected to switch to an overt form, 
when the host is on a poor resource quality since the host is less likely to survive, or as 
low resource quality could be a cue for high host density.  Many studies of insects have 
demonstrated that diet of poor quality can lead to a loss of immune function. Therefore, 
I examined the role of Plodia interpunctella’s food resource quality on the vertical 
transmission of covert baculovirus infections and their activation to overt infections. I 
found that lower resources increased the likelihood of vertical transmitted covert 
infections being detected.  However, I found no covert to overt activation across any 
resource environment in more than 1774 challenged individuals.  These results are 
novel in that they show that poor resources increase individual host’s risk of vertically 
transmitted covert infection. However due to the low number of covert infections that 
occurred I cannot conclude anything of the role of resources on activation of covert 
infection.  
2.1 Introduction 
Baculoviruses are a widely occurring infection within Lepidopteran species 
(Cory & Myers 2003). In the laboratory baculovirus Lepidopteran systems have 
provided a useful tool for exploring host-pathogen dynamics (Boots & Begon 1993; S. 
M. Sait et al. 1994b; S. M. Sait et al. 1994a; Boots & Mealor 2007) and because many 
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host Lepidopteron species are agricultural pests consequently the use of baculoviruses 
as bio-pesticides has been and is being actively researched (Smith & Rivers 1956; 
Grzywacz et al. 2013). Baculoviruses are DNA based viruses which are divided into 
two groups  nucleopolyhedroviruses (NPVs) and granuloviruses (GVs) (Cory & Myers 
2003). Infection of baculoviruses commonly occurs when larvae consume proteinaceous 
structures known as occlusion bodies (OBs). OBs contain either a single virus in the 
case of GVs or multiple viruses in the case of NPVs  (Cory & Myers 2003). Horizontal 
transmission of the overt form, occurs when the host body tissue is converted into 
millions of OBs, causing the death of the host and subsequent release of OBs (Cory & 
Myers 2003). 
Alternatively baculovirus infections can exist in a covert form, where the host 
does not suffer from observable symptoms but there is the possibility of vertical 
transmission and potentially reversion to an overtly infected state. Such covert forms of 
baculovirus infections have been found to be widespread within Lepidopteran species 
(Steinhaus 1958; Steinhaus & Dineen 1960; Jaques 1962; Longworth & Cunningham 
1968; Etzel 1976; Biever & Wilkinson 1978; Jurkovíčová 1979; Hughes et al. 1993; 
Hughes et al. 1997; Fuxa et al. 1999; Cooper et al. 2003; Burden et al. 2003; Burden et 
al. 2006; Vilaplana et al. 2008; Vilaplana et al. 2010; Murillo et al. 2011; Myers et al. 
2011). Covert forms of viral infection have been found in other host-virus systems such 
as the temperate bacteriophage Lambda of Escherichia coli (Madigan et al. 2003) and 
chronic asymptomatic infections in Humans, such as Herpes simplex 1 and 2 (Goering 
et al. 2008d). Covert baculovirus infections can be transmitted vertically within their 
Lepidopteran hosts and it has been suggested that the vertical transmission of viruses in 
a covert form may be how the pathogen persists in the host when overt horizontal 
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transmission rates vary, for example population fluctuations (Burden et al. 2003; Boots 
et al. 2003; Sorrell et al. 2009).   
The activation of a virus from a covert vertically transmitted state to an overt 
horizontally transmitted state would under certain circumstances be advantageous to the 
virus. In particular a number of studies have demonstrated that covert baculovirus 
infections in insects can be activated to an overt state through the hosts infection with 
another baculovirus with the potential for superinfection (Longworth & Cunningham 
1968; Jurkovíčová 1979; Hughes et al. 1993; Cooper et al. 2003; Burden et al. 2003). 
Secondly if the host is in a high population density, then it may be advantageous to the 
virus to switch to an overt state and transmit horizontally to the other hosts. . Steinhaus 
(1958) explored the role of crowding as a stress factor, causing increased infectious 
disease mortality in several lepidopteran species, none of which were orally infected 
with baculoviruses. Steinhaus (1958) found an increase in mortality for all causes with 
increased crowding. However, Steinhaus (1958) the statistical analyses was purely 
descriptive, not comparative and as such there is disagreement as to whether or not 
increased crowding led to increased baculovirus mortality (Jaques 1962; David & 
Gardiner 1965). Jaques (1962) found that both orally infected and non-lab infected 
control Trichoplusia ni had higher rates of TnNPV mortality in higher densities. 
However, as with Steinhaus (1958) statistical analyses was purely descriptive, not 
comparative. David & Gardiner (1965) found conflicting results in the effect of 
population density on the incidence of GV mortality in susceptible and resistant Pieris 
brassicae lines. Fuxa et al. (1999) found that the where greater activation rates and 
subsequent mortality rates from two baculoviruses, a NPV and CPV at higher densities 
of the host, Trichoplusia ni larvae. One potential cue for a virus detecting a host’s 
density may well be the drop in the resource quality associated with increased host 
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density. Moreover the virus may be directly selected to switch to an overt form, when 
the host is on a poor resource quality since the host is less likely to survive. 
Many studies of insects have demonstrated that diet of poor quality can lead to a 
loss of immune function (Myers et al. 2011; Triggs & Knell 2012). It should be noted 
however that this loss of immune function does not always lead to an increased 
susceptibility to horizontally transmitted baculovirus infection  (Boots & Begon 1994; 
Boots 2000; McVean et al. 2002). Two previous studies have noted food resources 
effect on activation of covert baculovirus infection in control specimens that had not 
been dosed with baculovirus. Jaques (1962) looked at the effects of minimal diet and 
starvation on TnNPV mortality in orally infected and non-lab infected control 
Trichoplusia ni larvae. Whilst none of the control T. ni larvae supplied excess food or a 
subsistence diet died from TnNPV some of those that where starved did, which suggests 
that starvation caused the activation of covert TnNPV.  However, (Jaques 1962) the 
statistical analyses again is purely descriptive and no statistical comparisons were made. 
Similarly a study of western tent caterpillar (Malacosoma pluviale califonicum) and 
food levels effect on its susceptibility NPV (Myers et al. 2011), noted that two larval 
controls (not dosed with virus in the lab) died from overt infection. However both were 
from two separate experiments; one was raised on normal food, whereas one was raised 
on half-food. Therefore it would be of interest to see if food resource level could affect 
the detection of vertically acquired covert PiGV infection, through molecular techniques 
and not being purely reliant on the activation of covert PiGV. 
Covert infections can occur in two forms. Either a viral infection that is actively 
translating proteins and/or replicating its genome, but does not course observable 
symptoms, here referred to as persistent infection. Alternatively a latent viral infection 
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that also does not cause observable symptoms, but is defined by a lack of these 
processes. (Hughes et al. 1997; Bonsall et al. 2005).  
 Burden et al. (2002) demonstrated that the baculovirus (PiGV) of 
surviving Plodia interpunctella was vertically transmitted by both sexes to offspring of 
either sex, causing a covert sub lethal infection that was actively transcribing the late 
stage granulin gene (therefore it was a persistent infection not a latent infection).  
Burden et al. (2002) found a high rate of vertical transmission to the offspring (60-
80%), although the sample sizes of offspring where small. For the reasons outlined 
above, I tested whether PiGV can be vertically transmitted in P. interpunctella and 
produce an overt infection in the offspring P. interpunctella. I then tested whether food 
quality can affect the activation of covert PiGV in the larval offspring of P. 
interpunctella that survived PiGV infection. I also further develop the molecular 
techniques used by Burden et al. (2002) to detect the level of covert PiGV in P. 
interpunctella larvae fed on the two different resource levels, whose parents had 
survived PiGV infection. 
2.2 Materials and methods 
2.2.1 Insects and virus 
A stock population of P. interpunctella which had being maintained at 
University of Exeter and University of Sheffield, for several years, was used for these 
experiments. Each generation of this stock had been maintained on a diet of 150g of the 
following mixture: 200g Ready Brek (porridge), 120g bran, 80g ground rice, 80g 
brewer’s yeast, 0.8g sorbic acid, 0.8g methyl paraben, 100 ml organic honey and 100 ml 
glycerol. This stock population was maintained at 27 (+/-1) °C on 16/8 hour light/dark 
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cycle. Similarly the PiGV used was from a stock which had being maintained at -20°C 
at University of Exeter and University of Sheffield, for several years. 
2.2.2 Experimental design 
Eight repeats of the following methodology were carried out. The first 
generation of P. interpunctella were taken from the stock population. At third instar 200 
individuals were dosed with a solution containing 75ml green food dye, 25ml distilled 
water and 5g sucrose, as a control. Another 200 third instar larvae were dosed with a 
solution of 95% (75ml green food dye, 25ml distilled water and 5g sucrose) and 5% 
virus solution. (NB in the third repeat only 100 larvae were dosed with the control or 
viral solution, similarly only 75 larvae of the 4
th
 repeat were dosed with the control or 
viral solution). Dosing occurred via placing several of the larvae on a petri dish along 
with small droplets of the dosing solution. The larvae given time would then feed on the 
dosing solution. Larvae were considered dosed when the green food dye was clearly 
visible within the third instar larvae. All dosed individuals were placed within a well of 
a 5 by 5 well petri dishes and supplied with enough food mixture (see above) to see 
them through to pupation.  Once these larvae reached fifth instar they were then 
separated according to gender, by means of a clearly visible spot on males.  
Table 2.1: Factorial design under which the first generation of P. interpunctella 
where placed, to breed and lay eggs. 
Gender Male 
Infected 
Female 
Infected 
Control 
Male 
Control 
Female 
Food type 
Percentage of adults 25% 25% 0% 0% Normal quality food 
 0% 0% 25% 25% Normal quality food 
 25% 0% 0% 25% Normal quality food 
 0% 25% 25% 0% Normal quality food 
 25% 25% 0% 0% Low quality food 
 0% 0% 25% 25% Low quality food 
 25% 0% 0% 25% Low quality food 
 0% 25% 25% 0% Low quality food 
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Once the surviving larvae had reached adulthood they were put in tubs of low 
and normal quality food according to the factorial design in Table 2.1. The Normal 
quality food was that used to maintain the lab stock (see earlier). The low quality food 
was made up from  150g of the following mixture: 100g Ready Brek (porridge), 60g 
bran, 40g ground rice, 200g methyl cellulose, 80g brewer’s yeast, 0.8g sorbic acid, 0.8g 
methyl paraben, 100 ml organic honey and 100 ml glycerol. Once the resulting 2
nd
 
generation of P. interpunctella had become 3
rd
 instar larvae. Up to 100 individuals were 
sampled and placed in an individual well of a 5 by 5 well dish and supplied with enough 
normal or low quality food to survive to 5
th
 instar larvae. This was carried out to prevent 
cannibalism between the P. interpunctella larvae. When the 2
nd
 generation larvae had 
become 5
th
 instar larvae they were checked for overt infection by distinctive difference 
in colour from healthy individuals, (white pale as opposed to the healthy yellow with 
pink tinges) and then stored individually in 100% ethanol for late molecular analyses. 
2.2.3 Molecular analyses 
2.2.3.1 DNA extraction 
Individual larvae where left to dry from ethanol, frozen in liquid nitrogen and 
ground using a pestle. The resulting solid was then made into a suspension, by adding 
500µl Tris EDTA pH 7.6. 50 µl of this vortexed suspension, which had 150 µl of 
stirring 5% Chelex suspension added to it. The remaining 450 µl was then frozen at -20 
°C should reanalyses need to be conducted. This was vortexed and incubated at 99 °C 
for 15 minutes. This was vortexed again and put in centrifuge for half an hour at 4 (+/- 
2) °C and 13000 rpm. 1 µl of the supernatant of this underwent PCR analysis for CO1 
lepidopteran mitochondrial gene and 1 µl of the supernatant underwent PCR analysis 
for the PiGV granulin gene. 
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2.2.3.2 PCR of CO1 lepidopteron mitochondrial gene 
In order to ascertain whether the preservation of DNA through storing samples 
in ethanol was successful, a PCR analyses for the host’s CO1 Lepidopteron 
Mitochondrial Gene was carried out. The PCR methodology for the host’s CO1 
lepidopteron mitochondrial gene was derived from Emery et al. (2009). For each set of 
samples a master mix was made up of the following solution multiplied up to provide 
enough master mix for all the samples. The 9 µl of master mix used in reactions 
comprised of 6.15 µl sterilized distilled water, 1 µl 10x PCR buffer (Qiagen), 0.2 µl 
dNTP (Qiagen), 0.6 µl MgCl2 (Qiagen), 0.5 µl CO1 LEP F1 primer (5’-
ATTCAACCAATCATAAAGATATTGG-3’), 0.5 µl CO1 LEP R1 primer (5’-
TAAACTTCTGGATGTCCAAAAAATCA-3’) and 0.05 µl Taq DNA polymerase 
(Qiagen). 1 µl of the sample was then added to the 9 µl master mix. This then 
underwent a PCR reaction comprising of one cycle of 3 minutes at 94°C, followed by 
35 cycles of 1 minute at 94°C, 1 minute at 53°C, and 1 minute at 72°C, with a final step 
of 10 minutes at 72°C. 5 µl of this was then visualised by gel electrophoresis, using 
1.2% agarose and RedSafe.  
2.2.3.3 PCR of PiGV granulin gene 
The PCR methodology for the PiGV’s granulin gene was derived from Burden 
et al. (2002). For each set of samples a master mix was made up of the following 
solution multiplied up to provide enough master mix for all the samples. The 9 µl of 
master mix used in reactions comprised of 6.35 µl sterilized distilled water, 1 µl 10x 
PCR buffer (Qiagen), 0.2 µl dNTP (Qiagen), 0.4 µl MgCl2 (Qiagen), 0.5 µl GRAN 5’ 
F1 primer  (5'-ACAATGAAGCTGGTGTGCAACTGGAGCG-3’), 0.5 µl GRAN 3’ R1 
primer (5'-TACGTCGGGTGCGAATTCCTTGATCTTG-3’) and 0.05 µl Taq DNA 
polymerase (Qiagen). 1 µl of the sample was then added to the 9 µl master mix. This 
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then underwent a PCR reaction comprising of one cycle of 2 minutes at 94°C, 1 minute 
at 65°C and 30 seconds at 72°C, followed by 31 cycles of 30 seconds at 94°C, 1 minute 
at 63°C and 30 seconds at 72°C, with a final step of 10 minutes at 72°C. 5 µl of this was 
then visualised by gel electrophoresis, using 1.2% agarose and RedSafe.  
2.2.3.4 Molecular analyses sampling method and controls 
The second generation larvae were analysed in blocks, with roughly equal 
numbers of each treatment. This was done  to determine if there is any variation in the 
molecular analyses in detecting PiGV infection. For every DNA extraction and PCR the 
following were analysed as controls, sterile distilled water, non-PiGV infected 5th instar 
larvae from the stock population, PiGV infected 5th instar larvae and pure stock virus 
solution. 
2.2.4 Statistical methods 
The blocks larvae were analysed in molecularly were ordered one after the other. 
Therefore it could be argued as to whether or not block was a fixed effect or random 
effect. As such the data was analysed twice with block as a fixed effect and then as a 
random effect. To analyse the data with block as a fixed effect, R 3.1.1’s generalized 
linear model function was used to analyse the data, with a binomial error structure. The 
GLM from the package “brglm” was used to fit the model Proportion of Larvae Infected 
with PiGV explained by Block plus Food Quality plus Parental Treatment.   
R 3.1.1’s glmer function from the package lme4 was used to construct GLMMs 
for explaining the variance within the proportion of larvae infected with PiGV, with a 
binomial error structure and now block as a random effect. The ANOVA feature in the 
“lme4” package is based upon model simplification by removal of none significant 
terms, until reaching the Minimum Adequate Model (MAM). Explanatory variables 
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where then removed and tested for significance using ANOVA. If a term was found to 
be significant it was kept in the model, if not it was dropped. This process was done 
until the MAM was reached. 
2.3 Results 
Many of the first generation P. interpunctella died either from PiGV infection or 
other factors. Leaving a limited number of female and male P. interpunctella from 
which to breed a second generation of larvae.  
2.3.1 Molecular analyses of the second generation larvae 
Only the 1
st
 repeat was analysed molecularly due to a lack of sample size 
covering all treatments and sample viability in the other repeats. In total 434/477 of the 
samples were positive for the CO1 Lepidopteron Mitochondrial Gene. The samples that 
were not positive for this host gene were excluded from further analysis, because their 
DNA had clearly degraded. Due to their high number of samples, the larvae where 
analysed in six blocks, with samples from each treatment being spread as evenly as 
possible across each block. 
Samples found positive for PiGV were double checked by being reanalysed at a 
later date, purified and PCR amplified. The PCR amplified PiGV granulin gene product 
was sent to University of Sheffield, Core Genomic Facility, FU27/28 Medical School 
for sequencing. Unfortunately 3 samples had degraded. However the PCR amplified 
PiGV granulin gene product of the other 11 samples showed high degrees of similarity 
to the granulin genes of highly related GV. At the time of writing the PiGV genome has 
not been published and is therefore unavailable for comparison. Furthermore the 
laboratory stock populations of P. interpunctella have been maintained for decades 
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without signs of GV infection. This suggests that the molecular techniques used in this 
study only detected the PiGV granulin gene only. 
 
Figure 2.1: Percentage of larvae from first experimental repeat that were positive 
for PiGV granulin gene by molecular analyses, given that they were positive for 
CO1 Lepidopteron mitochondrial gene and raised on low quality food. Arranged 
by the Block they were analysed in. 
 
None of the second generation larvae that were raised on the higher quality food 
was positive for the PiGV granulin gene, but 3.5% of the second generation larvae 
raised on lower quality food were found to be positive for the PiGV granulin gene. It 
can be seen from Figure 2.1 that there is a higher percentage of larvae infected with 
PiGV in the 1
st
 block, suggesting a block effect. I unexpectedly found that a single 
infected larva was found in the control treatment. There was no obvious effect of the 
different parental treatments on the second generation larvae’s PiGV infection status in 
the other treatments (See Figure 2.2). It is therefore unsurprising that fitting GLMs to 
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the results found that only block and food quality were significant factors in explaining 
the proportion of larvae infected with PiGV (Block χ2=25.2 DF=5 p=0.00013, Food 
χ2=6.39 DF=1 p=0.0114 and Parental Treatment χ2=4.95 DF=3 p=0.175). Likewise 
when block was fitted as a random effect GLMM analyses to the data found the MAM 
to be the food larvae where raised on (χ2=6.34 DF=1 p=0.0118). 
  
Figure 2.2: Percentage of larvae from first experimental repeat that were positive 
for PiGV granulin gene by molecular analyses, given that they were positive for 
CO1 Lepidopteron mitochondrial gene and raised on low quality food. Arranged 
by parental treatment. (CMCF=control male parent and control female perant, 
DMCF = dosed male parent and control female, CMDF control male and dosed 
female, DMDF dosed male and dosed female). 
 
Since PiGV infection was only detected in larvae raised on low quality, I 
analysed this data set separately to see if there was an effect of parental treatment. A 
GLM of Proportion of Larvae Infected with PiGV explained by block plus Parental 
Treatment, with binomial errors was fitted on the data for larvae that were raised upon 
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low quality food only. An ANOVA of this model shows that only block was significant 
and therefore there is no effect of parental treatment even on the low quality food 
(Block χ2=25.5 DF=5 p=0.00011 and Parental Treatment χ2=4.95 DF=3 p=0.175). 
Likewise GLMM analyses of only the low quality food data set, with block as a random 
effect, found that the effect of parental treatment was not significance when compared 
to the null model (χ2=4.6609 DF=3 p=0.198).  Again therefore there is a clear effect of 
food quality but not parental treatment. 
2.3.2 Observations of overt PiGV infection 
In all of the repeats of this experiment and across all treatments, no overt 
infection was observed in any of the fifth instar larvae of the second generation (1774 of 
which a parent had been dosed with PiGV, 955 of which neither parent had been dosed 
with PiGV). What is worth noting is that none of the 995 offspring of a dosed parent 
raised on low quality food showed signs of overt infection, thereby suggesting that the 
low quality food used does not cause activation of PiGV. 
2.4 Discussion 
The fact that none of the 995 larvae from PiGV treatments, raised on low quality 
food showed overt signs of PiGV infection, suggests that the lower quality food does 
not stress the larvae enough to cause the activation of PiGV.  Also as none of the1774 
larvae showed overt signs of PiGV infection from parents infected with PiGV, this 
experiment did not show any signs of vertical transmission of PiGV leading to an overt 
infection, unlike in SfNPV (Fuxa & Richter 1991). That being said I showed that food 
resource quality was a significant explanatory factor for vertical transmission of PiGV, 
whereas parental viral treatment was not (as suggested by Figure 2.2). As far as I know 
this is the only study to use molecular techniques to see if lower food quality can have 
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an effect in detecting vertically transmitted covert baculovirus infection. Two previous 
studies had noted food resources effect on activation of covert baculovirus infection, in 
control specimens that had not been dosed with baculovirus (Jaques 1962; Myers et al. 
2011). In the case of Jaques (1962) after being dosed with an NPV Trihoplusia ni where 
either provided with excess food, a subsistence diet or starved. The controls not dosed 
with NPV but starved for 3 days suffered an NPV mortality of 3%, NPV mortality for 
those controls starved for 4 days was 5-6%. None of the controls on other diets that 
suffered NPV mortality (Jaques 1962). Jaques (1962) provide no statistical comparisons 
of these results meaning it is unwise to draw conclusions. Myers et al. (2011) found that 
1 Malacosoma pluviale californicum larva died from its NPV from the half food feeding 
regime, being a control larva neither it nor its parents had been dosed with the NPV. 
Myers et al. (2011) also noted that one larva out of 159, of the full feeding regime, from 
the parental generation died from the NPV. This larva had been collected from the field 
as an egg, which was surface sterilised, meaning that the NPV infection would have to 
of been acquired vertically (Myers et al. 2011). The small sample size and conflicting 
results similarly mean that is unwise to draw conclusion from Myers et al. (2011) work 
on this. 
Burden et al. (2002) found a higher vertical transmission rate for PiGV (60-
80%) then was found in these experiments. The difference in the proportion of second 
generation larvae infected with PiGV between this work and Burden et al. (2002), may 
be due to the fact that Burden et al. (2002) used different strains of P. interpunctella and 
PiGV as well as a different food resource. Also Burden et al. (2002) dosed the parental 
generation at 5
th
 instar, in this experiment the parental generation were dosed as 3
rd
 
instar larvae. This suggests that larval instar may have an effect on vertical transmission 
of PiGV and other baculorviruses. Fuxa & Richter (1991) suggested that fifth instar 
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Spodoptera frugiperida dosed with two strains of SfNPV had higher levels of SfNPV in 
their offspring, compared to those dosed as third instars. However Fuxa & Richter 
(1991) did not make any statistical comparison to validate their claims.  Sait et al. 
(1994) studying dose response effects of horizontally transmitted PiGV in the five 
instars of P. interpunctella, found that PiGV mortality increased with dose, but 
decreased with P. interpunctella age. Furthermore Sait et al. (1994) found no PiGV 
mortality in fifth instars. If it is the case that late instars are less likely to succumb to 
baculovirus infection but vertically transmit the infection to their offspring, then this 
may suggest that vertical transmission occurs when a host can subdue a baculovirus 
infection but not clear it. 
In all the various statistical tests parental treatment did not have a significant 
effect on the proportion of offspring infected with PiGV. These results echo Burden et 
al. (2002) who also found no obvious differences in covert PiGV infection rate in the 
larvae of a PiGV infected mother and father. However, the unusual samples comparing 
5 pools of 5 larvae whose mothers were dosed with the 5 pools of 5 larvae whose 
fathers were dosed or 10 individual larvae from 1 egg batch of a dosed father with 10 
individual larvae from 1 egg batch of a dosed mother, mean that a statistical analyses of 
Burden et al. (2002) work on this is invalid due to reasons of statistical resolution, small 
sample size and pseudoreplication. 
Measuring an invertebrate’s susceptibility to an infectious agent, involves the 
measurement of the outcome of a combination of three processes. The first is the ability 
of the infectious agent in infecting the host. The second is the host ability to clear the 
infection. Thirdly the host’s ability to suppress the infection. Previous work on the 
effect of food resource  on P. interpunctella’s susceptibility  to PiGV (as measured by 
mortality), suggested that food resource level either had no effect (Boots & Begon 
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1994) or that lower food quality decreased susceptibility to PiGV (McVean et al. 2002). 
Both Boots & Begon (1994) and McVean et al. (2002) raised P. interpunctella larvae on 
the same resource level before and after oral infection with PiGV. With these two 
experimental set ups it is difficult untie whether resource level is affecting the host, 
firstly in terms of letting the infectious agent infect, secondly the host ability to clear the 
infection or thirdly the hosts ability to suppress the infection. When considering that in 
this experimental set up the effect of food resource level could only have taken place 
once a second generation P. interpunctella would of have hatched and therefore after P. 
interpunctella had been infected, this suggests that decreased food resource level 
reduced the second generation P. interpunctella’s ability to suppress or ultimately clear 
PiGV infection. Further experimentation would be needed to untie effect of food 
resource on these three processes in the infection of baculoviruses. Injection of PiGV 
into P. interpunctella may provide a possible solution, as the infection route would not 
be affected by any changes in P. interpunctella caused by food resource level.  
Myers et al. (2011) study and this study only used two resource levels, whereas 
Jaques (1962), had three. In order to fully ascertain whether lower food quality can 
cause the activation of latent baculovirus infection further experimentation is needed. A 
greater range of food qualities needs to be tested since it may well be the case that it is 
only starvation or near starvation levels that cause activation of baculorviruses. Whilst 
Jaques (1962) inadvertently looked at this. Jaques (1962) experimental set up was 
designed to look at the role of food resource level (up to starvation) on susceptibility to 
GV, not food resource level (up to starvation) on activation of covert GV.  Similarly, 
more recently starvation effect on activation of a baculovirus may have been 
inadvertently tested. As previously mentioned Fuxa et al. (1999) found that there were 
greater activation rates and subsequent mortality rates from NPV and CPV at higher 
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densities. However at the higher densities the T. ni 5
th
 instar larvae and pupal weight 
was lower and at the highest density T. ni larvae began to cannibalise each other. This 
suggests that Fuxa et al. (1999) may not have controlled for resource limitation and/or 
starvation at the higher densities and that these two factors may well be having an effect 
at the high densities of T. ni larvae, in causing the activation of NPV and CPV. Fuxa et 
al. (1999) also do not take into account the possibility of NPV and CPV activation 
through an increased dose occurring via cannibalism of latently infected T. ni larvae.  
 There is a suggestion that an unusual host diet, which leads to a general 
weakening of the host, may cause the activation of a covert baculovirus. David & 
Gardiner (1965) fed different strains of Pieris brassicae food that they were not 
habituated to. The Canary Islands strain of Pi. brassicae in the wild eat nasturtium. In 
the laboratory when fed cabbage there was a higher activation rates of PbGV, then on 
nasturtium. However with a long term laboratory strain of Pi. Brassicae that had been 
maintained on cabbage, activation rates of PbGV were higher on cabbage than 
nasturtium for the lab strain of PbGV. More recently Ilyinykh et al. (2013) in 
experiments with the gypsy moth (Lymantria dispar) from Khabarovsk and 
Novosibirsk, Russia and its NPV (LdNPV), found that they had to abandon feeding the 
Khabarovsk population on branches of the birch Betula pendula and instead feed them 
on their native Mongolian oak Quercus mongolica. All of the Khabarovsk population 
died, many of which were diagnosed with an NPV infection (28+/-3%), whereas none 
the Novosibirsk population that fed on their native birch B. pendula showed any signs 
of infection or suffered such a high mortality rate. It should be noted that Steinhaus & 
Dineen (1960) fed GV infected Peridroma margaristo the unusual diet of plantain, this 
did not induce activation of Pe. margaristo’s GV, however most larvae died through 
other causes. 
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It may also be the case that latent baculoviuses are not activated by low food 
quality in general, but rather by a lack or deficiency of a specific nutrient that an 
unusual diet might cause. Furthermore the higher rate of vertically transmitted covert 
PiGV infection found in second generation larvae raised on lower quality food may also 
not be caused by low food quality in general, but such  a lack or deficiency of a specific 
nutrient. David & Taylor (1977) found that sucrose deficient diets could lead to a 
greater susceptibility of Pieris brassicae to its GV. Biever & Wilkinson (1978) 
suggested that Pieris rapae fed on a dehydrated diet had a greater mortality rate due to 
its GV compared to those on a normal diet. However Biever & Wilkinson (1978) only 
used descriptive statistics in his data analysis, not comparative. A number of studies 
have demonstrated that low protein levels can affect an invertebrate’s immune function 
and susceptibility to infection (Lee et al. 2006; DeGrandi-Hoffman et al. 2010; Povey et 
al. 2013). Such a loss in an invertebrate immune function could lead to the covert PiGV 
infection not being cleared by the insects immune system, as such studying the effect of 
different protein and carbohydrate ratios on vertically acquired covert baculovirus 
infections needs exploration. Lee et al. (2006) and Povey et al. (2013) also 
demonstrated that when given a choice of protein: carbohydrate ratio in the diet, the 
larvae infected with a baculovirus that did not succumb to infection ate more protein. It 
would be interesting to know whether the larvae that did not succumb to the baculovirus 
infection just suppressed the baculovirus infection into a covert state or cleared the 
infection. This would shed light as to whether or not a covert baculovirus infection was 
mediated by the virus or the insect’s immune system supressing the infection but not 
clearing it. On this point, what might be of interest is that  (Fuxa et al. 1992) discovered 
a high degree of non-infectious SfNPV OBs that contained no virus in adult S. 
frugiperda whose parents had survived SfNPV infection. However this could be related 
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to the fact baculoviruses produce no overt infection in adults and unrelated to vertical 
transmission of baculoviruses.  
There is also the question of whether or not the surviving larvae would transmit 
any covert infection on to their offspring, i.e. does parental food resource level effect 
the vertical transmission of covert baculoviruses. On this subject a study by Boots & 
Roberts (2012) found that lower quality food in maternal parents increased measures of 
P. interpunctalla’s immune function and decreased susceptibility to orally acquired 
PiGV.  
Another process that leads to the activation of a latent or overt baculovirus may 
be an infection with another agent. Many previous studies have demonstrated the 
activation of a latent baculovirus through infection with another baculovirus 
(Longworth & Cunningham 1968; Jurkovíčová 1979; Hughes et al. 1993; Cooper et al. 
2003; Burden et al. 2003). Curiously Jurkovíčová (1979) found that not only were there 
higher infection rate of NPV particles in Adoxophyes orana and Barathra brassicae 
when they were dosed by the others NPV but that there higher infection rates for B. 
brassicae by its NPV when fed an extract from A. orana. This suggests that the 
activation of a covert baculovirus infection within a host may not be caused by a foreign 
baculovirus in of itself but by a substance embedded in the OB of the foreign 
baculovirus from its previous host. Further research to validate this point would be 
needed. 
To my knowledge no research has been published on whether or not latent 
baculoviruses can be activated through infection with viruses with RNA based 
genomes, bacteria, fungi, protozoan, filarial parasite or parasatoid wasps.  Baculoviruses 
infect many crop pests and field studies demonstrate that latent baculoviruses can be 
present in a large percentage of these pest species populations. Consequently the 
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potential use of infectious agents as bio-pesticides that lead to activation of latent 
baculoviruses could have an added advantage of causing increased mortality from the 
now activated baculoviruses, on top of their own mortality rates.  
Considering that only the 1
st
 repeat of the experiment was analysed molecularly, 
extrapolating this finding to the other repeats from this study would suggest that the 
number of second generation larvae with covert PiGV was around 22, 18 and 11 for 
those whose mother, father or both parents had both been dosed with PiGV respectively. 
This unfortunately represents a small number of samples from which a covert PiGV 
infection could activate to an overt PiGV infection. If the effect of diet on activation of 
vertically transmitted covert baculovirus infection was to be further explored, it may be 
better to use an insect baculovirus system with a higher rate of vertical transmission. 
Fuxa & Richter (1991) were able to select for an increased rate of vertical 
transmission of SfNPV through isolation SfNPV in the host pupae of Spodoptera 
frugiperda produced by parents who had survived SfNPV infection. Of interest to this 
study is that both the wild type and selected strains of SfNPV produced overt and covert 
infections within the offspring of orally infected S. frugiperda (Fuxa & Richter 1991). It 
is of note that further experimentation by Fuxa & Richter (1992) followed 
transgenerational mortality of SfNPV overt infections up to the F5 and F7 generations 
for the wild-type and selected strains of SfNPV. This demonstrates that the vertical 
transmission of baculoviruses can be selected for. The circumstances under which a 
vertically transmitted baculovirus would be selected for in nature were hypothesised by 
Sorrell et al. (2009). Through mathematical simulations they suggested that vertically 
transmitted covert viral infection would be promoted in highly fecund hosts that go 
through fluctuating population densities, as found in many insect baculovirus systems. 
Sorrell et al. (2009) pointed to work such as Burden et al. (2003), suggesting that the 
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high rates of covert vertically transmitting viruses seen in many insect systems are not 
solely explained by the lower rates of covert vertically transmitting viruses seen in 
Sorrell et al. (2009) mathematical simulations. Sorrell et al. (2009) suggests that 
therefore the high rates of covert viral infection seen in some field studies of insect 
populations may be mediated by an interaction between the host and the virus not the 
virus alone. One such interaction would be the host’s immunity suppressing the viral 
infection but not clearing it. Reduced host immune function through poor diet could 
cause such a process. If this is the case then outbreaks in overt baculoviruses at high 
host populations could be explained through the activation of covert baculovirus 
infection, when host immune function is decreased sufficiently through poor food 
quality, brought about by high host density. Further investigation of the effect of food 
resource on covert baculovirus infection or mathematical simulation, could shed light 
on the validity of this hypothesis.    
In conclusion I found a higher rate of vertically transmitted covert PiGV in P. 
interpunctella raised on low quality food, however only two food resource levels were 
used in this study and there was a low rate of vertical transmission of PiGV. Therefore 
in order to shed further light on the effect of food resource on the activation and vertical 
transmission of covert baculovirus, a greater range of food resources, different protein: 
carbohydrate levels and unusual food resources need to be utilised in experiments 
similar to this one. Burden et al. (2002) found higher rates of vertical transmission from 
5
th
 instar infected P. interpunctella, as opposed the 3
rd
 instar P. interpunctella infected 
in this study, this would suggest a need for research surrounding the effects of parental 
host instar at point of infection on the vertical transmission of covert baculoviruses. 
Added to this Sait et al. (1994) finding that PiGV mortality increased with dose, but 
decreased with P. interpunctella age would suggest a need for research into the effect of 
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infective dose of parental generation on the vertical transmission of covert baculovirus. 
A number of studies have demonstrated the activation of a latent baculovirus through 
infection with another baculovirus (Longworth & Cunningham 1968; Jurkovíčová 1979; 
Hughes et al. 1993; Cooper et al. 2003; Burden et al. 2003), but to my knowledge 
research on the role of other infectious agents in causing activation of covert 
baculovirus infections is lacking. Lastly, due to the low rate of vertical transmission of 
covert baculoviruses seen in this study, using an insect baculovirus system with a higher 
rate of vertical transmission and activation of covert baculovirus should be considered 
in further research. 
 
75 
 
Chapter 3: The effect of host inbreeding on the vertical transmission 
of PiGV within its host Plodia interpunctella 
Abstract 
The deleterious effects of inbreeding have been demonstrated consistently upon 
a variety of traits within many animal and plant species. However, studies have found 
varying effects of inbreeding on different measures of immune function in insects. No 
studies have looked at the effect of host inbreeding on a covert vertical transmitted virus 
in insects, or the covert pathogens of insects in general. Therefore, using the molecular 
techniques developed in the previous chapter, this chapter examines whether there are 
differences in covert vertically transmitted PiGV infections within 3 inbred populations 
of P. interpunctella and 2 outbred populations of P. interpunctella. There was no 
significant difference in the PiGV infection rates in the larvae of adult P. interpunctella 
from these different populations. This was true when the populations were compared 
individually or grouped together as larger inbred and outbred populations. Further to 
this none of the covert PiGV infection switched to an overt form, suggesting that host 
inbreeding had no effect on covert vertically transmitted PiGV infections. However, it 
should be noted that these findings could be due to the low rate of vertical transmission 
of PiGV leading to a small sample size.  
3.1 Introduction 
The deleterious effects of inbreeding has been demonstrated consistently upon 
many traits within many animal and plant species (Charlesworth 1987; Keller & Waller 
2002). In birds the deleterious effect of inbreeding has been found in hatching rates, 
survival and reproductive success (Keller & Waller 2002). Similarly in mammals 
reductions in survival, birth weight and reproductive success due to inbreeding have 
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been found (Keller & Waller 2002). Within insects many studies have demonstrated 
inbreeding’s deleterious effects. Roff (1998) and Roff & DeRose (2001) showed 
decreased growth and fecundity in the cricket Gryllus firmus. In the ant Formica exsecta 
Haag-Liautard et al. (2009) showed that inbreeding decreased a colony’s production of 
queens and survival. Mattey et al. (2013) found decreased hatching rates and survival in 
the inbred offspring of the burying beetle Nicrophorus vespilloides. The inbred parents 
of Ni. vespilloides also had lower hatching success and survival rates in raising outbred 
offspring. Such inbreeding depression is postulated to occur via two main processes. 
Inbreeding causes a greater number of homozygotes to be produced in a population, 
firstly this increases the chance of a deleterious trait being expressed if is recessive or 
partially recessive. The fact that deleterious mutations occur through time exacerbates 
this process (Charlesworth 1987; Keller & Waller 2002). Secondly, if there is 
heterozygote advantage, this is less likely to be expressed (Charlesworth 1987; Keller & 
Waller 2002). 
A study of soay sheep Ovis aries from the St. Kilda archipelago found that 
inbreeding increased susceptibility to gastrointestinal parasites (Coltman et al. 1999). 
Not only this Coltman et al. (1999) found that this increased susceptibility led to 
decreased overwinter survival. Similarly Ilmonen et al. (2008) found that full-sibling 
inbreeding in the house mouse Mux musculus domesticus led to increased susceptibility 
and mortality to Salmonella enterica. Infection with S. enterica also led to a further 
reduction in fitness in male first-cousin inbred mice, as measured by reproductive 
success (Ilmonen et al. 2008). Several studies have investigated inbreeding effects on 
measures of immune function in insects. Lee et al. (2012) found that heterozygosis did 
not affect encapsulation or phenoloxidase (PO) activity of honey bees Apis mellifera. 
Vitikainen & Sundström (2010) found no effect of inbreeding on the encapsulation 
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response of worker ants Formica exsecta, but did find an increased encapsulation 
response in the gynes (new reproductive females) of F. exsecta. Vitikainen & 
Sundström, (2010) suggest that this may be down to inbreeding acting as a 
physiological stressor leading to increased immune activity.  Gerloff et al. (2003) found 
no effect of inbreeding on encapsulation response in the bumble-bee Bombus terrestis. 
Similarly Whitehorn et al. (2011) found no effect of decreased genetic diversity on 
encapsulation and PO level in Bombus muscorum but did find increased prevalence of 
the gut parasite Crithidia bombi. Calleri et al. (2006) found no effect of inbreeding on 
encapsulation rate of the termite Zootermopsis angusticollis but found that whilst 
isolated inbred and outbred termites had no difference in susceptibility to conidia 
fungus, the grouped outbred termites were more likely to survive then the inbred 
grouped termites (no such findings were found with a bacterial agent). Calleri et al. 
(2006)  therefore suggest that inbreeding detrimentally affects social behavioural 
mechanisms of disease resistance but not physiological derived immunity in social 
insects. 
Relatively few studies have explored the effect of inbreeding on the 
susceptibility and immune function in non-social insects. Rantala & Roff (2007) found 
no effect of inbreeding on the immune function of the cricket Gryllus firums, as 
measured by lytic activity and encapsulation rate. Drayton & Jennions (2011) found no 
effect of inbreeding on immune function in terms of lysozyme-like activity but 
increased hymocyte activity in the cricket Teleogryllus commodus. Stevens et al. (1997) 
found an overall increased prevalence of the parasite Hymenpolepis diminuta in inbred 
female Tribolium castaneum but the opposite being true for males and there being no 
effect of inbreeding on the intensity of infection. However there was a great deal of 
variation with regards to H. diminuta prevalence and intensity among the different 
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inbred populations Tribolium castaneum, leading Stevens et al. (1997) to suggest that 
generalisations over his results cannot be made. 
As such the limited data suggests that there may not be a strong effect of 
inbreeding on the physiological immunity of insects to infectious disease. This is 
despite the presumption that a host’s genetic diversity is important for resistance to 
pathogens. As suggested by theoretical and empirical work on the selective pressure 
caused by pathogens in the evolution and maintenance of sexual reproduction (Neiman 
& Koskella 2009). No studies have looked at the effect of host inbreeding on a covert 
vertical transmitted virus in insects, or to my knowledge the covert pathogens of insects 
in general. A covert infection being an infection that produces no signs of symptoms, 
does not horizontally transmit the infection but may be activated (switch) to an overt 
symptomatic state, which does horizontally transmit the infection.  The Plodia 
interpunctella PiGV (baculovirus) system has been a useful system for studying host-
pathogen dynamics (Boots & Begon 1993; S. M. Sait et al. 1994b; S. M. Sait et al. 
1994a; Boots & Mealor 2007). Furthermore it has been demonstrated that vertical 
transmission of covert PiGV can occur within P. interpunctella (see Chapter 2 and the 
work of Burden et al. (2002)). Using the molecular techniques developed in Chapter 2, 
this chapter examines whether there are differences in covert vertical transmitted PiGV 
infections within 3 inbred populations of P. interpunctella and 2 outbred populations of 
P. interpunctella.  
3.2 Materials and methods 
3.2.1 Establishment of populations 
In order to examine the role of inbreeding on transmission of the virus, four new 
populations of P. interpunctella were established (3 Inbred and 1 more outbred known 
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as Kernow) by Dr Katherine Roberts, Steven Sharpe and Drew Willson. This 
experiment used a population known as the “Liverpool” strain as the standard outbred 
population. The “Liverpool” strain has been maintained for several years in the 
University of Exeter and the University of Sheffield. All the populations were 
maintained on a diet of 150g “Normal food”, comprising of the following: 200g Ready 
Brek (porridge), 120g bran, 80g ground rice, 80g brewer’s yeast, 0.8g sorbic acid, 0.8g 
methyl paraben, 100 ml organic honey and 100 ml glycerol. The populations were 
maintained at 27 (+/-1) °C on a 16/8 hour light/dark cycle. 
A new “Kernow” strain was created in the following manner: 6 tubs of 25 males 
of the Liverpool strain and 25 females of the Dundee strain (which had been maintained 
for several years in the University of Exeter and the University of Sheffield), were set 
up to breed to form the LD strain. At the same time 6 tubs of 25 males of the Dundee 
strain and 25 females of the Liverpool strain were set up to breed to form the DL strain. 
8 tubs of 25 males of the LD strain and 25 females of the DL strain were then set up to 
breed to form the UK strain. At the same time 8 tubs of 25 males of the DL strain and 
25 females of the LD strain were then set up to breed to form the UK strain. The P. 
interpunctella of both sets of UK strain were then bred with a strain of P. interpunctella 
from the US Department of Agriculture (USDA). 8 tubs of 25 males of the UK strain 
and 25 females of the USDA strain were then set up to breed to form the UK*USDA 
strain. At the same time 8 tubs of 25 males of the USDA strain and 25 females of the 
UK strain, were then set up to breed to a form the USDA*UK strain.  8 tubs of 25 males 
of the UK*USDA strain and 25 females of the USDA*UK strain and 8 tubs of 25 males 
of the USDA*UK strain and 25 females of the UK*USDA strain were then set up to 
breed to form the Kernow strain. The presumption being that the Kernow strain would 
therefore be more outbred than the Liverpool strain.    
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Four inbred strains were created by inbreeding from the Liverpool strain for 16 
generations in the following manner: Four pots containing a randomly selected male 
and female 5th instar larvae and 20g of the standard food were maintained at 27 (+/-1) 
°C on 16/8 hour light/dark cycle. Once the subsequent offspring had become 5th instar 
larvae a randomly selected male and a randomly selected female (between all four pots) 
was then placed into another four pots containing the same amount of standard food and 
maintained in the same way for production of the next generation. At each generation 
any larvae not used to create the next generation were placed in a larger pot along with 
their food, which was topped up with standard food to 200g and maintained at 27 (+/-1) 
°C on 16/8 hour light/dark cycle for use in experiments. Unfortunately one of the inbred 
populations (Inbred 1) did not survive the inbreeding process leaving three populations 
to experiment on. 
The PiGV used was from a stock which had being maintained at -20°C at 
University of Exeter. 
3.2.2 Experimental design 
Between 125 and 130 third instar of each of the five populations were dosed 
with a 75ml green food dye, 24ml distilled water, 1ml of virus solution and 5g sucrose 
solution giving a 10
-2
 dose of PiGV. This dose was chosen as a compromise between 
giving a high enough PiGV dose so that many of the larvae would transmit PiGV 
vertically but not a high enough dose to kill the majority of the parental generation, thus 
rendering a small sample size of offspring. Dosing was carried out using our standard 
bioassay technique. 3
rd
 instar larvae were placed on a petri dish, small 2-8μl droplets of 
the dosing solution were then placed in front of them. The larvae given time would feed 
on the dosing solution. Larvae could be seen to be dosed when the green food dye was 
clearly visible within the third instar larvae. All dosed individuals were placed within a 
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well of a 5 by 5 well petri dish and supplied with enough standard food media (see 
above) to see them through to pupation, and maintained at 27 (+/-1) °C on a 16/8 hour 
light/dark cycle. The larvae were checked for overt infection by distinctive difference in 
colour from healthy individuals, (white and pale, as opposed to the healthy yellow with 
pink tinges).  
The surviving larvae were then allowed to pupate. After pupation the adults of 
the same strain were allowed to mate and to lay eggs on 150g of a lower quality food. 
Low quality food is made from the following mixture: 100g Ready Brek (porridge), 60g 
bran, 40g ground rice, 200g methyl cellulose, 80g brewer’s yeast, 0.8g sorbic acid, 0.8g 
methyl paraben, 100 ml organic honey and 100 ml glycerol. The low quality food was 
chosen, as Chapter 2 suggested that vertical transmission of covert PiGV was more 
likely to be seen in P. interpunctella that had been raised on a lower food resource. P. 
interpunctella adults were maintained at 27 (+/-1) °C on a 16/8 hour light/dark cycle. 
Between 9-12 days after being put upon low quality food to breed and lay eggs, the 
adult 1
st
 generation P. interpunctella were removed, so as to prevent their remains from 
being eaten by their offspring. When the 2
nd
 generation larvae had become 5
th
 instar 
larvae they were checked for overt infection. The 2
nd
 generation larvae were then stored 
individually in 95% ethanol for later molecular analyses. 
The 1
st
 generation P. interpunctella emerged from pupae at different times due 
to them not all being the same age or dosed at the same time. This allowed for the 
creation of three blocks of the experiment.  
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3.2.3 Molecular analyses 
3.2.3.1 DNA extraction 
Individual larvae were left to dry from ethanol and ground using a pestle. The 
resulting solid was then made into a suspension by adding 500µl Tris EDTA pH 7.6. 25 
µl of this vortexed suspension had 75 µl of stirring 5% Chelex suspension added to it. 
The remaining 475 µl was then frozen at -20 °C should reanalysis need to be conducted. 
This was then vortexed and incubated at 99 °C for 15 minutes, after which it was then 
put in centrifuge for half an hour at 4 (+/- 2) °C and 13000 rpm. 1 µl of the supernatant 
of this underwent PCR analysis for CO1 lepidopteran mitochondrial gene and 1 µl of 
the supernatant underwent PCR analysis for the PiGV granulin gene. 
3.2.3.2 PCR of CO1 lepidopteran mitochondrial gene 
In order to ascertain that the DNA in the sample had not degraded in storage, a 
PCR analyses for the host’s CO1 lepidopteran mitochondrial gene was carried out. The 
PCR methodology for the host’s CO1 lepidopteran mitochondrial gene was derived 
from Emery et al. (2009). For each set of samples a master mix was made up of the 
following solution multiplied up to provide enough master mix for all the samples. The 
9 µl of master mix used in reactions comprised of 6.15 µl sterilized distilled water, 1 µl 
10x PCR buffer (Qiagen), 0.2 µl dNTP (Qiagen), 0.6 µl MgCl2 (Qiagen), 0.5 µl CO1 
LEP F1 primer (5’-ATTCAACCAATCATAAAGATATTGG-3’), 0.5 µl CO1 LEP R1 
primer (5’-TAAACTTCTGGATGTCCAAAAAATCA-3’) and 0.05 µl Taq DNA 
polymerase (Qiagen). 1 µl of the sample was then added to the 9 µl master mix. This 
then underwent a PCR reaction comprising of one cycle of 3 minutes at 94°C, followed 
by 35 cycles of 1 minute at 94°C, 1 minute at 53°C, and 1 minute at 72°C, with a final 
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step of 10 minutes at 72°C. 5 µl of this was then visualised by gel electrophoresis, using 
1.2% agarose and RedSafe.  
3.2.3.3 PCR of PiGV granulin gene 
The PCR methodology for the PiGV’s granulin gene was derived from (Burden 
et al. 2002). For each set of samples a master mix was made up of the following 
solution multiplied up to provide enough master mix for all the samples. The 9 µl of 
master mix used in reactions comprised of 6.35 µl sterilized distilled water, 1 µl 10x 
PCR buffer (Qiagen), 0.2 µl dNTP (Qiagen), 0.4 µl MgCl2 (Qiagen), 0.5 µl GRAN 5’ 
F1 primer (5'-ACAATGAAGCTGGTGTGCAACTGGAGCG-3’), 0.5 µl GRAN 3’ R1 
primer (5'-TACGTCGGGTGCGAATTCCTTGATCTTG-3’) and 0.05 µl Taq DNA 
polymerase (Qiagen). 1 µl of the sample was then added to the 9 µl master mix. This 
then underwent a PCR reaction comprising of one cycle of 2 minutes at 94°C, 1 minute 
at 65°C and 30 sec at 72°C, followed by 31 cycles of 30 sec at 94°C, 1 minute at 63°C 
and 30 sec at 72°C, with a final step of 10 minutes at 72°C. 5 µl of this was then 
visualised by gel electrophoresis, using 1.2% agarose and RedSafe.  
3.2.3.4 Molecular analyses sampling method and controls 
Each of the blocks were analysed in batches with roughly equal numbers of 
moth larvae from each line. This was done so as to determine if there is any variation in 
the molecular analyses in detecting PiGV infection. For every PCR I also analysed as 
controls, (1) sterile distilled water and (2) PiGV infected 5
th
 instar larvae. 
3.2.4 Statistical methods 
Block and batch larvae were molecularly analysed in were carried out in an 
order. Therefore block and batch larvae were molecularly analysed in could be 
considered as fixed effects or as random effects. Considering this the data was analysed 
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in two ways. Firstly with block and batch larvae were molecularly analysed in as fixed 
effects and then again with them as random effects. Both times this was done using 
binomial error structures. The first statistical analysis of the data was done using the R 
package “Bias reduction in Binomial-response GLMs” (BRGLM). The ANOVA feature 
in the BRGLM package is based upon model simplification by removal of none 
significant terms until reaching the Minimum Adequate Model (MAM). 
The second statistical analyses of the data was done using R 3.1.1’s glmer 
function from the package lme4, to construct GLMMs the proportion of larvae infected 
with PiGV explained by population of P. interpunctella. 
As comparing each of the inbred and outbred populations of P. interpunctella 
separately could be seen as pseudoreplication, GLM and GLMM analysis, as described 
above, was applied to the data with the Liverpool and Kernow populations grouped as 
outbred and Inbred population 2, 3 and 4 grouped as inbred.  
3.3 Results 
3.3.1 Molecular analyses of larvae and comparison between the different P. 
interpunctella populations 
As in the previous chapter none of the second generation 2950 larvae showed 
signs of overt infection (regardless of being from the outbred or inbred population).  
Table 3.1 Parental P. interpunctella generation that were bred from to produce the 
second generation larvae 
 
 
 
 
 
Block/repeat Kernow Liverpool Inbred 2 Inbred 3 Inbred 4 Total 
1 17 12 10 22 13 74 
2 24 20 20 22 13 99 
3 16 12 24 20 10 82 
Total 57 44 54 64 36 255 
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Table 3.2: Number of P. interpunctella 5
th
 larvae in second generation 
Block Kernow Liverpool Inbred 2 Inbred 
3 
Inbred 
4 
Total 
1st 200 200 200 200 200 1000 
2nd 200 200 200 200 23 823 
3rd 200 200 200 200 327 1127 
Total 600 600 600 600 550 2950 
 
Table 3.3 Number of P. interpunctella 5th larvae in second generation positive for 
CO1 mitochondrial DNA 
Block Kernow Liverpool Inbred 2 Inbred 
3 
Inbred 
4 
Total 
1st 106 189 172 174 182 823 
2nd 125 180 190 152 16 663 
3rd 193 192 185 163 309 1042 
Total 424 561 547 489 507 2528 
 
Table 3.4: Number of P. interpunctella 5
th
 larvae in second generation positive for 
PiGV granulin DNA 
Block Kernow Liverpool Inbred 2 Inbred 
3 
Inbred 
4 
Total 
1st 2 2 0 0 0 4 
2nd 0 0 0 2 0 2 
3rd 0 0 0 0 0 0 
Total 2 2 0 2 0 6 
 
2528/2948 of the samples were positive for the CO1 lepidopteran mitochondrial 
gene, with the samples that were not positive for the host gene being excluded from 
further analysis since the DNA had clearly degraded (see Tables 3.2-3). Note two 
samples had to be discarded due to them being accidentally knocked onto the floor. Due 
to the large number of samples, the molecular analysis was conducted in 32 batches. 
Samples from the 1st block were analysed within batches 1-11, each batch containing 
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roughly equal numbers of samples from each population. Samples from the 2nd block 
were analysed within batches 12-20, each batch containing roughly equal numbers of 
samples from each population and so on with the 3rd block. From the low percentage of 
larvae positive for PiGV granulin gene, Figure 3.1 suggests that the overall level of 
vertical transmission of PiGV is quite low. There was no sign PiGV granulin gene in 
Inbred lines 2 and 4, or in the 3rd block. Many of the batches also showed no signs of 
PiGV granulin gene. BRGLM analyses of Proportion of Larvae Infected with PiGV 
explained by experimental block, batch larvae was analysed in and population of P. 
interpunctella found the null model to be the MAM. (ANOVA comparison of the 
BRGLM of proportion of larvae infected with PiGV explained by block + batch larvae 
was analysed in + population of P. interpunctella to the block + population of P. 
interpunctella model had 29 degrees of freedom, a χ2=12.293 and p= 0.9972. ANOVA 
comparison of the BRGLM of proportion of larvae infected with PiGV explained by 
block + population of P. interpunctella to the block model had 4 degrees of freedom, a 
χ2= 3.6359  and p= 0.4575. ANOVA comparison of BRGLM of proportion of larvae 
infected with PiGV explained by block to the null model had 2 degrees of freedom, a 
χ2=5.5813 and p=0.06138). Likewise ANOVA of the GLMM of proportion of larvae 
infected with PiGV explained by population of P. interpunctella, with experimental 
block and batch larvae was analysed molecularly in, as random effects found the model 
none significant compared to the null model (4 degrees of freedom, a χ2= 6.1978 and p= 
0.1849). Note due to issues of non-convergence with other settings the R’s glmer 
function had the control set with the optimizer ="optimx” and optCtrl=list(method="L-
BFGS-B"). 
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Figure 3.1 Percentage of larvae that were positive for PiGV granulin gene by 
molecular analyses, given that they were positive for mitochondrial DNA, 
arranged by P. interpunctella population. Raw data available in Tables 3.3-4. 
 
3.3.2 Comparison the P. interpunctella populations grouped together as inbred 
and outbred populations 
Table 3.5 Number of P. interpunctella 5th larvae in second generation  
Block Outbred Inbred  Total 
1st 400 600 1000 
2nd 400 423 823 
3rd 400 727 1127 
Total 1200 1750 2950 
 
Table 3.6: Number of P. interpunctella 5
th
 larvae in second generation positive for 
CO1 mitochondrial DNA 
 
 
 
Block Outbred Inbred  Total 
1st 295 528 823 
2nd 305 358 663 
3rd 385 657 1042 
Total 985 1543 2528 
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Table 3.7: Number of P. interpunctella 5
th
 larvae in second generation positive for 
PiGV granulin gene 
Block Outbred Inbred  Total 
1st 4 0 4 
2nd 0 2 2 
3rd 0 0 0 
Total 4 2 6 
 
Figure 3.2 suggest there is little difference in PiGV infection rates between the 
different P. interpunctella population when grouped together as either outbred (Kernow 
and Liverpool populations) or inbred (Inbred populations 2-4). BRGLM analyses of 
proportion of larvae infected with PiGV explained by experimental block, batch larvae 
was molecularly analysed in and population of P. interpunctella found that the null was 
the MAM. (ANOVA of the BRGLM of proportion of larvae infected with PiGV 
explained by block + batch larvae was molecularly analysed in + population of P. 
interpunctella compared to the block + population of P. interpunctella model had 29 
degrees of freedom, a χ2= 10.547  and p= 0.9993. ANOVA of the BRGLM of 
proportion of larvae infected with PiGV explained by block + population of P. 
interpunctella compared to the block model had 1 degree of freedom, a χ2= 1.6289 and 
p=0.2019. ANOVA of BRGLM of proportion of larvae infected with PiGV explained 
by block compared to the null model had 2 degrees of freedom, a χ2=5.5813 and 
p=0.06138). Similarly ANOVA of the GLMM of proportion of larvae infected with 
PiGV explained by population of P. interpunctella, with experimental block and batch 
larvae was molecularly analysed in as random effects, compared to the null equivalent 
finds no significant difference (1 degree of freedom, a χ2= 1.7638 and p= 0.1842).  
89 
 
 
 
Figure 3.2. Percentage of larvae that were positive for PiGV granulin gene by 
molecular analyses, given that they were positive for mitochondrial DNA, 
arranged by P. interpunctella population. Raw data available in Tables 3.6-7. 
3.4 Discussion 
Assuming that larvae positive for PiGV granulin gene were infected with PiGV. 
I found no evidence that inbreeding affected the vertical transmission of the virus or it’s 
activation from a covert to overt state. This would seem to confirm the findings of 
others who also found no effect of inbreeding on insect immune function (Lee et al. 
2012; Gerloff et al. 2003; Rantala & Roff 2007). Considering that other studies found 
that inbreeding increased susceptibility to infection (Whitehorn et al. 2011) or increased 
immune function (Drayton & Jennions 2011). It may be the case that host inbreeding’s 
effect on immune function and susceptibility may be specific to a host or infectious 
agent. This may even reflect an insect hosts ecological niche down to its role within a 
social insect system (Vitikainen & Sundström 2010). Vitikainen & Sundström (2010) 
suggest that queen F. exsecta life history leads to an immune system that needs to be up 
and down regulated at certain times, whereas a worker F. exsecta immune system is 
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constantly active due to pathogen exposure. Inbreeding could affect the timing of queen 
F. exsecta immune system’s up regulation (Vitikainen & Sundström 2010). Hence 
Vitikainen & Sundström (2010) found no effect of inbreeding on the encapsulation 
response of worker ants F. exsecta but an increased encapsulation response in the gynes 
of F. exsecta. 
Whilst the sample size in terms of the number of larvae analysed is large, the 
lack in significance of population of P. interpunctella on PiGV infection rate, as seen by 
the various statistical tests, may be interpreted to be down to the sample size in terms of 
PiGV infected larvae (only 6), being too low to detect an effect of host inbreeding on 
PiGV infection rate. The low PiGV infection rate as seen in Figure 3.1-2 would seem to 
indicate this. To further illustrate this I used the proportion of larvae infected from the 
Kernow population (0.0047), Liverpool population (0.0036) and Inbred 3 population 
(0.0041) with R’s power.prop.test function. Comparing the proportions (each 
combination of two of the proportions) under the two way, 0.05 significance and 0.9 
power level setting, produces crude estimates of sample sizes needed to find significant 
differences in these proportions of infection of between 65309 – 290800 of each 
population sampled. These are unfeasibly large sample sizes for such an experimental 
setup. For this reason it may be worth looking at repeating this experiment in different 
insect baculovirus system with a greater vertical transmission rate, such as SfNPV in 
Spodoptera frugiperda (Fuxa & Richter 1992).  
I also found that none of the 1750 second generation larvae that were from 
inbred lines showed any signs of overt infection, thus suggesting that inbreeding does 
not have an effect on activation of covert baculovirus. Further causes of activation need 
to be investigated in order to determine the processes that lead to activation of 
baculoviruses in nature. Chapter 2 in comparing two qualities of food resources found 
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no activation of covert PiGV on either food resource. It was suggested that a greater 
range of food resource levels up to starvation needs to be tested, pointing to studies by 
Jaques (1962) and Fuxa et al. (1999), which may have inadvertently found that 
starvation led to the activation of covert baculoviruses (see Chapter 2). Covert 
baculoviruses may be activated by a lack or deficiency of a specific nutrient rather than 
low food levels in general (see Chapter 2). David & Taylor (1977) found that sucrose 
deficient diets could lead to a greater susceptibility of Pieris brassicae to its GV and a 
number of studies have demonstrated that low protein levels can affect an invertebrate’s 
immune function and susceptibility to infection (Lee et al. 2006; DeGrandi-Hoffman et 
al. 2010; Povey et al. 2013). Two studies suggest that unusual or non-native host diets 
could lead to activation of a baculovirus (David & Gardiner 1965; Ilyinykh et al. 2013). 
A number of studies have found that covert baculoviruses can be activated through 
infection with another baculovirus (Longworth & Cunningham 1968; Jurkovíčová 1979; 
Hughes et al. 1993; Cooper et al. 2003; Burden et al. 2003).  
In conclusion, whilst this study found that inbreeding had no significant effect 
on the vertical transmission of PiGV in P. interpunctella or its activation from a covert 
to overt state, this could be down to the low rate of vertical transmission leading to a 
low sample in terms of PiGV infected larvae. Further study of other insect baculovirus 
systems with much higher vertical transmission rates may be needed to verify the effect 
of inbreeding on the vertical transmission of baculoviruses or their activation from a 
covert to overt state. Repeating this experiment or carrying out a similar experiment in a 
different insect baculovirus laboratory system, which has a much high vertical 
transmission rate, such as SfNPV in S. frugiperda, would be a good first step. Other 
studies have found differing results regarding the effect of insect inbreeding on 
pathogen susceptibility and immunity. Comparing the outcome of such an experiment to 
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the wider literature may therefore reveal that the effects of inbreeding on an insect’s 
immunity and susceptibility to a pathogen are  specific to that insect, its ecological 
niche or the pathogen. 
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Chapter 4: How important is vertical transmission of dengue viruses 
by mosquitoes (Diptera: Culicidae)? 
Abstract 
Vertical transmission of dengue viruses by mosquitoes was discovered at the end 
of the late 1970s and has been suggested to be a means by which these viruses persist. 
However, it is unclear how widespread it is in nature and its importance in the 
epidemiology of this disease is still debated. Here, I review the literature on vertical 
transmission and discuss its role in dengue’s epidemiology and control. I conclude that 
given the number of studies that failed to find evidence of vertical transmission, as well 
as mathematical models and its mechanistic basis, it is unlikely that vertical 
transmission is important for the epidemiological persistence of dengue viruses. A 
combination of asymptomatic infection in humans and movement of people are likely to 
be more important determinants of dengue’s persistence. I argue, however, that there 
may be some need for further research into the prevalence of dengue viruses in 
desiccated, as well as diapausing eggs and the role of horizontal transmission through 
larval cannibalism.   
4.1 Introduction 
Since the 1950s the incidence of illness caused by dengue viruses has increased 
30 fold (Nathan et al. 2009). Over 40% of the world’s population are at risk, mostly in 
the urbanised tropics and subtropics and the WHO estimates that there are between 50-
100 million cases of dengue viral illnesses per year (WHO 2015b). Furthermore, 
recently Bhatt et al. (2013) have estimated that there are 390 million human dengue 
virus infections a year, causing 96 million cases of illnesses a year. As such the dengue 
virus has emerged as one of the world’s major public health problems and there is 
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therefore a pressing need to understand the mechanisms by which it persists in 
populations. 
Dengue viruses are positive sense RNA viruses of the Flavivirus genus, 
categorised into four closely related serotypes (DENV-1, DENV-2, DENV-3 and 
DENV-4). Infection with a serotype leads to lifelong immunity; however subsequent 
infection with a differing serotype is a major risk factor in the more severe forms of 
dengue viral illnesses (dengue haemorrhagic fever (DHF) and dengue shock syndrome 
(DSS)). Hospitalisation decreases the mortality of these severe forms of dengue viral 
illnesses from more than 20% to less than 1% (WHO 2015b).  
The urbanized Aedes aegypti (L.) is the principle DENV vector, with the more 
rural Ae. albopictus (Skuse) acting as a secondary vector in most regions (M. Service 
2012b). However, a meta-analyses of laboratory and natural experiments by Lambrechts 
et al. (2010) suggests Ae. albopictus is an inefficient vector of dengue virus. Both 
mosquitoes breed in small containers of water  and their eggs are able to withstand 
periods of desiccation (M. Service 2012b; WHO 2015d). The eggs of many Aedes 
species, including some strains of Ae. albopictus, undergo periods of diapause, but the 
eggs of many other Aedes species such as Ae. aegypti are incapable of diapause (M. 
Service 2012b; WHO 2015d).  
It is also known that the vertical transmission of dengue virus can occur in both 
of these key vectors (Rosen et al. 1983; Khin and Than 1983; Hull et al. 1984). As such 
there has been much interest and some debate concerning the epidemiological role of 
vertical transmission of dengue virus within mosquito populations (Angel and Joshi 
2008; Joshi et al. 2002; Rosen et al. 1983; Adams and Boots 2010; Pinheiro et al. 2005; 
Zeidler et al. 2008). A significant amount of work is still published on this subject 
(Martínez et al. 2014; Sanchez-Rodríguez et al. 2014; Yang et al. 2014; Espinosa et al. 
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2014) but a review looking solely at vertical transmission of dengue virus is lacking. 
Furthermore it has been suggested that the monitoring of larvae Aedes mosquitoes for 
dengue virus could be used to predict dengue fever epidemics (Chow et al. 1998; Lee & 
Rohani 2005). There is clearly therefore a need to examine the role that vertical 
transmission plays in the epidemiology of the dengue virus. 
4.2 Early work on vertical transmission of dengue virus 
The earliest experiments exploring the possibility of vertical transmission of 
dengue virus within mosquitoes date back to the 1920s and 30s (Siler et al. 1926; 
Simmons et al. 1931). Two studies involved feeding Ae. aegypti on a dengue virus 
infected patient. The offspring of these Ae. aegypti were then fed on susceptible 
volunteers who were then monitored for signs of infection. The parental generation of 
mosquitoes were determined as to being infected by feeding them on susceptible 
volunteers, who were also monitored for signs of infection. No infection occurred from 
the offspring generation and therefore these experiments suggested that vertical 
transmission of dengue virus was not possible.  
The next mention of the possibility of vertical infection, is a citation to 
unpublished work in a short report by Rosen et al. (1978) that suggests that transovarial 
transmission of dengue virus had occurred within Ae. albopictus from Hawaii, under 
laboratory conditions, however information on this is scant.  Then in 1979 Kubersk, 
using fluorescent antibody staining of Ae. albopictus infected with DENV-2 found the 
presence of DENV-2 antigens in the tissues surrounding the eggs and oviducts, although 
not within under-developed eggs or spermatheca (Kuberski 1979). This finding gave 
further impetus to experimental studies on vertical transmission leading to Jousset, 
(1981) showing that a DENV-2 virus strain could be vertically transmitted in Ae. 
aegypti (see Table 4.1).  Furthermore, mosquitoes from five distinct geographical 
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regions (Queensland, Hannoi, Lagos, Guadalope and Burkina Faso) were used in the 
experiments suggesting that this was a widespread phenomenon.  
Next Rosen et al. (1983) demonstrated again in another lab study that all four 
serotypes of dengue virus were capable of vertical transmission in Ae. albopictus, (see 
Table 4.1). Only DENV-1 was demonstrated to vertically transmit within Ae. aegypti. 
This led them to suggest that vertical transmission within Ae. albopictus may assist in 
the persistence of dengue virus.  Rosen et al. (1983) also tested how well three strains of 
vertically acquired DENV-1 survived through the life cycle of Ae. albopictus. However 
no statistics were carried out to verify if vertically acquired DENV-1 was significantly 
decreased in the pupae or adults, compared to the larval stages. They also found that 
many of the geographical strains of the dengue virus serotypes were not vertically 
transmitted. Following the introduction Ae. albopictus into South America, Mitchell & 
Miller (1990) infected 3 Brazilian strains of Ae. albopictus with DENV-1 and DENV-4 
and also found evidence of vertical transmission (see Table 4.1).  
Gubler et al., (1985) showed experimentally that vertical transmission of 
DENV-1 in Ae. mediovittatus was possible (see Table 4.2) and suggested that this 
uncommon vector for the horizontal transmission of dengue virus could be helping 
maintain the virus through vertical transmission. Later, experiments on mosquitoes of 
the Ae. scutellaris group found low or zero rates of vertical transmission for DENV-1-4 
(Freier & Rosen 1987). However, at about the same time in similar experiments on Ae. 
mediovittatus infected with DENV-1-3 much higher rates of vertical transmission were 
seen (Freier & Rosen 1988) (see Table 4.2) and de Souza & Freier (1991) reported 
vertical transmission of both larvae and pupae of a Panamanian strain of the largely 
sylvatic Haemgogus equinus mosquito from intrathorcical DENV-1 infection (see Table 
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4.2).  It was clear therefore from these early laboratory studies that vertical transmission 
was possible in a wide range of vectors. 
In the first field study Khin & Than (1983) detected DENV-2 within Ae. aegypti 
that had been caught in the field as larvae. A proportion of the larvae were raised to 
adults in the lab; others were raised to fourth instar larvae. They found DENV-2 within 
the larvae and the male adults, although no dengue virus was found in the adult females 
(see Table 4.3). Next Hull et al. (1984), caught Ae. aegypti, as well as larvae (using 
ovitraps) and raised them to adults in the lab. No dengue virus was found in the adults 
raised from larvae but DENV-4 was found in one pool of adults raised from eggs (see 
Table 4.3). As such there was the emergence of some evidence of vertical transmission 
in the field as well as in the laboratory.    
Nevertheless two further papers at this time cast doubt on the importance of 
vertical transmission in the field. In an extensive field study on Ae. aegypti and Ae. 
alboptictus in Bangkok no vertical transmission was detected in and around the houses 
of DHF cases (Watts et al. 1985) (see Table 5.4b). Then a field study in Kelang, 
Malaysia also found no evidence of vertical transmission of dengue virus in Ae. aegypti 
and Ae. alboptictus, from around the homes of dengue fever (DF), as well as DHF cases 
(Ramalingam et al. 1986) (see Table 5.4).  
As such by the start of the 1990s there was a very mixed set of results from the 
laboratory that showed vertical transmission occurred but it was dependent on the route 
of infection, the strain of dengue virus and both the species and the genotype of the 
mosquito vector.  In addition the very limited number of field observations showed that 
it occurred but cast doubt on the role that vertical transmission may play in the 
persistence of dengue virus.  There was however enough interest to encourage further 
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studies that took advantage of alternative approaches, including using novel dengue 
virus screening techniques. 
4.3 The measurement of vertical transmission of dengue virus 
It is important to understand that in the laboratory experiments reviewed in this 
study there are three ways of measuring vertical transmission. The first is the vertical 
transmission rate (VTR), which is defined as the proportion of infected parents that 
produce at least one infected offspring. The second is the filial infection rate (FIR) that 
is defined as the proportion of infected progeny produced from infected parents, given 
that vertical transmission has occurred. The third is the vertical infection rate (VIR) 
which is the VTR multiplied by the FIR.  
In many of the field surveys and laboratory studies reviewed in this study the 
sample size of specimens is so great and due to limited laboratory resources, specimens 
were analyzed in pools or groups. The simplest way of calculating the infection rate 
(IR) for pools of mosquitoes is the Minimum Infection Rate (MIR) (listed in the per 
1000s), which is the number of pools positive for infection divided by the total number 
of individual specimens tested. A few of the surveys reviewed here use the more 
statistically powerful Maximum Likelihood Estimator (MLE). It should be noted that 
pool size can affect the accuracy and the range of possible infection rates estimated. For 
example with 5 out of 200 mosquitos positive for an infectious agent, if analyzed 
individually this would produce an MIR of 25/1000, analyzed in pools of 10 the MIR 
could range from 5-25/1000, analyzed in pools of 50 the MIR could range from 5-
20/1000 and analyzed in pools of 100 the MIR could range from 5-10/1000. 
MLE was devised by Chiang and Reeves (1962) and improved by Walter et al. 
(1980) and Le (1981) and is generally seen as an improvement upon MIR (Katholi & 
Unnasch 2006; Gu et al. 2003; Gu & Novak 2004). At a high infection rate and a larger 
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pool size MIR’s assumption of a positive pool representing only one infected individual 
can lead to an inaccurate estimate of infection rate; MLE relaxes this assumption 
(Katholi & Unnasch 2006; Gu et al. 2003; Gu & Novak 2004). Gu et al. (2004) 
demonstrated that varying the pool size combined with MLE led to a more accurate 
measure of infection rate. However, at lower rates of infection (as seen in this review) 
there is likely to be very little difference between MIR and MLE (Gu et al. 2003). One 
study by Le Goff et al. (2011) calculates MIR and the more statistically based method 
of True Infection Rate (TIR). TIR like MLE does use a maximum likelihood procedure. 
As can be seen in Table 4.3, Le Goff et al. (2011) found a very similar infection rate 
when calculating MIR and TIR, for DENV-1 and DENV-3 in adult Ae. aegypti caught 
as larvae. Similarly, where possible I calculated the MIR for the few studies that 
calculated infection rate using MLE, for example, Chen et al. (2010) and Das et al. 
(2013). Chen et al. (2010) found a MLE for adult female Ae. aegypti of 0.97/1000 and I 
calculated a similar MIR of 0.97/1000 (see Table 5.4b). Likewise Das et al. (2013) 
found  MLEs of 8.92/1000, 6.09/1000 and 2.63/1000 for DENV-2 infected female adult 
Ae. albopictus, Ae. albopictus pupae and Ae. aegypti pupae, respectively. I calculated 
MIR of 8.9/1000, 5.8/1000 and 2.6/1000 for DENV-2 infected female adult Ae. 
albopictus, Ae. albopictus pupae and Ae. aegypti pupae, respectively (see Table 5.6). 
These findings would seem to support the assertion of Gu et al. (2003), that there is 
likely to be very little difference between MIR and MLE when infection rates are low 
and when pool sizes are similar.  
Despite the key issues highlighted in the main body of the text, the ease of 
carrying out more modern dengue virus detection techniques has led to a burgeoning 
literature on various aspects of vertical transmission of dengue virus. Laboratory and 
field studies find generally low rates of vertical transmission (MLEs and MIRs of less 
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than 10/1000) with MIRs and MLEs typically ranging from less than single digits to 
low double digits per 1000 (see Table 4.1-7). The VTR in Ae. albopictus and Ae. 
aegypti, when not selected for ranges from 0-41.2% and the FIR is less than 5% (see 
Table 4.1). VTR and FIR in uncommon dengue vectors ranges greatly from 12.4-94.7% 
and 0.1-20.3% respectively (see Table 4.2).  
4.4 Key issues with field and laboratory studies 
In the early-mid 1990s RT-PCR and ELISA began to be used to detect dengue 
viruses instead of the previously used immunological techniques. The immunological 
techniques required greater man power and sometimes the use of Toxomrhynchites 
amboinensis or Aedes mosquito colonies to amplify dengue viruses before the  
mosquitoes were stained using either indirect or direct fluorescent antibody techniques 
(IFAT or DFAT) (Kuberski & Rosen 1977). In some cases the squashed heads of the 
sample specimens were directly examined for dengue viruses using IFAT or DFAT. 
Some studies used peroxidase-antiperoxidase staining (PAP) or compliment fixation 
tests. Serufo et al. in 1993 was the first to detect vertical transmission of dengue viruses 
using molecular techniques in a field study. Other than finding DENV-1 in 2 pools of 
Ae. albopictus larvae collected from car tyres in Campos Altos (Brazil), information on 
this study is scant and it may not have gone through the peer review process. Older 
techniques such as amplification followed by IFAT were still being used as late as 2012 
(Martins et al. 2012). 
Rohani et al. (2007) is the only study to compare the sensitivity of different 
methods of analysing larval or adult male Aedes for dengue virus infections. They 
compared RT-PCR in detecting dengue viruses in field caught Ae. aegypti and Ae. 
albopictus (from several locations across Malaysia) with C6/36 Ae. albopictus cell 
culture amplification, followed by PAP staining (see Table 4.5). Rohani et al. (2007) 
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suggest that the latter method is most sensitive.  However, no statistical evaluation was 
presented and the sampling could be seen as flawed with unequal amounts of larvae 
from specific sample sites being tested through the different screening techniques. This 
led to 2,250 larval Ae. aegypti and 2,130 larval Ae. albopictus being analyzed in pools 
of 10 through immunological techniques in sites where vertical transmission was found 
compared to only 990 larval Ae. aegypti and 780 larval Ae. albopictus being analyzed in 
pools of 10 through RT-PCR in sites where vertical transmission was found (Rohani et 
al. 2007). A better way to compare these two methodologies would be to use both 
methods to analyse the same homogenised pools of larvae.  
Many studies do not mention using positive or negative controls in their RT-
PCR or ELISA screening for dengue virus (Table 4.1-7). If positive controls were not 
used there is a danger of false negative results. Similarly false positive results caused by 
contamination could occur if negative controls were omitted from the screening process. 
Several experiments used dengue virus that were passed many times through unusual 
hosts or Aedes cell lines (see Table 4.1-3 and Table 5.7) which may have affected the 
wider inferences that can be drawn from such studies. Chen et al. (2003) found that 
passage through a mammalian cell line caused higher nucleotide and amino acid 
changes in two DENV-2 genes than passage in Ae. albopictus cell lines or alternating 
passage through both of these cell lines (it should be noted that this difference was not 
assessed statistically).    
Two further cautionary notes should be made about interpretations made when 
using RT-PCR followed by gel electrophoresis as a diagnostic tool for dengue virus 
isolation.  Firstly careful consideration of primers should be made so as to avoid 
amplification of related Flaviviruses leading to false positives. Ideally viral RNA 
detected by RT-PCR should be followed by confirmation through sequencing, viral 
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antigen detection through IFA or other such techniques to avoid such false positives. 
Many of the studies reviewed in this chapter did not take either of these precautions (see 
Table 5.4-6). Secondly, the detected dengue virus RNA could for the most part belong 
to non-functional dengue virus particles (Choy et al. 2013). This second point would 
also be the case for studies that used qRT-PCR, as well as those that used RT-PCR   
A significant number of studies calculated MIRs or MLEs by combining data 
from all dengue virus serotypes (see Table 4.5) and given that different serotypes of 
dengue virus may be horizontally or vertically transmitted at different rates, as well as 
being present in different ratios within the mosquito population. This could lead to an 
inaccurate estimation in the rate of vertical transmission of dengue virus serotypes. The 
data on dengue virus infection rates in mosquitoes used for calculating the MIR or MLE 
varied greatly. Many studies calculated MIRs or MLEs for specific months in specific 
areas, whereas others calculated these statistics for combined data. This makes 
comparing surveys of dengue virus infection rates difficult. The ecology of different 
areas varies, thereby making the standardization by a specific area for a specific length 
of time not necessarily relevant.  However, if future studies attempted to standardize 
sampling methodologies it would nevertheless be easier to compare infection rates 
among studies. 
4.5 Overview 
Despite a lack of testing of the relative sensitivity of screening methods, the ease 
of carrying out the more modern techniques has led to a growth in the literature on 
various aspects of vertical transmission of dengue viruses. In Table 4.1-7 I summarise 
these studies. In the text, I discuss the mechanistic basis of vertical transmission (see 
section 4.6), transgenerational vertical transmission (see section 5.7), vertical 
transmission to desiccated and diapausing eggs (see section 4.8), field studies that 
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compare Ae. aegypti and Ae. albopictus (see section 4.9), comparison of vertical 
transmission in larvae and adults (see section 4.10), field studies comparing vertical and 
horizontal transmission (see section 4.11), seasonality in vertical transmission (see 
section 4.12), dengue fever epidemic prediction (see section 4.13), field studies that 
failed to find evidence of vertical transmission (see section 4.14), a recent laboratory 
experiment in relation to vertical transmission and subsequent horizontal transmission 
of dengue virus between larval mosquitoes (see section 4.15) and mathematical models 
(see section 4.16). I finish with a discussion of the current state of knowledge of the role 
of vertical transmission in dengue virus ecology (see section 4.17) and an overall 
summary (see section 4.18). 
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Table 4.1: Summary of laboratory studies on vertical transmission of dengue viruses in common vectors. 
Source Host Species  Infection route 
of parent 
generation 
Serotype 
of dengue 
Sample Size 
(individual 
specimens)* 
Infection rate* Type of 
infection 
rate 
Origin of dengue 
serotype 
Methodology of 
Screening 
Use of 
Controls in 
screening 
(Jousset 1981) 
 
 
 
 
 
(Rosen et al. 1983) 
 
 
 
 
 
 
(Ramalingam et al. 
1986) 
 
 
 
 
 
 
(Rosen 1987a)  
Ae. aegypti  
 
 
 
 
 
Ae. albopictus  
 
 
 
Ae. aegypti 
Ae. albopictus 
 
Ae. aegypti 
 
 
 
 
 
 
 
Ae. albopictus 
Intrathoracic 
inoculation 
 
 
 
 
Intrathoracic 
inoculation 
 
 
 
Oral inoculation 
 
Oral inoculation 
 
 
 
 
 
 
 
Intrathoracic 
inoculation 
DENV-2 
 
 
 
 
 
DENV-1 
DENV-2 
DENV-3 
DENV-4 
DENV-1 
DENV-1 
 
Unknown 
serotypes 
 
 
 
 
 
 
DENV-1 
1494-1903 
 
 
 
 
 
293-7522 
2193-4080 
1280-4420 
194-1070 
1543 
790-1197 
 
5320 
 
 
 
 
 
 
 
1570-2661 
0.52-2/1000 
 
 
 
 
 
1.7-14/1000 
0.91-2.5/1000 
0.23-0.78/1000 
0.22-5.2/1000 
0.65/1000 
1.2-13/1000 
 
None occurred 
 
 
 
 
 
 
 
0.38-5.1/1000 
MIR 
 
 
 
 
 
MIR 
MIR 
MIR 
MIR 
MIR 
MIR 
 
NA 
 
 
 
 
 
 
 
MIR 
New Guinea C strain 
of DENV-2, passed 
25 times through 
mice 
 
 
Many virus strains 
had been used. A 
few had been passed 
through monkeys; all 
had been passed 
through mosquitoes. 
 
Mosquitoes where 
fed on suspected 
human DF/DHF cases 
in Malaysia.  
 
 
 
 
Fiji, 1975. Method of 
passage unknown 
Amplification in 
mice, followed by 
complement fixation 
test. 
 
 
Amplification in Tx. 
amboinensis , 
followed by Direct 
Fluorescent 
Antibody Technique 
(DFAT) 
 
DFAT. Confirmation 
by amplification in 
Ae. pseudoscutellaris 
cell line or 
Toxorhynchites 
mosquitoes, 
followed by  DFAT  
 
Amplification in Tx. 
amboinensis, 
followed by 
Fluorescent 
Antibody Technique 
(FAT). 
Not 
mentioned  
 
 
 
 
Not 
mentioned 
 
 
 
 
 
Not 
mentioned 
 
 
 
 
 
 
Not 
mentioned 
 
*Where multiple infection rates were taken for the same type of host species, at the same stage of life-cycle, the range of sample sizes and infection rates are listed.  
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Table 4.1 continued. 
Source Host Species  Infection route 
of parent 
generation 
Serotype 
of dengue 
Sample Size 
(individual 
specimens)* 
Infection 
rate* 
Type of 
infection 
rate 
Origin of dengue 
serotype 
Methodology of 
Screening 
Use of 
Controls in 
screening 
(Rosen 1988) 
 
 
 
(Mitchell & Miller 
1990) 
 
 
 
(Bosio et al. 1992) 
 
 
 
 
(Joshi et al. 1996) 
 
 
(Lee et al. 1997) 
 
 
 
 
(Gokhale et al. 
2001)  
Ae. albopictus 
 
 
 
Ae. albopictus   
 
 
 
 
Various strains of 
Ae. albopictus   
Ae. aegypti 
 
 
Ae. aegypti 
 
 
Ae. aegypti 
 
 
 
 
Ae. albopictus 
Oral 
inoculation 
 
 
Parenteral 
inoculation 
 
 
 
Oral 
inoculation 
 
 
 
Intrathoracic 
inoculation 
 
Oral 
inoculation 
 
 
 
Intrathoracic 
inoculation 
DENV-1 
 
 
 
DENV-1 
DENV-4 
 
 
 
DENV-1 
 
DENV-1 
 
 
DENV-3 
 
 
DENV-1-4 
 
 
 
 
DENV-2 
 
96-4336 
 
 
 
84-626 
1022 
 
 
 
391-797 
 
756 
 
 
17 
 
 
390 
 
 
 
 
1965 
1046 
1083 
2.3-21/1000 
 
 
 
1.6-12/1000 
0.98/1000 
 
 
 
11.1-41.2% 
0.13-2.9% 
3% 
0.13% 
 
88% 
 
 
15/1000 
 
 
 
 
1.5/1000 
5.7/1000 
6.5/1000 
 
MIR 
 
 
 
MIR 
MIR 
 
 
 
VTR 
FIR 
VTR 
FIR 
 
VIR 
 
 
MIR 
 
 
 
 
MIR 
MIR 
MIR 
 
Fiji 
 
 
 
Puerto Rico (1985), 
passed once through 
Tx. amboinensis. 
 
 
Jamaica. Passed 
once through a 
mosquito and C6/36 
Ae. albopictus cells. 
 
Unknown 
 
 
Human serum, 
passed once through 
C6/36 Ae. albopictus 
cells. 
 
Jammu, India. 
Passed 8 times 
through mice. 
 
Amplification in Tx. 
amboinensis , 
followed by IFAT 
 
Amplification in Ae. 
albopictus or Tx. 
amboinensis, followed 
by DFAT 
 
IFAT 
 
 
 
 
IFAT 
 
 
Peroxidase-
antiperoxidase 
staining (PAP) and RT-
PCR 
 
ELISA and further 
confirmation through 
amplification in a 
mosquito, followed by 
IFAT 
Not 
mentioned 
 
 
Not 
mentioned 
 
 
 
Not 
mentioned 
 
 
 
Not 
mentioned 
 
Not 
mentioned 
 
 
 
Not 
mentioned 
 
*Where multiple infection rates were taken for the same type of host species, at the same stage of life-cycle, the range of sample sizes and infection rates are listed. 
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Table 4.1: Continued  
Source Host Species  Infection route 
of parent 
generation 
Serotype 
of dengue 
Sample Size 
(individual 
specimens)* 
Infection rate* Type of 
infection 
rate 
Origin of dengue 
serotype 
Methodology 
of Screening 
Use of 
Controls in 
screening 
(Mourya et al. 
2001) 
 
 
 
 
 
(de Castro et al. 
2004) 
 
 
 
 
 
 
 
(Guo et al. 2007) 
 
 
 
 
 
(Buckner et al. 
2013) 
Ae. aegypti   
Ae. aegypti  
 
 
 
 
 
4th instar larvae 
Ae. albopictus 
Adult female Ae. 
albopictus 
4th instar larvae 
Ae. aegypti 
Adult female Ae. 
aegypti 
 
Non-diapausing  
Ae. albopictus 
eggs 
Diapausing Ae. 
albopictus eggs 
 
Ae. aegypti 
Ae. albopictus 
Oral inoculation 
Intrathoracic 
inoculation 
 
 
 
 
Oral inoculation 
 
 
 
 
 
 
 
 
Oral inoculation 
 
 
 
 
 
Oral inoculation 
DENV-2 
 
 
 
 
 
 
DENV-2 
 
 
 
 
 
 
 
 
DENV-2 
 
 
 
 
 
DENV-1 
250-750 
 
 
 
 
 
 
284 
 
92 
 
521 
 
59 
 
 
NA 
 
 
NA 
 
 
36 
18 
2.2-5/1000 
7.1-63% 
 
 
 
 
 
56/1000 
 
98/1000 
 
17/1000 
 
51/1000 
 
 
3/5 pools 
 
 
2/5 pools  
 
 
8% 
11% 
MIR 
Pools of 
infected 
larvae (of 
unknown 
size) 
 
MIR 
 
MIR 
 
MIR 
 
MIR 
 
 
NA 
 
 
NA 
 
 
VTR 
VTR 
Jammu, India. Passed 8 
times through mice. 
 
 
 
 
 
Rio de Janeiro (1998). 
Passed an unspecified 
number of times 
through C6/36 Ae. 
albopictus cells. 
 
 
 
 
New Guinea, passed at 
last once through a 
mouse.  
 
 
 
Florida (2010). Passed 3 
times through kidney 
cells. 
ELISA 
 
 
 
 
 
 
IFAT and 
confirmation 
with RT-PCR 
 
 
 
 
 
 
RT-PCR and 
Southern-blot 
 
 
 
 
qRT-PCR 
Not 
mentioned 
 
 
 
 
 
Positive and 
negative for 
RT-PCR 
 
 
 
 
 
 
Positive 
controls 
 
 
 
 
Positive and 
negative 
*Where multiple infection rates were taken for the same type of host species, at the same stage of life-cycle, the range of sample sizes and infection rates are listed. 
  
107 
 
Table 4.2: Summary information of laboratory studies on vertical transmission of dengue viruses in uncommon dengue vectors. 
*Where multiple infection rates were taken for the same type of host species, at the same stage of life-cycle, the range of sample sizes and infection rates are listed. 
º Offspring of a single female. 
  
Source Host Species  Infection route 
of parent 
generation 
Serotype 
of dengue 
Sample Size 
(individual 
specimens)* 
Infection 
rate* 
Type of 
infection 
rate 
Origin of dengue serotype Methodology of 
Screening 
Use of 
Controls in 
screening 
(Gubler et al. 
1985) 
 
 
 
(Freier & 
Rosen 1987) 
 
 
 
 
 
(Freier & 
Rosen 1988) 
 
 
 
 
 
 
 
 
(de Souza & 
Freier 1991) 
Ae. mediovittatus 
(Coquillett) 
 
 
 
Various mosquitoes 
of the Ae. 
scultellaris  
(Walker) group 
 
 
 
Ae. mediovittatus 
 
 
 
 
 
 
 
 
 
Haemagogus 
equinus (Theobald) 
Parenteral 
Inoculation 
 
 
 
Intrathoracic 
inoculation 
 
 
 
 
Intrathoracic 
inoculation 
 
 
 
 
 
 
 
 
Intrathoracic 
inoculation 
DENV-1 
 
 
 
 
DENV-1 
DENV-2 
DENV-3 
DENV-4 
 
 
 
DENV-1 
DENV-2 
DENV-3 
DENV-4 
 
DENV-1 
DENV-2 
DENV-3 
DENV-4 
 
DENV-1 
384 
 
 
 
 
50-1724 
90-1500 
341-2031 
169-2958 
 
 
 
6-19 Families º 
7-15 Families º 
NA 
12 Families º 
 
130-720 
114-601 
257-510 
310-506 
 
989 
1500 
2.6 /1000 
 
 
 
 
0-1.7% 
0-1.4% 
0-1.9% 
0-0.6% 
 
 
 
26.7-94.7% 
23.1-75% 
12.5% 
66.7% 
 
0.7-18.8% 
0.7-20.3% 
0.7-3.1% 
0.3-10.5% 
 
2/1000 
1.3/1000 
MIR 
 
 
 
 
FIR 
FIR 
FIR 
FIR  
 
 
 
VTR 
VTR 
VTR 
VTR 
 
FIR 
FIR 
FIR 
FIR 
 
MFIR 
Puerto Rican strain, 
passed at least once 
through a mosquito 
species. 
 
DENV-1 Fiji (1975), DENV-
2 Thailand (1974), DENV-3 
Burma (1976) and DENV-4 
Indonesia (1973). All were 
passed through  Tx. 
amboinensis 
 
Many virus strains had 
been used. All had been 
passed through Tx. 
amboinensis at least once. 
 
 
 
 
Fiji (1975). Passed 3 times 
through Tx. amboinensis. 
Amplification in a 
mosquito, followed 
by  DFAT  
 
 
Amplification in Tx. 
amboinensis, 
followed by Indirect 
fluorescent antibody 
test (IFAT). 
 
 
Amplification in Tx. 
amboinensis , 
followed by  IFAT  
 
 
 
 
 
 
 
IFAT 
Not 
mentioned 
 
 
 
Not 
mentioned 
 
 
 
 
 
Not 
mentioned 
 
 
 
 
 
 
 
 
Not 
mentioned 
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Table 4.3: Summary information of field surveys studying vertical transmission of dengue viruses in mosquitoes that list infection rates for 
individual dengue virus serotypes. 
Source Location Host Species # 
 
Serotype Sample Size 
(individual 
specimens) 
Infection rate Type of 
infection 
rate 
Methodology of Screening Use of 
Controls in 
screening 
(Khin & Than 
1983) 
 
 
 
(Hull et al. 
1984) 
 
 
 
(Serufo et al. 
1993) 
 
 
 
 
(Joshi et al. 
1996) 
 
(Thenmozhi et 
al. 2000) 
 
Rangoon, 
Myanmar 
 
 
 
Trinidad 
 
 
 
 
Campos 
Altos City, 
Brazil 
 
 
 
Jalore, 
India 
 
Tamil 
Nadu, 
India 
 
Ae. aegypti  larvae 
Larval male Ae. aegypti (RAL) 
 
 
 
 Ae. aegypti eggs (RAL) 
 
 
 
 
Larval Ae. albopictus 
 
 
 
 
 
Larval Ae. aegypti (RAL) 
 
 
Adult male Ae. aegypti   
 
Male larvae Ae. aegypti (RAL)   
Female larvae Ae. aegypti 
(RAL) 
DENV-2 
DENV-2 
 
 
 
DENV-4 
 
 
 
 
DENV-1 
 
 
 
 
 
DENV-3 
 
 
DENV-2 
DENV-3 
Unknown 
 
Not found 
6200 
7730 
 
 
 
10957 
 
 
 
 
1128 
 
 
 
 
 
388 
 
 
3701 
3701 
3583 
0.48/1000 
0.26/1000 
 
 
 
0.091/1000 
 
 
 
 
1.77/1000 
 
 
 
 
 
5.7% 
 
 
0.54/1000 
0.27/1000 
0.28/1000 
 
NA 
MIR 
MIR 
 
 
 
MIR 
 
 
 
 
MIR 
 
 
 
 
 
VIR 
 
 
MIR 
MIR 
MIR 
 
NA 
Amplification in Tx. amboinensis 
followed by Direct Fluorescent 
Antibody Technique (DFAT). 
 
 
Amplification in Ae. 
psedoscutellaris cell lines, 
followed by Indirect fluorescent 
antibody test (IFAT). 
 
Amplification in Ae. albopictus 
C6/C36 cell lines, followed by 
Fluorescent Antibody Technique 
(FAT). ELISA followed by RT-PCR 
was used to identify serotyping. 
 
IFAT  
 
 
ELISA. Serotype confirmation 
through amplification in Tx. 
splendens, followed by IFAT. 
Positive 
and 
negative 
controls 
 
Not 
mentioned 
 
 
 
Not 
mentioned 
 
 
 
 
Not 
mentioned 
 
Not 
mentioned 
 
 
 
# Specimens caught in the field and raised to adulthood in the laboratory are listed with the acronym (RAL). 
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Table 4.3: Continued 
Source Location Host Species # 
 
Serotype Sample Size 
(individual 
specimens) 
Infection rate Type of 
infection 
rate 
Methodology of 
Screening 
Use of Controls in 
screening 
(Günther et al. 
2007) 
 
 
 
 
(Akbar et al. 
2008) 
 
(Cecílio et al. 
2009) 
 
 
 
 
 
(Le Goff et al. 
2011) 
 
 
 
(Martins et al. 
2012) 
Oaxaca, 
Mexico 
 
 
 
 
Bandung, 
Indonesia 
 
Minas 
Gerais, 
Brazil 
 
 
 
 
Santa Cruz, 
Bolivia 
 
 
 
Fortaleza, 
Ceara, Brazil 
Larval Ae. aegypti 
Larval Ae. aegypti (RAL)  
 
 
 
 
Larval Ae. aegypti (RAL) 
Larval Ae. aegypti 
 
Immature Aedes species raised to 
4th instar larvae in the lab  
Immature Ae. albopictus raised to 
4th instar larvae in the lab 
Female larval Ae. albopictus (RAL) 
Male larval Ae. albopictus (RAL) 
 
Larvae and pupae Ae. aegypti 
(RAL) 
 
 
 
Female larvae and pupae Ae. 
aegypti  (RAL) 
Female larvae and pupae Ae. 
albopictus (RAL) 
Not found 
DENV-4 
DENV-
2&3 
 
 
DENV-2 
Not found 
 
Combined 
DENV-1-4 
 
DENV-1 
DENV-2 
DENV-2 
 
DENV-1 
DENV-3 
DENV-1 
DENV-3 
 
DENV-2 
 
DENV-2 
DENV-3 
280 and 340 
400 
460 
 
 
 
653 
 
 
3482 
1241 
 
1241 
7 
11 
 
1383 
1383 
1383 
1383 
 
2005 
 
212 
212 
NA 
5/1000 
4.3/1000 
 
 
 
1.5/1000 
NA 
 
22/1000 
1.6/1000 
 
28/1000 
4/7 individuals 
4/11 individuals 
 
3.6/1000 
6.5/1000 
0.37% 
0.68% 
 
0.5/1000 
 
4.7/1000 
9.4/1000 
NA 
MIR 
MIR 
 
 
 
MIR 
NA 
 
MIR 
MIR 
 
MIR 
VIR 
VIR 
 
MIR 
MIR 
TIR 
TIR 
 
MIR 
 
MIR 
MIR 
RT-PCR. Confirmation 
not mentioned. 
 
 
 
 
RT-PCR. Confirmation 
not mentioned. 
 
RT-PCR. Confirmation 
not mentioned. 
 
 
 
 
 
RT-PCR. Confirmation 
not mentioned. 
 
 
 
Amplification in Ae. 
albopictus C6/C36 cell 
lines, followed by IFAT. 
Further confirmation 
with RT-PCR followed by 
nucleotide sequencing. 
Use of negative 
controls for all but 
positive only 
mentioned in a 
figure 
 
Not mentioned 
 
 
Negative and 
positive control 
 
 
 
 
 
Negative controls 
 
 
 
 
Negative control 
for IFAT. Negative 
and positive 
control for RT-PCR 
# Specimens caught in the field and raised to adulthood in the laboratory are listed with the acronym (RAL).  
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Table 4.4a: Summary information of field surveys that failed to find evidence of vertical transmission of dengue viruses in mosquitoes. 
Source Location Host Species# 
 
Serotype Sample Size 
(individual 
specimens) 
Infection 
rate 
Type of 
infection 
rate 
Methodology of Screening Use of 
Controls in 
screening 
(Ramalingam 
et al. 1986) 
 
 
 
 
(Hutamai et al. 
2007) 
 
 
(Zeidler et al. 
2008) 
Kelang, 
Malaysia 
 
 
 
 
Northern 
Thailand 
 
 
Roraima, 
Brazil 
Immature female Ae. aegypti  (RAL) 
Immature male Ae. aegypti (RAL) 
Immature female Ae. albopictus (RAL) 
Immature male Ae. albopictus (RAL) 
 
 
Larval Ae. aegypti (RAL).  
Larval Ae. albopictus (RAL). 
 
 
Ae. aegypti eggs raised to 4th instar larvae 
Not found 
Not found 
Not found 
Not found 
 
 
Not found 
Not found 
 
 
Not found  
20 
34 
215 
221 
 
 
9825 
150 
 
 
Larva 
resulting 
from 1422 
eggs  
NA 
NA 
NA 
NA 
 
 
NA 
NA 
 
 
NA 
NA 
NA 
NA 
NA 
 
 
NA 
NA 
 
 
NA 
Amplification in Tx. 
splendens or Ae. aegypti, 
followed by Direct 
fluorescent antibody test 
(DFAT). 
 
RNA extraction and the 
molecular technique 
NASBA 
 
RT-PCR. Confirmation not 
mentioned. 
Not 
mentioned 
 
 
 
 
Positive and 
negative 
controls 
 
Positive 
controls  
# Specimens caught in the field and raised to adulthood in the laboratory are listed with the acronym (RAL). 
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Table 4.4b: Summary information of field surveys that failed to find evidence of vertical transmission of dengue viruses in mosquitoes, but did 
find evidence of horizontal transmission of dengue viruses. 
Source Location Host Species # 
 
Serotype Sample Size 
(individual 
specimens) 
Infection 
rate 
Type of 
infection 
rate 
Methodology of Screening Use of 
Controls in 
screening 
(Watts et al. 
1985) 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Ilkal et al. 
1991) 
 
 
 
Bangkok, 
Thailand 
 
 
 
 
 
 
 
 
 
 
 
 
 
Maharashtra, 
India 
 
 
 
 
Adult female Ae. aegypti in 
Bangkok 
Adult male Ae. aegypti in Bangkok 
Larvae Ae. aegypti in Bangkok 
Pupae Ae. aegypti in Bangkok 
 
Immature female Ae. aegypti in 
Ban Yang (RAL) 
Immature male Ae. aegypti in Ban 
Yang (RAL) 
Immature female Ae. albopictus in 
Ban Yang (RAL) 
Immature male Ae. albopictus in 
Ban Yang (RAL) 
 
Adult Female Ae. aegypti  
 
 
Adult Male Ae. aegypti  
Larval Male Ae. aegypti  (RAL) 
Larval Female Ae. aegypti  (RAL) 
DENV-2 
 
Not found 
Not Found 
Not Found 
 
Not found 
 
Not found 
 
Not found 
 
Not found 
 
 
DENV-2 
DENV-3 
Unknown  
Not Found 
Not Found 
Not Found 
268 
 
85 
5839 
39 
 
505 
 
187 
 
1740 
 
1459 
 
 
375 
375 
375 
64 
281 
323 
5.2% 
 
NA 
NA 
NA 
 
NA 
 
NA 
 
NA 
 
NA 
 
 
2.1% 
0.8% 
4.8% 
NA 
NA 
NA 
IR 
 
NA 
NA 
NA 
 
NA 
 
NA 
 
NA 
 
NA 
 
 
IR 
IR 
IR 
NA 
NA 
NA 
DFAT. Confirmation by 
amplification in Ae. 
pseudoscutellaris cell line or 
Tosorhynshites mosquitoes, 
followed by  DFAT  
 
 
 
 
 
 
 
 
 
 
IFAT. Confirmation by 
amplification in Ae. aegypti, 
followed by IFAT. Serotype 
identification through 
amplification in Ae. albopictus 
cell lines or mice, followed by 
complement fixation. 
Not 
mentioned 
 
 
 
 
 
 
 
 
 
 
 
 
 
Not 
mentioned 
# Specimens caught in the field and raised to adulthood in the laboratory are listed with the acronym (RAL). 
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Table 4.4b: Continued  
Source Location Host Species  Serotype Sample Size 
(individual 
specimens)* 
Infection rate* Type of 
infection 
rate 
Methodology of Screening Use of 
Controls in 
screening 
(Chow et al. 
1998) 
 
 
 
 
 
 
 
(Romero-Vivas 
et al. 1998) 
 
 
 
(Pinheiro et al. 
2005) 
 
 
 
(Chen et al. 
2010) 
 
Singapore 
 
 
 
 
 
 
 
 
Puerto 
Triunfo 
Columbia 
 
 
Manaus, 
Amazonas, 
Brazil 
 
 
Southern 
Taiwan 
Adult Female Ae. aegypti   
 
 
Larval Aedes   
 
Adult Female Ae. albopictus  
 
 
 
Adult Female Ae. aegypti   
 
Adult Male Ae. aegypti   
 
 
Adult Female Ae. aegypti 
Adult Male Ae. aegypti 
Immature Ae. aegypti 
 
 
Adult female Ae. aegypti pooled 
across all sample 
Adult female Ae. aegypti by month 
Adult female Ae. aegypti by month 
and city level 
Adult male Ae. aegypti 
Adult female Ae. albopictus 
Adult male Ae. albopictus 
DENV-1 
DENV-2 
DENV-3 
Not Found 
 
DENV-1 
DENV-2 
DENV-4 
 
DENV-1 
DENV-2 
Not Found 
 
 
DENV-3 
Not Found 
Not Found  
 
 
Combined 
DENV-1-4 
DENV-1-4 
DENV-1-4 
 
Not found 
Not found 
Not found 
409 
409 
409 
53 pools of 1-
10 individuals 
784 
784 
784 
 
130-670 
359-670 
1522 
 
 
374 
300 
1142 
 
 
12372 
12372 
939-1996 
75-1364 
 
49759 
57,319  
21,996 
44/1000 
4.9/1000 
2.5/1000 
NA 
 
10/1000 
6.4/1000 
1.3/1000 
 
0.15-0.77% 
0.27-1.9% 
NA 
 
 
37/1000 
NA 
NA 
 
 
0.97/1000 
0.97/1000 
0.5-2.2/1000 
0.73-12.6 /1000 
 
NA 
NA 
NA 
MIR 
MIR 
MIR 
NA 
 
MIR 
MIR 
MIR 
 
IR 
IR 
NA 
 
 
MIR 
NA 
NA 
 
 
MLE 
MIR 
MLE 
MLE 
 
NA 
NA 
NA 
RT-PCR. Confirmation of DENV-
1 and DENV-2 by nucleotide 
sequencing. 
 
 
 
 
 
 
FAT 
 
 
 
 
RT-PCR. And further 
confirmation by amplification in 
C6/C36 cells, followed by IFAT 
and nucleotide sequencing. 
 
qRT-PCR. Confirmation by 
nucleotide sequencing. 
Not 
mentioned  
 
 
 
 
 
 
 
Positive 
controls 
 
 
 
Negative 
controls for 
IFAT 
 
 
Not 
mentioned 
*Where multiple infection rates were taken for the same type of host species, at the same stage of life-cycle, the range of sample sizes and infection rates are listed.  
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Table 4.5: Summary information of field surveys studying vertical transmission of dengue viruses in mosquitoes that list infection rates for 
dengue virus serotypes combined. 
Source Location Host Species # 
 
Sample Size 
(individual 
specimens)* 
Infection rate 
* 
Type of 
infection 
rate 
Methodology of Screening Use of 
Controls in 
screening 
(Ahmad et al. 
1997) 
 
 
 
(Kow et al. 
2001) 
 
(Lee & Rohani 
2005) 
 
 
 
(Joshi et al. 
2006) 
 
 
(Rohani et al. 
2007)  
Malaysia 
 
 
 
 
Singapore 
 
 
Kuala 
Lumpur, 
Malaysia 
 
 
Johpur 
City, India 
 
 
Malaysia 
 
Larval Ae. aegypti  (RAL) 
Larval Ae. albopictus (RAL) 
 
 
 
Adult male Ae. aegypti   
Adult male Ae. albopictus 
 
Immature Ae. aegypti (raised to 3rd instar larvae 
within the lab). 
Immature Ae. albopictus (raised to 3rd instar 
larvae within the lab). 
 
Tree-hole found larvae Ae. albopictus (RAL)   
Tree-hole found larvae Ae. aegypti (RAL)   
Tree-hole found larvae Ae. vittatus (Bigot) (RAL)   
 
Larval Ae. aegypti (via PAP staining) 
For All Larval Ae. aegypti (via PAP staining) 
Larval Ae. aegypti (via RT-PCR) 
For All Larval Ae. aegypti (via RT-PCR) 
Larval Ae. albopictus (via PAP staining) 
For All Larval Ae. albopictus (via PAP staining) 
Larval Ae. albopictus (via RT-PCR) 
For All Larval Ae. albopictus (via RT-PCR) 
14605 
47804 
 
 
 
600 
837 
 
19434 
 
3759 
 
 
67 
23 
4 
 
40-510 
2250 
20-290 
990 
10-340 
2130 
220-290 
780 
0.14/1000 
0.15/1000 
 
 
 
1.33% 
2.15% 
 
5.77-40/1000  
 
2.4-14/1000 
 
 
9% 
Not found 
Not found 
 
3.9-31/1000 
16/1000 
6.9-50/1000 
12/1000 
2.9-100/1000 
17/1000 
4.5-10/1000 
7.7/1000 
MIR 
MIR 
 
 
 
VIR 
VIR 
 
MIR 
 
MIR 
 
 
VIR 
NA 
NA 
 
MIR 
MIR 
MIR 
MIR 
MIR 
MIR 
MIR 
MIR 
Amplification in Ae. 
albopictus C6/C36 cell lines, 
followed by PAP. Further 
confirmation with RT-PCR 
 
RT-PCR. Confirmation by 
nucleotide sequencing. 
 
Amplification in C6/C36 
cells, followed by PAP. 
 
 
 
IFAT 
 
 
 
Amplification in C6/C36 cells 
followed by PAP staining and 
RT-PCR 
 
Positive and 
negative 
controls for 
PAP staining. 
 
Negative 
controls 
 
Not 
mentioned 
 
 
 
Not 
mentioned 
 
 
Positive and 
negative 
controls for 
RT-PCR 
# Specimens caught in the field and raised to adulthood in the laboratory are listed with the acronym (RAL). 
*Where multiple infection rates were taken for the same type of host species, at the same stage of life-cycle, the range of sample sizes and infection rates are listed.  
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Table 4.5: Continued. 
Source Location Host Species # 
 
Sample Size 
(individual 
specimens)* 
Infection rate * Type of 
infection 
rate 
Methodology of Screening Use of Controls 
in screening 
(Arunachalam 
et al. 2008) 
 
 
(Angel et al. 
2008) 
 
 
 
 
 
 
(Angel & Joshi 
2008) 
 
 
(Thongrungkiat 
et al. 2011) 
Chennai, 
Tamil 
Nadu, India 
 
Rajasthan, 
India  
 
 
 
 
 
 
Rajasthan, 
India 
 
 
Bangkok, 
Thailand 
 
Adult male Ae. aegypti 
 
 
 
Larval Ae. aegypti (RAL)  Jodhpur Strain  
Larval Ae. aegypti (RAL)  Kota Strain 
Larval Ae. vittatus (RAL) Jodhpur Strain 
Larval Ae. vittatus (RAL) Jaipur Strain 
Larval Ae. albopictus (RAL) Jodhpur Strain 
 
 
 
Larval Ae. aegypti (RAL) 
Larval Ae. albopictus (RAL) 
Larval Ae. vittatus (RAL) 
 
Larval Ae. aegypti  dark form strain (RAL)  
Larval Ae. aegypti  pale form strain (RAL)  
 
 
5408 
 
 
 
37 
35 
61 
11 
39 
 
 
 
977 
251 
383 
 
15179 
278 
2.7-28/1000 
 
 
 
160/1000 
29/1000 
16/1000 
180/1000 
26/1000 
 
 
 
11.2% 
15.9% 
8.4% 
 
15.6/1000 
12.9/1000 
MIR 
 
 
 
VIR 
VIR 
VIR 
VIR 
VIR 
 
 
 
VIR 
VIR 
VIR 
 
MIR 
MIR 
ELISA. Serotype confirmation 
through amplification in Tx. 
splendens, followed by IFAT. 
 
IFAT, further confirmed by 
pooling positives, amplifying in 
mice and retesting by IFAT. 
 
 
 
 
 
IFAT, further confirmed by 
pooling positives, amplifying in 
mice and retesting by IFAT. 
 
RT-PCR. Confirmation not 
mentioned. 
 
 
 
Not mentioned 
 
 
 
Not mentioned 
 
 
 
 
 
 
 
Positive and 
negative 
controls 
 
Positive and 
negative 
control in 
example figure. 
# Specimens caught in the field and raised to adulthood in the laboratory are listed with the acronym (RAL). 
*Where multiple infection rates were taken for the same type of host species, at the same stage of life-cycle, the range of sample sizes and infection rates are listed. 
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Table 4.6: Summary information of field survey that searched for vertical and horizontal transmission of dengue viruses in mosquitoes. 
Source Location Host Species # Serotype Sample Size 
(individual 
specimens) 
Infection 
rate 
Type of 
infection 
rate 
Methodology of Screening Use of 
Controls in 
screening 
(Ibáñez-
Bernal et al. 
1997) 
 
 
 
(Fouque et 
al. 2004) 
 
 
 
(Thavara et 
al. 2006) 
 
 
 
(Thenmozhi 
et al. 2007) 
 
 
 
 
(Das Bina et 
al. 2008) 
 
Reynosa, 
Mexico 
 
 
 
 
French 
Guiana 
 
 
 
Southern 
Thailand 
 
 
 
Kerala, 
Southern 
India 
 
 
 
Jaipur and 
Delhi, India 
Adult female Ae. aegypti 
Adult male Ae. aegypti 
Adult female Ae. albopictus 
Adult male Ae. albopictus 
 
 
Eggs Ae. aegypti (RAL). 
Larval Ae. aegypti (RAL). 
Adult Male Ae. aegypti 
Adult Female Ae. aegypti 
 
Adult Female Ae. aegypti 
 
Adult Male Ae. aegypti 
 
 
Female larval Ae. albopictus (RAL). 
Adult female Ae. albopictus 
 
Adult male Ae. albopictus 
 
 
Adult male Ae. aegypti 
Adult Female Ae. aegypti 
Larval Ae. aegypti (RAL) 
Not found 
Not found 
Not found 
DENV-2 
DENV-3 
 
DENV-4 
DENV-4 
Not found 
Not found 
 
Combined 
DEN1-4 
Combined 
DEN1-4 
 
DENV-1 
Unknown 
serotype 
Unknown 
serotypes 
 
Not found 
Not found 
Combined 
DENV-1-4 
1051 
1600 
2339 
647 
647 
 
3435 
4078 
502 
251 
 
145 
 
324 
 
 
1485 
1445 
 
1817 
 
 
3 
3 
63 
NA 
NA 
NA 
1.5/1000 
1.5/1000 
 
0.58/1000 
0.25/1000 
NA 
NA 
 
15% 
 
16% 
 
 
0.67/1000 
0.69/1000 
 
2.2/1000 
 
 
NA 
NA 
48/1000 
NA 
NA 
NA 
MIR 
MIR 
 
MIR 
MIR 
NA 
NA 
 
IR 
 
VIR 
 
 
MIR 
MIR 
 
MIR 
 
 
NA 
NA 
MIR 
 
Amplification in (Ae. albopictus) 
C6/C36 cells or VERO (green-
monkey kidney) cells, followed 
by haemagglutination, IFAT and 
confirmation by RT-PCR. 
 
Amplification in AP61 cell 
culture, followed by IFAT. 
 
 
 
RT-PCR. Confirmation not 
mentioned. 
 
 
 
ELISA. Serotype confirmation 
through amplification in Tx. 
splendens, followed by IFAT. 
 
 
 
ELISA 
 
Negative 
controls 
 
 
 
 
Not 
mentioned 
 
 
 
Positive and 
negative 
controls 
 
 
Positive and 
negative 
controls 
used for 
ELISA 
 
Positive and 
negative 
controls 
# Specimens caught in the field and raised to adulthood in the laboratory are listed with the acronym (RAL). 
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Table 4.6: Continued 
Source Location Host Species # 
 
Serotype Sample Size 
(individual 
specimens)* 
Infection rate * Type of 
infection 
rate 
Methodology of 
Screening 
Use of Controls 
in screening 
(Guedes et al. 
2010) 
 
 
 
 
 
(Vilela et al. 
2010) 
 
 
(de Figueiredo 
et al. 2010)  
Recife, Brazil 
 
 
 
 
 
 
Minas 
Gerais, 
Brazil 
 
 
Various 
regions of 
Brazil 
Ae. aegypti eggs (RAL) 
 
 
Adult Female Ae. aegypti 
 
 
 
Female adult Ae. aegypti 
Male adult Ae. aegypti 
Ae. aegypti  eggs raised to larvae 
for identification 
 
Female adult Haemagogus 
leucocelaenus (Dyar & Shannon) 
Female adult Ae. aegypti 
Female adult Ae. aegypti 
Larval Ae. albopictus 
Female adult Ae. albopictus 
Male adult Ae. albopictus 
Male adult Ae. aegypti 
DENV-1 
DENV-2 
DENV-3 
DENV-1 
DENV-2 
DENV-3 
 
DENV-3 
DENV-3 
DENV-3 
 
 
DENV-1 
 
DENV-1 
DENV-2 
DENV-3 
Not found 
Not found 
Not found 
2972 
2972 
2972 
301 
301 
301 
 
137 
100 
5573 
 
 
170 
 
43 
403 
542 
49 
39 
31 
1/1000 
3.4/1000 
1.3/1000 
17/1000 
6.6/1000 
6.6/1000 
 
21.9/1000 
10/1000 
0.18/1000 
 
 
5.8/1000 
 
23/1000 
2.5/1000 
5.5/1000 
NA 
NA 
NA 
MIR 
MIR 
MIR 
MIR 
MIR 
MIR 
 
MIR 
MIR 
MIR 
 
 
MIR 
 
MIR 
MIR 
MIR 
NA 
NA 
NA 
RT-PCR. 
Confirmation 
not mentioned. 
 
 
 
 
RT-PCR. 
Confirmation by 
nucleotide 
sequencing. 
 
RT-PCR. DENV-3 
confirmed by 
nucleotide 
sequencing.  
 
Not mentioned 
 
 
 
 
 
 
Not mentioned 
 
 
 
 
Positive and 
negative control 
in example 
figure.  
 
# Specimens caught in the field and raised to adulthood in the laboratory are listed with the acronym (RAL). 
*Where multiple infection rates were taken for the same type of host species, at the same stage of life-cycle, the range of sample sizes and infection rates are listed. 
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Table 4.6: Continued 
Source Location Host Species # 
 
Serotype Sample Size 
(individual 
specimens)* 
Infection rate 
* 
Type of 
infection 
rate 
Methodology of 
Screening 
Use of Controls 
in screening 
(Mulyatno 
et al. 2012)  
 
 
 
 
 
(Das et al. 
2013) 
 
 
 
 
 
 
 
 
(Martínez 
et al. 2014) 
Surabaya, 
Indonesia 
 
 
 
 
 
Orissa state, 
India 
 
 
 
 
 
 
 
 
Acapulco, 
Mexico 
Female adult Ae. aegypti 
 
Male adult Ae. aegypti 
Female larval Ae. aegypti (RAL) 
Male larval Ae. aegypti (RAL) 
Larval Ae. aegypti  
 
Adult Female Ae. albopictus 
Pupae Ae. albopictus (RAL) 
Pupae Ae. aegypti  (RAL) 
Adult Female Ae. albopictus 
Pupae Ae. albopictus (RAL) 
 
Pupae Ae. aegypti  (RAL) 
Pupae Ae. albopictus (RAL) 
from control site 
 
Male larvae Ae. aegypti (RAL)   
Female larvae Ae. aegypti (RAL)   
Adult male Ae. aegypti   
Adult female Ae. aegypti   
DENV-1 
DENV-2 
DENV-1 
DENV-1 
DENV-1 
DENV-1 
 
DENV-2 
DENV-2 
DENV-2 
DENV-2 
DENV-2 
DENV-3 
DENV-2 
DENV-2 
 
 
DENV-1 
Not found 
DENV-1 
Not found 
65-94 
127 
62-78 
250-453 
350-582 
550 
 
112 
687 
381 
112 
687 
687 
381 
440 
 
 
Unclear 
Unclear 
Unclear 
Unclear 
23-32/1000  
16/1000 
16-26/1000 
8-2.1/1000 
5.7-8.6/1000 
5.5/1000 
 
8.92/1000 
6.09 /1000 
2.63/1000 
8.9/1000 
5.8/1000 
1.5/1000 
2.6/1000 
2.27/1000 
 
 
1.4/1000 
NA 
6.18/1000 
NA 
MIR 
MIR 
MIR 
MIR 
MIR 
MIR 
 
MLE 
MLE 
MLE 
MIR 
MIR 
MIR 
MIR 
MLE 
 
 
MLE 
NA 
MLE 
NA 
Amplification in C6/C36 
cells followed by RT-
PCR. Confirmation not 
mentioned. 
 
 
 
RT-PCR. 4 DENV-2 pools 
and 1 DENV-3 pool 
confirmed by nucleotide 
sequencing. 
 
 
 
 
 
 
RT-PCR. Confirmation 
not mentioned.  
 
Not mentioned 
  
 
 
 
 
 
Positive 
controls 
(negative 
control in an 
example 
figure.) 
 
 
 
 
Not mentioned 
 
# Specimens caught in the field and raised to adulthood in the laboratory are listed with the acronym (RAL). 
*Where multiple infection rates were taken for the same type of host species, at the same stage of life-cycle, the range of sample sizes and infection rates are listed. 
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Table 4.6: Continued 
Source Location Host Species # 
 
Serotype Sample Size 
(individual 
specimens) 
Infection rate  Type of 
infection 
rate 
Methodology of Screening Use of Controls 
in screening 
(Sanchez-
Rodríguez 
et al. 2014) 
 
 
 
 
(Yang et al. 
2014) 
 
 
 
(Espinosa 
et al. 2014) 
Monterrey, 
Mexico 
 
 
 
 
 
Shenzhen, 
China 
 
 
 
Puerto Iguazú, 
Misiones, 
Argentina 
Larvae Ae. aegypti (RAL)   
Larvae Ae. albopictus  (RAL)   
Adult male Ae. aegypti   
Adult female Ae. aegypti   
Adult male Ae. albopictus   
Adult female Ae. albopictus 
 
Larvae Ae. aegypti (RAL)   
Adult male Ae. aegypti   
Adult female Ae. aegypti   
 
 
Adult male Ae. aegypti   
Adult female Ae. aegypti   
Not found 
Unknown 
Not found 
Not found 
Not found 
Not found 
 
DENV-1 
Not found 
Not found 
 
 
DENV-3 
Not found 
833 
1836 
81 
67 
151 
405 
 
9000 
Not mentioned 
Not mentioned 
 
 
Not mentioned 
Not mentioned 
NA 
0.544/1000 
NA 
NA 
NA 
NA 
 
0.3/1000 
NA 
NA 
 
 
1 positive pool 
NA 
NA 
MIR 
NA 
NA 
NA 
NA 
 
MIR 
NA 
NA 
 
 
NA 
NA 
RT-PCR. Confirmation not 
mentioned. 
 
 
 
 
 
RT-PCR. Unclear if 
nucleotide sequence 
confirmation was used 
mosquito samples. 
 
RT-PCR Confirmation by 
nucleotide sequencing. 
Positive and 
negative 
controls 
 
 
 
 
Not mentioned 
for entomology 
screenings 
 
 
Not mentioned 
# Specimens caught in the field and raised to adulthood in the laboratory are listed with the acronym (RAL). 
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Table 4.7: Summary information of laboratory studies on the vertical transmission of dengue viruses through several generations of 
mosquitoes. 
Source Host Species Infection 
route of F0 
Generation 
Serotype 
of 
dengue 
Sample Size 
(Generation followed by 
individuals tested) 
Infection 
rate 
Type of 
infection 
rate 
Origin of dengue 
serotype 
Methodology of 
Screening 
Use of 
Controls in 
screening 
(Shroyer 
1990) 
 
 
 
 
 
 
 
 
(Joshi & 
Sharma 2001) 
 
 
 
 
 
 
 
 
(Joshi et al. 
2002) 
Ae. albopictus  
F0 to F3 
 
 
 
 
 
 
 
 
Ae. aegypti F0 
to F7 
 
 
 
 
 
 
 
 
Ae. aegypti F0 
to F7 
Intrathoracic 
inoculation 
 
 
 
 
 
 
 
 
Intrathoracic 
inoculation 
 
 
 
 
 
 
 
 
Intrathoracic 
inoculation 
 
DENV-1 
 
DENV-1 
 
 
 
 
 
 
 
DENV-3 
 
 
 
 
 
 
 
 
 
DENV-3 
 
 
 
F0 279, F1 475 
F1 2,      F2 104 
F0 279,  F1 475 
F1 2,      F2 24 and 80 
F2 2,      F3 11 and 59 
 
 
 
 
 
F0 16,  F1 50 
F1 Unclear, F2 142 
F2 Unclear, F3 431 
F3 Unclear, F4 37 
F4 Unclear, F5 65 
F5 Unclear, F6 26 
F6 Unclear, F7 180 
 
 
 
F0 Unclear probably 200, F1 123 
F1 200, F2 158 
F2 200, F3 258 
F3 200, F4 122 
F4 200, F5 154 
F5 200, F6 145 
F6 200, F7 157 
0.7% 
100% 
0.4% 
2.5 and 4.2% 
0 and 3.4% 
 
 
 
 
 
52% 
55.6% 
55.6% 
67.5% 
30.7% 
23.0% 
15.5% 
 
 
 
2.8% 
8.6% 
13.0% 
11.7% 
11.6% 
11.7% 
12.6% 
VTR 
VTR 
FIR 
FIR 
FIR 
 
 
 
 
 
VIR 
VIR 
VIR 
VIR 
VIR 
VIR 
VIR 
 
 
 
VIR 
VIR 
VIR 
VIR 
VIR 
VIR 
VIR 
Fiji. Passed once 
through Ae. 
albopictus and 
twice in Tx. 
amboinensis. 
 
 
 
 
 
Other than the 
serial number for 
the National 
Institute of 
Virology, Pune, 
India, where the 
virus is stored 
information is 
scant (633978). 
 
Thailand (1963). 
Passed through 
mice 21 times. 
 
 
 
Individual 
samples directly 
analyzed by IFAT. 
Followed by 
double checking 
of negatives, by 
amplification in 
Tx. amboinensis, 
followed by IFAT. 
 
IFAT 
 
 
 
 
 
 
 
 
 
Amplification in a 
mosquito, 
followed by IFAT 
 
 
Not 
mentioned 
 
 
 
 
 
 
 
 
Not 
mentioned 
 
 
 
 
 
 
 
 
Not 
mentioned 
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Table 4.7: Continued 
Source Host Species Infection 
route of F0 
Generation 
Serotype 
of 
dengue 
Sample Size 
(Generation followed by 
individuals tested) 
Infection 
rate 
Type of 
infection 
rate 
Origin of 
dengue 
serotype 
Methodolog
y of 
Screening 
Use of 
Controls in 
screening 
(Wasinpiyamo
ngkol et al. 
2003) 
 
 
 
 
 
 
 
 
 
 
 
 
(Rohani et al. 
2008) 
 
Pale Ae. aegypti F0 to 
F1 
 
 
Dark Ae. aegypti F0 
F3 
 
 
 
 
 
 
 
 
 
Ae. aegypti  F0 to F5 
Oral 
inoculation 
 
 
 
 
 
 
 
 
 
 
 
Oral 
inoculation 
DENV-2 
 
 
 
 
 
 
 
 
 
 
 
 
 
DENV-2 
F0 41,  F1 36 from a vertically 
transmitting family,  11, 10 
and 5 from non- vertically 
transmitting families  
F0 63, F1 54 from a vertically 
transmitting family, 17 and 5 
from non- vertically 
transmitting families  
F1 2, F2 59 from a vertically 
transmitting family, 17 from 
a non- vertically transmitting 
family  
F2 2, F3 70 from a vertically 
transmitting family 
 
F0 100-150, F1 200 
F1 approximately 250, F2 200 
F2 approximately 250, F3 200 
F3 approximately 250, F4 200 
F4 approximately 250, F5 200 
2.7% 
 
 
 
3.7% 
 
 
 
3.3% 
 
 
 
1.4% 
 
 
45/1000 
45/1000 
35/1000 
35/1000 
30/1000 
FIR 
 
 
 
FIR 
 
 
 
FIR 
 
 
 
FIR 
 
 
MIR 
MIR 
MIR 
MIR 
MIR 
Thailand 
passed a 
number of 
times through 
Toxorhynchite
s mosquitoes. 
 
 
 
 
 
 
 
 
Malaysia 
(2004). Passed 
an unspecified 
number of 
times through 
C6/36 Ae. 
albopictus 
cells. 
IFAT  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amplification 
in cell 
culture, 
followed by 
PAP. 
Not 
mentioned 
 
 
 
 
 
 
 
 
 
 
 
 
 
Positive 
and 
negative 
control 
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4.6 The mechanistic basis of vertical transmission 
Rosen (1987a) suggests that the reason for the low rate of vertical transmission 
of dengue viruses may be due to its mechanical basis. Infection of Aedes would have to 
take place after the development of the egg via the micropyle during fertilisation at the 
time of oviposition (transmission occurring from either the father or mother), due to the 
fact that the eggs begin to develop as soon as the blood meal is taken and once 
developed the eggs are surrounded by a thick chorion. This chorion would present a 
barrier for dengue viruses reaching the eggs. 
Many field studies in this review use the detection of dengue viruses in male 
mosquitoes to infer that vertical transmission has taken place because male mosquitoes 
do not feed on blood (Service 2012). In order to discount the possibility that male 
mosquitoes have not acquired dengue viruses through sexual transmission, Rosen in 
1987(b) determined that whilst male Ae. albopictus could sexually infect female Ae. 
albopictus, females could not infect males. However this is the only direct research on 
sexual transmission of dengue viruses in mosquitoes. Also worth noting is that this 
study found that some of the offspring of female Ae. albopictus infected from males, 
were dengue virus positive and suggested that the incubation rate for vertical 
transmission via this route was quicker than through the oral or intrathoracic 
inoculation. Rosen (1987b) suggested that these findings support his previous 
suggestion (Rosen 1987a) that vertical transmission occurs during fertilisation at the 
time of oviposition.  
Immunoflourscent techniques have been used to stain the organs of orally and 
parenterally DENV-1 infected Ae. albopictus and Ae. aegypti (Chen et al. 1993). 
DENV-1 infections were found in the female ovarioles, oviducts and accessory glands. 
The male testes, vas deferens, seminal vesicles and accessory glands were infected but 
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the spermathecae were not, possibly due to a chitinous barrier. This work supports the 
previous finding that whilst male Ae. albopictus could sexually infect female Ae. 
albopictus, females could not infect males sexually (Rosen 1987b). Chen et al. (1993) 
also suggest that the mechanism of vertical infection is during fertilisation at the time of 
oviposition (Rosen 1987a), however their report suggests that further study would be 
needed. 
Tu et al. (1998) used IFAT and electron-microscopy to study the reproductive 
system of DENV-2 intrathoracically infected male Ae. aegypti. As with previous studies 
(Chen et al. 1993) most of the tissue of male reproductive system was found to be 
infected but the actual germ cells (i.e. spermatogonia, spermatocytes, spermatid and 
spermatozoa) were not infected. This work further supports the findings of Rosen 
(1987b) that infected males have the ability to sexually transmit dengue viruses and also 
transmit the virus to their offspring at fertilisation (Rosen 1987a; Rosen 1987b). 
In a survey of ovarian proteins and dengue virus infections of Ae. aegypti, Ae. 
albopictus and Ae. vittatus (caught in the field as larvae and raised to adulthood in the 
lab) Angel et al. (2008) suggested a negative association between dengue virus 
infections and a 200kDa protein (see Table 4.5). If associations exist between ovarian 
proteins and dengue virus infections this could shed light on the mechanism of vertical 
transmission and any genetic associations with vertical transmission within the vector. 
However Angel et al. (2008) provided no statistical evidence for this association. 
Using RT-PCR and Western blot screening for dengue virus E protein, Zhang et 
al. (2010) detected no DENV-2 replication in the ovaries of intrathoracic infected Ae. 
albopictus. This may well add to Rosen (1987a) suggestion that vertical transmission 
occurs during fertilisation at the time of oviposition. Zhang et al. (2010) suggest that the 
lack of viral replication in the ovaries may explain why vertical transmission occurs at 
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such a low rate and that further study on the mechanism of vertical transmission may 
shed light on this. As such there is relatively little knowledge of the mechanistic basis of 
vertical transmission of dengue viruses, although the research available is reasonably 
consistent. 
4.7 Transgenerational vertical transmission of dengue virus 
Shroyer (1990) found that DENV-1 virus could be transmitted vertically across 
3 generations, by selecting the eggs of those females that had been infected through 
vertical transmission. The VTR increased dramatically from the F1 to the F2 generation 
from 0.7% to 100% (see Table 5.7), suggesting that there was heritable variation in 
VTR for dengue viruses within either the mosquito host or the dengue virus.  The 
number of offspring that had acquired DENV-1 from their mother ranged from 0-4.2% 
FIR. Bosio et al. (1992) in a lab study using DENV-1 infected several strains of Ae. 
albopictus and measured the variation in their FIR and VTR. Bosio et al. (1992) found 
that the variation in FIR was insignificant between strains of Ae. albopictus. However 
Bosio et al. (1992) found a greater source of variation in FIR in the different families, 
within the strains (≈95.2%) (see Table 4.1). The study by Bosio et al. (1992) finding 
high variation in FIR between different families and the findings of Shroyer (1990) 
selection experiment suggest that higher rates of FIR and VTR could be selected for. 
Joshi et al. (2002) demonstrated using a lab strain of Ae. aegypti, that DENV-3 
viruses could persist through vertical transmission for 7 generations (see Table 5.7). The 
vertically infected lines had an increased larval mortality rate compared to control lines, 
but no statistical analysis was carried out (Joshi et al. 2002). In what seems to have been 
a preliminary study to Joshi et al. 2002, the progeny of Ae. aegypti infected with 
DENV-3, were measured for success in reaching adulthood, for seven generations 
(Joshi & Sharma 2001) (see Table 5.7). It is unclear whether each of the seven 
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generations was intrathoracically infected with DENV-3, or whether the eggs of 
vertically infected adults were selected for use in the proceeding generation. Joshi & 
Sharma (2001) state there was a higher failure rate in reaching adulthood for the virus 
infected line compared to the control line (however no statistical analyses was 
presented). Wasinpiyamongkol et al. (2003) was similarly able to demonstrate using Ae. 
aegypti that DENV-2 viruses could persist through vertical transmission for 3 
generations of mosquitoes (see Table 5.7). The experimental procedure of selecting 
eggs from mothers that were found to be positive for DENV-2, was similar to Joshi et 
al. (2002) but unlike Joshi et al. (2002) no comparisons were made with a control group. 
Rohani et al. (2008) using a laboratory strain of Ae. aegypti and DENV-2 further 
showed that dengue viruses can persist through several generation of Ae. aegypti via 
vertical transmission (see Table 5.7). The experimental set up was similar to that of 
Joshi et al. (2002). It is worth noting that the decrease in MIR found with subsequent 
generations led to DENV-2 not persisting past the 5
th
 generation. Rohani et al. (2008) 
report a low hatching rate of 50% within this study but as no experimental control line 
was used during their experiment, the effect of dengue viruses upon Ae. aegypti egg 
hatching rate cannot be inferred.  
Taken together these studies suggest that there may be heritability in vertical 
transmission and that the virus has the potential to persist through multiple generations, 
via vertical transmission. Furthermore some studies suggest that such heritability in 
vertical transmission of dengue viruses could lead to its selection. However it remains 
unclear with many studies whether heritability of this trait is within the host or the virus 
and it is unknown how important is such selection in nature. 
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4.8 Lab studies on vertical transmission to desiccated and diapausing eggs 
As stated in the introduction to this chapter (section 4.1) the eggs of both Ae. 
aegypti and Ae. albopictus can withstand desiccation but only certain strains of Ae. 
albopictus eggs undergo diapause (M. Service 2012b; WHO 2015d). The vertical 
transmission of dengue virus to either diapausing or desiccated mosquito eggs could 
provide a reservoir of dengue virus capable of persisting through seasons of low adult 
vector abundance. In a lab experiment using Ae. albopictus, Gokhale et al. (2001) found 
that the larvae and adult offspring of Ae. albopictus, intrathoracically infected with 
DENV-2, had higher rates of DENV-2 infection if the eggs from which they had 
emerged were desiccated for 1-2 months (see Table 4.1). Whilst this is one of the few 
studies to look at the role of diapausing or desiccated eggs on vertical transmission of 
dengue viruses, Gokhale et al. (2001) do not present the statistics used in their findings 
and the pools used to analyse their samples were of different sizes leading to a possible 
bias. Mourya et al. (2001) similarly found that the larvae, adult male and female 
offspring of female adult Ae. aegypti intrathoracically infected with DENV-2, had 
higher rates of DENV-2 infection if the eggs from which they had emerged were 
desiccated for 1-2 months (see Table 4.1). However again no statistic comparison is 
made and the pool sizes of samples used in the analysis are not discussed.  
In one of the few studies to look at dengue virus replication in Aedes eggs, Guo 
et al. (2007) found that DENV-2 was replicating in non-diapausing Ae. albopictus but 
not in diapausing Ae. albopictus (see Table 4.1). Guo et al. (2007) suggests that dengue 
viruses could be surviving in diapausing eggs in a quiescent state. This would seem to 
suggest that leaving dengue virus infected Aedes eggs in a diapausing state for a long 
period of time should have no positive effect on whether the mosquito still has the 
dengue virus infection later in life. If dengue viruses were replicating during diapause 
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you would expect a higher viral load at the start of the mosquito’s life cycle and 
therefore a decreased chance of the mosquito clearing the infection as it progresses 
through the life-cycle. Unusually Guo et al. (2007) only used eggs from the second and 
third gonotrophic cycle and no reason is given as to why eggs from the first gonotrophic 
cycle were not used. Guo et al. (2007) found no significant difference between the 
survivorship of DENV-2 exposed and non-DENV-2 exposed eggs but did find 
significantly higher hatching rates in infected non-diapausing eggs compared to infected 
diapausing eggs. However, Guo et al. (2007) did not make a comparison between 
infected and non-infected diapausing eggs. If such a comparison was made it would be 
possible to determine if dengue virus infection has a detrimental effect on Aedes eggs 
surviving through diapause. 
Questions remain on whether infection in diapausing or desiccated eggs is 
detrimental to the pharate embryo (Adams and Boots 2010). The work of Joshi and 
Sharma (2001) and Joshi et al. (2002) suggests that vertically acquired dengue virus 
could have a detrimental effect on a mosquito’s mortality rate and fecundity due to lost 
resources and damage through the viral infection. Some laboratory studies have 
demonstrated that horizontally acquired dengue virus can also have a negative effect on 
Ae. aegypti longevity and fecundity (Maciel-de-Freitas et al. 2011; Sylvestre et al. 2013) 
but others have found no effect on Ae. aegypti mortality rate (Carrington et al. 2015).  
As such not only is there a need to assess the efficiency of dengue virus transmission to 
eggs but any effects on the fitness of vertically infected mosquitoes, including 
mosquitoes that survive diapause or being desiccated as eggs.    
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4.9 Field and lab studies comparing vertical transmission in Ae. albopictus and 
Ae. aegypti 
Malaysian strains of Ae. albopictus and Ae. aegypti, were fed a blood meal 
containing either one or all four of dengue virus serotypes (Lee et al. 1997). It is unclear 
if all four dengue virus serotypes were in the infectious blood meal or in separate blood 
meals given to separate groups of mosquitoes. Pools of fourth instar Ae. aegypti from 
the resulting second batch of eggs were found to be positive for dengue viruses (see 
Table 4.1) but no dengue viruses were detected in the larvae from the first and second 
batch of Ae. albopictus or the first batch Ae. aegypti. This suggests that Ae. aegypti has 
a higher rate of vertical transmission. 
Countering this, in comparing a strain of DENV-2 infected Ae. albopictus 
(derived from specimens collected in Rio de Janeiro and kept in a lab for a year) with a 
well-established lab colony of DENV-2 infected Ae. aegypti, de Castro et al. (2004) 
suggest that Ae. albopictus have a higher vertical transmission rate (see Table 4.1), 
implying that Ae. albopictus could be playing a role as reservoir for dengue virus 
through vertical transmission (de Castro et al. 2004). However, statistical analysis 
comparing the larval infection rates of Ae. albopictus and Ae. aegypti was not presented 
and de Castro et al. (2004) only give the percentage of pools positive for DENV-2. 
Studies from the field would possibly suggest that Ae. albopictus may well have 
a higher rate of vertical transmission. In areas known for dengue fever in humans within 
Singapore, Kow et al. (2001) used RT-PCR to individually screen field caught adult 
male Ae. aegypti and Ae. albopictus. Kow et al. (2001) report relatively high rates of 
infection with dengue virus, which was higher in Ae. albopictus (2.15% VIR, as 
opposed to 1.33%), however no statistical analysis was presented (see Table 4.5) .  
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Furthermore a survey of immature Aedes species in Jodhpur, Rajasthan, India 
(Joshi et al. 2006), found that Ae. aegypti and Ae. vittatus in tree-holes, domestic and 
peri-domestic water containers, were negative for dengue viruses, while some Ae. 
albopictus were found to be positive (Joshi et al. 2006) (see Table 4.5). Finally Das et 
al. (2013) following the first outbreak of dengue fever in 2010 in Orissa state, India, 
conducted a screening of adult, larval and pupae Ae. aegypti and Ae. ablopictus, in areas 
known for dengue virus infection (see Table 5.6). Das et al. (2013) found a higher MLE 
for immature Ae. albopictus than in immature Ae. aegypti.  
Overall then, there is some evidence of higher vertical transmission in Ae. 
albopictus but the data is rather limited. It should be noted, however that a meta-
analysis by Lambrechts et al. (2010) suggests that Ae. albopictus may not be an 
important vector of dengue virus.  
4.10 Field work comparing vertical transmission in adult or late stage larvae 
Günther et al. (2007) in a RT-PCR field survey of larval Ae. aegypti in two 
locations of Oaxaca, Mexico found dengue viruses in the samples, in larvae raised to 
adulthood in the lab, but none in samples that were analysed as larvae (see Table 4.3). 
They suggested that vertically transmitted dengue virus is more likely to be detected in 
adults. Unfortunately the sample size of samples analysed as adults from the two 
locations was much higher than the sample size for those analysed as larva.  
In a survey of dengue virus infections in Aedes larvae in the Pampulha region of 
Brazil, eggs of Ae. albopictus were collected using ovitraps in areas known for dengue 
fever (Cecílio et al. 2009) (see Table 4.3). These eggs were raised to 4
th
 instar within the 
lab and then screened for dengue virus infection, in pools of 50. Upon confirmation of 
dengue virus infection in larvae in certain areas Cecílio et al. (2009) made another 
collection of eggs from those areas. These eggs were then raised to adulthood within the 
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lab and the resulting adult Ae. albopictus were then screened for Dengue viruses 
individually (4/7 females and 4/11 males were found positive for DENV-2).  Cecílio et 
al. (2009) give no reason as to why this second collection of eggs, raising to them to 
adults and individual screening took place. If it was to compare the ability to detect 
vertical transmission in adult Aedes to that of larvae, then there are several issues with 
this approach. First the sample size from the eggs that were raised to adults was much 
lower than those analysed as larvae. Secondly the result is biased towards the eggs that 
were raised to adults (through the individual screening and selection of collections 
based upon areas known for vertical transmission of dengue virus). Thirdly if there was 
a time difference between the two sets of egg collection then there may have been a 
difference in the proportion eggs infected with dengue virus. 
In one season of the study conducted by Mulyatno et al. (2012) Ae. aegypti 
larvae were collected and either screened for dengue viruses as larvae or raised to 
adulthood in the laboratory and then screened as adults (see Table 5.6). Other than 
stating the DENV-1 MIRs for these samples, no comparisons are made between these 
groups (this may be because the sample size is too small but this is not stated).  
Overall the faults with these three studies and the lack of data in this area mean 
that it is still inconclusive as to whether vertically acquired dengue virus infection is 
more readily detected in certain stages of the Aedes’ life cycle. Further work on this area 
would not only shed light on the best morphological stage for detecting vertically 
acquired dengue virus, but also determine if vertically acquired dengue virus can be 
cleared by the mosquitoes during their lifecycle. Within the laboratory Nelms et al. 
(2013) measured significantly higher rates of vertically transmitted West Nile Virus 
when screening first instar larvae of Culex pipiens complex than adult C. pipiens, 
suggesting that West Nile virus infection was lost in development from larvae to adult.   
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4.11 Field based studies comparing horizontal transmission and vertical 
transmission of dengue virus 
The possession of data from the field on dengue viruses in adult female 
mosquitoes and either the rate of infection in adult male mosquitoes or immature 
mosquitoes, could allow vertical transmission rates to be inferred statistically. However, 
the studies that survey such subgroups of Aedes populations have run into a number of 
problems that have prevented this analysis. 
Some field surveys fail to find evidence of vertical transmission. For instance, 
Ilkal et al. (1991) in a field study in Maharashta, India, found dengue virus antigens in 
wild caught female Ae. aegypti but none within wild caught adult male Ae. aegypti and 
Ae. aegypti larvae that were caught as larvae, which were then reared to adulthood in 
the lab (see Table 5.4a). Similarly in 16 sites known for dengue virus transmission 
across Singapore Chow et al. (1998) found dengue virus infection in female adult Ae. 
aegypti and Ae. albopictus but not in the larvae (see Table 5.4b). A virological 
screening of adult Ae. aegypti in Puerto Triunfo, Colombia, found DENV-1 and DENV-
2 in females but not adult males (Romero-Vivas et al. 1998) (see Table 5.4b). Likewise, 
in the city of Manaus (Amazonas, Brazil) a survey of dengue virus infections of Ae. 
aegypti found virus in adult females but not in the 1142 larvae and pupae analysed 
(Pinheiro et al. 2005) (see Table 5.4b). Pinheiro et al. (2005) suggest that the low 
sample size could be the reason for not detecting dengue viruses in immature Ae. 
aegypti. In an extensive survey of Ae. aegypti and Ae. albopictus adults conducted in 
southern Taiwan from 2004-2007, Chen et al. (2010) found a few pooled samples of Ae. 
aegypti females, positive for one of the dengue virus serotypes (see Table 5.4b) but 
none of the male Ae. aegypti, male Ae. albopictus or female Ae. albopictus turned out to 
be infected with any dengue viruses. 
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Other studies found evidence of vertical transmission, but found no sign of 
dengue virus infections in adult females. Ibáñez-Bernal et al. (1997) were the first to 
detect dengue virus infection in wild adult male Ae. albopictus but detected no dengue 
virus infections in the adult females (see Table 5.6). A survey of dengue virus infections 
in Ae. aegypti in French Guiana found DENV-4 in eggs and larvae (Fouque et al. 2004) 
(see Table 5.6) yet no dengue viruses were isolated from adult Ae. aegypti, this may not 
be surprising considering that the adult sample size was 753, compared to 3435 eggs 
and 4078 larvae. In May 2007, within the urban area of Jaipur and Delhi, India Das 
Bina et al. (2008) despite extremely low sample sizes found 3 pools of Ae. aegypti that 
had been field caught as larvae positive for dengue virus but found no virus in female or 
male adults (see Table 5.6).   
Thavara et al. (2006) found dengue viruses in adult male and female Ae. aegypti 
that were collected in the rainy season in villages in southern Thailand, which had 
experienced recent DHF cases (see Table 5.6). As Thavara et al. (2006) states that 
serotypes DENV-2, DENV-3 and DENV-4 were found but neglects to mention the 
proportions or numbers of each serotype. It is therefore not possible to calculate an 
estimate of vertical infection rate for each of the dengue virus serotypes. 
In a survey of adult and larvae (which were raised to adulthood in the lab) Ae. 
albopictus in Kerala, southern India, Thenmozhi et al. (2007) found low MIRs for 
dengue virus in both the adult female mosquitoes, adult males and larvae (see Table 
5.6). Other than identifying the one pool of female larvae as positive for DENV-2 
Thenmozhi et al. (2007) were unable to identify the serotypes of dengue virus found. 
This and the low number of samples positive for dengue viruses means calculating an 
estimate for vertical transmission is not possible. 
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Vilela et al. (2010) and Guedes et al. (2010) both screened adult female Ae. 
aegypti for dengue viruses and eggs caught from ovitraps in Minas Gerais, Brazil and 
Racife, Brazil respectively (see Table 5.6). Guedes et al. (2010) calculate MIR for 
combined dengue virus serotypes, eventhough the number of pools positive for dengue 
virus is listed for individual serotypes (see Table 5.6). Neither Vilela et al. (2010) or 
Guedes et al. (2010) can easily be used to crudely infer vertical transmission rate, as 
either the adult caught Ae. aegypti or the larvae/adult raised in the lab from field caught 
eggs, have small sample sizes (see Table 5.6).  
In a survey of dengue virus infections of the genera Psoropora, Haemagogus 
and Aedes from across Northeast, Southeast, and South Brazil, de Figueiredo et al. 
(2010) found 3 pools of Ae. albopictus larvae positive for DENV-3 (542 individuals) 
from the city of Santos but did not find any DENV-3 in any of the 88 adults (see Table 
5.6). The low sample size of adult Ae. albopictus from Santos and lack of data on where 
in Santos the samples were collected means a statistical inference of the rate of vertical 
transmission cannot be made. 
Mulyatno et al. (2012) conducted several surveys of dengue virus infections in 
adult and larval Ae. aegypti in Surabaya, Indonesia (see Table 5.6). Other than stating 
the findings that there was a generally higher MIR for dengue virus infections in wild 
caught females (horizontal transmission) than in specimens caught as larvae, Mulyatno 
et al. (2012) do not attempt to quantify the rate of vertical transmission (this may be 
because the sample size is too small but this is not stated). Das et al. (2013) found 
dengue virus infection in both female adult Ae. albopictus and pupal Ae. albopictus. 
However very few adult female Aedes were caught, making a comparison of horizontal 
and vertical infection rates difficult (see Table 5.6). As such there is still a lack of good 
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data comparing adult and larval infection in the field, which could be used to infer the 
vertical transmission rate of dengue virus. 
4.12 Seasonality 
Several studies suggest a peak in vertical transmission of dengue virus in certain 
seasons. In a survey of adult male Ae. aegypti in Chennai, India conducted from March 
2003-December 2004, Arunachalam et al. (2008), suggested a peak in MIRs in June and 
July of 2003 (see Table 4.5). Arunachalam et al. (2008) conclude that vertical 
transmission helps in the maintenance of dengue viruses through the dry season (when 
adult vector numbers would be low). However, Arunachalam et al. (2008)  provide no 
statistical evidence for this spike in MIRs and a similar rise in MIRs did not occur the 
following year. Similarly Angel & Joshi (2008) found a higher rate of dengue virus 
infection in the larvae of Ae. albopictus in winter. Suggesting that Ae. albopictus acts as 
a reservoir for dengue viruses through the winter, when incidents of dengue fever in 
humans is low (see Table 4.5) (although again no statistical analyses was presented).  
Mulyatno et al. (2012) conducted several surveys of dengue virus infections in 
adult and larval Ae. aegypti in Surabaya, Indonesia (see Table 5.6) and suggested that 
there are higher rates of vertical transmission in the rainy season but do not present a 
statistical analyses. Overall then the picture is far from clear and without statistical 
analysis it is unclear whether there is significant seasonality in the vertical transmission 
of dengue virus. 
4.13 Predicting dengue outbreaks 
Chow et al. (1998) found dengue viruses in female adult Aedes species 6 weeks 
before the 1995 and 1996 outbreaks of dengue fever (see Table 5.4b). They suggest that 
monitoring of adult female Aedes mosquitoes for dengue virus serotypes could be used 
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to predict when outbreaks of human dengue fever would occur. A similar suggestion but 
using the monitoring of Aedes larvae would later be made by Lee & Rohani (2005). 
It is interesting to note that previously, Joshi et al. (1996) in a survey of dengue 
virus infections in Ae. aegypti larvae, in  Jalore, India, suggests a peak in infected Ae. 
aegypti larvae coincided with an outbreak of dengue fever but provided no statistical 
analyses backing this (see Table 4.1).  
Lee & Rohani (2005) based upon a study of dengue viruses in Ae. aegypti and 
Ae. albopictus larval caught as eggs in ovitraps in Kuala Lumpa (August 1996-
December 1997) (see Table 4.5), suggest that since they detect dengue virus in larval 
Ae. aegypti and Ae. albopictus 7-41 days before dengue fever cases in humans, ongoing 
surveillance of immature Ae. aegypti and Ae. albopictus could be used as an early 
warning system for dengue fever cases occurring. However, between 7 and 41 days is a 
large amount of variation and a statistical model would be needed to test this assertion.  
In a monthly survey of dengue virus infections in larvae of two strains of Ae. 
aegypti (see Table 4.5), Thongrungkiat et al. (2011) suggests there was a peak in dengue 
virus infections four months before cases of dengue fever. They suggest that the 
monitoring of Aedes larvae for dengue viruses could therefore be used as an early 
warning system for dengue fever outbreaks. However whilst Thongrungkiat et al. 
(2011) do use a statistical analyses to rule out a correlation between dengue virus 
infections of larvae with either rainfall or human cases, they do not provide any 
statistical evidence for a significant peak in dengue virus infections in mosquito larvae 
four months before cases of dengue fever.  
Martins et al. (2012) conducted a quarterly survey of female immature Ae. 
aegypti and Ae. albopictus in Fortaleza, Brazil (March 2007-July2009) (see Table 4.3). 
After finding evidence of vertical transmission, before the largest epidemic of dengue 
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fever seen in Fortaleza (2008), they suggest that the monitoring of immature Aedes 
could be used as an early warning system for detecting dengue fever epidemics. 
However the three pools of immature mosquitoes positive for dengue viruses were 
collected in May 2007, July 2007 and January 2008 and no statistical evidence for an 
association were provided. 
When considering the costs in resources and man power of such an early 
warning system, the monitoring of Aedes larvae for dengue virus would be unfeasible.  
As suggested by Zeidler et al. (2008) after finding no signs of vertical transmission of 
dengue virus. This becomes more apparent when you consider the sampling effort 
undertaken in finding samples of immature Aedes specimens infected with dengue virus 
through vertical transmission (running from the 100s to the 10000s of samples) (see 
Table 4.3-6), the low rates of vertical transmission seen in the field (see Table 4.3-6) 
and the field based studies that found no evidence of vertical transmission (see Table 
5.4a-b and section 4.14 below). 
4.14 Field based studies that found no evidence of vertical transmission 
Several field studies that I have already discussed found no evidence for vertical 
transmission of dengue viruses (Watts et al. 1985; Ramalingam et al. 1986; Ilkal et al. 
1991; Romero-Vivas et al. 1998; Chow et al. 1998; Pinheiro et al. 2005; Chen et al. 
2010) (see Table 4a-b). There are a number of other studies that have also failed to find 
evidence for vertical transmission of dengue viruses. A survey across 17 locations in the 
Chiang Mai and Lumpang provinces of Thailand detected no dengue viruses in field 
caught Ae. aegypti (9825) and Ae. albopictus (150) larvae (Hutamai et al. 2007) (see 
Table 5.4a). 
Within areas of high dengue fever incidence, in the city Boa Vista, Brazil, 
Zeidler et al. (2008) used ovitraps to collect Ae. aegypti mosquitoes and then raise them 
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within the lab to third or fourth instar larvae (see Table 5.4a). Using a RT-PCR 
technique, Zeidler et al. (2008) were unable to detect dengue viruses in the 1,172 larvae 
screened. Zeidler et al. (2008) use their findings and those from studies that either find 
low or none existent dengue virus infection rates in immature and male Aedes species, 
to suggest that the movement of people may play a greater role in the epidemiology of 
dengue virus than vertical transmission. A similar argument would be made by Chen et 
al. (2010), who pointed out that results of their study and other studies suggest that the 
dengue virus is not endemic to Taiwan but it is constantly being reintroduced by travel 
from other countries. This may explain Chen et al. (2010) finding no dengue virus in 
either Ae. aegypti and Ae. albopictus adult males. Given the likelihood of a reporting 
bias against studies that do not find vertical transmission, this large body of studies may 
indicate that vertical transmission is often absent or very low in many areas endemic for 
dengue virus, even in areas with high incidences of dengue fever.  
4.15 Vertical transmission followed by horizontal transmission between larval 
mosquitoes, via cannibalism of dead or living infected larvae. 
Bara et al. (2013) measured the susceptibility Ae. aegypti and Ae. albopictus 2
nd
 
instar larvae to DENV-2, DENV-3 and DENV-4 infections via horizontal transmission. 
Bara et al. (2013) tested horizontal transmission of dengue viruses occurring through 
either the larval growth environment or dengue virus infected tissue culture with viral 
supernatant. The mosquitos were then screened for dengue virus infection as pupae or 
occasionally as late instar larvae in pools. Bara et al. (2013) found that both species 
were susceptible to the three serotypes but there was significant variation in the 
infection rates and viral titres between the serotypes.  Bara et al. (2013) suggest, given 
the low viral titres needed for horizontal transmission of dengue viruses, it is possible 
for larvae to become infected via ingestion of dead infected larvae, which have acquired 
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dengue viruses through vertical transmission. Bara et al. (2013) go on to suggest that 
future research on the viral titer of larvae infected through vertical transmission, in 
natural populations, is needed to verify this. It should be noted, that if it is possible for 
larvae to become infected via ingestion of dead infected larvae, that have acquired 
dengue viruses through vertical transmission, then it is also possible for larvae to 
become infected via ingestion of dead female adult mosquitoes that have acquired 
dengue virus through blood feeding. 
Given the low viral titers needed for horizontal transmission in these 
experiments, it would seem possible for larvae to become infected via cannibalism of 
not only dead but also living vertically dengue virus infected larvae. Whilst this could 
contribute to the persistence of dengue virus, it should be noted that in order for the oral 
transmission of dengue virus in Aedes larvae to occur, the already rare event of vertical 
transmission of dengue virus must have occurred.  Bara et al. (2013) work may also 
suggest that the rates of vertical transmission in the wild could be an overestimate.  
4.16 Theoretical models of the role of vertical transmission in the persistence of 
dengue viruses 
Although field and laboratory studies have shown that vertical transmission of 
dengue virus occurred, mathematical models can provide insight as to whether vertical 
transmission is important to the epidemiology of the dengue virus and point towards 
needed empirical work. The first model to examine this was by Esteva & Vargas (2000) 
who modelled the effect of both partial blood feeding and vertical transmission on 
dengue virus epidemiology.  They suggested that vertical transmission favoured an 
endemic level of dengue virus and that vertical transmission of dengue viruses could be 
important in areas of low human density. Subsequently, Coutinho et al. (2006)  
developed models that suggested that vertical transmission could aid dengue viruses in 
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surviving through seasons of low adult vector populations, although they did not persist 
in the long term and Coutinho et al. (2006) used a high FIR of 50%, as stated in section 
4.3 FIRs for Ae. albopictus and Ae. aegypti when not selected for are less than 5% (see 
Table 4.1). 
An extensive modelling treatment of the question of the impact of vertical 
transmission on dengue virus epidemiology was given by Adams & Boots (2010). They 
examined the impact on endemic and epidemic dynamics of different levels of vertical 
transmission and focus on the persistence of the virus using stochastic models. Overall 
they conclude that the levels of vertical transmission generally seen suggest that it is not 
likely to be important to either epidemic dynamics or the persistence of the virus. Only 
the exceptional high rates of dengue virus infections in larvae seen by Angel & Joshi 
(2008), in Rajasthan, would affect the epidemic persistence of dengue virus in these 
models (see Table 4.5).  The models do however highlight the importance of conducting 
further research into vertical transmission of dengue viruses to diapausing or desiccated 
mosquito eggs as a possible role in the persistence of dengue viruses (Adams & Boots 
2010). 
Similarly Charron et al. (2013) used mathematical models to test various 
methods of persistence of several dipteran born viral infections through unfavourable 
seasons. Charron et al. (2013) finds that vertical transmission to a diapausing insect 
vector could lead to persistence over many years, especially when the vector numbers in 
unfavourable seasons and vertical transmission rate was high. Thus Charron et al. 
(2013) suggest that vertical transmission to diapausing eggs, could not always guarantee 
persistence through unfavourable seasons. However Charron et al. (2013) cite values for 
parameters from a review conducted in 1987 when more up to date studies were 
available.  
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Based on the findings of Bara et al. (2013) (see section 4.15), Tennakone (2014) 
modelled of vertical transmission of dengue viruses followed by horizontal transmission 
between larvae via cannibalism. Tennakone (2014) found that these two processes in 
combination could cause persistence of dengue virus without human transmission. 
However, Tennakone's (2014) model is rather limited, a more in depth model including 
diapause, seasonality and a range of parameter values is needed to explore how these 
processes combined could relate to persistence. 
Amaku et al. (2014) included vertical transmission at a VIR of 0.1 when 
assessing different dengue vector control strategies. Amaku et al. (2014) found that 
killing adult mosquitoes followed by reducing the mosquito biting rate were the most 
effective ways of controlling dengue and that larvaciding followed by reducing larval 
carrying capacity were the least effective control strategies. This would suggest that 
vertical transmission had little effect on dengue virus epidemiology. As a whole the 
mathematical modelling suggests that only high levels of vertical transmission are likely 
to significantly impact on the epidemiology of dengue virus but its most important role 
may be in diapause or combined with horizontal transmission between larvae via 
cannibalism. 
4.17 The role of vertical transmission in persistence of disease 
From looking at the levels of vertical transmission that are most often seen in the 
laboratory and the field, as well as the trends from mathematical models, it is unlikely 
that vertical transmission of dengue viruses within Aedes species plays an important 
role in the epidemiological persistence of dengue viruses. As suggested by Adams & 
Boots (2010) only one study (Angel & Joshi 2008) suggests a high enough vertical 
transmission rate to have a positive effect on the epidemiological persistence of dengue 
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viruses. It therefore seems likely that dengue viruses persist due to asymptomatic human 
infections and spatial reintroductions.  
Many studies suggest that the vertical transmission of dengue virus in 
mosquitoes is acting as a reservoir, when asymptomatic dengue virus infections of 
humans are more likely to be acting as a reservoir for dengue virus. The outbreak of 
dengue fever in the Florida Keys 2009 is a case in point. Using DENV-1 isolated in the 
2010 outbreak of dengue fever in Key West, Florida,  Buckner et al. (2013) orally 
infected Ae. aegypti and Ae. albopictus (see Table 4.1). If the adult mosquitoes had 
undergone full DENV-1 dissemination, their late instar larvae were then screened for 
DENV-1. Buckner et al. (2013) suggests from the high VIR rates found and the findings 
of Muñoz-jordán et al. (2013), genetic sequencing showing that the 2010 DENV-1 
outbreak in Key West was just a continuation of the 2009 outbreak and that DENV-1 
had persisted via vertical transmission through the interepidemic period. Another 
possible explanation for the continuation of the outbreak from 2009 to 2010 could be 
that the majority of DENV-1 infection in humans were asymptomatic and acted as a 
reservoir of infection. Evidence for this comes from the fact that 27 cases of dengue 
fever were reported in Key West in 2009 (Trout et al. 2010), yet a seroprevelance 
survey of dengue virus antibodies conducted in September 2009 suggested that 
approximately 600-1000 residents of Old Town, Key West (population 19,846) were 
infected during the 2009 outbreak (Radke et al. 2012). Das et al. (2013) following the 
first outbreak of dengue fever in 2010 in Orissa state, India, conducted a screening of 
adult, larval and pupae Ae. aegypti and Ae. ablopictus in areas known for dengue fever 
and areas 1.5 km away not known for dengue fever (as control sites). Das et al. (2013) 
find an MLE of 2.27 for DENV-2 in Ae. albopictus pupae, in the control sites (see Table 
5.6). On similar note, Yang et al. (2014) after finding evidence of vertical transmission 
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of DENV-1 (see Table 5.6) suggested that the importation of vertically infected 
diapausing eggs had been responsible for an outbreak of dengue fever in Shenzhen, 
China. The introduction of dengue to the area by asymptomatically infected humans 
who were missed by the health services may also have been responsible. Further 
demonstrating that asymptomatic dengue virus infection in humans may well be acting 
as a more likely reservoir for dengue virus than the vertical transmission of dengue 
viruses in mosquitoes. 
A review by Grange et al. (2014) of asymptomatic infections found that 20-97% 
of dengue virus infections were asymptomatic, the mean percentage of infections that 
were asymptomatic in cohort studies was 76% and for index cluster studies it was 37% 
(Grange et al. 2014). This under reporting of dengue virus infections may not just be 
due to asymptomatic infection but also misdiagnosis, as many of the symptoms of 
dengue fever, are similar to other viral illnesses (WHO 2015c). The suggested peak in 
dengue virus infections in larvae and adult male Aedes occurring before a peak in 
dengue fever cases may reflect an under reporting of dengue fever cases in humans. 
Perception of the disease increases as a dengue fever outbreak progresses; this may well 
lead to greater reporting of dengue fever, in the latter stages of an outbreak. 
Dengue viruses will also go extinct in certain areas and then be reseeded from 
other areas where dengue viruses still persist by human movement. From a statistical 
analysis of DHF cases in Thailand, Cummings et al. (2004) found that DHF cases seem 
to move in a wave emanating from Bangkok at a speed 148 km per month. Furthermore 
Gubler (2004) suggested that Cummings et al. (2004) work is evidence to support the 
hypothesis that dengue viruses are maintained in large urban centres and move out to 
smaller communities after periodic extinction. A metapopulation model by Adams and 
Kapan (2009) showed how patches of large vector populations can act as hubs and 
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reservoirs of dengue virus. Increased movement of viremic humans among these 
patches increases the influence of the large vector population patches in establishing 
new foci of transmission.  
Stoddard et al. (2014) found that low-level transmission of dengue virus 
occurred throughout the year when evidenced by the occurrence of clinical illness in the 
small city of Iquitos, Peru. Combined with the review by Grange et al. (2014), this 
would suggest that dengue virus persists though seasons of low vector capacity in large 
enough towns or cities (Gubler 2004) at a low level, with most human dengue virus 
infections being unreported due to either a mild range or complete lack of symptoms. 
Furthermore, Stoddard et al. (2013) and Reiner et al. (2014) demonstrated that in the 
light of Ae. aegypti’s spatial heterogeneity and lack of dispersal (Getis et al. 2003; 
Rodhain & Rosen 1997; Harrington et al. 2005; Maciel-de-Freitas et al. 2010), that 
human movement was responsible for the spread of dengue virus. Dengue virus infected 
humans who are asymptomatic are likely to be more mobile than those who are 
symptomatic. As such the movement of asymptomatic dengue virus infections may 
reseed dengue virus to an area after its extinction at small spatial scales, leading to 
dengue virus persistence at the larger spatial scale.  
4.18 Summary 
Further research into vertical transmission of dengue viruses may be logistically 
difficult due to its low rate and sampling effort attested to in Table 4.1-7. That being 
said there are a few areas where research is lacking. Before such research takes place 
there needs to be an assessment of the different screening techniques for detecting 
vertically acquired dengue virus taking into account accuracy, resource costs and 
labour. Specifically there is a lack of work on whether vertically acquired dengue virus 
infection is more readily detected in certain stages of the Aedes’ life cycle. Further work 
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on this would not only shed light on the best morphological stage for detecting 
vertically acquired dengue virus but also determine if vertically acquired dengue virus 
can be cleared by the mosquitoes during their lifecycle. On a similar note there has been 
relatively little work on the mechanistic basis of vertical transmission of dengue viruses 
since the 1990s. Field work aiming to quantify the rate of vertical transmission from the 
proportion of dengue virus infected adult female mosquitoes and larval or adult male 
mosquitoes has so far either lacked a large enough sample size or adequate statistical 
analyses. There is some evidence of a higher rate of vertical transmission of dengue 
viruses in Ae. albopictus than Ae. aegypt but the data is rather limited. However, the 
work by Lambrechts et al. (2010) suggests that Ae. albopictus may not be an important 
vector of dengue virus. Within many of the laboratory studies on transgenerational 
vertical transmission of dengue virus it was unclear if heritability for vertical 
transmission of dengue virus is within the mosquito host or the virus. It also remains 
unknown how important selection for such a trait is in nature. Studies that suggest a 
seasonal peak in vertical transmission of dengue virus have lacked systematic statistical 
modelling. Research into detecting dengue virus infections in larval Aedes species as a 
dengue fever epidemic warning system is not a priority as such a system would be 
economically and logistically unfeasible. The possibility of vertical transmission of 
dengue virus to larvae, leading to the horizontal transmission of dengue virus between 
larvae via cannibalism of larvae needs to be further explored as a possible contributing 
factor in the persistence of dengue virus. Furthermore, there is a lack of work on vertical 
transmission of dengue virus into diapausing or desiccated eggs and the impact of 
dengue virus infection on survivorship. Data on this area is lacking despite the fact that 
if vertical transmission is likely to have any effect on the maintenance of dengue virus 
then it will be through diapausing or desiccated eggs.  
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Overall, however, it must be stated that the low rates of vertical transmission 
seen (typically less than 10/1000 MIR or MLE) in the field, the sheer sampling effort in 
obtaining such results (running from 100s to 10000s of samples) and the many field 
studies, which found no evidence of vertical transmission of dengue virus would point 
to the vertical transmission of dengue virus being of little importance to the 
epidemiology and persistence of dengue virus. A combination of asymptomatic dengue 
virus infection in humans and movement of dengue virus infected humans may well be 
more important. 
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Chapter 5: Frequency dependent models of asymptomatic dengue 
infections: their relation to epidemic success, persistence and 
population at risk of developing dengue haemorrhagic fever 
Abstract 
Recent estimates suggest that there are 390 million dengue virus infections a 
year, but only 96 million episodes of dengue illness. Furthermore, a recent review found 
that 20-97% of dengue infections are asymptomatic. In order to further the 
understanding of the role of asymptomatic dengue virus infections on dengue’s 
epidemic success, persistence and the population at risk of developing dengue 
haemorrhagic fever, I adapted two frequency dependent SIR type dengue models that 
include an asymptomatic class (SAIR models). In the first model upon infection 
individuals either become symptomatic or asymptomatic. In the second model infected 
individuals first become asymptomatic and then progressed to either being symptomatic 
or immune. For both models the level and duration of transmission from the 
asymptomatic class was varied over a wide range due to the lack of data. Whilst the 
inclusion of asymptomatic infections did not lead to the dengue virus becoming 
endemic, asymptomatic infections could lead to dengue virus persisting for several 
years in lower transmission settings. Furthermore, it was found that a larger proportion 
of the population could also be left at risk of DHF, than suggested by symptomatic 
dengue infections. 
5.1 Introduction 
Recent work by Bhatt et al. (2013) estimates that there are 390 million dengue 
infections a year, but only 96 million episodes of dengue illness. Whilst suggesting that 
this RNA positive flavivirus is the most important arboviral pathogen on the planet 
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(Guzman et al. 2010; Rodenhuis-Zybert et al. 2010), this raises the question of how 
important unreported infections are to the epidemiology of dengue viruses. Primary 
infection of a dengue virus can lead to asymptomatic infection through to dengue fever 
(DF). After a suggested 1-3 year period after primary infection by one of the serotypes 
of dengue virus (DENV-1, DENV-2, DENV-3 and DENV-4), heterotypic immunity to 
the other dengue serotypes wanes (Guzman et al. 2010; Rodenhuis-Zybert et al. 2010; 
Reich et al. 2013). At this point subsequent infection with another dengue serotype can 
lead to dengue haemorrhagic fever (DHF) (Guzman et al. 2010; Rodenhuis-Zybert et al. 
2010; Andraud et al. 2012; WHO 2015b). DHF can cause dengue shock syndrome 
(DSS), both DHF and DSS are life threatening. Grouped together as severe dengue, 
DHF and DSS have been estimated to cause 500,000 cases of illness, mostly in children 
and have a mortality rate of 2.5% (WHO 2015b). Therefore unreported dengue 
infections may not only affect dengue’s epidemiology in terms of dengue’s persistence 
and spread but also in determining the proportion of the population left immune to a 
dengue serotype after an epidemic, that would thereby be at risk of developing DHF in 
an epidemic of a differing dengue serotype.  
Since the 1980s there has been a growth in studies that attempt to quantify the 
proportion of dengue infections that are asymptomatic (Grange et al. 2014). A recent 
review by Grange et al. (2014) found that 20-97% of dengue infections were inapparant. 
In many studies the term apparent dengue infection is used to describe a dengue 
infection sufficiently severe to alter a person’s regular schedule causing absenteeism 
from school or work. Whereas an inapparent dengue infection is one that does not cause 
such disruption to a person’s routine. Therefore an inapparent dengue infection ranges 
from asymptomatic to mildly symptomatic infection. 
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Considering that asymptomatic dengue viral infections seem so common, the 
question remains as to what extent an asymptomatic dengue infection is transmissible to 
a biting mosquito and thereby playing a role in the persistence of dengue viruses. Not a 
single study has directly researched transmission from asymptomatic dengue viral 
infections to biting mosquitoes. However, a key to such transmission is to determine the 
level of viremia in asymptomatic dengue infections. Two studies using RT-PCR have 
demonstrated that asymptomatic dengue infections can produce detectable levels of 
viremia in the blood (Beckett et al. 2005; Reyes et al. 2010). However this method of 
detection does not quantify the level of viremia (Carrington & Simmons 2014). Duong 
et al. (2011) found a lower but not significantly different level of viremia in 
asymptomatic dengue infections compared to symptomatic infections using real-time 
RT-PCR, although Duong et al. (2011) sample size of asymptomatic infections is low 
(13 compared to 176 symptomatic dengue infections). Nguyet et al. (2013) found that 
whilst ambulatory mildly symptomatic dengue infections had a lower viremia than 
dengue infections that lead to hospitalisation, many still had levels of viremia greater 
than the relevant MID50 for the infecting dengue serotype (Nguyet et al. 2013). MID50 
(Mosquito Infective Dose 50%) being the viremia level corresponding to a 50% 
probability of human-mosquito transmission (Nguyet et al. 2013). If Nguyet et al. 
(2013) work is any indication then many asymptomatic dengue infections may well be 
infectious to a biting mosquito but fewer asymptomatic dengue infections could be 
above the MID50 when compared to symptomatic dengue infection. Therefore, many 
asymptomatic dengue infections may be less infectious when compared to symptomatic 
dengue infection. Countering this asymptomatic dengue infected humans are probably 
more ambulatory than symptomatic dengue infected humans. Considering that the 
Aedes species that act as vectors of dengue virus bite during the day and early evening 
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(M. Service 2012b), this could lead to asymptomatic dengue infected humans having 
greater contact with these biting mosquitoes, thereby having a higher transmission rate.  
Given that asymptomatic infections are so common and have the potential to 
transmit dengue viruses, it is important to model their role in the epidemiology of 
dengue. To this end, I adapted two SIR type dengue models that include an 
asymptomatic class (SAIR models) based on the flu models by Robinson & Stilianakis 
(2013). The first (Model A) assumes that on infection individuals either become 
symptomatic or asymptomatic, while in the second (Model B) individuals first become 
asymptomatic and then progress to either being symptomatic or immune. Both of these 
models are reasonable assumptions of how asymptomatic infections may work and it is 
important that in the absence of clear data on how the process works that the 
implications of both frameworks are examined. The assumption of transmission from 
the asymptomatic class was varied over a wide range due to the lack of data concerning 
asymptomatic viremia and the possibility of asymptomatic dengue infected  humans 
having a greater ambulatory nature leading to greater contact with biting mosquitoes. 
The duration of the asymptomatic class’s transmissibility was varied as to my 
knowledge there is no work on the duration of viremia in asymptomatic infections. The 
models were carried out in low, medium and high dengue transmission settings. 
5.2 Methods 
5.2.1 Description of Model A under frequency dependent transmission 
I developed a frequency dependent transmission version of the 2
nd
  framework 
described in  Robinson & Stilianakis (2013) (here referred to as Model A), as described 
by Equation 5.1-4 below and the flow diagram in Figure 6.1. Table 6.1 contains a list of 
all Model A’s parameter and variables. I assumed frequency dependent transmission as 
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many other models of dengue transmission do (Johansson et al. 2011; Andraud et al. 
2012), justifying this simplification of vector transmission into an aggregated mean 
vector mediated transmission rate (Johansson et al. 2011), as the vector population is 
considered to be dense and timescale of transmission is sufficiently short (Andraud et 
al. 2012). 
𝛥𝑆
𝛥𝑡
= 𝜇𝑁 −
𝑆(𝛽𝐴𝐴+𝛽𝐼𝐼)
𝑁
− 𝜇𝑆     Equation 5.1 
𝛥𝐴
𝛥𝑡
= (1 − 𝑝)
𝑆(𝛽𝐴𝐴 + 𝛽𝐼𝐼)
𝑁
− 𝛾𝐴𝐴 − 𝜇𝐴 Equation 5.2 
𝛥𝐼
𝛥𝑡
= 𝑝
𝑆(𝛽𝐴𝐴 + 𝛽𝐼𝐼)
𝑁
− 𝛾𝐼𝐼 − 𝜇𝐼 Equation 5.3 
𝛥𝑅
𝛥𝑡
= 𝛾𝐼𝐼 + 𝛾𝐴𝐴 − 𝜇𝑅 Equation 5.4 
 
 
 
  
Figure 5.1: Flow diagram representing Model A 
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Table 5.1 Variables at starting value and parameters used in Model A 
Symbol Name Value 
μ Birth and death rate (per day) 1/(60*365) 
c Infectivity of asymptomatic infections compared to 
symptomatic infections 
0 to 2 
βI Symptomatic transmission rate (per day) 200/365 to 
400/365 
βA Asymptomatic transmission rate (per day) c*βI 
φ Days symptomatic 8 
γI Symptomatic recovery rate (per day) φ-1 
d Asymptomatic recovery rate compared to symptomatic 
recovery rate 
0.05 to 2 
γ
A
 Asymptomatic recovery rate (per day) (dφ)-1 
p Probability of being symptomatic 0 to 1 
S Susceptible population 106-1 
A Asymptomatic population 0 to 1 
I Symptomatic population 0 to 1 
R Recovered population 0 
N Total population 106 
 
The total human population (N) is divided into susceptible (S), 
asymptomatically infected (A), symptomatically infected (I) and recovered (R) classes. 
Every class of human experiences loss due to a constant death rate μ, however the 
human population remains constant as humans are born into the susceptible class at a 
birth rate of μN. Susceptible humans become infected at a frequency dependent 
transmission term that is the sum of transmission from asymptomatically and 
symptomatically infected humans, given by S(βAA+ βII)/N. Upon infection humans 
either become asymptomatic at a rate of (1-p)S(βAA+ βII)/N or symptomatically 
infected at a rate of pS(βAA+ βII)/N. Asymptomatically infected people gain complete 
lifelong immunity at a rate of γA and symptomatically infected people gain complete 
lifelong immunity at a rate of γI, in both cases moving to the recovered class (R). 
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The formula for models A’s basic reproduction number (R0) is listed with 
equations below (Robinson & Stilianakis 2013). 
𝑅0 = (1 − 𝑝) (
𝛽𝐴
𝛾𝐴 + 𝜇
) + 𝑝
𝛽𝐼
𝛾𝐼 + 𝜇
 Equation 5.5 
5.2.2 Description of Model B under frequency dependent transmission 
A frequency dependent version of the 1
st
 framework described in  Robinson & 
Stilianakis (2013) (here to referred to as Model B), where all infections start as 
asymptomatic, is expressed in Equation 5.6-9 and the flow diagram in Figure 6.2. Table 
6.2 contains a list of all the parameters and variables used in Model B.  
𝛥𝑆
𝛥𝑡
= 𝜇𝑁 −
𝑆(𝛽𝐴𝐴 + 𝛽𝐼𝐼)
𝑁
− 𝜇𝑆 Equation 5.6 
𝛥𝐴
𝛥𝑡
=
𝑆(𝛽𝐴𝐴 + 𝛽𝐼𝐼)
𝑁
− 𝛿𝐴 − 𝛾𝐴𝐴 − 𝜇𝐴 Equation 5.7 
𝛥𝐼
𝛥𝑡
= 𝛿𝐴 − 𝛾𝐼𝐼 − 𝜇𝐼 Equation 5.8 
𝛥𝑅
𝛥𝑡
= 𝛾𝐼𝐼 + 𝛾𝐴𝐴 − 𝜇𝑅 Equation 5.9 
 
 
 
Figure 5.2: Flow diagram representing Model B 
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Table 5.2: Variables at starting value and parameters used in Model B 
Symbol Name Value 
μ Birth and death rate (per day) 1/(60x365) 
c Infectivity of asymptomatic infections compared to 
symptomatic infections 
0 to 2 
βI Symptomatic transmission rate (per day) 200/365 to 
400/365 
βA Asymptomatic transmission rate (per day) cβI 
φ Days symptomatic 8 
γI Symptomatic recovery rate (per day) φ-1 
d Asymptomatic recovery rate compared to symptomatic 
recovery rate 
0.05 to 2 
γ
A
 Asymptomatic recovery rate (per day) (dφ)-1 
p Probability of being symptomatic 0 to 0.95 
δ Progression rate from asymptomatic to symptomatic (per 
day) 
P(γ
A
+μ)/ 
(1-p) 
S Susceptible population 106-1 
A Asymptomatic population 0 to 1 
I Symptomatic population 0 to 1 
R Recovered population 0 
N Total population 106 
 
Again the total human population (N) is divided into susceptible (S), 
asymptomatically infected (A), symptomatically infected (I) and recovered (R) classes. 
Every class of human experiences loss due to a constant death rate μ, however the 
human population remains constant as humans are born into the susceptible class at a 
birth rate of μN. Susceptible humans become infected at a frequency dependent 
transmission term that is the sum of transmission from asymptomatically and 
symptomatically infected humans, given by S(βAA+ βII)/N, upon  this infection 
susceptible humans move to the asymptomatic class. Asymptomatically infected people 
gain complete lifelong immunity at a rate of γA, die μ or progress to symptomatic 
infection δ. This means that a proportion p, which is equal to δ/(δ+γA+μ), of 
asymptomatic infection will become symptomatically infected. Symptomatically 
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infected people gain immunity at a rate of γI. Once immunity is gained in the 
symptomatic or asymptomatic class humans move to the recovered class. 
Formula for the basic reproduction number (R0) is listed with equations below 
(Robinson & Stilianakis 2013). 
𝑅0 =
𝛽𝐴
𝛾𝐴 + 𝛿 + 𝜇
+
𝛿
𝛾𝐴 + 𝛿 + 𝜇
(
𝛽𝐼
𝛾𝐼 + 𝜇
) Equation 5.10 
5.2.3 Analyses of Model A and Model B 
Model A and Model B were coded in Matlab. The parameter space was then 
explored with ode45, under the 'RelTol', 10
-6
 setting, using Dengue parameters sourced 
as mid-range values from the parameters listed in Andraud et al. (2012) literature review 
of Dengue transmission models (unless otherwise stated) (see Table 6.1-2).  
In principle asymptomatic individuals could be transmitting dengue at a lower 
rate due to a lower viremia. However asymptomatic individuals could also be 
transmitting dengue at a higher rate due to the higher exposure of infected individuals to 
mosquito bites through their lack of illness causing greater mobility. For these reasons 
parameter c of both models, the coefficient relating βA to βI (βA=c βI), was varied 0-2. 
For each of these settings of c, the proportion of infection leading to symptoms (p) was 
varied from 0-1 in Model A. In Model B however for each of these settings of c 
parameter p (proportion of infection leading to symptoms) was varied from 0-0.95 due 
to the fact that altering p alters δ as δ=p(γA+μ)/(1-p) and at p=1 δ=∞.  Parameter d, the 
coefficient relating γA and γI (γA=1/dφ, γI=1/φ) was kept at 1. There is no information on 
the immune recovery rate for asymptomatically dengue infected humans. I therefore 
varied parameter d from 0.05-2, as at d=0 γA would equal infinity (γA=1/dφ, γI=1/φ). For 
each of these settings of d parameter p (proportion of infection leading to symptoms) 
was varied from 0-1 in Model A, while in Model B for each of these settings of d 
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parameter p was varied from 0-0.95 due to the fact that altering p alters δ as 
δ=p(γA+μ)/(1-p) and at p=1 δ=∞.  
The range in parameter space for the probability of a dengue virus infection 
leading symptoms (p) could be considered a large sample. Therefore it was decided to 
highlight a conservative sample of parameter space for this parameter through labelling 
certain axis values regarding this parameter in green on figures that display model 
outputs with respect to changes in this parameter. The lower limit to this conservative 
parameter space p=0.2 is based on the rounded down mean possibility of symptomatic 
dengue virus infection from cohort studies in Grange et al. (2014). The upper limit to 
this conservative parameter space of p=0.7 is based on the rounded up mean possibility 
of symptomatic dengue virus infection from index cluster studies in Grange et al. 
(2014). The non-rounded mean symptomatic dengue virus infection rate (p) in cohort 
studies was 24% whereas in index cluster studies it was 63% (Grange et al. 2014). 
Cohort studies quantify the ratio of asymptomatic to symptomatic dengue infections by 
following a cohort of people and use case reporting, absenteeism and/or symptom 
questionnaires, combined with blood screening for dengue antibodies at regular 
intervals (Endy 2002a; Endy 2002b; Arguello et al. 2015). Index cluster studies sample 
people surrounding an index case of dengue illness. Sampled individuals’ symptoms are 
quantified through symptom questionnaires or clinical diagnosis and their blood is 
screened for dengue antibodies (Singh et al. 2000; Beckett et al. 2005; Reyes et al. 
2010; Wang et al. 2015). 
Likewise, the range in parameter space for the level and duration of transmission 
from asymptomatic dengue virus infections (c and d, respectively) could be considered 
large samples. Therefore it was decided to highlight conservative samples of parameter 
space for these parameters through labelling certain axis values regarding these 
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parameters in green for figures that display model outputs with respect to changes in 
these parameters. The lower limit of these conservative parameter spaces is 0.5 and the 
upper limit is 1.5. Note that at the time of submission of this thesis there was no data 
regarding the level or duration of transmission from asymptomatic dengue virus 
infected humans available, which could be used to base a more conservative region of 
parameter space for both of these parameters. For the exploration of the parameter space 
surrounding the asymptomatic class’s transmission rate βA and recovery rate γA, Model 
A and B were run with 999,999 susceptible humans and the arrival of a single 
symptomatically infected individual. At a very low rate of transmission or duration of 
transmission for the asymptomatic class (c and d, respectively) an epidemic may start 
with the arrival of a symptomatic dengue infected human but not with the arrival of an 
asymptomatic dengue infected human. For this reason I then reran the same simulation 
with 999,999 susceptible humans and the arrival of an asymptomatically infected 
individual. The exploration of the two models’ sets of parameter space was conducted at 
the low-transmission setting of βI=200/365, mid-level transmission setting of 
βI=300/365 and high-level transmission setting of βI=400/365, (this is the range of 
transmission setting cited in the review by Andraud et al. (2012)). 
5.3 Results 
5.3.1 Epidemic dynamics 
When no infections lead to symptoms (p=0), the level and duration of 
transmission in both the symptomatic and asymptomatic class is the same (c=1 and d=1 
respectively) models A and B both become a simple frequency dependent SIR model, 
with the asymptomatic class taking the place of the symptomatic class. This 
demonstrates a typical SIR epidemic as the disease dramatically spreads through the 
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population and declines as the pool of susceptible humans is used up (see Figure 5.3). 
As the proportion of infections leading to symptoms (p) increases in both models the 
symptomatic curve takes the place of the asymptomatic curve, however in Model B the 
symptomatic curve has a larger spread and lower peak for mid-levels of infections 
leading to symptoms (p) (see Figure 5.4-5). At a different set of parameter Robinson & 
Stilianakis (2013) observed that in Model B the symptomatic curve had a higher peak, 
than Model A, which aids in demonstrating the two different models can produce a 
different peak incidence of asymptomatic and symptomatic infections. The epidemic 
patterns seen across Model A and B’s parameter space follows this pattern, except in 
differing heights and spreads in the symptomatic and asymptomatic curves. However 
epidemics with a basic reproduction number R0 of less than 1 or started with the arrival 
of an asymptomatic individual when there is no transmission from that class (c=0) in 
Model A, fail to spread through the population (see Figure 5.6-14). 
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A) 
 
B) 
 
Figure 5.3 Infected human population after the arrival of symptomatically infected 
human at mid-level transmission (βI = 300/365), with no symptomatic infections 
(p=0), the duration of an asymptomatic and symptomatic infection being the same 
(d=1) and the transmission from an asymptomatic and symptomatic infection 
being the same (c=1). Symptomatically infected humans in red and 
asymptomatically infected humans in yellow. A) Model A. B) Model B 
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A) 
 
B)
 
Figure 5.4: Infected human population after the arrival of symptomatically 
infected human at mid-level transmission (βI = 300/365), with 50% of infections 
being symptomatic (p=0.5), the duration of an asymptomatic and symptomatic 
infection being the same (d=1) and the transmission from an asymptomatic and 
symptomatic infection being the same (c=1). Symptomatically infected humans in 
red and asymptomatically infected humans in yellow. A) Model A. B) Model B 
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A) 
 
B)
 
Figure 5.5: Infected human population after the arrival of symptomatically 
infected at mid-level transmission (βI = 300/365), with 95% of infections being 
symptomatic (p=0.95), the duration of an asymptomatic and symptomatic infection 
being the same (d=1) and the transmission from an asymptomatic and 
symptomatic infection being the same (c=1). Symptomatically infected humans in 
red and asymptomatically infected humans in yellow. A) Model A. B) Model B 
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5.3.1 Basic reproduction number R0 
Both models A and B produce the same basic reproduction number R0 for the 
same transmission settings (βI), proportion of infections leading to symptoms (p), level 
and duration of transmission in the asymptomatic class (c and d respectively) (see 
Figure 5.6-8). As a note of intuitive sense for all three transmission settings (βI) when 
the level and duration of transmission is the same in both the asymptomatic and 
symptomatic class (c=1 and d=1, respectively), the R0 value is the same no matter the 
proportion of infections leading to symptoms (p) (see Figure 5.8-8). Furthermore this 
happens to be the same R0 value for Model A when all infections are symptomatic (p=1) 
no matter the level and duration of transmission in the asymptomatic class (c and d, 
respectively) (see Figure 5.6-8).  Beyond this R0 increases with a lower proportion of 
infections leading to symptoms (p) combined with a high level or duration of 
transmission in the asymptomatic class (c and d respectively) but decreases with a low 
proportion of infections leading to symptoms (p) combined with a low level or duration 
of transmission in the asymptomatic class (c and d respectively) (see Figure 5.6-8). This 
pattern in the value of R0 is similar across all three transmission setting (βI) but the 
overall values of R0 increases as βI increases from 200/365 to 400/365.  
At the low transmission setting (βI=200/365) the areas of parameter space that 
lead to an R0 below 1 and therefore produce no epidemic, occur below a threshold. This  
threshold forms a line on the figures depicting the epidemic effects of varying levels of 
transmission in the asymptomatic class (c) combined with varying the proportion of 
infections leading to symptoms (p), from c=0.2 and p=0 to c=0 and p=0.2 (see Figure 
5.6 A-B, Figure 5.9 and Figure 5.15). For figures depicting the epidemic effects of 
varying durations of transmission in the asymptomatic class (d) combined with varying 
the proportion of infections leading to symptoms (p), this line occurs from d=0.2 and 
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p=0 to d=0.05 and p=0.15 (see Figure 5.6 C-D, Figure 5.10 and Figure 5.16). The area 
of this parameter space decreases at the medium transmission setting (βI=300/365) as 
this threshold moves to the bottom left hand corner. For figures depicting epidemic 
effects of varying levels of transmission in the asymptomatic class (c) combined with 
varying the proportion of infections leading to symptoms (p), the line now occurs from 
c=0.15 and p=0 to c=0 and p=0.15 (see Figure 5.7 A-B, Figure 5.11 and Figure 5.17). 
For figures depicting varying durations of transmission in the asymptomatic class (d) 
combined with varying the proportion of infections leading to symptoms (p), this line 
occurs from d=0.15 and p=0 to d=0.05 and p=0.1 (see Figure 5.7 C-D, Figure 5.12 and 
Figure 5.18).   This area of parameter space decreases even further in the high 
transmission setting (βI=400/365) as this threshold moves further to the bottom left hand 
corner for figures depicting epidemic effects of varying levels of transmission in the 
asymptomatic class (c) combined with varying the proportion of infections leading to 
symptoms (p), the line now occurring from c=0.1 and p=0 to c=0 and p=0.1 (see Figure 
5.8 A-B, Figure 5.13 and Figure 5.19). For figures depicting varying durations of 
transmission in the asymptomatic class (c) combined with varying the proportion of 
infections leading to symptoms (p), this line occurs from d=0.1 and p=0 to d=0.05 and 
p=0.05 (see Figure 5.8 C-D, Figure 5.14 and Figure 5.20).  
The more conservative samples of parameter space for the proportion of 
infections leading to symptoms (p), the level and duration of transmission in the 
asymptomatic class (c and d respectively) do not lead to the lower values of R0 seen in 
the bottom left corner of the sub-figures of Figure 5.6-8. Likewise they do not lead to 
the higher values of R0 seen in the top left corner of the sub-figures of Figure 5.6-8. 
This means that the areas of parameter space that lead to an R0 below 1 (see Figure 5.6-
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8) and therefore lead to no epidemic spreading through the population, are not included 
in the more conservative sample of parameter space (see Figure 5.9-14). 
A) B)  
C) D)  
Figure 5.6: Basic reproduction number (R0) at low-level transmission (βI=200/365).  
A) Model A at different proportions of infections developing symptoms (p) and 
different levels of transmission in asymptomatic infections (c), when the duration 
of asymptomatic and symptomatic infections is the same (d=1). B) Model B at 
different proportions of infections developing symptoms (p) and different levels of 
transmission in asymptomatic infections (c), when the durations of asymptomatic 
and symptomatic infections is the same (d=1). C) Model A at different proportions 
of infections developing symptoms (p) and different durations of asymptomatic 
infections (d), when transmission from the asymptomatic and symptomatic 
infections is the same (c=1).  D) Model B at different proportions of infections 
developing symptoms (p) and different durations of asymptomatic infection (d), 
when transmission from the asymptomatic and symptomatic infections is the same 
(c=1). For all sub-figures the more conservative parameter space is displayed in 
green. 
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A) B)  
C) D)  
Figure 5.7: Basic reproduction number (R0) at mid-level transmission 
(βI=300/365). A) Model A at different proportions of infections developing 
symptoms (p) and different levels of transmission in asymptomatic infections (c), 
when the duration of asymptomatic and symptomatic infections is the same (d=1). 
B) Model B at different proportions of infections developing symptoms (p) and 
different levels of transmission in asymptomatic infections (c), when the duration 
of asymptomatic and symptomatic infections is the same (d=1). C) Model A at 
different proportions of infections developing symptoms (p) and different 
durations of asymptomatic infections (d), when transmission from the 
asymptomatic and symptomatic infections is the same (c=1).  D) Model B at 
different proportions of infections developing symptoms (p) and different 
durations of asymptomatic infection (d), when transmission from the 
asymptomatic and symptomatic infections is the same (c=1). For all sub-figures the 
more conservative parameter space is displayed in green. 
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A) B)  
C) D)  
Figure 5.8: Basic reproduction number (R0) at high level transmission 
(βI=400/365). A) Model A at different proportions of infections developing 
symptoms (p) and different levels of transmission in asymptomatic infections (c), 
when the duration of asymptomatic and symptomatic infections is the same (d=1). 
B) Model B at different proportions of infections developing symptoms (p) and 
different levels of transmission in asymptomatic infections (c), when the durations 
of asymptomatic and symptomatic infections is the same (d=1). C) Model A at 
different proportions of infections developing symptoms (p) and different 
durations of asymptomatic infection (d), when transmission from the 
asymptomatic and symptomatic infections is the same (c=1).  D) Model B at 
different proportions of infections developing symptoms (p) and different 
durations of asymptomatic infection (d), when transmission from the 
asymptomatic and symptomatic infections is the same (c=1). For all sub-figures the 
more conservative parameter space is displayed in green. 
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5.3.2 Epidemic persistence 
For the vast majority of epidemics asymptomatic and symptomatic dengue 
infections die out after three months to a year, regardless of the level and duration of 
transmission in the asymptomatic class (c and d respectively), the proportion of 
infections leading to symptoms (p), transmissions setting (βI) or model (see Figure 5.9-
14). Epidemics that last more than a year occur, for a lower proportion of infections 
leading to symptoms (p) combined with low levels or durations of transmission in the 
asymptomatic class in proportion to the symptomatic class (c and d respectively). The 
lower the transmission settings (βI) the longer the epidemics that last for greater than a 
year last. Epidemics that last more than 5 years and in some cases longer than 10 years 
occur at the lowest transmission setting (βI=200/365) (see Figure 5.9-10). For the 
medium transmission setting (βI=300/365) the longer lasting epidemics range from 1.5-
3 years (see Figure 5.11-12). For the high transmission setting (βI=400/365) the longer 
lasting epidemics range from just over a year to 3 years (see Figure 5.13-14). Across all 
three transmission settings (βI) these longer lasting epidemics also coincide with the R0 
being only slightly over 1, or put another way, for the parameter values just above the 
threshold lines for R0 values less than 1 described in section 5.3.1 above (compare 
Figure 5.9-14 with Figure 5.6-8). This suggests that whilst at these parameter settings 
dengue can spread through the population, R0 being greater than 1, dengue spreads 
slowly, due to a low force of infection. It should be noted that the more conservative 
samples of parameter space for the proportion of infections leading to symptoms (p), the 
level and duration of transmission in the asymptomatic class (c and d respectively), did 
not produce the longer lasting epidemics (see Figure 5.9-14). This was in a similar 
fashion to the more conservative samples of parameter space not producing the lower 
values of R0  (compare Figure 5.6-8 with Figure 5.9-14).  
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This epidemic pattern is broadly similar between models A and B, whether an 
epidemic is started by the arrival of an asymptomatic individual or symptomatic 
individual. However in Model B and an epidemic started by the arrival of an 
asymptomatic individual lengthen the course of the longer lasting epidemics. Another 
exception is that an epidemic fails to even start with the arrival of an asymptomatic 
individual when there is no transmission from that class (c=0) in Model A (see Sub-
Figure A of Figure 5.9, Figure 5.11 and Figure 5.13).  
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A) B)  
C) D)  
Figure 5.9: Days until epidemic extinction against different levels of transmission 
from asymptomatic infections (c) and different proportions of infections 
developing symptoms (p), when durations of asymptomatic and symptomatic 
infections were the same (d=1), under low-level transmission (βI=200/365). Days 
until epidemic extinction is defined as the first occurrence of the asymptomatic and 
symptomatic classes being less than 1 after the peak total of symptomatic and 
asymptomatic infections. Epidemics that had an R0 of less than 1 or last less than 
20 days are in white. A) Model A with an epidemic started by the arrival of an 
asymptomatic individual. B) Model A with an epidemic started by the arrival of a 
symptomatic individual. C) Model B with an epidemic started by the arrival of an 
asymptomatic individual. D) Model B with an epidemic started by the arrival of a 
symptomatic individual. Note the colour scale represents 0-6000 days for 
subfigures A-D. For all sub-figures the more conservative region of parameter 
space is displayed through the axis labelled values being green. 
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A) B)  
C) D)  
Figure 5.10: Days until epidemic extinction against different durations of 
asymptomatic infection (d) and different proportions of infections developing 
symptoms (p), when levels of transmission from asymptomatic and symptomatic 
infections were the same (c=1), under low-level transmission (βI=200/365). Days 
until epidemic extinction is defined as the first occurrence of the asymptomatic and 
symptomatic classes being less than 1 after the peak total of symptomatic and 
asymptomatic infections. Epidemics that had an R0 of less than 1 or last less than 
20 days are in white. A) Model A with an epidemic started by the arrival of an 
asymptomatic individual. B) Model A with an epidemic started by the arrival of a 
symptomatic individual. C) Model B with an epidemic started by the arrival of an 
asymptomatic individual. D) Model B with an epidemic started by the arrival of a 
symptomatic individual. Note the colour scale represents 0-6000 days for 
subfigures A-D. For all sub-figures the more conservative region of parameter 
space is displayed through the axis labelled values being green.  
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A) B)  
C) D)  
Figure 5.11: Days until epidemic extinction against different levels of transmission 
from asymptomatic infections (c) and different proportions of infections 
developing symptoms (p), when durations of asymptomatic and symptomatic 
infections were the same (d=1), under mid-level transmission (βI=300/365). Days 
until epidemic extinction is defined as the first occurrence of the asymptomatic and 
symptomatic classes being less than 1 after the peak total of symptomatic and 
asymptomatic infections. Epidemics that had an R0 of less than 1 or last less than 
20 days are in white. A) Model A with an epidemic started by the arrival of an 
asymptomatic individual. B) Model A with an epidemic started by the arrival of a 
symptomatic individual. C) Model B with an epidemic started by the arrival of an 
asymptomatic individual. D) Model B with an epidemic started by the arrival of a 
symptomatic individual. Note the colour scale represents 0-1500 days for 
subfigures A-D. For all sub-figures the more conservative region of parameter 
space is displayed through the axis labelled values being green.  
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A) B)  
C) D)  
Figure 5.12: Days until epidemic extinction against different durations of 
asymptomatic infection (d) and different proportions of infections developing 
symptoms (p), when levels of transmission from asymptomatic and symptomatic 
infections were the same (c=1), under mid-level transmission (βI=300/365). Days 
until epidemic extinction is defined as the first occurrence of the asymptomatic and 
symptomatic classes being less than 1 after the peak total of symptomatic and 
asymptomatic infections. Epidemics that had an R0 of less than 1 or last less than 
20 days are in white. A) Model A with an epidemic started by the arrival of an 
asymptomatic individual. B) Model A with an epidemic started by the arrival of a 
symptomatic individual. C) Model B with an epidemic started by the arrival of an 
asymptomatic individual. D) Model B with an epidemic started by the arrival of a 
symptomatic individual. Note the colour scale represents 0-1500 days for 
subfigures A-D. For all sub-figures the more conservative region of parameter 
space is displayed through the axis labelled values being green.   
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A) B)  
C) D)   
Figure 5.13: Days until epidemic extinction against different levels of transmission 
from asymptomatic infections (c) and different proportions of infections 
developing symptoms (p), when durations of asymptomatic and symptomatic 
infections were the same (d=1), under high-level transmission (βI=400/365). Days 
until epidemic extinction is defined as the first occurrence of the asymptomatic and 
symptomatic classes being less than 1 after the peak total of symptomatic and 
asymptomatic infections. Epidemics that had an R0 of less than 1 or last less than 
20 days are in white. A) Model A with an epidemic started by the arrival of an 
asymptomatic individual. B) Model A with an epidemic started by the arrival of a 
symptomatic individual. C) Model B with an epidemic started by the arrival of an 
asymptomatic individual. D) Model B with an epidemic started by the arrival of a 
symptomatic individual. Note the colour scale represents 0-1500 days for 
subfigures A-D. For all sub-figures the more conservative region of parameter 
space is displayed through the axis labelled values being green.  
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A) B)  
C) D)  
Figure 5.14: Days until epidemic extinction against different durations of 
asymptomatic infection (d) and different proportions of infections developing 
symptoms (p), when levels of transmission from asymptomatic and symptomatic 
infections were the same (c=1), under high-level transmission (βI=400/365). Days 
until epidemic extinction is defined as the first occurrence of the asymptomatic and 
symptomatic classes being less than 1 after the peak total of symptomatic and 
asymptomatic infections. Epidemics that had an R0 of less than 1 or last less than 
20 days are in white. A) Model A with an epidemic started by the arrival of an 
asymptomatic individual. B) Model A with an epidemic started by the arrival of a 
symptomatic individual. C) Model B with an epidemic started by the arrival of an 
asymptomatic individual. D) Model B with an epidemic started by the arrival of a 
symptomatic individual. Note the colour scale represents 0-1500 days for 
subfigures A-D. For all sub-figures the more conservative region of parameter 
space is displayed through the axis labelled values being green.  
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5.3.3 Percentage of the population resistant at the end of an epidemic 
Both models A and B produce an extremely similar percentage of population 
resistant to dengue by the end of the epidemic. At each of the transmission settings (βI), 
proportion of infections leading to symptoms (p), level and duration of transmission in 
the asymptomatic class in proportion to the symptomatic class (c and d respectively), 
regardless if an outbreak is started by the arrival of a symptomatic or asymptomatic 
individual (see Figure 5.15-20).  
In the lower transmission setting of βI=200/365, levels of transmission in the 
asymptomatic class lower than the symptomatic class (c<1) combined with not all 
infections becoming symptomatic (p<1), leads to the percentage of population resistant 
to dengue dropping from near 100% to less than 10 % with falling levels of 
transmission in the asymptomatic class (c) and decreasing proportions of infections 
leading to symptoms (p) (see Figure 5.15). This is also true for the duration of 
transmission in the asymptomatic class (d) (see Figure 5.16). Meaning that at the low 
level transmission setting (βI=200/365) the more conservative samples of parameter 
space for the proportion of infections leading to symptoms (p), the level and duration of 
transmission in the asymptomatic class (c and d respectively), produce epidemics where 
above 85% of the population is resistant to dengue virus (see Figure 5.15-16). 
In the medium transmission setting of βI=300/365 for levels of transmission in 
the asymptomatic class (c) less than 0.7 combined with a proportion of infections 
leading to symptoms (p) less than 0.7, the percentages of population resistant to dengue 
drops from near 100% to less than 40 % with a decreasing level of transmission in the 
asymptomatic class (c) and proportion of infections leading to symptoms (p) (see Figure 
5.17). This is also true for the duration of transmission in the asymptomatic class in 
proportion to the symptomatic class (d) (see Figure 5.18). Meaning that at the mid-level 
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transmission setting (βI=300/365) the more conservative samples of parameter space for 
the proportion of infections leading to symptoms (p), the level and duration of 
transmission in the asymptomatic class (c and d respectively), produce epidemics where 
above 90% of the population is resistant to dengue virus (see Figure 5.17-18).  
In the higher transmission setting (βI=400/365) for levels of transmission in the 
asymptomatic class less than half that of the symptomatic class (c<0.5) combined with 
less than half the of infections becoming symptomatic (p<0.5), the percentages of 
population resistant to dengue drops from near 100% to less than 40 % with decreasing 
levels of transmission in the asymptomatic class (c) and proportions of infections 
leading to symptoms (p) (see Figure 5.19). This is also true for the duration of 
transmission in the asymptomatic class (d) (see Figure 5.20). Meaning that at the    
high-level transmission setting of βI=400/365 the more conservative samples of 
parameter space for the proportion of infections leading to symptoms (p), the level and 
duration of transmission in the asymptomatic class (c and d respectively), produce 
epidemics where above 95% of the population is resistant to dengue virus (see Figure 
5.19-20). 
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A) B)  
C) D)  
Figure 5.15: Percentage of the population resistant at the end of the epidemic 
against different levels of transmission from asymptomatic infections (c) and 
different proportions of infections developing symptoms (p), when durations of 
asymptomatic and symptomatic infections were the same (d=1), under low-level 
transmission (βI=200/365). Epidemics that had an R0 of less than 1 or last less than 
20 days are in white. A) Model A with an epidemic started by the arrival of an 
asymptomatic individual. B) Model A with an epidemic started by the arrival of a 
symptomatic individual. C) Model B with an epidemic started by the arrival of an 
asymptomatic individual. D) Model B with an epidemic started by the arrival of a 
symptomatic individual. For all sub-figures the more conservative region of 
parameter space is displayed through the axis labelled values being green.  
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A) B)  
C) D)  
Figure 5.16: Percentage of the population resistant at the end of the epidemic, 
against different durations of asymptomatic infection (d) and different proportions 
of infections developing symptoms (p), when levels of transmission from 
asymptomatic and symptomatic infections were the same (c=1), under low-level 
transmission (βI=200/365). Epidemics that had an R0 of less than 1 or last less than 
20 days are in white. A) Model A with an epidemic started by the arrival of an 
asymptomatic individual. B) Model A with an epidemic started by the arrival of a 
symptomatic individual. C) Model B with an epidemic started by the arrival of an 
asymptomatic individual. D) Model B with an epidemic started by the arrival of a 
symptomatic individual. For all sub-figures the more conservative region of 
parameter space is displayed through the axis labelled values being green.  
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A) B)  
C) D)   
Figure 5.17: Percentage of the population resistant at the end of the epidemic, 
against different levels of transmission from asymptomatic infections (c) and 
different proportions of infections developing symptoms (p), when durations of 
asymptomatic and symptomatic infections were the same (d=1), under mid-level 
transmission (βI=300/365). Epidemics that had an R0 of less than 1 or last less than 
20 days are in white. A) Model A with an epidemic started by the arrival of an 
asymptomatic individual. B) Model A with an epidemic started by the arrival of a 
symptomatic individual. C) Model B with an epidemic started by the arrival of an 
asymptomatic individual. D) Model B with an epidemic started by the arrival of a 
symptomatic individual. For all sub-figures the more conservative region of 
parameter space is displayed through the axis labelled values being green.  
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A) B)  
C) D)  
Figure 5.18: Percentage of the population resistant at the end of the epidemic, 
against different durations of asymptomatic infection (d) and different proportions 
of infections developing symptoms (p), when levels of transmission from 
asymptomatic and symptomatic infections were the same (c=1), under mid-level 
transmission (βI=300/365). Epidemics that had an R0 of less than 1 or last less than 
20 days are in white. A) Model A with an epidemic started by the arrival of an 
asymptomatic individual. B) Model A with an epidemic started by the arrival of a 
symptomatic individual. C) Model B with an epidemic started by the arrival of an 
asymptomatic individual. D) Model B with an epidemic started by the arrival of a 
symptomatic individual. For all sub-figures the more conservative region of 
parameter space is displayed through the axis labelled values being green.  
179 
 
A) B)  
C) D)  
Figure 5.19: Percentage of the population resistant at the end of the epidemic, 
against different levels of transmission from asymptomatic infections (c) and 
different proportions of infections developing symptoms (p), when durations of 
asymptomatic and symptomatic infections were the same (d=1), under high-level 
transmission (βI=400/365). Epidemics that had an R0 of less than 1 or last less than 
20 days are in white. A) Model A with an epidemic started by the arrival of an 
asymptomatic individual. B) Model A with an epidemic started by the arrival of a 
symptomatic individual. C) Model B with an epidemic started by the arrival of an 
asymptomatic individual. D) Model B with an epidemic started by the arrival of a 
symptomatic individual. For all sub-figures the more conservative region of 
parameter space is displayed through the axis labelled values being green.  
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A) B)  
C) D)  
Figure 5.20: Percentage of the population resistant at the end of the epidemic, 
against durations of asymptomatic infection (d) and different proportions of 
infections developing symptoms (p), when levels of transmission from 
asymptomatic and symptomatic infections were the same (c=1), under high-level 
transmission (βI=400/365). Epidemics that had an R0 of less than 1 or last less than 
20 days are in white. A) Model A with an epidemic started by the arrival of an 
asymptomatic individual. B) Model A with an epidemic started by the arrival of a 
symptomatic individual. C) Model B with an epidemic started by the arrival of an 
asymptomatic individual. D) Model B with an epidemic started by the arrival of a 
symptomatic individual. For all sub-figures the more conservative region of 
parameter space is displayed through the axis labelled values being green.  
5.3.4 Biological unrealistic time lengths for progression from an asymptomatic 
infection to a symptomatic infection (δ-1) within Model B 
Results from Model B should be interpreted with a cautionary note in terms of 
what is biologically realistic. Recalling Equation 5.7 and Equation 5.8, δ represents the 
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rate at which an infected human develops symptoms and moves from the asymptomatic 
class to the symptomatic class (Robinson & Stilianakis 2013). Therefore δ-1 represents 
the number of days an individual would spend asymptomatically infected if they do not 
die (μ) or their immune system fails to clear the infection (γA) (Robinson & Stilianakis 
2013). Considering that p=δ/(δ+γA+μ) and γA=1/dφ, where φ is the number of days until 
immunity clears infection in a symptomatic infection and d represents how long 
immunity clears infection in an asymptomatic infection in proportion to a symptomatic 
infection, Equation 5.11 can be derived.  
𝛿−1 =
1 − 𝑝
𝑝((𝑑𝜑)−1 + 𝜇)
 Equation 5.11 
Equation 5.11 demonstrates that the number of days spent with an asymptomatic 
infection before progression to a symptomatic infection (δ-1) can be affected by both the 
proportion of infections that are symptomatic (p) and the time until immunity clears all 
dengue virus in an asymptomatic infection in proportion to a symptomatic infection (d). 
As demonstrated by Figure 5.21 this means that certain combinations of these two 
proportions can lead to the period of time spent from becoming asymptomatic infected 
until progressing to a symptomatic infection (δ-1), being biologically unfeasibly long, 
depending if longer than a month, two weeks or a week is seen as being biologically 
unfeasible (See Figure 5.21 B, C and D respectively).  
This not only affects the biological realism of the results obtain from using 
Model B when altering the time until immunity clears all dengue virus in an 
asymptomatic infection (d), but the biological realism of the results when varying the 
transmission from asymptomatic infection (c), along with the proportion of infections 
that lead to development of symptoms (p). This is because whilst acquisition of 
immunity was kept equal between asymptomatic and symptomatic infection (i.e. d was 
kept at 1), the proportion of infections leading to symptomatic infection was altered (p). 
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Therefore if longer than a month is considered a biologically unlikely amount of time 
spent from becoming asymptomatic infected until progressing to a symptomatic 
infection (δ-1), then 0-0.2 are unrealistic values for the proportion of infections that lead 
to development of symptoms (p), when the symptomatic and the asymptomatic 
infections develop immunity at the same rate (d=1) (see Figure 5.21B). Likewise if 
longer than two weeks is considered a biologically unlikely amount of time spent from 
becoming asymptomatic infected until progressing to a symptomatic infection (δ-1), then 
0-0.35 are unrealistic values for the proportion of infections that lead to development of 
symptoms (p), when the symptomatic and the asymptomatic infections develop 
immunity at the same rate (d=1) (see Figure 5.21C). If longer than a week is considered 
a biologically unlikely amount of time spent from becoming asymptomatic infected 
until progressing to a symptomatic infection (δ-1), then 0-0.5 are unrealistic values for 
the proportion of infections that lead to development of symptoms (p), when the 
symptomatic and the asymptomatic infections develop immunity at the same rate (d=1) 
(see Figure 5.21D). This therefore also demonstrates that as the tolerance for the 
duration of progression from asymptomatic to symptomatic infection (δ-1)  decreases, 
more of the conservative samples of parameter space for the proportion of infections 
leading to symptoms (p), the duration of transmission in the asymptomatic class (d) and 
the level of transmission in the asymptomatic class (c) can also be seen as having an 
unfeasible duration of progression from asymptomatic to symptomatic infection (δ-1) 
(see Figure 5.21B-D).  
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A) B)  
C) D)  
Figure 5.21: Effect of altering the duration of asymptomatic infection (d) and the 
proportion of infections that are symptomatic (p), on the duration of progression 
from asymptomatic to symptomatic infection (δ-1) for Model B, values equal to 
infinity are in black. A) Without values above a certain number of days being 
coloured white. Note the colour scale represents 0-300 days. B) Values greater the 
28 days are in white. Note the colour scale represents 0-28 days.  C) Values greater 
the 14 days are in white. Note the colour scale represents 0-14 days. D) Values 
greater the 7 days are in white. Note the colour scale represents 0-7 days. For all 
sub-figures the more conservative region of parameter space is displayed through 
the axis labelled values being green.    
5.4 Discussion 
Robinson & Stilianakis (2013) do not explore how the parameter space 
surrounding the probability of an infection leading to symptoms (p), the level and 
duration of transmission from asymptomatic infections (c and d respectively) effects the 
outcomes of Models A and B. Instead Robinson & Stilianakis (2013) use fixed 
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parameters based on influenza to explore the long term behaviours of both Model A and 
B, then going on to modify Model B in order to explore the consequences of the 
evolution of a drug resistant strain of influenza. That being said there are comparisons 
between the results found here and those of Robinson & Stilianakis (2013) that can be 
made, some of which enable generalisations over the outcomes from Model A and B to 
be made. This study found that in terms of R0 Models A and B produce identical results 
(see Figure 5.6-9). There is little comparison that can be made concerning R0 when 
looking at Robinson & Stilianakis (2013) as they calculate the asymptomatic and 
symptomatic transmission terms (βA and βI, respectively) using a fixed value of R0 from 
the 2009 H1N1 influenza pandemic, along with fixed values for other parameters based 
on influenza studies. This study found that epidemic persistence time and percentage of 
the population being left resistant to dengue was extremely similar between models A 
and B (see Figure 5.9-20), despite there been differences in the peak incidence of 
asymptomatic and symptomatic infections between the two models (see Figure 5.4). 
Likewise Robinson & Stilianakis (2013) found that epidemic persistence time was 
similar between the two models, despite there been differences in the peak incidence of 
asymptomatic and symptomatic infections between models A and B. It should be noted 
that Robinson & Stilianakis (2013) did not mention the percentage of the population 
being left resistant to influenza in their simulations, most likely because they did not 
think it was of relevance to their study. The findings from my study and a comparison to 
the finding of Robinson & Stilianakis (2013), therefore lead to two generalisations 
regarding models A and B. Firstly that when modelled in a deterministic frequency 
dependent framework there is little overall difference between modelling infection 
leading to an asymptomatic state or symptomatic state compared to modelling infection 
leading to an asymptomatic state that can possibly progress to a symptomatic state. 
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Secondly that this is despite differences in the peak incidence of asymptomatic and 
symptomatic infections between two such modelling approaches.  
A caveat to this and many other observations made from using Model B, is that 
certain combinations of the proportion of asymptomatic infections becoming 
symptomatic (p) and the period of time that immunity takes to clear an asymptomatic 
infection (d) can produce biologically unrealistic lengths of time in the progression from 
an asymptomatic infection to a symptomatic infection (δ-1) (see Figure 5.21). This is not 
only true for large parts of the parameter space explored from altering the proportion of 
asymptomatic infections becoming symptomatic (p) and the period of time that 
immunity takes to clear an asymptomatic infection (d) but the parameter space explored 
from altering the proportion of asymptomatic infections becoming symptomatic (p) and 
the transmission from asymptomatic infections (c) (see Figure 5.21). This also affects 
large parts of the more conservative samples of parameter space for the proportion of 
infections leading to symptoms (p), the duration of transmission in the asymptomatic 
class (d) and to a lesser extent the level of transmission in the asymptomatic class (c) 
(see Figure 5.21). 
For both models A and B most combinations of the proportion of infections 
leading to symptoms (p), level and duration of transmission from asymptomatic 
infections (c and d respectively) produce epidemics that last little over a year or less 
(see Figure 5.9-14). The few epidemics lasting over several years occur for a proportion 
of infections that develop symptoms (p), which is towards the low end. p=0 to 0.25 for a 
low-level transmission setting (βI=200/365), p=0 to 0.2 for a mid-level transmission 
setting (βI=300/365), p=0 to 0.15 for a high-level transmission setting (βI=400/365) (see 
Figure 5.9-13). Especially when compared to the range sampled in the more 
conservative sample of parameter space based on the review by Grange et al. (2014) 
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(thus often been excluded from this conservative sample). Grange et al. (2014) found 
that 3-80% of dengue infections were symptomatic with a mean rate in cohort studies of 
22.9% and 25.6%, for the Americas and Asia, respectively. The mean symptomatic 
infection rate in cohort studies was 24% whereas in index cluster studies it was 63% 
(Grange et al. 2014). Cohort studies quantify the ratio of asymptomatic to symptomatic 
dengue infections by following a cohort of people and use case reporting, absenteeism 
and/or symptom questionnaires, combined with blood screening for dengue antibodies 
at regular intervals (Endy 2002a; Endy 2002b; Arguello et al. 2015). The other 
commonly used method is index cluster analysis, where people surrounding an index 
case of dengue illness are sampled. Their symptoms are quantified through symptom 
questionnaires or clinical diagnosis and there blood is screened for dengue antibodies 
(Singh et al. 2000; Beckett et al. 2005; Reyes et al. 2010; Wang et al. 2015). The 
difference in proportions of symptomatic dengue infections observed through these two 
methodologies led Grange et al. (2014) to point out that in cohort studies, the common 
use of questionnaires of perceived symptoms may well be biased against the number of 
dengue infections defined as symptomatic. Furthermore Grange et al. (2014) points to 
Yoon et al. (2012) who used both index cluster analysis and cohort methodologies 
finding that the cohort methodology may have underestimated the rate of symptomatic 
infection. Countering this Grange et al. (2014) also points out that the index cluster 
approach may be biased towards higher rates of symptomatic infection, as the virus 
responsible for the index case may be more likely to produce symptoms. The more 
conservative samples of parameter space for the level and duration of transmission from 
asymptomatic infections (c and d respectively) leads to all these longer lasting 
epidemics being excluded (see Figure 5.9-13). However, there was no literature 
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available to base the more conservative samples of parameter space for the level and 
duration of transmission from asymptomatic infections (c and d respectively). 
The epidemics that last more than a year occur for a low proportion of infections 
becoming symptomatic (p) combined with either a low duration or level of transmission 
from asymptomatic infections (c and d, respectively). This translates as very few 
infections becoming symptomatic and those that are asymptomatic either becoming 
immune very quickly (a low value for d) or transmitting dengue to very few people (a 
low value of c) as such the R0 value is only just above 1 (compare Figure 5.9-14 with 
Figure 5.6-8). Considering that R0 is defined as the average number of infections 
produced by the arrival of an infected individual in a completely susceptible population 
(Anderson & May 1991a), this could mean that if these models were to be modelled 
stochastically instead of in a deterministic manner, the parameter settings that produce 
the longer lasting epidemics may produce dengue outbreaks that do not infect more than 
a few individuals. These few individuals would simply become immune or die before 
infecting someone else with dengue virus. As such, there would also be few individuals 
who are immune to dengue and thereby at a risk of DHF in an outbreak of a different 
dengue serotype.     
Across most of the parameter space, epidemics lead to nearly 100% of the 
population being immune to the invading dengue serotype. With between 5%-98% 
being immune for proportions of infection leading to symptoms (p) less than 1 when 
combined with levels or duration of transmission from asymptomatic infections (c and d 
respectively) that are also less than 1 in the lower transmission setting (βI=200/365) (see 
Figure 5.15-16). In the medium transmission setting (βI=300/365) this becomes 36%-
98% of the population being immune, for proportions of infection leading to symptoms 
(p) less than 0.7 when combined with levels or durations of transmission from 
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asymptomatic infections (c and d respectively), that are also less than 0.7 (see Figure 
5.17-18). Likewise for the higher transmission setting (βI=400/365) this becomes 39%-
98% of the population being immune, for less than half of infections leading to 
symptoms (p<0.5) when combined with levels or durations of transmission from 
asymptomatic infections that are half that of symptomatic infections (c<0.5 and d<0.5 
respectively) (see Figure 5.19-20). Looking at the more conservative samples of 
parameter space this means that even at the  low level transmission setting (βI=200/365) 
above 85% of the population is resistant to dengue virus at the end of an epidemic. If 
within 1-3 years after the initial epidemic another dengue serotype were to invade the 
majority of the population would be immune through cross protective immunity (Reich 
et al. 2013). However as time progresses past this period, the large proportion that are 
immune to the initial serotype would become increasingly at risk of DHF in any 
subsequent dengue epidemics caused by another serotype (Guzman et al. 2010; 
Rodenhuis-Zybert et al. 2010). Unless seroprevalence surveys had been carried out this 
large proportion of the population at risk of DHF would be completely unknown to a 
health authority, as they would be relying on reported cases from the first epidemic.   
The percentage of population left immune by a dengue serotype and therefore at 
risk of DHF upon infection with another serotype in epidemics produced by Models A 
and Model B, may well explain the historical occurrence of DF and DHF in Cuba. From 
1977-1979 there was a nationwide epidemic of DENV-1, with a further nationwide 
epidemic of DENV-2 in 1981 and an outbreak of DENV-2 restricted to the city of 
Santiago de Cuba in 1997. Of the 205 DHF/DSS cases in Santiago de Cuba in 1997 all 
but three had evidence of a prior dengue infection, and all where over 15, suggesting 
that they had been infected with DENV-1 during the island wide 1977-1979 outbreak 
(Guzmán 2000; Vaughn et al. 2000; Guzmán et al. 2000). Furthermore there was a 
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greater DHF/DSS mortality rate in the 1997 DENV-2 outbreak, than the 1981 DENV-2 
outbreak (Guzmán et al. 2002). Some have suggested that this greater risk of disease 
severity seen in the second DENV-2 outbreak may be connected to a decrease in 
heterologous neutralizing antibody titre (Guzmán et al. 2002; Guzman et al. 2007). The 
results from these models would suggest that an initial outbreak of a dengue serotype 
would lead to a large proportion of the population becoming immune to that serotype. 
An epidemic by a second serotype would be unlikely in the near future, as Reich et al. 
(2013) approximated that cross protective immunity lasts for 1-3 years. Unfortunately 
as time progressed there would be an increased chance of a successful epidemic that 
would lead to more severe dengue infections in those that are immune to the serotype 
responsible for the first epidemic (Guzmán et al. 2002; Guzman et al. 2007), as cross 
protective immunity wanes (Reich et al. 2013). A health authority using reported 
dengue illnesses would not necessarily know how big a proportion of the population had 
become immune to the initial serotype. Results from this model suggest that even at low 
probabilities of developing symptoms, a large proportion of the population could be 
immune to this initial serotype. Therefore in order to understand the risks of DHF/DSS 
in countries that suffer from infrequent dengue epidemics not only is there a need for 
knowledge of the immunity to specific serotypes, the sequence of serotype immunity 
and length of time between serotype infections that leads to DHF, but also further 
knowledge about the proportion of primary dengue infections that are asymptomatic. 
On this point Grange et al. (2014) review suggested that there was no significant 
difference between primary and secondary dengue infections leading to asymptomatic 
dengue infection. It should be noted that there was significant difference between the 
general rates of asymptomatic dengue infection between studies (Grange et al. 2014). 
There has also been very few studies looking at viremia in asymptomatic dengue 
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infections (Beckett et al. 2005; Reyes et al. 2010; Carrington & Simmons 2014), let 
alone quantifying the differences in viremia in either primary or secondary dengue 
infections which are asymptomatic (Duong et al. 2011). 
The 1997 outbreak in Santiago de Cuba highlights another observation that can 
be inferred from this model. The first reported cases of dengue were in January 1997, 
although retrospective serological evidence suggest that the initial transmission 
occurred in the latter half of December 1996 (Kourí et al. 1998). As dengue had not 
been reported since 1981 in Cuba and the first reported case was in a male who had 
never been outside of Cuba (Guzmán 2000), this would suggest that dengue had been 
introduced by an international traveller who was asymptomatically infected. Likewise 
subfigures A and C of Figure 5.9-14 illustrate that the arrival of an asymptomatic 
individual can produce a dengue epidemic. Even in a low transmission setting with low 
probabilities of developing symptoms (p), combined with either low levels of 
asymptomatic transmissibility (c) or short periods of viremia (d), the arrival of an 
asymptomatic infection can cause an outbreak in Models A and B (see Subfigures A 
and C of Figure 5.9-10). Asymptomatic infections would therefore also limit the 
effectiveness of airport fever screening as an dengue epidemic prevention strategies as 
suggested by Kuan et al. (2010), Kuan & Chang (2012) and Chastel (2012). Whilst 
there has been reported cases of travellers returning from dengue endemic countries 
with fever or developing fever (Jelinek 2000; Wichmann et al. 2005; Freedman et al. 
2010; Kuan & Chang 2012; Chastel 2012), there has been little work on estimating the 
number of imported asymptomatic dengue infections to non-endemic countries. 
Autochthonous cases of dengue fever were reported in France and Croatia in 2010, 
furthermore there was an outbreak of dengue fever in the Portuguese islands of Madeira 
(WHO 2015b). In 2007 in north-eastern Italy there was an outbreak of chikungunya, 
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with Ae. albopictus being implicated as the vector (WHO 2015a). In light of these 
incidences Quam et al. (2015) through mathematical modelling estimated a yearly 
importation of 572 apparent and 1747 inapparent dengue infections through Rome’s 
airport. If Quam et al. (2015) approximations are reliable then it may be the case that 
stochasticity plays a role in preventing imported dengue from causing regular epidemics 
from taking place in Italy. Incorporation of such stochasticity into Models A or Model B 
may shed further light on this. 
Literature reviews by Jelinek (2000) and Chastel (2012) and the results from the 
models used in this study highlight two key aspects of asymptomatic infection in the 
risk of asymptomatically dengue infected travellers causing epidemics. These two 
aspects are the level and duration of transmission from asymptomatic dengue infections. 
To date no studies have directly researched the duration or degree of transmissibility of 
asymptomatic dengue virus infections to a biting mosquito. However, the degree and 
duration of transmissibility relate to the level and duration of dengue virus viremia in 
asymptomatic dengue infections, respectively. Viremia of an asymptomatic dengue 
infection has to be high enough to produce an infectious blood meal for a mosquito and 
work by Nguyet et al. (2013) suggest the higher the viral titre, the greater the likelihood 
of a blood meal infecting a mosquito. Figure 5.6-8 demonstrate that a very low 
proportion of infections developing symptoms (p) combined with either a very low 
asymptomatic transmission rate (c) or period of infection in asymptomatic infection (d) 
could produce an R0 less than 1, meaning an epidemic could not take place (see Figure 
5.9-14). This becomes more important at lower transmission levels (βI=200/365) as the 
range at which the proportion of infection leading to symptoms (p) combined with 
levels or duration of transmission from asymptomatic infections (c and d respectively) 
leading to an R0 less than 1 increase (see Figure 5.6-8) and these low level of 
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transmission settings may reflect the transmission settings of non-dengue endemic 
countries.   
5.5 Conclusions 
Modelled deterministically with frequency dependent transmission there is little 
difference regarding epidemiological aspects between Model A and Model B. This is 
despite Model B making unrealistic assumptions about the length of time an infection 
progresses from an asymptomatic state to a symptomatic state (δ-1) and for many 
different proportions of asymptomatic infections becoming symptomatic (p) or periods 
of time that immunity takes to clear an asymptomatic infection (d). The addition of 
stochastic elements to Models A or Model B would shed greater light on the role of 
asymptomatic infections in terms of the likelihood of dengue epidemics taking hold in a 
population. Above all models A and B demonstrate the need for further research on the 
level and duration of transmission in asymptomatic infections, as well as the proportion 
of dengue infections that remain asymptomatic. This affects not only whether or not a 
dengue epidemic can occur in a population and how long that epidemic persists but the 
proportion of the population left immune to dengue that would thereby be at risk of 
developing DHF in any subsequent dengue epidemic. The longer lasting epidemics 
were either on the edge of or excluded from the more conservative sample of parameter 
space for the proportion dengue virus infection that are symptomatic, which was based 
on the review by Grange et al. (2014). Considering this the differences in the proportion 
dengue virus infection that are symptomatic seen in Grange et al. (2014) review 
highlight the need for comparative research between cohort studies and index cluster 
studies in order to assess which is the most accurate, followed by standardisation of 
methodologies in future studies assessing this. To date there have been no studies 
demonstrating that asymptomatically dengue virus infected humans can transmit dengue 
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virus to a biting mosquito, and very few studies speculating on the degree or duration of 
transmissibility. Therefore the findings of this study highlight these areas as a key 
priority for future research. These areas could be researched by studying how the level 
and duration viremia in asymptomatically dengue virus infected humans compares to 
that of symptomatically dengue virus infected humans capable of transmitting dengue 
virus to a mosquito.  
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Chapter 6: Mosquito dependent models of asymptomatic dengue 
infections: their relationship to epidemic success, persistence and 
population at risk of developing dengue haemorrhagic fever 
Abstract 
In order for an Aedes mosquito to act as a competent vector of dengue virus, the 
virus has to surmount several barriers, replicate and disseminate into the saliva, ready 
for injection at a mosquito’s next blood meal. All of these processes take a period of 
time. This could have the effect of slowing dengue’s transmission dynamics down. This 
slowing down of dengue’s transmission could reduce the speed at which an epidemic 
progresses or uses up the newly born susceptible population; this in turn could lead to 
an epidemic becoming endemic. For these reasons I modified the two models in the 
previous chapter to include mosquitoes in dengue virus transmission. As in the previous 
chapter the level and duration of transmission from the asymptomatic class was varied 
over a wide range due to the lack of data. The inclusion of mosquitoes within the 
models produced broadly similar results, across most of the parameter space. Except for 
finding that the dengue virus could become endemic, provided the transmission setting 
was high, the probability of developing symptoms was less than 1 and there was either a 
high level or duration of transmission from asymptomatic infections. 
6.1 Introduction 
Dengue is the most important arboviral pathogen causing an estimated 390 
million dengue infections per year, of which 96 million manifest as clinical illness 
(Bhatt et al. 2013). Being from the Flavivirus genus dengue viruses are positive-
stranded RNA viruses (Guzman et al. 2010; Rodenhuis-Zybert et al. 2010). Dengue 
viruses are separated into four immunological serotypes (DENV-1, DENV-2, DENV-3 
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and DENV-4), (Guzman et al. 2010; Rodenhuis-Zybert et al. 2010). Primary infection 
leads to asymptomatic infection through to dengue fever (DF) (Guzman et al. 2010; 
Andraud et al. 2012; Grange et al. 2014; WHO 2015c). Upon recovery from primary 
infection an individual is immune to that serotype for life (Guzman et al. 2010; 
Rodenhuis-Zybert et al. 2010; Andraud et al. 2012). For an estimated 1-3 years an 
individual is also immune to other dengue serotypes (Reich et al. 2013). After this 
period of time however, secondary infection with another serotype can lead to a person 
developing dengue haemorrhagic fever (DHF) (Guzman et al. 2010; Rodenhuis-Zybert 
et al. 2010; Andraud et al. 2012; WHO 2015c). DHF can lead to dengue shock 
syndrome (DSS), both of which are life threatening. Often grouped together  as ‘severe 
dengue’, DHF and DSS have been estimated to cause 500,000 cases of illness, mostly in 
children and have a mortality rate of 2.5% (WHO 2015c). 
Mosquitoes of the Aedes genus act as the vector of dengue viruses (M. Service 
2012b). Aedes aegypti being the principal vector of dengue viruses, with Ae. albopictus 
having less of a role as a vector of dengue (M. Service 2012b; Lambrechts et al. 2010). 
With Ae. albopictus increasing its range to include 29 states of the USA, 15 European 
countries, Australia and New Zealand (M. Service 2012b; Lambrechts et al. 2010; 
WHO 2015c), there has been a growing concern that there could be an increasing risk of 
outbreaks of dengue fever in these countries (Lambrechts et al. 2010).  
Given that a large proportion of dengue infections are thought to be 
asymptomatic (Bhatt et al. 2013; Grange et al. 2014) in Chapter 5 I used two SAIR 
frequency dependent models previously developed by Robinson & Stilianakis (2013), to 
explore the role of asymptomatic dengue infections on several features of dengue virus 
epidemiology. The key finding of the work in Chapter 5 was that asymptomatic 
infections did not lead to dengue becoming endemic. Whilst epidemics usually lasted 
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only a year or two, when the probability of developing symptoms was low and 
combined with low asymptomatic transmission or short duration of transmission 
epidemics could extend over 2 years. Furthermore epidemics could extend to over 15 
years in the low transmission setting. Extremely low probabilities of developing 
symptoms combined with extremely low values of asymptomatic transmission or the 
duration of asymptomatic transmission caused the basic reproductive number (R0) to 
drop below 1 meaning dengue could not spread through the population. This was the 
case even in the high transmission setting. Another finding from Chapter 5 was that 
across most of the explored parameter space more than 90% of the population was 
immune to dengue at the end of an epidemic and thereby at risk of DHF in subsequent 
epidemics caused by a different dengue serotype. This at risk population decreased with 
lower transmission settings, a lower probability of being symptomatic, as well as a 
lower transmission and duration of transmission in the asymptomatic class. 
Lacking from Chapter 5’s two models was the explicit inclusion of mosquitoes 
in the transmission dynamics. In order for an Aedes mosquito to act as a competent 
vector of dengue, the virus has to surmount two gut barriers, disseminate to the salivary 
glands, replicate and disseminate into the saliva, ready for injection at a mosquitoes next 
blood meal (Lambrechts et al. 2010). All of these processes take a period of time often 
referred to as the extrinsic incubation period (EIP) (Andraud et al. 2012). Dengue’s EIP 
could have an effect on dengue’s transmission by slowing its dynamics down compared 
to that seen in a frequency dependent model of transmission, where EIP is not included. 
This slowing down of dengue’s transmission could reduce the speed at which an 
epidemic progresses or uses up the newly born susceptible population; this in turn could 
lead to an epidemic becoming endemic. For these reasons I modified the two models in 
the previous chapter to include mosquitoes in dengue virus transmission.  
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6.2 Methods 
6.2.1 Description of Model A under mosquito dependent transmission 
The two frameworks used to Model Asymptomatic Dengue infection were adapted from 
the work of Robinson & Stilianakis (2013). As discussed the EIP within the mosquito 
may affect dengue’s transmission dynamics and so affect the persistence of dengue 
epidemics. Therefore a mosquito dependent transmission version of the 2
nd
  framework 
described in Robinson & Stilianakis (2013) (here referred to as Model A) was made and 
adapted to dengue transmission dynamics (see the Equation 6.1-8 below and the flow 
diagram in Figure 6.1). Table 6.1 contains a list of all parameter and variables in Model 
A under mosquito dependent transmission.  
𝛥𝑆𝐻
𝛥𝑡
= 𝜇𝐻𝑁𝐻 −
𝑆𝐻
𝑁𝐻
𝛽𝑉𝐼𝑉 − 𝜇𝐻𝑆𝐻 Equation 6.1 
𝛥𝐴𝐻
𝛥𝑡
= (1 − 𝑝)
𝑆𝐻
𝑁𝐻
𝛽𝑉𝐼𝑉 − 𝛾𝐴𝐴𝐻 − 𝜇𝐻𝐴𝐻 Equation 6.2 
𝛥𝐼𝐻
𝛥𝑡
= 𝑝
𝑆𝐻
𝑁𝐻
𝛽𝑉𝐼𝑉 − 𝛾𝐼𝐼𝐻 − 𝜇𝐻𝐼𝐻 Equation 6.3 
𝛥𝑅𝐻
𝛥𝑡
= 𝛾𝐼𝐼𝐻 + 𝛾𝐴𝐴𝐻 − 𝜇𝐻𝐼𝐻 Equation 6.4 
𝛥𝑆𝐸
𝛥𝑡
= 𝜇𝑉𝑁𝑉 − 𝜔𝑆𝐸   Equation 6.5 
𝛥𝑆𝑉
𝛥𝑡
= 𝜔𝑆𝐸 − 𝑆𝑉
𝛽𝐴𝐴𝐻 + 𝛽𝐼𝐼𝐻
𝑁𝐻
− 𝜇𝑉𝑆𝑉 Equation 6.6 
𝛥𝐸𝑉
𝛥𝑡
= 𝑆𝑉
𝛽𝐴𝐴𝐻 + 𝛽𝐼𝐼𝐻
𝑁𝐻
− 𝜀𝐸𝑉 − 𝜇𝑉𝐸𝑉 Equation 6.7 
𝛥𝐼𝑉
𝛥𝑡
= 𝜀𝐸𝑉 − 𝜇𝑉𝐼𝑉 Equation 6.8 
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Figure 6.1: Flow diagrams representing Model A under mosquito dependent 
transmission  
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Table 6.1: Variables at starting value and parameters used in Model A under 
mosquito dependent transmission 
Symbol Name Value 
μH Birth and death rate (per day) 1/(60x365) 
c Infectivity of asymptomatic infections compared to 
symptomatic infections 
0 to 2 
b Biting rate (per day) 0.3-1 
βi Probability of symptomatic transmission to a vector 0-1 
βI Symptomatic transmission rate (per day) bβi 
βA Asymptomatic transmission rate (per day) cβI 
φ Days symptomatic 8 
γI Symptomatic recovery rate (per day) φ-1 
d Asymptomatic recovery rate compared to symptomatic 
recovery rate 
0.05 to 2 
γ
A
 Asymptomatic recovery rate (per day) (dφ)-1 
p Probability of being symptomatic 0 to 1 
SH Susceptible population 106-1 
AH Asymptomatic population 0 to 1 
IH Symptomatic population 0 to 1 
RH Recovered population 0 
NH Total population 106 
μ
V
 Mosquito birth and death rate (per day) 1/6 
ω Mosquito maturation rate (per day) 1/11 
β
v
 Probability of vector transmission to a human 0.425 
β
V
 Mosquito transmission rate (per day) bβ
v
 
ε Extrinsic incubation period 1/10 
S
E
 Pre-adult mosquitos (ω/μ
V
)N
V
 
 S
V
 Susceptible adult mosquito population 9.5x106 
E
V
 Latent adult mosquito population 0 
I
V
 Infectious adult mosquitoes population 0 
N
V
 Total adult mosquito population 9.5x106 
 
The total human population (NH) is divided into susceptible (SH), 
asymptomatically infected (AH), symptomatically infected (IH) and recovered (RH) 
classes. The total mosquito population (NV) is divided into immature mosquito (SE), 
susceptible mosquito (SV), incubating mosquito (EV) and infected mosquito (IV) classes. 
Every class of human experiences loss due to a death rate μH, however the human 
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population remains constant as humans are born into the susceptible class at a birth rate 
of μHNH. Susceptible humans become infected at a mosquito dependent transmission 
term, given by SH/NH(βVIV). Upon infection humans either become asymptomatic at a 
rate of (1-p)SH/NH(βVIV) or symptomatically infected at a rate of pSH/NH(βVIV). 
Asymptomatically infected people gain complete lifelong immunity at a rate of γA and 
symptomatically infected people gain complete lifelong immunity at a rate of γI, both of 
which then move to the recovered class. Every class of mosquito experiences loss due to 
death rate μV, however the mosquito population remains constant as mosquitoes are 
oviposited into the immature mosquito class at a of μVNV. Mosquitoes mature into 
adults at a rate ω and become infected at a rate of SV(βAAH+ βIIH)/NH moving to the 
incubating class, after a period of incubation ε mosquitoes move to the infectious class.  
The symptomatic transmission term βI is made up of two component terms, the 
mosquito biting rate b and probability of infection from biting a symptomatic human βi 
(βI=bβi). Likewise the mosquito transmission term βV is made up of two component 
terms, the mosquito biting rate b and probability of infection from an infectious 
mosquito βv (βV=bβv). 
6.2.2 Description of Model B under mosquito dependent transmission 
A mosquito dependent transmission version of the 1
st
 framework described in  
Robinson & Stilianakis (2013) (here referred to as Model B) was made and adapted to 
dengue transmission dynamics (see Equation 6.9-16 and the flow diagram in Figure 
6.2). Table 6.2 contains a list of all parameters and variables.  
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𝛥𝑆𝐻
𝛥𝑡
= 𝜇𝐻𝑁𝐻 −
𝑆𝐻
𝑁𝐻
𝛽𝑉𝐼𝑉 − 𝜇𝐻𝑆𝐻 Equation 6.9 
𝛥𝐴𝐻
𝛥𝑡
=
𝑆𝐻
𝑁𝐻
𝛽𝑉𝐼𝑉 − 𝛿𝐴𝐻 − 𝛾𝐴𝐴𝐻 − 𝜇𝐻𝐴𝐻 Equation 6.10 
𝛥𝐼𝐻
𝛥𝑡
= 𝛿𝐴𝐻 − 𝛾𝐼𝐼𝐻 − 𝜇𝐻𝐼𝐻 Equation 6.11 
𝛥𝑅𝐻
𝛥𝑡
= 𝛾𝐼𝐼𝐻 + 𝛾𝐴𝐴𝐻 − 𝜇𝐻𝐼𝐻 Equation 6.12 
𝛥𝑆𝐸
𝛥𝑡
= 𝜇𝑉𝑁𝑉 − 𝜔𝑆𝐸   Equation 6.13 
𝛥𝑆𝑉
𝛥𝑡
= 𝜔𝑆𝐸 − 𝑆𝑉
𝛽𝐴𝐴𝐻 + 𝛽𝐼𝐼𝐻
𝑁𝐻
− 𝜇𝑉𝑆𝑉 Equation 6.14 
𝛥𝐸𝑉
𝛥𝑡
= 𝑆𝑉
𝛽𝐴𝐴𝐻 + 𝛽𝐼𝐼𝐻
𝑁𝐻
− 𝜀𝐸𝑉 − 𝜇𝑉𝐸𝑉 Equation 6.15 
𝛥𝐼𝑉
𝛥𝑡
= 𝜀𝐸𝑉 − 𝜇𝑉𝐼𝑉 Equation 6.16 
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Figure 6.2: Flow diagrams representing Model B under mosquito dependent 
transmission 
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Table 6.2: Variables at starting value and parameters used in Model B under 
mosquito dependent transmission 
Symbol Name Value 
μH Human birth and death rate (per day) 1/(60x365) 
c Infectivity of asymptomatic infections compared to 
symptomatic infections 
0 to 2 
b Biting rate (per day) 0.3 to 1 
βi Probability of symptomatic transmission to a Vector 0.5 to 1 
βI Symptomatic transmission rate (per day) bβi 
βA Asymptomatic transmission rate (per day) cβI 
φ Days symptomatic 8 
γI Symptomatic recovery rate (per day) φ-1 
d Asymptomatic recovery rate compared to symptomatic 
recovery rate 
0.05 to 2 
γ
A
 Asymptomatic recovery rate (per day) (dφ)-1 
p Probability of being symptomatic 0 to 0.95 
δ Progression rate from asymptomatic to symptomatic (per day) P(γ
A
+μh)/ 
(1-p) 
SH Susceptible population 106-1 
AH Asymptomatic population 0 to 1 
IH Symptomatic population 0 to 1 
RH Recovered population 0 
NH Total population 106 
μ
V
 Mosquito oviposition and death rate (per day) 1/6 
ω Mosquito maturation rate (per day) 1/11 
β
v
 Probability of vector transmission to a human 0.425 
β
V
 Mosquito transmission rate (per day) bβ
v
 
ε Extrinsic incubation period 1/10 
S
E
 Pre-adult mosquitos (ω/μ
V
)N
V
 
 S
V
 Susceptible adult mosquito population 9.5x106 
E
V
 Latent adult mosquito population 0 
I
V
 Infectious adult mosquitoes population 0 
N
V
 Total adult mosquito population 9.5x106 
 
The total human population (NH) is divided into susceptible (SH), 
asymptomatically infected (AH), symptomatically infected (IH) and recovered (RH) 
classes. The total mosquito population (NV) is divided into immature (SE), susceptible 
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(SV), incubating (EV) and infected (IV) classes. Every class of human experiences loss 
due to a death rate μH, however the human population remains constant as humans are 
born into the susceptible class at a birth rate of μHNH. Susceptible humans become 
infected at a mosquito dependent transmission term, given by SH/NH(βVIV) and move to 
the asymptomatic class. Asymptomatically infected people gain complete lifelong 
immunity at a rate of γA moving to the recovered class, die μH or progress to 
symptomatic infection δ. This means that a proportion p, which is equal to δ/(δ+γA+μH), 
of asymptomatic infection will become symptomatically infected. Symptomatically 
infected people gain complete lifelong immunity at a rate of γI moving to the recovered 
class. Every class of mosquito experiences loss due to death rate μV, however the 
mosquito population remains constant as mosquitoes are oviposited into the immature 
mosquitoes class at a of μVNV. Mosquitoes mature into adults at a rate ω and become 
infected at a rate of SV(βAAH+ βIIH)/NH moving to the incubating class, after a period of 
incubation ε mosquitoes move to the infectious class.  
The symptomatic transmission term βI is made up of two component terms, the 
mosquito biting rate b and probability of infection from biting a symptomatic human βi 
(βI=bβi). Likewise the mosquito transmission term βV is made up of two component 
terms, the mosquito biting rate b and probability of infection from an infectious 
mosquito βv (βV=bβv). 
6.2.3 Model A’s basic reproduction number (R0) under mosquito dependent 
transmission 
R0 of the mosquito dependent transmission version of Model A was calculated 
using the next generation matrix methods as outlined in Diekmann et al. (2010) (see 
Equation 6.17-19). Note that in a completely susceptible population SH=NH and SV=NV.  
 
205 
 
𝜑 = 𝑡 + 𝜎 Equation 
6.17a 
𝜑 = |
𝐴𝐻
𝐼𝐻
𝐸𝑉
𝐼𝑉
|,  𝑡 = |
|
(1 − 𝑝)𝛽𝑉𝐼𝑉
𝑝𝛽𝑉𝐼𝑉
𝑁𝑉 (
𝛽𝐴𝐴𝐻+𝛽𝐼𝐼𝐻 
𝑁𝐻
)
0
|
|,  𝜎 = |
|
−𝛾𝐴𝐴𝐻 −  𝜇𝐻𝐴𝐻
𝛾𝐼𝐼𝐻–  𝜇𝐻𝐼𝐻 
−𝜀𝐸𝑉 − 𝜇𝑉𝐸𝑉 
𝜀𝐸𝑉  − 𝜇𝑉𝐼𝑉
|
| 
 
Equation 
6.17b 
𝐾𝐿 = 𝑇*-𝛴 
−1
 Equation 
6.18a 
𝑇 =
|
|
0 0 0 (1 − 𝑝)𝛽𝑉
0 0 0 𝑝𝛽𝑉
𝛽𝐴𝑁𝑉
𝑁𝐻
𝛽𝐼𝑁𝑉
𝑁𝐻
0 0
0 0 0 0
|
|
 
 
Equation 
6.18b  
𝛴 = |
−𝛾𝐴 −  𝜇𝐻 0 0 0
0 −𝛾𝐼 −  𝜇𝐻 0 0
0 0 −𝜀 − 𝜇𝑉 0
0 0 𝜀 −𝜇𝑉
| 
Equation 
6.18b 
continued  
𝐾𝐿 =
|
|
0 0 −
(𝑝 − 1)𝜀𝛽𝑉
𝜇𝑉(𝜀 + 𝜇𝑉)
−
(𝑝 − 1)𝛽𝑉
𝜇𝑉
0 0
𝑝𝜀𝛽𝑉
𝜇𝑉(𝜀 + 𝜇𝑉)
𝑝𝛽𝑉
𝜇𝑉
𝛽𝐴𝑁𝑉
𝑁𝐻(𝛾𝐴 + 𝜇𝐻)
𝛽𝐼𝑁𝑉
𝑁𝐻(𝛾𝐼 + 𝜇𝐻)
0 0
0 0 0 0
|
|
 
 
Equation 
6.18b 
continued  
𝐿𝑎𝑟𝑔𝑒𝑠𝑡 𝑒𝑖𝑔𝑒𝑛 𝑣𝑎𝑙𝑢𝑒 (𝜆) 𝑜𝑓 𝐾𝐿 = 𝑅0 Equation 6.19a 
𝑅0 = √
𝑁𝑉
𝑁𝐻
×
𝜀𝛽𝑉
𝜇𝑉(𝜀 + 𝜇𝑉)
×
(1 − 𝑝)𝛽𝐴(𝛾𝐼 + 𝜇𝐻) + 𝑝𝛽𝐼(𝛾𝐴 + 𝜇𝐻)
(𝛾𝐼 + 𝜇𝐻)(𝛾𝐴 + 𝜇𝐻)
 
Equation 6.19b 
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6.2.4 Model B’s basic reproduction number (R0) under mosquito dependent 
transmission 
R0 of the mosquito dependent transmission version of Model B was calculated 
using the next generation matrix methods as outlined in Diekmann et al. (2010) (see 
Equation 6.20-22). Note that in a completely susceptible population SH=NH and SV=NV. 
𝜑 = 𝑡 + 𝜎 Equation 6.20a 
𝜑 = |
𝐴𝐻
𝐼𝐻
𝐸𝑉
𝐼𝑉
|  ,    𝑡 = |
|
𝛽𝑉𝐼𝑉
0
𝑁𝑉 (
𝛽𝐴𝐴𝐻 + 𝛽𝐼𝐼𝐻 
𝑁𝐻
)
0
|
| 
 
Equation 6.20b 
𝜎 = |
−𝛾𝐴𝐴𝐻 − 𝛿𝐴𝐻 −  𝜇𝐻𝐴𝐻
𝛿𝐴𝐻 − 𝛾𝐼𝐼𝐻–  𝜇𝐻𝐼𝐻 
−𝜀𝐸𝑉 − 𝜇𝑉𝐸𝑉  
𝜀𝐸𝑉  − 𝜇𝑉𝐼𝑉
| 
Equation 6.20b 
continued 
𝐾𝐿 = 𝑇*-𝛴 
−1
 Equation 6.21a 
𝑇 = ||
0 0 0 𝛽𝑉
0 0 0 0
𝛽𝐴𝑁𝑉
𝑁𝐻
𝛽𝐼𝑁𝑉
𝑁𝐻
0 0
0 0 0 0
||   Equation 6.21b  
𝛴 = |
−𝛿−𝛾𝐴 −  𝜇𝐻 0 0 0
𝛿 −𝛾𝐼 −  𝜇𝐻 0 0
0 0 −𝜀 − 𝜇𝑉 0
0 0 𝜀 −𝜇𝑉
| 
Equation 6.21b 
continued  
𝐾𝐿 =
|
|
0 0
𝜀𝛽𝑉
𝜇𝑉(𝜀 + 𝜇𝑉)
𝛽𝑉
𝜇𝑉
0 0 0 0
𝛽𝐴𝑁𝑉
𝑁𝐻(𝛿+𝛾𝐴 + 𝜇𝐻)
+
𝛿𝛽𝐼𝑁𝑉
𝑁𝐻(𝛾𝐼 + 𝜇𝐻)(𝛿+𝛾𝐴 + 𝜇𝐻)
𝛽𝐼𝑁𝑉
𝑁𝐻(𝛾𝐼 + 𝜇𝐻)
0 0
0 0 0 0
|
|
 
Equation 
6.21b 
continued  
𝐿𝑎𝑟𝑔𝑒𝑠𝑡 𝑒𝑖𝑔𝑒𝑛𝑣𝑎𝑙𝑢𝑒 (𝜆) 𝑜𝑓 𝐾𝐿 = 𝑅0  Equation 6.22a 
𝑅0 = √
𝑁𝑉
𝑁𝐻
×
𝜀𝛽𝑉
𝜇𝑉(𝜀 + 𝜇𝑉)
×
𝛾𝐼𝛽𝐴 + 𝜇𝐻𝛽𝐴 + 𝛿𝛽𝐼
(𝛿 + 𝛾𝐴 + 𝜇𝐻)(𝛾𝐼 + 𝜇𝐻)
 Equation 6.22b 
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6.2.5 Analyses of Models A and Model B under mosquito dependent transmission 
Models A and B were coded in Matlab. The parameter space was then explored 
with ode45, under the 'RelTol', 10
-6
 setting, using Dengue parameters sourced as mid-
range values from the parameters listed in Andraud et al. (2012) literature review of 
Dengue transmission models (unless otherwise stated) so as to make the model 
comparable with other models of dengue virus transmission. Mosquito oviposition and 
mortality rate (μV) where the average mortality rates of Aedes aegypti and Ae. 
albopictus, as sourced from a meta-analyses of marked release recapture studies (Brady 
et al. 2013). Mosquito maturation rate (ω) was sourced from (M. Service 2012b) (see 
Table 6.1 and Table 6.2).  
Asymptomatic individuals could be transmitting dengue at a lower rate due to a 
decreased viremia. Likewise asymptomatic individuals could be transmitting dengue at 
a higher rate, as they may be more likely to pass through areas of high mosquito 
abundance, due to not exhibiting the decreased movement through illness as seen in 
symptomatically infected humans. For these reasons parameter c of both models, the 
coefficient relating βA to βI (βA=cβI), was varied from 0-2. For each of these settings of 
c parameter p was varied from 0-1 in Model A. In Model B however for each of these 
settings of c parameter p was varied from 0-0.95, due to the fact that altering p alters δ 
as δ=p(γA+μ)/1-p and at p=1 δ=∞. Parameter d, the coefficient relating γA and γI 
(γA=1/dφ, γI=1/φ), was kept at 1.  
As information on the immune recovery rate for asymptomatically dengue 
infected humans is unavailable.  Parameter d, the coefficient relating γA and γI, was 
varied from 0.05-2, as at d=0 γA would equal infinity (γA=1/dφ, γI=1/φ). For each of 
these settings of d parameter p was varied from 0-1 in Model A. In Model B however 
for each of these settings of d parameter p was varied from 0-0.95, due to the fact that 
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altering p alters δ as δ=p(γA+μ)/1-p and at p=1 δ=∞.  Parameter c, the coefficient 
relating βA to βI (βA=cβI), was kept at 1. 
The range in parameter space for the probability of a dengue virus infection 
leading symptoms (p) could be considered a large sample. Therefore it was decided to 
highlight a conservative sample of parameter space for this parameter, through labelling 
certain axis values regarding this parameter in green on figures that display model 
outputs with respect to changes in this parameter. The lower limit to this conservative 
parameter space p=0.2 is based on the rounded down mean possibility of symptomatic 
dengue virus infection from cohort studies in Grange et al. (2014). The upper limit to 
this conservative parameter space of p=0.7 is based on the rounded up mean possibility 
of symptomatic dengue virus infection from index cluster studies in Grange et al. 
(2014). The non-rounded mean symptomatic dengue virus infection rate (p) in cohort 
studies was 24% whereas in index cluster studies it was 63% (Grange et al. 2014). 
Cohort studies quantify the ratio of asymptomatic to symptomatic dengue infections by 
following a cohort of people and use case reporting, absenteeism and/or symptom 
questionnaires, combined with blood screening for dengue antibodies at regular 
intervals (Endy 2002a; Endy 2002b; Arguello et al. 2015). Index cluster studies sample 
people surrounding an index case of dengue illness. Sampled individuals’ symptoms are 
quantified through symptom questionnaires or clinical diagnosis and their blood is 
screened for dengue antibodies (Singh et al. 2000; Beckett et al. 2005; Reyes et al. 
2010; Wang et al. 2015). 
Likewise, the range in parameter space for the level and duration of transmission 
from asymptomatic dengue virus infections (c and d, respectively) could be considered 
large samples. Therefore it was decided to highlight more conservative samples of 
parameter space for these parameters, through labelling certain axis values regarding 
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these parameters in green for figures that display model outputs with respect to changes 
in these parameters. The lower limit of these conservative parameter spaces is 0.5 and 
the upper limit is 1.5. Note that at the time of submission of this thesis there was no data 
regarding the level or duration of transmission from asymptomatic dengue virus 
infected humans available, which could be used to base a more conservative region of 
parameter space for both of these parameters.  
For the exploration of the parameter space surrounding the asymptomatic class’s 
transmission rate βA and recovery rate γA, Model A and Model B were run with 999,999 
susceptible humans and the arrival of a symptomatically infected individual. At a very 
low rate of transmission or duration of transmission for the asymptomatic class (c and d, 
respectively) an epidemic may start with the arrival of a symptomatic dengue infected 
human, but not with the arrival of an asymptomatic dengue infected human. For this 
reason I then reran the same simulation with 999,999 susceptible humans and the arrival 
of an asymptomatically infected individual. 
Furthermore the exploration of the two models sets of parameter space was 
conducted at the low-transmission setting of b=0.3 and βi=0.5, mid-level transmission 
setting of b=0.65 and βi=0.75, high-level transmission setting of b=1 and βi=1 (this is 
the range of transmission setting cited in the review by Andraud et al. (2012)). 
6.3 Results 
6.3.1 Epidemic dynamics 
When no infections led to symptoms (p=0), the level and duration of 
transmission in both the symptomatic and asymptomatic class is the same (c=1 and d=1 
respectively) Model A and Model B both become a simple frequency dependent SIR 
model, with the asymptomatic class taking the place of the symptomatic class. This 
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demonstrates a typical SIR epidemic as the disease dramatically spreads through the 
population and declines as the pool of susceptible humans is used up (see Figure 6.3). 
As the proportion of infections leading to symptoms (p) increases in both models the 
symptomatic curve takes the place of the asymptomatic curve, however in Model B the 
symptomatic curve has a larger spread and lower peak for mid-levels of infections 
leading to symptoms (p) (see Figure 6.4-5). The epidemic patterns seen across Model 
A’s and  Model B’s parameter space follows this pattern, except in differing heights and 
spreads in the symptomatic and asymptomatic curves. However epidemics with a basic 
reproduction number R0 of less than 1 or started with the arrival of an asymptomatic 
individual when there is no transmission from that class (c=0) in Model A, fail to spread 
through the population (see Figure 6.6-14). 
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A) 
B) 
 
Figure 6.3: Infected human population after the arrival of symptomatically 
infected human at mid-level transmission (βi=0.75 and b=0.65), with no 
symptomatic infections (p=0), the duration of an asymptomatic and symptomatic 
infection being the same (d=1) and the transmission from an asymptomatic and 
symptomatic infection being the same (c=1). Symptomatically infected humans are 
in red and asymptomatically infected humans are in yellow. A) Model A. B) Model 
B 
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A) 
 
B) 
 
Figure 6.4: Infected human population after the arrival of symptomatically 
infected human at mid-level transmission (βi=0.75 and b=0.65), with 50% of 
infections being symptomatic (p=0.5), the duration of an asymptomatic and 
symptomatic infection being the same (d=1) and the transmission from an 
asymptomatic and symptomatic infection being the same (c=1). Symptomatically 
infected humans are in red and asymptomatically infected humans are in yellow. 
A) Model A. B) Model B 
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A) 
 
B) 
 
Figure 6.5: Infected human population after the arrival of symptomatically 
infected human at mid-level transmission (βi=0.75 and b=0.65), with 95% of 
infections being symptomatic (p=0.95), the duration of an asymptomatic and 
symptomatic infection being the same (d=1) and the transmission from an 
asymptomatic and symptomatic infection being the same (c=1). Symptomatically 
infected humans are in red and asymptomatically infected humans are in yellow. 
A) Model A. B) Model B 
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6.3.2 Basic reproduction number R0 
As with the frequency dependent versions from Chapter 5, both Model A and 
Model B produce the same basic reproduction number R0 for the same transmission 
settings (b and βi), proportion of infections leading to symptoms (p) level and duration 
of transmission in the asymptomatic class (c and d respectively) (see Figure 6.6-8). Yet 
again, as a note of intuitive sense for all three transmission settings (βi and b), when the 
level and duration of transmission is the same in both the asymptomatic and 
symptomatic class (c=1 and d=1, respectively), the R0 value is the same no matter the 
proportion of infections leading to symptoms (p) (see Figure 6.6-8). Furthermore this 
happens to be the same R0 value for Model A when all infections are symptomatic 
(p=1), no matter the level and duration of transmission in the asymptomatic class (c and 
d, respectively) (see Figure 6.6-8). Also similarly to Chapter 5, R0 increases with a 
lower proportion of infections leading to symptoms (p) combined with a high level or 
duration of transmission in the asymptomatic class (c and d respectively) but decreases 
with a low proportion of infections leading to symptoms (p) combined with a low level 
or duration of transmission in the asymptomatic class (c and d respectively) (see Figure 
6.6-8). This pattern in the value of R0 is similar across all three transmission setting (b 
and βi) but the overall values of R0 increases as b and βi increases from 0.3-1 and 0.5-1, 
respectively. 
What is different in terms of R0 between the frequency dependent models of 
Chapter 5 and the mosquito transmission models of this chapter is the threshold 
dynamic of R0 being less than 1. At the low transmission setting (b=0.3 and βi=0.5) the 
areas of parameter space that leads to an R0 less than 1 is much larger with the threshold 
forming a line on the figures depicting epidemic effects of varying levels of 
transmission in the asymptomatic class (c) combined with varying the proportion of 
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infections leading to symptoms (p), from c=0.3 and p=0 to c=0 and p=0.3 (see Figure 
6.6 A-B, Figure 6.9 and Figure 6.16). On figures depicting varying durations of 
transmission in the asymptomatic class (c) combined with varying the proportion of 
infections leading to symptoms (p), this line occurs from d=0.3 and p=0 to d=0.05 and 
p=0.25 (see Figure 6.6 C-D, Figure 6.10 and Figure 6.17). For mosquito dependent 
models this area of parameter space decreases much more rapidly to the point that for 
both the medium transmission setting (b=0.65 and βi=0.75) and the high transmission 
setting (b=1 and βi=1), R0 is only less than 1 when there is no transmission from the 
asymptomatic class (c=0) and all infections are asymptomatic (p=0) (see Figure 6.7-8, 
Figure 6.11-14 and Figure 6.18-21). 
The more conservative samples of parameter space for the proportion of 
infections leading to symptoms (p), the level and duration of transmission in the 
asymptomatic class (c and d respectively) do not lead to the lower values of R0 seen in 
the bottom left corner of the sub-figures of Figure 6.6-8, likewise they do not lead to the 
higher values of R0 seen in the top left corner of the sub-figures of Figure 6.6-8. This 
means that the areas of parameter space that lead to an R0 below 1 (see Figure 6.6-8) 
and therefore lead to no epidemic spreading through the population are not included in 
the more conservative samples of parameter space (see Figure 6.9-14). 
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A) B)  
C) D)  
Figure 6.6: Basic reproduction number (R0) at low-level transmission (βi=0.5 and 
b=0.3). A) Model A at different proportions of infections developing symptoms (p) 
and different levels of transmission in asymptomatic infections (c), when the 
duration of asymptomatic and symptomatic infections is the same (d=1). B) Model 
B at different proportions of infections developing symptoms (p) and different 
levels of transmission in asymptomatic infections (c), when the durations of 
asymptomatic and symptomatic infections is the same (d=1). C) Model A at 
different proportions of infections developing symptoms (p) and different 
durations of asymptomatic infection (d), when transmission from the 
asymptomatic and symptomatic infections is the same (c=1).  D) Model B at 
different proportions of infections developing symptoms (p) and different 
durations of asymptomatic infection (d), when transmission from the 
asymptomatic and symptomatic infections is the same (c=1). For all sub-figures the 
more conservative region of parameter space is displayed through the axis labelled 
values being green.  
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A) B)  
C) D)  
Figure 6.7: Basic reproduction number (R0) at mid-level transmission (βi=0.75 and 
b=0.65). A) Model A at different proportions of infections developing symptoms (p) 
and different levels of transmission in asymptomatic infections (c), when the 
duration of asymptomatic and symptomatic infections is the same (d=1). B) Model 
B at different proportions of infections developing symptoms (p) and different 
levels of transmission in asymptomatic infections (c), when the durations of 
asymptomatic and symptomatic infections is the same (d=1). C) Model A at 
different proportions of infections developing symptoms (p) and different 
durations of asymptomatic infection (d), when transmission from the 
asymptomatic and symptomatic infections is the same (c=1).  D) Model B at 
different proportions of infections developing symptoms (p) and different 
durations of asymptomatic infection (d), when transmission from the 
asymptomatic and symptomatic infections is the same (c=1). For all sub-figures the 
more conservative region of parameter space is displayed through the axis labelled 
values being green.  
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A) B)  
C) D)  
Figure 6.8: Basic reproduction number (R0) at high-level transmission (βi=1 and 
b=1). A) A) Model A at different proportions of infections developing symptoms 
(p) and different levels of transmission in asymptomatic infections (c), when the 
duration of asymptomatic and symptomatic infections is the same (d=1). B) Model 
B at different proportions of infections developing symptoms (p) and different 
levels of transmission in asymptomatic infections (c), when the durations of 
asymptomatic and symptomatic infections is the same (d=1). C) Model A at 
different proportions of infections developing symptoms (p) and different 
durations of asymptomatic infection (d), when transmission from the 
asymptomatic and symptomatic infections is the same (c=1).  D) Model B at 
different proportions of infections developing symptoms (p) and different 
durations of asymptomatic infection (d), when transmission from the 
asymptomatic and symptomatic infections is the same (c=1). For all sub-figures the 
more conservative region of parameter space is displayed through the axis labelled 
values being green.  
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6.3.3 Epidemic extinction 
At the low to mid-level transmission settings (b and βi) in the vast majority of 
epidemics asymptomatic and symptomatic dengue infections die out after a year or two, 
regardless of the proportion of infections leading to symptoms (p), the level and 
duration of transmission in the asymptomatic class (c and d respectively) or model (see 
Figure 6.9-12). Epidemics that last more than a year occur for a lower proportion of 
infections leading to symptoms (p) combined with low level or duration of transmission 
in the asymptomatic class (c and d respectively). For the lower transmission settings (b 
and βi) the longer lasting epidemics last even longer. Epidemics that last more than 5 
and in some cases longer than 10 years occur at the lowest transmission setting (b=0.3 
and βi=0.5) (see Figure 6.9-10) or in the mid-level transmission setting for a level of 
asymptomatic transmission at 5% of the symptomatic transmission (c=0.05) with no one 
developing symptoms (p=0) and no transmission from asymptomatic infections (c=0) 
with only 5% of infections being symptomatic (p=0.05). These longer lasting epidemics 
also coincide with the Basic Reproduction Number R0 being only slightly over 1 or put 
another way, for the parameter values just above the threshold lines described in section 
6.3.2 above (compare Figure 6.9-12 with Figure 6.6-7). This suggests that whilst at 
these parameter settings dengue virus can spread through the population, R0 being 
greater than 1, dengue virus spreads slowly, due to a low force of infection. It should be 
noted that the more conservative samples of parameter space for the proportion of 
infections leading to symptoms (p), the level and duration of transmission in the 
asymptomatic class (c and d respectively) did not produce the longer lasting epidemics 
(see Figure 6.9-12). This was in a similar fashion to the more conservative samples of 
parameter space not producing the lower values of R0 above (compare Figure 6.9-12 
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with Figure 6.6-7). These finding were also observed for the frequency dependent 
versions of Model A and Model B seen Chapter 5. 
At the higher transmission setting (b=1 and βi=1) epidemics tend to last from 5-
17 months. However for levels or durations of transmission in the asymptomatic class 
greater than those of the symptomatic class (c>1 and d>1 respectively) combined with 
all but the highest proportions of infections leading to symptoms (p) the epidemics are 
still extant by 30 years (see Figure 6.13-14). This is because as seen by Figure 6.15 the 
epidemic pattern has shifted to a system of low level endemic persistence of dengue 
viral infections. A large area of the more conservative samples of parameter space for 
the proportion of infections leading to symptoms (p), the level and duration of 
transmission in the asymptomatic class (c and d respectively) includes these regions 
where the dengue virus becomes endemic (see Figure 6.13-14). 
This epidemic pattern is broadly similar between models A and B, whether an 
epidemic is started by the arrival of an asymptomatic individual or symptomatic 
individual. However an epidemic started by the arrival of an asymptomatic individual 
lengthens the course of the longer lasting epidemics (see Figure 6.9-12).  
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A) B)  
C) D)  
Figure 6.9: Days until epidemic extinction against different levels of transmission 
from asymptomatic infections (c) and different proportions of infections 
developing symptoms (p), when durations of asymptomatic and symptomatic 
infections were the same (d=1), under low-level transmission (βi=0.5 and b=0.3). 
Days until epidemic extinction is defined as the first occurrence of the 
asymptomatic and symptomatic classes being less than 1 after the peak total of 
symptomatic and asymptomatic infections. Epidemics that had an R0 of less than 1 
or last less than 20 days are in white. A) Model A with an epidemic started by the 
arrival of an asymptomatic individual. B) Model A with an epidemic started by the 
arrival of a symptomatic individual. C) Model B with an epidemic started by the 
arrival of an asymptomatic individual. D) Model B with an epidemic started by the 
arrival of a symptomatic individual. Note the colour scale represents 0-8000 days 
for subfigures A-D. For all sub-figures the more conservative region of parameter 
space is displayed through the axis labelled values being green. 
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A) B)  
C) D)  
Figure 6.10: Days until epidemic extinction against different durations of 
asymptomatic infection (d) and different proportions of infections developing 
symptoms (p), when levels of transmission from asymptomatic and symptomatic 
infections were the same (c=1), under low-level transmission (βi=0.5 and b=0.3). 
Days until epidemic extinction is defined as the first occurrence of the 
asymptomatic and symptomatic classes being less than 1 after the peak total of 
symptomatic and asymptomatic infections. Epidemics that had an R0 of less than 1 
or last less than 20 days are in white. A) Model A with an epidemic started by the 
arrival of an asymptomatic individual. B) Model A with an epidemic started by the 
arrival of a symptomatic individual. C) Model B with an epidemic started by the 
arrival of an asymptomatic individual. D) Model B with an epidemic started by the 
arrival of a symptomatic individual. Note the colour scale represents 0-8000 days 
for subfigures A-D. For all sub-figures the more conservative region of parameter 
space is displayed through the axis labelled values being green. 
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A) B)  
C) D)  
Figure 6.11: Days until epidemic extinction against different levels of transmission 
from asymptomatic infections (c) and different proportions of infections 
developing symptoms (p), when durations of asymptomatic and symptomatic 
infections were the same (d=1), under mid-level transmission (βi=0.75 and b=0.65). 
Days until epidemic extinction is defined as the first occurrence of the 
asymptomatic and symptomatic classes being less than 1 after the peak total of 
symptomatic and asymptomatic infections. Epidemics that had an R0 of less than 1 
or last less than 20 days are in white. A) Model A with an epidemic started by the 
arrival of an asymptomatic individual. B) Model A with an epidemic started by the 
arrival of a symptomatic individual. C) Model B with an epidemic started by the 
arrival of an asymptomatic individual. D) Model B with an epidemic started by the 
arrival of a symptomatic individual. Note the colour scale represents 0-3500 days 
for subfigures A-D. For all sub-figures the more conservative region of parameter 
space is displayed through the axis labelled values being green.  
224 
 
A) B)  
C) D)  
Figure 6.12: Days until epidemic extinction against different durations of 
asymptomatic infection (d) and different proportions of infections developing 
symptoms (p), when levels of transmission from asymptomatic and symptomatic 
infections were the same (c=1), under mid-level transmission (βi=0.75 and b=0.65). 
Days until epidemic extinction is defined as the first occurrence of the 
asymptomatic and symptomatic classes being less than 1 after the peak total of 
symptomatic and asymptomatic infections. Epidemics that had an R0 of less than 1 
or last less than 20 days are in white. A) Model A with an epidemic started by the 
arrival of an asymptomatic individual. B) Model A with an epidemic started by the 
arrival of a symptomatic individual. C) Model B with an epidemic started by the 
arrival of an asymptomatic individual. D) Model B with an epidemic started by the 
arrival of a symptomatic individual. Note the colour scale represents 0-3500 days 
for subfigures A-D. For all sub-figures the more conservative region of parameter 
space is displayed through the axis labelled values being green.  
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A) B)  
C) D)  
Figure 6.13: Days until epidemic extinction against different levels of transmission 
from asymptomatic infections (c) and different proportions of infections 
developing symptoms (p), when durations of asymptomatic and symptomatic 
infections were the same (d=1), under high-level transmission (βi=1 and b=1). Days 
until epidemic extinction is defined as the first occurrence of the asymptomatic and 
symptomatic classes being less than 1 after the peak total of symptomatic and 
asymptomatic infections. Epidemics that had an R0 of less than 1 or last less than 
20 days are in white, epidemics where asymptomatic and symptomatic classes 
never reached less than 1 in 30 years are in black. A) Model A with an epidemic 
started by the arrival of an asymptomatic individual. B) Model A with an epidemic 
started by the arrival of a symptomatic individual. C) Model B with an epidemic 
started by the arrival of an asymptomatic individual. D) Model B with an epidemic 
started by the arrival of a symptomatic individual. Note the colour scale represents 
0-500 days for subfigures A-D. For all sub-figures the more conservative region of 
parameter space is displayed through the axis labelled values being green. 
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A) B)  
C) D)  
Figure 6.14: Days until epidemic extinction against different durations of 
asymptomatic infection (d) and different proportions of infections developing 
symptoms (p), when levels of transmission from asymptomatic and symptomatic 
infections were the same (c=1), under high-level transmission (βi=1 and b=1). Days 
until epidemic extinction is defined as the first occurrence of the asymptomatic and 
symptomatic classes being less than 1 after the peak total of symptomatic and 
asymptomatic infections. Epidemics that had an R0 of less than 1 or last less than 
20 days are in white, epidemics where asymptomatic and symptomatic classes 
never reached less than 1 in 30 years are in black.  A) Model A with an epidemic 
started by the arrival of an asymptomatic individual. B) Model A with an epidemic 
started by the arrival of a symptomatic individual. C) Model B with an epidemic 
started by the arrival of an asymptomatic individual. D) Model B with an epidemic 
started by the arrival of a symptomatic individual. Note the colour scale represents 
0-500 days for subfigures A-D. For all sub-figures the more conservative region of 
parameter space is displayed through the axis labelled values being green.  
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A) B)  
C) D)  
Figure 6.15: Infected human population in epidemics started by the arrival of an 
asymptomatic human in a high-level transmission setting (βi=1, b=1). 
Symptomatically infected humans are in red and asymptomatically infected 
humans are in yellow.  A) Model A when transmission from asymptomatic 
infections is twice that of symptomatic infections (c=2), the duration of 
asymptomatic and symptomatic infections is the same (d=1) and the proportion of 
infections that develop symptoms is 10% (p=0.1). B) Model B when transmission 
from asymptomatic infections is twice that of symptomatic infections (c=2), the 
duration of asymptomatic and symptomatic infections is the same (d=1) and the 
proportion of infections that develop symptoms is 10% (p=0.1). C) Model A when 
transmission from asymptomatic infections is same as symptomatic infections 
(c=1), the duration of asymptomatic infections twice that of symptomatic infections 
(d=2) and the proportion of infections that develop symptoms is 10% (p=0.1). D) 
Model B when transmission from asymptomatic infections is same as symptomatic 
infections (c=1), the duration of asymptomatic infections twice that of symptomatic 
infections (d=2) and the proportion of infections that develop symptoms is 10% 
(p=0.1). 
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6.3.4 Percentage of the population resistant at the end of an epidemic or when an 
epidemic becomes endemic  
Both Model A and Model B produce an extremely similar percentage of 
population resistant to dengue by the end of the initial epidemic, for each of the 
transmission settings (b and βi), proportion of infections leading to symptoms (p), level 
and duration of transmission in the asymptomatic class (c and d respectively). This is 
regardless if an outbreak is started by the arrival of a symptomatic or asymptomatic 
individual (see Figure 6.16-21). Across the different transmission settings most 
combinations of the proportion of infections leading to symptoms (p), level and duration 
of transmission in the asymptomatic class (c and d respectively) produce epidemics 
where above 90% of the population are immune to dengue.  
In the lower transmission setting of b=0.3 and βi=0.5, levels of transmission in 
the asymptomatic class (c) less than 0.85 combined with proportions of infections 
leading to symptoms (p) less than 0.85 lead to the percentages of population resistant to 
dengue dropping from 90% to 8% as these parameters decrease. This is also true for the 
duration of transmission in the asymptomatic class in proportion to the symptomatic 
class (d) (see Figure 6.16-7). Meaning that at the low-level transmission setting (b=0.3 
and βi=0.5) the more conservative samples of parameter space for the proportion of 
infections leading to symptoms (p), the level and duration of transmission in the 
asymptomatic class (c and d respectively) produce epidemics where above 80% of the 
population is resistant to dengue virus (see Figure 6.16-7).  
In the medium transmission setting of b=0.65 and βi=0.75, for a level of 
transmission in the asymptomatic class (c) less than 0.15 combined with a proportion of 
infections leading to symptoms of less than 0.15, the percentage of population resistant 
to dengue drops to 85% and further until 24% as values of these parameters decrease. 
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This is also true for the duration of transmission in the asymptomatic class in proportion 
to the symptomatic class (d) (see Figure 6.18-19). The pattern means that at the mid-
level transmission setting (b=0.65 and βi=0.75) the more conservative samples of 
parameter space for the proportion of infections leading to symptoms (p), the level and 
duration of transmission in the asymptomatic class (c and d respectively) produce 
epidemics where above 95% of the population is resistant to dengue virus (see Figure 
6.18-19).  
In the higher transmission setting of b=1 and βi=1, provided an epidemic 
happened at all, above 90% of the population become resistant to dengue by the end of 
the initial epidemic, regardless of the proportion of infections that developed symptoms 
or the duration and level of transmission of the asymptomatic class (see Figure 6.20-21). 
At this high-level transmission setting (b=1 and βi=1) the more conservative samples of 
parameter space for the proportion of infections leading to symptoms (p), the level and 
duration of transmission in the asymptomatic class (c and d respectively) produce 
epidemics where above 95% of the population is resistant to dengue virus (see Figure 
6.20-21). 
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A) B)  
C) D)  
Figure 6.16: Percentage of the population resistant at the end of the epidemic, 
against different levels of transmission from asymptomatic infections (c) and 
different proportions of infections developing symptoms (p), when durations of 
asymptomatic and symptomatic infections were the same (d=1), under low-level 
transmission (βi=0.5 and b=0.3). Epidemics that had an R0 of less than 1 or last less 
than 20 days are in white. A) Model A with an epidemic started by the arrival of 
an asymptomatic individual. B) Model A with an epidemic started by the arrival of 
a symptomatic individual. C) Model B with an epidemic started by the arrival of 
an asymptomatic individual. D) Model B with an epidemic started by the arrival of 
a symptomatic individual. For all sub-figures the more conservative region of 
parameter space is displayed through the axis labelled values being green.  
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A) B)  
C) D)  
Figure 6.17: Percentage of the population resistant at the end of the epidemic, 
against different durations of asymptomatic infection (d) and different proportions 
of infections developing symptoms (p), when levels of transmission from 
asymptomatic and symptomatic infections were the same (c=1), under low-level 
transmission (βi=0.5 and b=0.3). Epidemics that had an R0 of less than 1 or last less 
than 20 days are in white. A) Model A with an epidemic started by the arrival of 
an asymptomatic individual. B) Model A with an epidemic started by the arrival of 
a symptomatic individual. C) Model B with an epidemic started by the arrival of 
an asymptomatic individual. D) Model B with an epidemic started by the arrival of 
a symptomatic individual. For all sub-figures the more conservative region of 
parameter space is displayed through the axis labelled values being green.  
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A) B)  
C) D)  
Figure 6.18: Percentage of the population resistant at the end of the epidemic, 
against different levels of transmission from asymptomatic infections (c) and 
different proportions of infections developing symptoms (p), when durations of 
asymptomatic and symptomatic infections were the same (d=1), under mid-level 
transmission (βi=0.75 and b=0.65). Epidemics that had an R0 of less than 1 or last 
less than 20 days are in white. A) Model A with an epidemic started by the arrival 
of an asymptomatic individual. B) Model A with an epidemic started by the arrival 
of a symptomatic individual. C) Model B with an epidemic started by the arrival of 
an asymptomatic individual. D) Model B with an epidemic started by the arrival of 
a symptomatic individual. For all sub-figures the more conservative region of 
parameter space is displayed through the axis labelled values being green.  
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A) B)  
C) D)  
Figure 6.19: Percentage of the population resistant at the end of the epidemic, 
against durations of asymptomatic infection (d) and different proportions of 
infections developing symptoms (p), when levels of transmission from 
asymptomatic and symptomatic infections were the same (c=1), under mid-level 
transmission (βi=0.75 and b=0.65). Epidemics that had an R0 of less than 1 or last 
less than 20 days are in white. A) Model A with an epidemic started by the arrival 
of an asymptomatic individual. B) Model A with an epidemic started by the arrival 
of a symptomatic individual. C) Model B with an epidemic started by the arrival of 
an asymptomatic individual. D) Model B with an epidemic started by the arrival of 
a symptomatic individual. For all sub-figures the more conservative region of 
parameter space is displayed through the axis labelled values being green.  
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A) B)  
C) D)  
Figure 6.20: Percentage of the population resistant at the end of the epidemic, 
against different levels of transmission from asymptomatic infections (c) and 
different proportions of infections developing symptoms (p), when durations of 
asymptomatic and symptomatic infections were the same (d=1), under high-level 
transmission (βi=1 and b=1). Epidemics that had an R0 of less than 1 or last less 
than 20 days are in white. A) Model A with an epidemic started by the arrival of 
an asymptomatic individual. B) Model A with an epidemic started by the arrival of 
a symptomatic individual. C) Model B with an epidemic started by the arrival of 
an asymptomatic individual. D) Model B with an epidemic started by the arrival of 
a symptomatic individual. For all sub-figures the more conservative region of 
parameter space is displayed through the axis labelled values being green.  
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A) B)  
C) D)  
Figure 6.21: Percentage of the population resistant at the end of the epidemic, 
against durations of asymptomatic infection (d) and different proportions of 
infections developing symptoms (p), when levels of transmission from 
asymptomatic and symptomatic infections were the same (c=1), under high-level 
transmission (βi=1 and b=1). Epidemics that had an R0 of less than 1 or last less 
than 20 days are in white. A) Model A with an epidemic started by the arrival of 
an asymptomatic individual. B) Model A with an epidemic started by the arrival of 
a symptomatic individual. C) Model B with an epidemic started by the arrival of 
an asymptomatic individual. D) Model B with an epidemic started by the arrival of 
a symptomatic individual. For all sub-figures the more conservative region of 
parameter space is displayed through the axis labelled values being green. 
6.3.5 Biological unrealistic time lengths for progression from an asymptomatic 
infection to a symptomatic infection (δ-1) within Model B 
As discussed in Chapter 5 the results from Model B should be interpreted with a 
cautionary note in terms of what is biologically realistic. Recalling Equation 6.10 and 
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Equation 6.11, δ represents the rate at which an infected individual develops symptoms 
and moves from the asymptomatic class to the symptomatic class (Robinson & 
Stilianakis 2013). Therefore δ-1 represents the number of days an individual would 
spend asymptomatically infected if they do not die (μ) or their immune system fails to 
clear the infection (γA) (Robinson & Stilianakis 2013). Considering that p=δ/(δ+γA+μ) 
and γA=1/dφ, where φ is the number of days until immunity clears infection in a 
symptomatic infection and d represents how long immunity clears infection in an 
asymptomatic infection in proportion to a symptomatic infection, Equation 6.23 can be 
derived for the mosquito dependent version of Model B. Note Equation 6.23 is the same 
as Equation 5.11 from Chapter 5. 
𝛿−1 =
1 − 𝑝
𝑝((𝑑𝜑)−1 + 𝜇)
 Equation 6.23 
As with the frequency dependent version of Model B (see Chapter 5), Equation 
6.23 demonstrates that the number of days spent with an asymptomatic infection before 
progression to a symptomatic infection (δ-1) can be affected by both the proportion of 
infections that are symptomatic (p) and the time until immunity clears all dengue virus 
in an asymptomatic infection in proportion to a symptomatic infection (d). As 
demonstrated by Figure 6.22 this means that certain combinations of these two 
proportions can lead to the period of time spent from becoming asymptomatic infected 
until progressing to a symptomatic infection (δ-1), being biologically unfeasibly long, 
(depending if longer than a month, two weeks or a week is seen as being biologically 
unfeasible) (See Figure 6.22 B, C and D respectively). As observed in the frequency 
dependent version of Model B (see Chapter 5), this not only affects the biological 
realism of the results obtained from using Model B when altering the time until 
immunity clears all dengue virus in an asymptomatic infection (d) but the biological 
realism of the results when varying the transmission from asymptomatic infection (c), 
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along with the proportion of infections that lead to development of symptoms (p) (see 
Figure 6.22). Also as in Chapter 5, as the tolerance for the duration of progression from 
asymptomatic to symptomatic infection (δ-1) decreases, more of the conservative 
samples of parameter space for the proportion of infections leading to symptoms (p), the 
duration of transmission in the asymptomatic class (d) and the level of transmission in 
the asymptomatic class (c) can also be seen as having an unfeasible duration of 
progression from asymptomatic to symptomatic infection (δ-1) (see Figure 6.22 B-D). 
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A) B)  
C) D)  
Figure 6.22: Effect of altering the duration of asymptomatic infection (d) and the 
proportion of infections that are symptomatic (p), on the duration of progression 
from asymptomatic to symptomatic infection (δ-1) for Model B, values equal to 
infinity are in black. A) Without values above a certain number of days being 
coloured white. Note the colour scale represents 0-300 days. B) Values greater the 
28 days are in white. Note the colour scale represents 0-28 days.  C) Values greater 
the 14 days are in white. Note the colour scale represents 0-14 days. D) Values 
greater the 7 days are in white. Note the colour scale represents 0-7 days. For all 
sub-figures the more conservative region of parameter space is displayed through 
the axis labelled values being green. 
6.4 Discussion 
From comparing the results of this chapter with those of Chapter 5, it can be 
seen that for the most part moving from a frequency dependent transmission model to 
one that explicitly includes mosquitoes in transmission, changes few of the 
epidemiological patterns, caused by asymptomatic dengue infections. A striking 
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similarity is that whether modelled with frequency dependent transmission or mosquito 
dependent transmission, Model A and Model B produce extremely similar results across 
the different proportions of infections leading to symptoms (p), levels and durations of 
transmission in the asymptomatic class (c and d respectively) for all of the transmission 
setting barring the highest values of b and βi (see Figure 6.6-14 and Figure 6.16-21). 
The mosquito dependent transmission version of Model B still has the limitation from 
certain combinations of the proportion of asymptomatic infections becoming 
symptomatic (p) and the period of time that immunity takes to clear an asymptomatic 
infection (d) thus producing biologically unrealistic lengths of time in the progression 
from an asymptomatic infection to a symptomatic infection (δ-1) (see Figure 6.22). As in 
Chapter 5 this is not only true for large parts of the parameter space explored from 
altering the proportion of asymptomatic infections becoming symptomatic (p) and the 
period of time that immunity takes to clear an asymptomatic infection (d) but the 
parameter space explored from altering the proportion of asymptomatic infections 
becoming symptomatic (p) and the transmission from asymptomatic infections (c), as 
well (see Figure 6.22).   
Moving beyond the technical similarities between the two types of transmission 
there are three remaining similarities that relate more widely to dengue virus 
epidemiology. The first of which is that the explicit inclusion of mosquitoes does not 
change the fact that at extremely low proportions of infections developing symptoms (p) 
combined with low levels or durations of transmission in the asymptomatic class (c and 
d, respectively) causes R0 to drop below 1, meaning that an epidemic of dengue could 
not occur. In the lowest transmission setting this occurs for proportions of infections 
developing symptoms (p) that are less than 0.3 combined with levels or durations of 
transmission in the asymptomatic class (c and d, respectively) less than 0.3 (see Figure 
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6.6, Figure 6.9 and Figure 6.10). This therefore excludes these values of R0 from the 
more conservative samples of parameter space concerning level and duration of 
transmission in the asymptomatic class (c and d, respectively) but not concerning the 
proportions of infections developing symptoms (p) (see Figure 6.6, Figure 6.9 and 
Figure 6.10). There is a difference in the mosquito dependent transmission versions of 
Model A and Model B, in that in the medium and high transmission setting this only 
occurs when no one develops symptoms (p=0) and asymptomatic infections do not 
transmit infection (c=0) (see Figure 6.7-8, Figure 6.11 and Figure 6.13). Therefore 
excluding these values of R0 from the more conservative samples of parameter space for 
proportions of infections developing symptoms (p), the level and duration of 
transmission in the asymptomatic class (c and d, respectively) (see Figure 6.7-8, Figure 
6.11 and Figure 6.13). 
The second similarity is that in the low and medium transmission setting 
epidemics usually lasted only a year or two. However in very low proportions of 
infections developing symptoms (p) combined with very low levels or durations of 
transmission in the asymptomatic class (c and d, respectively) epidemics could extend 
to over 2 years, extending to over 20 years in the low transmission settings for mosquito 
dependent models. As in Chapter 5 this therefore excludes these longer lasting 
epidemics from the more conservative samples of parameter space concerning levels 
and durations of transmission in the asymptomatic class (c and d, respectively) but not 
concerning the proportions of infections developing symptoms (p) (see Figure 6.9-10). 
Furthermore, as with the frequency dependent model these longer lasting epidemics 
have an R0 of just over 1 (see Chapter 5). This could mean that if these models were to 
be modelled stochastically instead of in a deterministic manner, the parameter settings 
that produce the longer lasting epidemics may produce dengue outbreaks that do not 
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infect more than a few individuals, who simply become immune or die before infecting 
a mosquito with dengue virus. These low numbers of infections would also produce 
very few individuals who are immune to dengue and therefore at risk of developing 
DHF, in any future epidemic caused by a differing dengue viral serotype. 
The third similarity is that the frequency dependent models and mosquito 
transmission models produce similar proportions of the population left immune to the 
invading dengue serotype and therefore at risk of developing DHF in an epidemic 
caused by another invading serotype (see Chapter 5). As in Chapter 5 high proportions 
of the population are left immune from epidemics simulated using the more 
conservative samples of parameter space for the proportion of infections leading to 
symptoms (p), the level and duration of transmission in the asymptomatic class (c and d 
respectively). This therefore adds further validity to the point made in the previous 
chapter that after a dengue epidemic a larger proportion of the population may be at risk 
of DHF in a future epidemic caused by a different dengue serotype, than would be 
known to a health authority relying on reported cases from the first epidemic. As stated 
in Chapter 5 the DHF epidemic pattern in Cuba would suggest that this at risk group 
may persist for quite some time (Guzmán 2000; Vaughn et al. 2000; Guzmán et al. 
2000).  
There is a major key difference between the frequency dependent transmission 
models and the models that explicitly include mosquitoes. In the mosquito transmission 
models at the high transmission setting for levels or durations of transmission in the 
asymptomatic class that are higher than those of the symptomatic class (c>1 and d>1, 
respectively), combined with most of the proportions of infections that lead to 
symptoms (p) that are less than 1, dengue can become endemic (see Figure 6.13-15). 
This includes large regions of the more conservative samples of parameter space for the 
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proportion of infections leading to symptoms (p), the level and duration of transmission 
in the asymptomatic class (c and d respectively) (see Figure 6.13-14). Further 
demonstrating that asymptomatic dengue infections may provide a means by which 
dengue could become endemic in areas of high transmission.  
A dengue serotype becoming endemic in this high transmission setting 
represents more of an ongoing risk in terms of proportion of the population at risk of 
developing DHF should another dengue viral serotype be introduced. Where the 
original dengue serotype has become endemic, Model A and Model B have reached an 
equilibrium point (see Figure 6.15). This means that the proportion of the population 
resistant to the original dengue serotype and therefore at risk of developing DHF should 
a different dengue serotype be introduced remains constant.  This at risk group 
represents above 98% of the population (compare Figure 6.13-14 to Figure 6.20-21) and 
may be a larger proportion of the population then would be known to a health authority 
relying on reported cases of dengue illness.  
Asymptomatic infections causing dengue virus persistence in a high 
transmission setting probably represents the case in areas where dengue is already 
endemic. In such areas there is a high abundance of Ae. aegypti, the primary vector of 
dengue viruses (Lambrechts et al. 2010; WHO 2015c). In recent years, another vector of 
dengue Ae. albopictus has become established in many European countries, 29 states of 
the USA and the Australasian continent (M. Service 2012b; WHO 2015c). Ae. 
albopictus is more of a catholic feeder than Ae. aegypti, feeding much more readily on 
other animals and less suited to the urban environment then Ae. aegypti (Lambrechts et 
al. 2010). Therefore the low transmission setting, with a low biting rate and vector 
transmission is probably indicative of the areas where Ae. albopictus has recently been 
introduced. This would suggest from the results of Model A and Model B in the low 
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transmission setting, that an epidemic may well occur in area where Ae. albopictus has 
been introduced but it would not become endemic. 
Knowing whether a mosquito can become infected through feeding on an 
asymptomatic dengue infected human is key to understanding whether asymptomatic 
dengue infections play a role in dengue’s epidemiology. Whilst no studies have 
researched this directly (possibly due to logistical feasibility), there have been a limited 
number of studies that have detected viremia in asymptomatic dengue infections 
(Beckett et al. 2005; Reyes et al. 2010; Duong et al. 2011; Chastel 2012; Carrington & 
Simmons 2014). Duong et al. (2011) has so far been the only study to quantify the level 
of viremia in asymptomatic dengue infections, finding no significant difference between 
the levels of viremia in asymptomatic dengue infections then symptomatic dengue 
infections. However Duong et al. (2011) had a small sample size and to date no one has 
tested whether or not mosquitoes feeding on viremic asymptomatically dengue infected 
humans can become infected with dengue virus (Carrington & Simmons 2014). Nguyet 
et al. (2013) found in reported symptomatic dengue infections that ambulatory dengue 
fever cases had a lower viremia, but still infectious viremia, than hospitalised cases.  
This work would suggest that asymptomatic infections may have a lower viremia 
leading them to being less infectious to blood feeding mosquitoes (Nguyet et al. 2013). 
However Nguyet et al. (2013) suggested that mildly fibril dengue cases could have a 
greater contact with mosquitoes due to greater movement, thereby leading to greater 
transmission, this could also be the case for asymptomatic dengue infections. In Model 
A and Model B such greater transmission through greater movement in the 
asymptomatic class was represented in values of c that were more than 1. It can be seen 
that such values of c could lead to dengue becoming endemic in the higher transmission 
setting (see Figure 6.13). 
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Related to whether or not a mosquito can become infected from feeding of an 
asymptomatically dengue infected human, is how long would such an asymptomatic 
dengue infection be infectious. Both Model A and Model B demonstrate that the 
duration of viremia of asymptomatic dengue infections (d) can have large effects on 
dengue epidemiology, even leading to its persistence. There have to my knowledge been 
no studies quantifying the duration of viremia of asymptomatic dengue infections. 
Furthermore, several reviews on the different epidemiological roles of asymptomatic 
dengue infection (Chastel 2012; Carrington & Simmons 2014; Grange et al. 2014) do 
not mention any such studies.   
Model A and Model B demonstrate that large scale dengue epidemics can 
happen, with very few dengue infections being symptomatic. This presents a risk to the 
blood supply as asymptomatically dengue virus infected people may make a donation 
without realising they are viremic. The evidence from Model A and Model B, as well  
as the detection of dengue viruses in blood donations in several countries (Mohammed 
et al. 2008; Linnen et al. 2008) would suggest that the expense of screening of blood for 
dengue viruses needs to be considered (Teo et al. 2009).  
6.5 Conclusion 
As with Chapter 5’s frequency dependent models, the addition of stochastic 
elements to Models A or Model B would shed greater light on the role of asymptomatic 
infections in terms of the likelihood of dengue epidemics taking hold in a population. 
The major finding of this chapter was that at high transmission setting higher levels and 
durations of transmission from asymptomatic dengue virus infections could lead to the 
dengue virus becoming endemic. Therefore further research into these two aspects of 
asymptomatic dengue virus infections needs to be made. Direct research via screening 
mosquitoes fed on asymptomatic dengue virus infected humans for dengue virus has so 
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far been completely lacking (possibly due to feasibility). There has been some related 
research on the viremia of asymptomatic dengue virus infected humans but this so far 
has been limited (Beckett et al. 2005; Reyes et al. 2010; Duong et al. 2011; Chastel 
2012; Carrington & Simmons 2014). This research could be improved upon by studying 
how the level and duration viremia in asymptomatically dengue virus infected humans 
compares to symptomatically dengue virus infected humans. Asymptomatic dengue 
virus infected humans could be greater transmitters of dengue virus through their greater 
ambulatory nature leading to a high number of mosquito bites when compared to 
symptomatic dengue virus infected humans. Therefore, if possible, differences in the 
mosquito biting rates experienced by asymptomatic and symptomatic dengue virus 
infected humans needs to be assessed. As this may not be feasible, this could be inferred 
by comparing the mosquito biting rates experienced by more and less ambulatory non-
dengue virus infected humans.  
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Chapter 7: Stochastic susceptible asymptomatic infectious recovered 
(SAIR) models of the transmission of dengue viruses 
Abstract 
In both previous chapters, epidemics that occurred over 2 years coincided with a 
Basic Reproductive Number (R0) just over 1. R0 is defined as the average number of 
infections caused by an average primary infectious case over the lifetime of that 
infection. Therefore, when R0 is just over 1 in a stochastic setting there is a greater 
chance of an infected individual either becoming immune or dying before infecting 
someone else. For this reason in this chapter, one of the SAIR models is modelled 
stochastically in both the frequency transmission dependent and mosquito transmission 
dependent forms. Where combinations of parameters led to R0 being only just over 1, 
epidemics often did not occur due to stochasticity. Furthermore, under parameter 
settings where dengue virus had become endemic in the previous chapter the inclusion 
of stochasticity meant that the dengue virus did not always become endemic. Higher 
durations of asymptomatic dengue virus infection showed this result to a lesser extent, 
suggesting that the duration of asymptomatic dengue virus infection may be more of a 
key determinant for a dengue virus epidemic becoming endemic than the transmission 
from such infections. 
7.1 Introduction 
There are an estimated 390 million dengue infections per year, of which 96 
million manifest as clinical illness (Bhatt et al. 2013), making dengue viruses the most 
important of the arboviruses. Dengue viruses are of the Flavivirus genome, with a RNA 
positive genome and are separated into four immunological serotypes (DENV-1, 
DENV-2, DENV-3 and DENV-4), (Guzman et al. 2010; Rodenhuis-Zybert et al. 2010). 
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Infection with a single serotype can either lead to asymptomatic infection or dengue 
fever (DF) (Guzman et al. 2010; Andraud et al. 2012; Grange et al. 2014; WHO 2015c). 
Immunity to a single serotype is for life (Guzman et al. 2010; Rodenhuis-Zybert et al. 
2010; Andraud et al. 2012). However immunity to other serotypes only lasts for an 
estimated 1-3 years (Reich et al. 2013). Secondary infection with another serotype, after 
this period of time can lead to a person developing Dengue Haemorrhagic Fever (DHF) 
(Guzman et al. 2010; Rodenhuis-Zybert et al. 2010; Andraud et al. 2012; WHO 2015c). 
A clinical complication can occur in DHF called dengue shock syndrome (DSS). 
Grouped together as severe dengue, DHF and DSS have been estimated to cause 
500,000 cases of illness, mostly in children and have a mortality rate of 2.5% (WHO 
2015c). 
Aedes aegypti is the principal vector of dengue viruses, with Aedes albopictus 
having a lesser role as a vector of dengue (M. Service 2012b; Lambrechts et al. 2010). 
Other mosquitoes of the Aedes genus also occasionally acting as dengue vectors (M. 
Service 2012b).  In recent years, Ae. albopictus has increased its range to include 
southern US states, 15 southern European countries, Australia and New Zealand (M. 
Service 2012b; Lambrechts et al. 2010; WHO 2015c), and therefore there has been a 
growing concern that there could be an increasing risk of outbreaks of DF in these areas 
(Lambrechts et al. 2010).  
Because many studies suggest that asymptomatic dengue infections are common 
(Bhatt et al. 2013; Grange et al. 2014), Chapter 5 and Chapter 6 used two SAIR models 
(previously used by Robinson & Stilianakis (2013) to model influenza) to explore the 
role of asymptomatic infections in dengue’s epidemiology. In Chapter 5 dengue viruses 
were transmitted through frequency dependent transmission whereas in the Chapter 6 
mosquitoes were explicitly modelled in transmission. Both forms of transmission led to 
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four similar results. Firstly there were little differences between the various 
epidemiological outcomes in the two SAIR models. Secondly extremely low 
probabilities of developing symptoms combined with extremely low rates or durations 
of transmission in the asymptomatic class caused the basic reproductive number (R0) to 
drop below 1 meaning dengue virus could not spread in a population. This was the case 
even in the high transmission setting. Thirdly whilst epidemics usually lasted only a 
year or two, under lower transmission settings when the probability of developing 
symptoms was low combined with low transmission or a short duration of transmission 
in the asymptomatic class, epidemics could extend over 2 years. (Even to over 15 and 
20 years in the low transmission setting, for the frequency and mosquito transmission 
dependent models respectively.) The final similarity was that across most of the 
explored parameter space above 90% of the population was immune to dengue at the 
end of an epidemic and thereby at risk of DHF in subsequent epidemics caused by a 
different serotype of dengue virus. This population at risk of DHF did decrease with 
lower transmission setting, lower probability of being symptomatic, as well as lower 
transmission and duration of transmission in the asymptomatic class. 
The striking difference between the two previous chapters was that dengue 
epidemics could become endemic in the mosquito dependent models provided the 
transmission setting was high, the probability of developing symptoms was less than 1 
and there was either a high rate or duration of transmission in the symptomatic class. 
Dengue becoming endemic also meant that the population at risk of developing DHF 
should any other dengue virus serotype be introduced would remain constant through 
time.  
In Chapter 5 and Chapter 6 it was pointed out that the epidemics that occurred 
over 2 years coincided with an R0 just over 1. If the outbreak of dengue was modelled 
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stochastically instead of deterministically this could lead to an epidemic not spreading 
beyond a few individuals. This is as R0 is defined as the average number of infections 
caused by an infectious individual in a completely susceptible population over the 
lifetime of that infection. As such when R0 is just over 1 in a stochastic setting there is a 
greater chance of an infected individual either dying or more likely becoming immune 
before infecting someone else (Anderson & May 1991a).  
In both of the previous chapters these longer lasting epidemics with an R0 just 
over 1 are more common in the low transmission setting. It was suggested that this 
lower transmission setting may be indicative of the more climatically temperate 
countries where Ae. albopictus has recently been established. This is due to Ae. 
albopictus feeding much more readily on other animals and being less suited to the 
urban environment than Ae. aegypti (Lambrechts et al. 2010). Quam et al. (2015) give 
the yearly importation of approximately 572 symptomatic and 1747 asymptomatic 
dengue infections through Rome’s airport. Should Quam et al. (2015) approximation be 
typical for the importation of dengue infections, then it may be the case that 
stochasticity plays a role in preventing imported dengue from causing regular epidemics 
from taking place in developed countries where Ae. albopictus has become established. 
As such in this chapter one of the SAIR models is modelled stochastically in both the 
frequency transmission dependent and mosquito transmission dependent forms, in order 
to ascertain whether stochasticity could affect any of the insights into dengue’s 
epidemiology gained in Chapter 5 and Chapter 6.  
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7.2 Methods 
7.2.1 Model of asymptomatic dengue virus infection. 
7.2.1.1 Model A under frequency dependent transmission. 
A frequency dependent version of the 2
nd
 framework described in  Robinson & 
Stilianakis (2013) (here to referred to as Model A) is expressed as a series of ordinary 
differential equations (see Equation 7.1-4) and the flow diagram in Figure 8.1. Model A 
was chosen as unlike Model B it does not make biologically unfeasible assumptions 
about the length of time an infected person can remain asymptomatically infected (see 
Chapter 5 and Chapter 6). Table 8.1 contains a list of all parameters and variables used 
in Model A under frequency dependent transmission.  
𝛥𝑆
𝛥𝑡
= 𝜇𝑁 −
𝑆(𝛽𝐴𝐴 + 𝛽𝐼𝐼)
𝑁
− 𝜇𝑆 Equation 7.1 
𝛥𝐴
𝛥𝑡
= (1 − 𝑝)
𝑆(𝛽𝐴𝐴 + 𝛽𝐼𝐼)
𝑁
− 𝛾𝐴𝐴 − 𝜇𝐴 Equation 7.2 
𝛥𝐼
𝛥𝑡
= 𝑝
𝑆(𝛽𝐴𝐴 + 𝛽𝐼𝐼)
𝑁
− 𝛾𝐼𝐼 − 𝜇𝐼 Equation 7.3 
𝛥𝑅
𝛥𝑡
= 𝛾𝐼𝐼 + 𝛾𝐴𝐴 − 𝜇𝑅 Equation 7.4 
 
 
 Figure 7.1: Flow diagram representing Model A. 
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Table 7.1: Variables at starting value and parameters used in Model A under 
frequency dependent transmission. 
Symbol Name Value 
μ Birth and death rate (per day) 1/(60*365) 
c Infectivity of asymptomatic infections compared to 
symptomatic infections 
0 to 2 
βI Symptomatic transmission rate (per day) 200/365 to 
400/365 
βA Asymptomatic transmission rate (per day) c*βI 
φ Days symptomatic 8 
γI Symptomatic recovery rate (per day) φ-1 
d Asymptomatic recovery rate compared to symptomatic 
recovery rate 
0.05 to 2 
γ
A
 Asymptomatic recovery rate (per day) (dφ)-1 
p Probability of being symptomatic 0 to 1 
S Susceptible population 106-1 
A Asymptomatic population 0 to 1 
I Symptomatic population 0 to 1 
R Recovered population 0 
N Total population 106 
 
The total human population (N) is divided into susceptible (S), 
asymptomatically infected (A), symptomatically infected (I) and recovered (R) classes. 
Every class of human experiences loss due to a constant death rate μ, however the 
human population remains constant as humans are born into the susceptible class at a 
birth rate of μN. Susceptible humans become infected at a frequency dependent 
transmission term that is the sum of transmission from asymptomatically and 
symptomatically infected humans, given by S(βAA+ βII)/N. Upon infection humans 
either become asymptomatic at a rate of (1-p)S(βAA+ βII)/N or symptomatically 
infected at a rate of pS(βAA+ βII)/N. Asymptomatically infected people gain complete 
lifelong immunity at a rate of γA and symptomatically infected people gain complete 
lifelong immunity at a rate of γI, in both cases moving to the recovered class (R). 
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The formula for Model A’s basic reproduction number (R0) under frequency 
dependent transmission is listed in Equation 7.5 (Robinson & Stilianakis 2013). 
𝑅0 = (1 − 𝑝) (
𝛽𝐴
𝛾𝐴 + 𝜇
) + 𝑝
𝛽𝐼
𝛾𝐼 + 𝜇
 Equation 7.5 
7.2.2 Model A under mosquito dependent transmission. 
The incubation period within the mosquito may cause a lag in dengue’s 
transmission dynamics and so affect the persistence of dengue epidemics. Therefore a 
mosquito dependent transmission version of the 2
nd
 framework described in  Robinson 
& Stilianakis (2013) (here to referred to as Model A) is expressed as a series of ordinary 
differential equations (see Equation 7.6-13) and the flow diagram in Figure 7.2. Model 
A was chosen as unlike Model B it does not make biologically unfeasible assumptions 
about the length of time an infected person can remain asymptomatic (see Chapter 5 and 
Chapter 6). Table 7.2 contains a list of all the parameters and variables.  
𝛥𝑆𝐻
𝛥𝑡
= 𝜇𝐻𝑁𝐻 −
𝑆𝐻
𝑁𝐻
𝛽𝑉𝐼𝑉 − 𝜇𝐻𝑆𝐻 Equation 7.6 
𝛥𝐴𝐻
𝛥𝑡
= (1 − 𝑝)
𝑆𝐻
𝑁𝐻
𝛽𝑉𝐼𝑉 − 𝛾𝐴𝐴𝐻 − 𝜇𝐻𝐴𝐻 Equation 7.7 
𝛥𝐼𝐻
𝛥𝑡
= 𝑝
𝑆𝐻
𝑁𝐻
𝛽𝑉𝐼𝑉 − 𝛾𝐼𝐼𝐻 − 𝜇𝐻𝐼𝐻 Equation 7.8 
𝛥𝑅𝐻
𝛥𝑡
= 𝛾𝐼𝐼𝐻 + 𝛾𝐴𝐴𝐻 − 𝜇𝐻𝐼𝐻 Equation 7.9 
𝛥𝑆𝐸
𝛥𝑡
= 𝜇𝑉𝑁𝑉 − 𝜔𝑆𝐸   Equation 7.10 
𝛥𝑆𝑉
𝛥𝑡
= 𝜔𝑆𝐸 − 𝑆𝑉
𝛽𝐴𝐴𝐻 + 𝛽𝐼𝐼𝐻
𝑁𝐻
− 𝜇𝑉𝑆𝑉 Equation 7.11 
𝛥𝐸𝑉
𝛥𝑡
= 𝑆𝑉
𝛽𝐴𝐴𝐻 + 𝛽𝐼𝐼𝐻
𝑁𝐻
− 𝜀𝐸𝑉 − 𝜇𝑉𝐸𝑉 Equation 7.12 
𝛥𝐼𝑉
𝛥𝑡
= 𝜀𝐸𝑉 − 𝜇𝑉𝐼𝑉 Equation 7.13 
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Figure 7.2 Flow diagrams representing Model A under mosquito dependent 
transmission.  
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Table 7.2: Variables at starting value and parameters used in Model A under 
mosquito dependent transmission. 
Symbol Name Value 
μH Birth and death rate (per day) 1/(60x365) 
c Infectivity of asymptomatic infections compared to 
symptomatic infections 
0 to 2 
b Biting rate (per day) 0.3-1 
βi Probability of symptomatic Transmission to a Vector 0-1 
βI Symptomatic transmission rate (per day) bβi 
βA Asymptomatic transmission rate (per day) cβI 
φ Days symptomatic 8 
γI Symptomatic recovery rate (per day) φ-1 
d Asymptomatic recovery rate compared to symptomatic 
recovery rate 
0.05 to 2 
γ
A
 Asymptomatic recovery rate (per day) (dφ)-1 
p Probability of being symptomatic 0 to 1 
SH Susceptible population 106-1 
AH Asymptomatic population 0 to 1 
IH Symptomatic population 0 to 1 
RH Recovered population 0 
NH Total population 106 
μ
V
 Mosquito oviposition and death rate (per day) 1/6 
ω Mosquito maturation rate (per day) 1/11 
β
v
 Probability of vector transmission to a human 0.425 
β
V
 Mosquito transmission rate (per day) bβ
v
 
ε Extrinsic incubation period 1/10 
S
E
 Pre-adult mosquitos (ω/μ
V
)N
V
 
 S
V
 Susceptible adult mosquito population 9.5x106 
E
V
 Latent adult mosquito population 0 
I
V
 Infectious adult mosquitoes population 0 
N
V
 Total adult mosquito population 9.5x106 
 
The total human population (NH) is divided into susceptible (SH), 
asymptomatically infected (AH), symptomatically infected (IH) and recovered (RH) 
classes. The total mosquito population (NV) is divided into immature mosquito (SE), 
susceptible mosquito (SV), incubating mosquito (EV) and infected mosquito (IV) classes. 
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Every class of human experiences loss due to a death rate μH, however the human 
population remains constant as humans are born into the susceptible class at a birth rate 
of μHNH. Susceptible humans become infected at a mosquito dependent transmission 
term, given by SH/NH(βVIV). Upon infection humans either become asymptomatic at a 
rate of (1-p)SH/NH(βVIV) or symptomatically infected at a rate of pSH/NH(βVIV). 
Asymptomatically infected people gain complete lifelong immunity at a rate of γA and 
symptomatically infected people gain complete lifelong immunity at a rate of γI, both of 
which then move to the recovered class. Every class of mosquito experiences loss due to 
death rate μV, however the mosquito population remains constant as mosquitoes are 
oviposited into the immature mosquito class at a of μVNV. Mosquitoes mature into 
adults at a rate ω and become infected at a rate of SV(βAAH+ βIIH)/NH moving to the 
incubating class, after a period of incubation ε mosquitoes move to the infectious class.  
The symptomatic transmission term βI is made up of two component terms, the 
mosquito biting rate b and probability of infection from biting a symptomatic human βi 
(βI=bβi). Likewise the mosquito transmission term βV is made up of two component 
terms, the mosquito biting rate b and probability of infection from an infectious 
mosquito βv (βV=bβv). 
Formula for the basic reproductive number R0 is listed is Equation 7.14-16 and 
is sourced from Chapter 6.  
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𝜑 = 𝑡 + 𝜎 Equation 
7.14a 
𝜑 = |
𝐴𝐻
𝐼𝐻
𝐸𝑉
𝐼𝑉
|,  𝑡 = |
|
(1 − 𝑝)𝛽𝑉𝐼𝑉
𝑝𝛽𝑉𝐼𝑉
𝑁𝑣 (
𝛽𝐴𝐴𝐻+𝛽𝐼𝐼𝐻 
𝑁𝐻ℎ
)
0
|
|,  𝜎 = |
|
−𝛾𝐴𝐴𝐻 −  𝜇𝐻𝐴𝐻
𝛾𝐼𝐼𝐻–  𝜇𝐻𝐼𝐻  
−𝜀𝐸𝑉 − 𝜇𝑉𝐸𝑉  
𝜀𝐸𝑉 − 𝜇𝑉𝐼𝑉
|
| 
 
Equation 
7.14b 
𝐾𝐿 = 𝑇*-𝛴 
−1
 Equation 
7.15a 
𝑇 =
|
|
0 0 0 (1 − 𝑝)𝛽𝑉
0 0 0 𝑝𝛽𝑉
𝛽𝐴𝑁𝑉
𝑁𝐻
𝛽𝐼𝑁𝑉
𝑁𝐻
0 0
0 0 0 0
|
|
 
 
Equation 
7.15b 
𝛴 = |
−𝛾𝐴 −  𝜇𝐻 0 0 0
0 −𝛾𝐼 −  𝜇𝐻 0 0
0 0 −𝜀 − 𝜇𝑉 0
0 0 𝜀 −𝜇𝑉
| 
Equation 
7.15b 
continued 
𝐾𝐿 =
|
|
0 0 −
(𝑝 − 1)𝜀𝛽𝑉
𝜇𝑣(𝜀 + 𝜇𝑉)
−
(𝑝 − 1)𝛽𝑉
𝜇𝑉
0 0
𝑝𝜀𝛽𝑉
𝜇𝑣(𝜀 + 𝜇𝑉)
𝑝𝛽𝑉
𝜇𝑉
𝛽𝐴𝑁𝑉
𝑁𝐻(𝛾𝐴 + 𝜇𝐻)
𝛽𝐼𝑁𝑉
𝑁𝐻(𝛾𝐼 + 𝜇𝐻)
0 0
0 0 0 0
|
|
 
 
Equation 
7.15b 
continued 
𝐿𝑎𝑟𝑔𝑒𝑠𝑡 𝑒𝑖𝑔𝑒𝑛 𝑣𝑎𝑙𝑢𝑒 (𝜆) 𝑜𝑓 𝐾𝐿 = 𝑅0 Equation 7.16a 
𝑅0 = √
𝑁𝑉
𝑁𝐻
×
𝜀𝛽𝑉
𝜇𝑣(𝜀 + 𝜇𝑉)
×
(1 − 𝑝)𝛽𝐴(𝛾𝐼 + 𝜇𝐻) + 𝑝𝛽𝐼(𝛾𝐴 + 𝜇𝐻)
(𝛾𝐼 + 𝜇𝐻)(𝛾𝐴 + 𝜇𝐻)
 
Equation 7.16b  
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7.2.3 Analyses Model A under frequency and mosquito dependent transmission 
in a stochastic framework. 
In order to explore the effects of differing proportions of infection leading to 
symptoms, as well as the levels and durations of transmission in the asymptomatic class 
on epidemiology of dengue virus, in a stochastic based setting; Model A under 
frequency dependent transmission and mosquito dependent transmission was coded 
using τ-leap methodology within Matlab (Keeling & Rohani 2008b). Table 7.3 contains 
a list of the various rates of change used in the τ-leap methodology in the frequency 
dependent transmission version of Model A and Table 7.4A-B contains a list of the 
various rates of change used in the τ-leap methodology in the mosquito dependent 
transmission version of Model A. Dengue parameters were sourced as the mid-range 
values from the parameters listed in Andraud et al. (2012) literature review of dengue 
virus transmission models (unless otherwise stated), so as to make the model 
comparable with other models of dengue virus transmission (see Table 7.1 and Table 
7.2). Mosquito oviposition and mortality rate (μV) where the average mortality rates of 
Ae. aegypti and Ae. albopictus, as sourced from a meta-analyses of marked release 
recapture studies (Brady et al. 2013), mosquito maturation rate (ω) was sourced from 
(M. Service 2012b) (see Table 7.2). 
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Table 7.3 Tau leap rates of change in classes for Model A under frequency 
dependent transmission 
Rate of Change Change in 
Susceptible 
Class (S) 
Change in 
Asymptomatic 
Class (A) 
Change in 
Symptomatic 
Class (I) 
Change in 
Resistant    
Class (R) 
𝜇𝑁 +1 0 0 0 
𝑝𝑆(𝛽𝐴𝐴 + 𝛽𝐼𝐼)
𝑁
 
-1 +1 0 0 
(1 − 𝑝)𝑆(𝛽𝐴𝐴 + 𝛽𝐼𝐼)
𝑁
 
-1 0 +1 0 
𝛾𝐴𝐴 0 -1 0 +1 
𝛾𝐼𝐼 0 0 -1 +1 
𝜇𝑆 -1 0 0 0 
𝜇𝐴 0 -1 0 0 
𝜇𝐼 0 0 -1 0 
𝜇𝑅 0 0 0 -1 
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Table 7.4A: Tau leap rates of change in human classes for Model A 
Rate of Change Change in 
Susceptible 
Class (Sh) 
Change in 
Asymptomatic 
Class (Ah) 
Change in 
Symptomatic 
Class (Ih) 
Change in 
Resistant    
Class (Rh) 
μHNH +1 0 0 0 
𝑝𝛽𝑉𝐼𝑉𝑆𝐻
𝑁𝐻
 
-1 +1 0 0 
(𝑝 − 1)𝛽𝑉𝐼𝑉𝑆𝐻
𝑁𝐻
 
-1 0 +1 0 
𝛾𝐴𝐴H 0 -1 0 +1 
𝛾𝐼𝐼H 0 0 -1 +1 
μHSH -1 0 0 0 
μHAH 0 -1 0 0 
μHIH 0 0 -1 0 
μHRH 0 0 0 -1 
 
Table 7.4B Tau leap rates of change in mosquito classes for Model A 
Rate of Change Change in 
Immature 
Class (Se) 
Change in 
Susceptible 
Class (Sv) 
Change in 
Latent Class 
(Ev) 
Change in 
Infected 
Class (Iv) 
μVNV +1 0 0 0 
ωSE -1 +1 0 0 
𝑆𝑉
𝛽𝐴𝐴𝐻 + 𝛽𝐼𝐼𝐻
𝑁𝐻
 
0 -1 +1 0 
εEV 0 0 -1 +1 
μVSV 0 -1 0 0 
μVEV 0 0 -1 0 
μVIV 0 0 0 -1 
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Asymptomatic individuals could be transmitting dengue at a lower rate due to a 
decreased viremia. Likewise asymptomatic individuals could be transmitting dengue at 
a higher rate, as they may be more likely to pass through areas of high mosquito 
abundance, due to not exhibiting the decreased movement, through illness, seen in 
symptomatically infected humans. For these reasons parameter c of both Model A, the 
coefficient relating βA to βI (βA=c βI) was varied from 0-2. For each of these settings of 
c the proportion of infections developing symptoms (p) was varied from 0-1.  Parameter 
d, the coefficient relating γA and γI (γA=1/dφ, γI=1/φ), was kept at 1.  
As information on the immune recovery rate for asymptomatically dengue 
infected humans was unavailable. Parameter d, the coefficient relating γA and γI 
(γA=1/dφ, γI=1/φ), was varied from 0.05-2, as at d=0 γA would equal infinity (γA=1/dφ, 
γI=1/φ). For each of these settings of d parameter p was varied from 0-1. Parameter c 
the coefficient relating βA to βI (βA=cβI), was kept at 1. 
The range in parameter space for the probability of a dengue virus infection 
leading symptoms (p) could be considered a large sample. Therefore it was decided to 
highlight a conservative sample of parameter space for this parameter through labelling 
certain axis values regarding this parameter in green on figures that display model 
outputs with respect to changes in this parameter. The lower limit to this conservative 
parameter space p=0.2 is based on the rounded down mean possibility of symptomatic 
dengue virus infection from cohort studies in Grange et al. (2014). The upper limit to 
this conservative parameter space of p=0.7 is based on the rounded up mean possibility 
of symptomatic dengue virus infection from index cluster studies in Grange et al. 
(2014). The non-rounded mean symptomatic dengue virus infection rate (p) in cohort 
studies was 24% whereas in index cluster studies it was 63% (Grange et al. 2014). 
Cohort studies quantify the ratio of asymptomatic to symptomatic dengue infections by 
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following a cohort of people and use case reporting, absenteeism and/or symptom 
questionnaires, combined with blood screening for dengue antibodies at regular 
intervals (Endy 2002a; Endy 2002b; Arguello et al. 2015). Index cluster studies sample 
people surrounding an index case of dengue illness. Sampled individuals’ symptoms are 
quantified through symptom questionnaires or clinical diagnosis and their blood is 
screened for dengue antibodies (Singh et al. 2000; Beckett et al. 2005; Reyes et al. 
2010; Wang et al. 2015). 
Likewise, the range in parameter space for the level and duration of transmission 
from asymptomatic dengue virus infections (c and d, respectively) could be considered 
large samples. Therefore it was decided to highlight more conservative samples of 
parameter space for these parameters through labelling certain axis values regarding 
these parameters in green for figures that display model outputs with respect to changes 
in these parameters. The lower limit of these conservative parameter spaces is 0.5 and 
the upper limit is 1.5. Note that at the time of submission of this thesis there was no data 
regarding the level or duration of transmission from asymptomatic dengue virus 
infected humans available, which could be used to base a more conservative region of 
parameter space for both of these parameters.  
For two reasons, for both the variations in the asymptomatic class transmission 
rate βA and recovery rate γA, 100 trials of Model A under frequency dependent 
transmission and mosquito dependent transmission were run with 999,999 susceptible 
humans and the arrival of an asymptomatically infected human. Firstly, as the previous 
two chapters established there was little difference between epidemics started by the 
arrival of an asymptomatically infected human and those started by a symptomatically 
infected human. Secondly, as due to their more ambulatory nature an asymptomatically 
infected human is more likely to travel to a new area and start an epidemic than a 
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symptomatically infected human. In order to test whether there was an effect of 
transmission setting, the 100 trials for each parameter setting were conducted at a low-
transmission setting, a mid-level transmission setting and a high-level transmission 
setting (this is the range of transmission setting cited in the review by Andraud et al. 
(2012)) (see Table 7.1-2 and Table 7.5).  
Table 7.5: Transmission settings at which trials where run. 
Version of Model B Low Transmission Medium 
Transmission 
High Transmission  
Frequency Dependent 
Transmission 
βI=200/365 βI=300/365 βI=400/365 
Mosquito Dependent 
Transmission 
βi=0.5 and b=0.3 βi=0.75 and b=0.65. βi=1 and b=1. 
7.3 Results 
7.3.1 Trials were epidemics of dengue virus did not occur. 
A number of trials produce epidemics that failed to spread through the 
population. For this reason a cut off was set whereby trials where dengue infections did 
not manage to infect more than 100 humans, as measured by the maximum total of 
humans in the asymptomatic, symptomatic and resistance classes, were excluded in 
calculating the mean extinction time of an epidemic. Subfigure C of Figure 7.3-14 show 
the number of trials excluded by this cut-off and subfigure D shows the mean dengue 
extinction time of these excluded trials (which never exceeds 40 days). The parameter 
settings where a higher proportion of dengue infection trials fail to spread through the 
population follow three trends across all three transmission settings. The first trend is 
for the lowest levels of transmission in the asymptomatic class (c) combined with the 
lowest proportion of infections developing symptoms (p) (see Figure 7.3c, Figure 7.5c, 
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Figure 7.7c, Figure 7.9c, Figure 7.11c and Figure 7.13c). This first non-epidemic trend 
is either at the low end or excluded from the more conservative samples of parameter 
space for the proportion of infections developing symptoms (p) and level of 
transmission from the asymptomatic class (c) (see Figure 7.3c, Figure 7.5c, Figure 7.7c, 
Figure 7.9c, Figure 7.11c and Figure 7.13c). The second trend is for the lowest 
durations of transmission in the asymptomatic class (d) combined with the lowest 
proportion of infections developing symptoms (p) (see Figure 7.4c, Figure 7.6c, Figure 
7.8c, Figure 7.10c, Figure 7.12c and Figure 7.14c). This second non-epidemic trend is 
either at the low end or excluded from the more conservative samples of parameter 
space for the proportion of infections developing symptoms (p) and duration of 
transmission from the asymptomatic class (d) (see Figure 7.4c, Figure 7.6c, Figure 7.8c, 
Figure 7.10c, Figure 7.12c and Figure 7.14c). Of note is that both of these two trends 
also occur when R0 is slightly over 1 or below 1 (see Subfigure A of Figure 7.3-14). The 
third trend occurs when there is no transmission from the asymptomatic class (c=0), at 
this parameter setting no epidemic occurs in all 100 trials. This is logical since the 
arrival of an asymptomatically infected human will not cause an epidemic of dengue 
fever if such an infection does not transmit dengue virus to another host (see Figure 
7.3c, Figure 7.5c, Figure 7.7c, Figure 7.9c, Figure 7.11c and Figure 7.13c). This third 
non-epidemic trend is excluded from the more conservative samples of parameter space 
for the level of transmission from the asymptomatic class (c) (see Figure 7.3c, Figure 
7.5c, Figure 7.7c, Figure 7.9c, Figure 7.11c and Figure 7.13c). 
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A) B)  
C) D)  
Figure 7.3: The effects of different levels of transmission from asymptomatic 
infections (c) and different proportions of infections developing symptoms (p), 
when durations of asymptomatic and symptomatic infections were the same (d=1), 
under low-level transmission (βI=200/365), on the frequency dependent 
transmission version of Model A. A) Basic reproductive number (R0). B) Mean 
dengue virus extinction time, excluding trials that do not reach a total of 100 
individuals in the Asymptomatic, Symptomatic and Resistant classes combined (i.e. 
non-epidemic trials). C) Total number of non-epidemic trials. D) Mean dengue 
virus extinction time of non-epidemic trials. For all sub-figures the more 
conservative region of parameter space is displayed through the axis labelled 
values being green. 
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A) B)  
C) D)  
Figure 7.4: The effects of different durations of asymptomatic infection (d) and 
different proportions of infections developing symptoms (p), when levels of 
transmission from asymptomatic and symptomatic infections were the same (c=1), 
under low-level transmission (βI=200/365), on the frequency dependent 
transmission version of Model A. A) Basic reproductive number (R0). B) Mean 
dengue virus extinction time, excluding trials that do not reach a total of 100 
individuals in the Asymptomatic, Symptomatic and Resistant classes combined (i.e. 
non-epidemic trials). C) Total number of non-epidemic trials. D) Mean dengue 
virus extinction time of non-epidemic trials. For all sub-figures the more 
conservative region of parameter space is displayed through the axis labelled 
values being green. 
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A) B)  
C) D)  
Figure 7.5: The effects of different levels of transmission from asymptomatic 
infections (c) and different proportions of infections developing symptoms (p), 
when durations of asymptomatic and symptomatic infections were the same (d=1), 
under mid-level transmission (βI=300/365), on the frequency dependent 
transmission version of Model A. A) Basic reproductive number (R0). B) Mean 
dengue virus extinction time, excluding trials that do not reach a total of 100 
individuals in the Asymptomatic, Symptomatic and Resistant classes combined (i.e. 
non-epidemic trials). C) Total number of non-epidemic trials. D) Mean dengue 
virus extinction time of non-epidemic trials. For all sub-figures the more 
conservative region of parameter space is displayed through the axis labelled 
values being green. 
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A) B)  
C) D)  
Figure 7.6: The effects of different durations of asymptomatic infection (d) and 
different proportions of infections developing symptoms (p), when levels of 
transmission from asymptomatic and symptomatic infections were the same (c=1), 
under mid-level transmission (βI=300/365), on the frequency dependent 
transmission version of Model A. A) Basic reproductive number (R0). B) Mean 
dengue virus extinction time, excluding trials that do not reach a total of 100 
individuals in the Asymptomatic, Symptomatic and Resistant classes combined (i.e. 
non-epidemic trials). C) Total number of non-epidemic trials. D) Mean dengue 
virus extinction time of non-epidemic trials. For all sub-figures the more 
conservative region of parameter space is displayed through the axis labelled 
values being green. 
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A) B)  
C) D)  
Figure 7.7: The effects of different levels of transmission from asymptomatic 
infections (c) and different proportions of infections developing symptoms (p), 
when durations of asymptomatic and symptomatic infections were the same (d=1), 
under high-level transmission (βI=400/365), on the frequency dependent 
transmission version of Model A. A) Basic reproductive number (R0). B) Mean 
dengue extinction time, excluding trials that do not reach a total of 100 individuals 
in the Asymptomatic, Symptomatic and Resistant classes combined (i.e. non-
epidemic trials). C) Total number of non-epidemic trials. D) Mean dengue virus 
extinction time of non-epidemic trials. For all sub-figures the more conservative 
region of parameter space is displayed through the axis labelled values being 
green. 
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A) B)  
C) D)  
Figure 7.8: The effects of different durations of asymptomatic infection (d) and 
different proportions of infections developing symptoms (p), when levels of 
transmission from asymptomatic and symptomatic infections were the same (c=1), 
under high-level transmission (βI=400/365), on the frequency dependent 
transmission version of Model A. A) Basic reproductive number (R0). B) Mean 
dengue extinction time, excluding trials that do not reach a total of 100 individuals 
in the Asymptomatic, Symptomatic and Resistant classes combined (i.e. non-
epidemic trials). C) Total number of non-epidemic trials. D) Mean dengue virus 
extinction time of non-epidemic trials. For all sub-figures the more conservative 
region of parameter space is displayed through the axis labelled values being 
green. 
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A) B)  
C) D)  
E)  
Figure 7.9: The effects of different levels of transmission from asymptomatic infections (c) and 
different proportions of infections developing symptoms (p), when durations of asymptomatic and 
symptomatic infections were the same (d=1), under low-level transmission (βi=0.5 and b=0.3), on the 
mosquito dependent transmission version of Model A. A) Basic reproductive number (R0). B) Mean 
dengue extinction time, excluding trials that do not reach a total of 100 individuals in the 
Asymptomatic, Symptomatic and Resistant classes combined (i.e. non-epidemic trials). C) Total 
number of non-epidemic trials. D) Mean epidemic extinction time of non-epidemic trials. E) Number 
of trials with extant epidemics at 10 years (Note colour scale is from 0-5). For all sub-figures the more 
conservative region of parameter space is displayed through the axis labelled values being green.   
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A) B)  
C) D)  
E)  
Figure 7.10: The effects different durations of asymptomatic infection (d) and different proportions of 
infections developing symptoms (p), when levels of transmission from asymptomatic and symptomatic 
infections were the same (c=1), under low-level transmission (βi=0.5 and b=0.3), on the mosquito 
dependent transmission version of Model A. A) Basic reproductive number (R0). B) Mean dengue 
extinction time, excluding trials that do not reach a total of 100 individuals in the Asymptomatic, 
Symptomatic and Resistant classes combined (i.e. non-epidemic trials). C) Total number of non-
epidemic trials. D) Mean epidemic extinction time of non-epidemic trials. E) Number of trials with 
extant epidemics at 10 years (Note colour scale is from 0-5). For all sub-figures the more conservative 
region of parameter space is displayed through the axis labelled values being green. 
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A) B)  
C) D)  
E)  
Figure 7.11: The effects of different levels of transmission from asymptomatic infections (c) and 
different proportions of infections developing symptoms (p), when durations of asymptomatic and 
symptomatic infections were the same (d=1), under mid-level transmission (βi=0.75 and b=0.65), on 
the mosquito dependent transmission version of Model A. A) Basic reproductive number (R0). B) 
Mean dengue extinction time, excluding trials that do not reach a total of 100 individuals in the 
Asymptomatic, Symptomatic and Resistant classes combined (i.e. non-epidemic trials). C) Total 
number of non-epidemic trials. D) Mean epidemic extinction time of non-epidemic trials. E) Number 
of trials with extant epidemics at 10 years (Note colour scale is from 0-5). For all sub-figures the more 
conservative region of parameter space is displayed through the axis labelled values being green.   
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A) B)   
C) D)  
E)  
Figure 7.12: The effects different durations of asymptomatic infection (d) and different proportions of 
infections developing symptoms (p), when levels of transmission from asymptomatic and symptomatic 
infections were the same (c=1), under mid-level transmission (βi=0.75 and b=0.65), on the mosquito 
dependent transmission version of Model A. A) Basic reproductive number (R0). B) Mean dengue 
extinction time, excluding trials that do not reach a total of 100 individuals in the Asymptomatic, 
Symptomatic and Resistant classes combined (i.e. non-epidemic trials). C) Total number of non-
epidemic trials. D) Mean epidemic extinction time of non-epidemic trials. E) Number of trials with 
extant epidemics at 10 years (Note colour scale is from 0-5). For all sub-figures the more conservative 
region of parameter space is displayed through the axis labelled values being green.  
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A) B)  
C) D)  
E)  
Figure 7.13: The effects of different levels of transmission from asymptomatic infections (c) and 
different proportions of infections developing symptoms (p), when durations of asymptomatic and 
symptomatic infections were the same (d=1), under high-level transmission (βi=1 and b=1), on the 
mosquito dependent transmission version of Model A. A) Basic reproductive number (R0). B) Mean 
dengue extinction time, excluding trials that do not reach a total of 100 individuals in the 
Asymptomatic, Symptomatic and Resistant classes combined (i.e. non-epidemic trials). C) Total 
number of non-epidemic trials. D) Mean epidemic extinction time of non-epidemic trials. E) Number 
of trials with extant epidemics at 10 years (Note colour scale is from 0-100). For all sub-figures the 
more conservative region of parameter space is displayed through the axis labelled values being green.  
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A) B)  
C) D)  
E)  
Figure 7.14: The effects different durations of asymptomatic infection (d) and different proportions of 
infections developing symptoms (p), when levels of transmission from asymptomatic and symptomatic 
infections were the same (c=1), under high-level transmission (βi=1 and b=1), on the mosquito 
dependent transmission version of Model A. A) Basic reproductive number (R0). B) Mean dengue 
extinction time, excluding trials that do not reach a total of 100 individuals in the Asymptomatic, 
Symptomatic and Resistant classes combined (i.e. non-epidemic trials). C) Total number of non-
epidemic trials. D) Mean epidemic extinction time of non-epidemic trials. E) Number of trials with 
extant epidemics at 10 years (Note colour scale is from 0-100). For all sub-figures the more 
conservative region of parameter space is displayed through the axis labelled values being green. 
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7.3.2 General trends in epidemics of DF 
For the vast majority of parameter settings, when dengue viruses succeed in 
spreading through the population, the model produces on average epidemics that last at 
most a year and a half. Across the low, mid and high level transmission settings the 
epidemics that last more than a year and a half on average follow two similar trends to 
the parameter settings where a higher proportion of dengue infection trials fail to spread 
through the population. The first trend is for low levels of transmission from the 
asymptomatic class (c), combined with low proportions of infections leading to 
symptoms (p) (see Figure 7.3, Figure 7.5, Figure 7.7, Figure 7.9 and Figure 7.11). This 
first on average longer lasting epidemic trend is either at the low end or excluded from 
the more conservative samples of parameter space for the proportion of infections 
developing symptoms (p) and level of transmission from the asymptomatic class (c) 
(see Figure 7.3, Figure 7.5, Figure 7.7, Figure 7.9 and Figure 7.11). The second trend is 
for low durations of transmission in asymptomatic class (d), combined with low 
proportions of infections leading to symptoms (p) (see Figure 7.4, Figure 7.6, Figure 
7.10 and Figure 7.12). This second on average longer lasting epidemic trend is either at 
the low end or excluded from the more conservative samples of parameter space for the 
proportion of infections developing symptoms (p) and duration of transmission from the 
asymptomatic class (d) (see Figure 7.4, Figure 7.6, Figure 7.10 and Figure 7.12). Of 
note is that both of these two trends also occur when R0 is slightly over 1 (see Subfigure 
A of Figure 7.3-7 and Figure 7.9-12).  
The fact that the longer lasting epidemics have overlapping parameter values in 
which a high proportion of trials have dengue viruses failing to spread through the 
population; suggests that whilst at these parameter settings dengue viruses can spread 
through the population, R0 being greater than 1, dengue spreads slowly, due to a low 
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force of infection. However, at the parameter settings which cause this low force of 
infection, many individuals who become infected often become immune before 
transmitting the infection, which can lead to a dengue epidemic dying out before it 
spreads beyond a few individuals. 
7.3.3 Epidemics that are extant by 10 years 
For reasons of expediency model runtime of trials was limited to 10 years. None 
of the simulated epidemics in the frequency dependent versions of Model A ran over 
this limit. A few trials in the mosquito dependent versions of Model A had dengue 
persisting over this limit (see subfigures E of Figure 7.9-14). In order to ascertain why 
certain parameter settings caused dengue viruses to persist in the population for at least 
10 years for some of those parameter settings Model A was run repeatedly until a trial 
had the dengue virus persisting in the population over 10 years. Figures of the infected 
human population over time were then plotted (see Figure 7.15-20).  The trials that had 
dengue persisting over this limit fall into five trends in terms of parameter space.  
The first trend is for low probabilities of an infection leading to symptoms (p) 
combined with either low levels or durations of transmission from the asymptomatic 
class (c and d, respectively) at the low transmission setting (βi=0.5 and b=0.3) (see 
Figure 7.9E and Figure 7.10E). Here as seen by Figure 7.15 dengue viruses have simply 
persisted in the population beyond 10 years, but do eventually die out. These two 
greater than 10 year epidemics are excluded from the more conservative samples of 
parameter space for the level or duration of transmission from the asymptomatic class (c 
and d respectively). They are also either at the low end of or excluded from the more 
conservative samples of parameter space for the proportion of infections developing 
symptoms (p).  
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In the four other trends dengue viruses become endemic to the human and 
mosquito population. There is an initial spike in dengue infections followed by dengue’s 
persistence at a low level (see subfigures A of Figure 7.16-20). The population of 
infected humans then begins to oscillate around a set value, with amplitude that 
decreases to a point (see subfigures B of Figure 7.16-20). This would suggest that for 
these trials the reason why the dengue virus is still within the human and mosquito 
population by 10 years is that the number of dengue infections is fluctuating around an 
endemic equilibrium of dengue infections, and will continue to do so. 
The first of the trends in parameter space where dengue becomes endemic 
occurs when the transmission in the asymptomatic class is equal to that in the 
symptomatic class (c=1), at medium transmission level (βi=0.75 and b=0.65), for high 
lengths of time spent in the asymptomatic class (d) combined with low proportions of 
infections that lead to symptoms (p), such as d=2 and p=0, d=1.85 and p=0.05, d=1.8 
and p=0.05, d=1.8 and p=0.25, d=1.95 and p=0.3, as well as d=1.85 and p=0.3 (see 
Figure 7.12E and Figure 7.16). This happened for 1-2 of the 100 trials for each of these 
parameter settings (see Figure 7.12E and Figure 7.16). All of the trials for this trend of 
epidemics becoming endemic are excluded from the more conservative samples of 
parameter space for the duration of transmission from the asymptomatic class (d) (see 
Figure 7.12E and Figure 7.16). They are also either at the low end of or excluded from 
the more conservative samples of parameter space for the proportion of infections 
developing symptoms (p) (see Figure 7.12E and Figure 7.16). 
The second of the trends in parameter space where dengue becomes endemic 
occurs at the highest transmission setting (βi=1 and b=1) where the model essentially 
becomes an SIR type model, due to all infections being symptomatic (p=1) or Model A 
closely resembles an SIR model, due to nearly all infections developing symptoms (p is 
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close to 1), the level and duration of transmission from the asymptomatic class being 
similar to the symptomatic class (c and d are 1 or close to it) (see Figure 7.13E, Figure 
7.14E and Figure 7.19-20). Many trials from this second trend are excluded from the 
more conservative sample of parameter space for the proportion of infections 
developing symptoms (p), as they occur when p<0.7.  
The third of the trends in parameter space where dengue becomes endemic 
occurs for proportions of infection becoming symptomatic (p) that are lower than 1 
combined with greater transmission from the asymptomatic class than the symptomatic 
class (c>1), when the durations of transmission in the symptomatic and asymptomatic 
class are the same (d=1), at the highest transmission setting (βi=1 and b=1) (see Figure 
7.13E and Figure 7.17). As the transmission from the asymptomatic class increases to 
reach double of that from the symptomatic class (c=2) and the proportion of infections 
developing symptoms (p) decreases to 0, at this high transmission setting (βi=1 and b=1) 
the number of trials where dengue is extant at 10 years increases to the high fifties out 
of 100 (see Figure 7.13E and Figure 7.17). This excludes many of the trials for this 
trend of epidemics becoming endemic from the more conservative samples of parameter 
space for the proportion of infections developing symptoms (p) and level of 
transmission from the asymptomatic class (c), but not all. 
The fourth of the trends in parameter space where dengue becomes endemic 
occurs for proportions of infection becoming symptomatic (p) that are lower than 1, 
combined with higher lengths of time spent in the asymptomatic class than in the 
symptomatic class (d>1), when the transmission from asymptomatic and symptomatic 
infections are the same (c=1), at the high transmission setting (βi=1 and b=1) (see 
Figure 7.14E and Figure 7.18). As both the length of time spent in the asymptomatic 
class increases to double of that spent in the symptomatic class (d=2) and the proportion 
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of infections developing symptoms (p) decreases to 0, at this high transmission setting 
(βi=1 and b=1) the number of trials where dengue is extant at 10 years increases to 100 
out of 100 (see Figure 7.14E and Figure 7.18). This excludes many of the trials for this 
trend of epidemics becoming endemic from the more conservative samples of parameter 
space for the proportion of infections developing symptoms (p) and duration of 
transmission from the asymptomatic class (d), but not all. However this exclusion from 
the more conservative samples of parameter space for trials were dengue becomes 
endemic is to a lesser extent than seen in the third trend (compare Figure 7.14E to 
Figure 7.13E). 
It should be noted that the third and fourth trends in regions of parameter space 
where dengue becomes endemic were observed in the deterministic version of model A 
in Chapter 6. This would suggest that these two regions are “true” regions of endemic 
disease. The other trends in parameter regions where the dengue virus becomes endemic 
are regions where this has occurred due to the role of stochasticity.  
 
 
 
 
 
281 
 
A) B)  
Figure 7.15: Example trials where dengue viruses extant are extant after 10 years 
but do eventually die out, in the mosquito dependent version of Model A. 
Asymptomatic human infections in yellow and symptomatic human infections in 
red. A) At low-level transmission (βi=0.5 and b=0.3), when transmission 
asymptomatic infections is 20% of symptomatic infection c=0.2, the duration of 
asymptomatic and symptomatic infection are the same (d=1) and the proportion of 
infections that develop symptoms is 15% (p=0.15). B) At low-level transmission 
(βi=0.5 and b=0.3), when transmission from symptomatic and asymptomatic 
infections is the same (c=1), the proportional duration of asymptomatic infection is 
15% that of symptomatic infection (d=0.15) and 20% of infections develop 
symptoms p=0.2. 
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A) B)  
C) D)  
Figure 7.16: Example trials where dengue viruses are extant after 10 years through 
becoming endemic, in the mosquito dependent version of Model A, at mid-level 
transmission (βi=0.75 and b=0.65). Asymptomatic human infections in yellow and 
symptomatic human infections in red. A) When transmission from asymptomatic 
and symptomatic infections is the same (c=1), the duration of asymptomatic 
infections is twice that of symptomatic infections (d=2) and no infections develop 
symptoms (p=0), from 0-500 days. B) Same trial from 100 days – 15 years. C) 
When transmission from asymptomatic and symptomatic infections is the same 
(c=1), the duration of infections for asymptomatic infections is 185% that of 
symptomatic infections (d=1.85) and 5% of infections develop symptoms (p=0.05), 
from 0-500 days. D) Same trial from 100 days – 15 years.
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A) B)  
C) D)  
Figure 7.17: Example trials where dengue viruses are extant after 10 years through 
becoming endemic, in the mosquito dependent version of Model A, at high-level 
transmission (βi=1 and b=1). Asymptomatic human infections in yellow and 
symptomatic human infections in red. A) When transmission from asymptomatic 
infections is twice that of symptomatic infections (c=2), the duration of 
asymptomatic and symptomatic infections if the same (d=1) and no infections 
develop symptoms (p=0), from 0-500 days. B) Same trial from 50 days – 15 years. 
C) When transmission from asymptomatic infections is 145% that of symptomatic 
infections (c=1.45), durations of asymptomatic and symptomatic infections is the 
same (d=1) and half of infections develop symptoms (p=0.5), from 0-500 days. D) 
Same trial from 50 days – 15 years.  
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A) B)  
C) D  
Figure 7.18: Example trials where dengue viruses are extant after 10 years through 
becoming endemic, in the mosquito dependent version of Model A, at high-level 
transmission βi=1 and b=1. Asymptomatic human infections in yellow and 
symptomatic human infections in red. A) When transmission from asymptomatic 
and symptomatic infections is the same (c=1), durations of asymptomatic infections 
are twice that of symptomatic infections (d=2) and no infections develop symptoms 
(p=0), from 0-500 days. B) Same trial from 100 days – 15 years. C) When 
transmission from asymptomatic and symptomatic infections is the same (c=1), 
durations of infection in asymptomatic infections are 140% that of symptomatic 
infections (d=1.4) and half of infections develop symptoms (p=0.5), from 0-500 
days. D) Same trial from 50 days – 15 years. 
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A) B)  
C) D)  
Figure 7.19: Example trials where dengue viruses are extant after 10 years through 
becoming endemic, in the mosquito dependent version of Model A, at high-level 
transmission (βi=1 and b=1). Asymptomatic human infections in yellow and 
symptomatic human infections in red. A) When transmission from asymptomatic 
infections is 95% that of symptomatic infections (c=0.95), durations of 
asymptomatic and symptomatic infection are the same (d=1) and three quarters of 
infections develop symptoms (p=0.75), from 0-500 days. B) Same trial from 100 
days – 15 years. C) When transmission from asymptomatic infections is 85% that 
of symptomatic infections (c=0.85), durations of asymptomatic and symptomatic 
infection are the same (d=1) and 95% of infections develop symptoms (p=0.95), 
from 0-500 days. D) Same trial from 50 days – 15 years.  
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A) B)  
C) D)  
Figure 7.20: Example trials where dengue viruses are extant after 10 years through 
becoming endemic, in the mosquito dependent version of Model A, at high-level 
transmission (βi=1 and b=1). Asymptomatic human infections in yellow and 
symptomatic human infections in red. A) When transmission from asymptomatic 
and symptomatic infections is the same (c=1), durations of asymptomatic infection 
are 80% that of symptomatic infections (d=0.8) and all infections develop 
symptoms (p=1), from 0-500 days. B) Same trial from 50 days – 15 years. C) When 
transmission from asymptomatic and symptomatic infections is the same (c=1), 
durations of asymptomatic infection are 70% that of symptomatic infections 
(d=0.7) and 90% of infections develop symptoms (p=0.9), from 0-500 days. D) 
Same trial from 50 days – 15 years. 
7.3.4 Population left immune to the invading dengue serotype and thereby at risk 
of DHF 
For the stochastic form of modelling both mosquito dependent and frequency 
dependent versions of Model A, provided epidemics occur, the proportion of population 
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that becomes resistant to the invading serotype and thereby at risk of DHF, remains 
similar to the deterministic form of modelling (see Chapter 5 and Chapter 6). For the 
most part on average over 80-90% of the population is in this at risk group, however 
this becomes lower for lower transmission settings (βI, βi and b), proportions of 
infections that lead to symptoms (p), levels and durations of transmission in 
asymptomatic class (c and d respectively) (see Figure 7.21-22). Within the more 
conservative samples of parameter space for levels and durations of transmission in 
asymptomatic class (c and d respectively) on average epidemics lead to from 60% to 
near 100% of the population being resistant to dengue virus (see Figure 7.21-22). This 
is also the case for the more conservative samples of parameter space for proportions of 
infections that lead to symptoms (p) at mid and high level transmission setting (see Sub-
figures C-F of Figure 7.21-22). However, at the lower transmission setting the 
conservative samples of proportions of infections that lead to symptoms (p), combined 
with lower levels and durations of transmission in asymptomatic class (c and d 
respectively) can lead to epidemics with a mean percentage of population resistant as 
low as a single digit (see Sub-figures A-B of Figure 7.21-22). Where an invading 
dengue viral serotype becomes endemic on average above 90% of the population is in 
this at risk group (see Figure 7.23).  
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A) B)  
C) D)  
E) F)  
Figure 7.21: Mean percentage of the population resistant at the end of an epidemic, against different 
levels of asymptomatic infection (c) and proportions of infections developing symptoms (p), when the 
durations of asymptomatic and symptomatic infections are the same d=1. A) Model A under 
frequency dependent transmission, at low level transmission (βI=200/365). B) Model A under 
mosquito dependent transmission, at low level transmission (βi=0.5 and b=0.3). C) Model A under 
frequency dependent transmission, at mid-level transmission (βI=300/365). D) Model A under 
mosquito dependent transmission at mid-level transmission (βi=0.75 and b=0.65). E) Model A under 
frequency dependent transmission, at high-level transmission (βI=400/365). F) Model A under 
mosquito dependent transmission, at (βi=1 and b=1). For all sub-figures the more conservative region 
of parameter space is displayed through the axis labelled values being green. 
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A) B)  
C) D)  
E) F)  
Figure 7.22: Mean percentage of the population resistant at the end of an epidemic, against duration 
of asymptomatic infections (d) and proportions of infections developing symptoms (p), when 
transmission from asymptomatic and symptomatic infections is the same (c=1). A) Model A under 
frequency dependent transmission, at low level transmission (βI=200/365). B) Model A under 
mosquito dependent transmission, at low level transmission (βi=0.5 and b=0.3). C) Model A under 
frequency dependent transmission, at mid-level transmission (βI=300/365). D) Model A under 
mosquito dependent transmission at mid-level transmission (βi=0.75 and b=0.65). E) Model A under 
frequency dependent transmission, at high-level transmission (βI=400/365). F) Model A under 
mosquito dependent transmission, at (βi=1 and b=1). For all sub-figures the more conservative region 
of parameter space is displayed through the axis labelled values being green. 
290 
 
A) B)  
C) D)  
Figure 7.23: Mean percentage of the population resistant after 10 years if dengue is 
still within the population, in Model A under mosquito dependent transmission. A) 
Against asymptomatic transmission (c) and proportion of symptomatic infections 
(p), duration asymptomatic and symptomatic infections being the same (d=1), at 
low-level transmission (βi=0.5 and b=0.3). B) Against durations of asymptomatic 
infection (d) and proportion of symptomatic infections (p), asymptomatic and 
symptomatic transmission being the same (c=1), at low-level transmission (βi=0.5 
and b=0.3). C) Against asymptomatic transmission (c) and proportion of 
symptomatic infections (p), duration of asymptomatic and symptomatic infections 
being the same (d=1), at    mid-level transmission (βi=0.75 and b=0.65). D) Against 
durations of asymptomatic infection (d) and proportion of symptomatic infections 
(p), when asymptomatic and symptomatic transmission is the same (c=1), at mid-
level transmission (βi=0.75 and b=0.65). For all sub-figures the more conservative 
region of parameter space is displayed through the axis labelled values being 
green. 
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E) F)  
Figure 7.23 continued: E) Against asymptomatic transmission (c) and proportion 
of symptomatic infections (p), duration asymptomatic and symptomatic infections 
being the same (d=1), at high-level transmission (βi=1 and b=1). F) Against 
duration of asymptomatic infection (d) and proportion of symptomatic infections 
(p), when asymptomatic and symptomatic transmission is the same (c=1), at high-
level transmission (βi=1 and b=1). For all sub-figures the more conservative region 
of parameter space is displayed through the axis labelled values being green. 
7.4 Discussion 
The switching from deterministic to a stochastic version of the mosquito 
dependent Model A caused several changes to epidemiological outcomes. Firstly in the 
higher transmission setting, when not all infections led to symptoms (p<1), combined 
with a higher duration or level of transmission in the asymptomatic class (d>1 and c>1, 
respectively), there was no longer a guarantee of epidemics becoming endemic. As 
values of the length of time before immunity takes hold in the asymptomatic class 
increased (d) and the proportion of infections that developed symptoms decreased more 
of the trials had epidemics becoming endemic. For increased transmission from the 
asymptomatic class (c) combined with a decreased proportion of infections developing 
symptoms this effect exists to a lesser extent (compare subfigure E of Figure 7.13-14). 
Meaning that more of these trials were dengue virus becomes endemic were excluded 
from the more conservative sample of parameter space for the level transmission from 
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the asymptomatic class (c), than for the duration transmission from the asymptomatic 
class (d). Similarly the occasional epidemic becomes endemic in the medium 
transmission setting (βi=0.75 and b=0.65) for longer lengths of time until immunity is 
acquired for asymptomatic infections (d) combined with lower proportions of infections 
becoming symptomatic (p) (see Figure 7.12E and Figure 7.16). This did not occur in the 
deterministic models for the mosquito dependent versions of Model A. This would 
suggest that when combined with stochasticity, a greater duration of asymptomatic 
dengue virus infection than symptomatic dengue virus infection (d) is more likely to 
lead to dengue becoming endemic than a similar increase in transmission from 
asymptomatic dengue virus infection (c). To this author’s knowledge and that of several 
reviewers on the different epidemiological roles of asymptomatic dengue infection 
(Chastel 2012; Carrington & Simmons 2014; Grange et al. 2014), there have been no 
studies quantifying the duration of viremia of asymptomatic dengue virus infections; let 
alone comparing it with the duration of viremia seen in symptomatic dengue virus 
infections.   
This is not to suggest that the level of transmission from asymptomatic dengue 
virus infections (c) is not important to dengue’s epidemiology. At lower transmission 
settings (βI=200/365 or βi=0.5 and b=0.3), low proportions of infections becoming 
symptomatic (p) combined with both lower levels and durations of transmission in the 
asymptomatic class (c and d respectively) in the stochastically modelled versions of 
Model A led to a greater chance of a dengue epidemic not occurring (compare 
subfigures A and C of Figure 7.3-13). This occurred either towards the low end of or 
excluded from the more conservative samples of parameter space for the proportion of 
infections developing symptoms (p) and level or duration of transmission from the 
asymptomatic class (c and d respectively). These regions of parameter space also 
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coincided with R0 values just above 1. Therefore, validating the suggestion made in 
Chapter 5 and Chapter 6 that sets of parameters, which led to epidemics persisting more 
than two years without becoming endemic, would in a stochastic framework lead to a 
higher chance of those epidemics not occurring in the first place. As at values of R0 
being just above 1 there was a higher chance of an infected individual either becoming 
immune or dying before infecting someone else then at much higher values of R0 
(Anderson & May 1991a; Keeling & Rohani 2008a).  
The lower transmission settings that had the highest number of trials not leading 
to an epidemic could be seen as representing Italy, several other European countries, 29 
states of the USA and the parts of the Australasian continent, that have all seen the 
introduction of Ae. albopictus (M. Service 2012b; WHO 2015c). As discussed in the 
previous chapter Ae. albopictus feeds much more readily on other animals and is less 
suited to the urban environment then Ae. aegypti (Lambrechts et al. 2010). As such the 
low transmission setting for the mosquito dependent transmission version of Model A 
(βi=0.5 and b=0.3), with a low biting rate is probably indicative of the areas where Ae. 
albopictus has recently been introduced. The change from modelling Model A in a 
deterministic fashion to stochastic fashion would modify the suggestion made in the 
previous chapter that from looking at Model A in the low transmission setting, that an 
epidemic may well occur in an area where Ae. albopictus has been introduced but it 
would not become endemic. To add the prevision that if the duration or level of 
asymptomatic transmission is low and there is a high rate of asymptomatic infection, 
then stochasticity would make such dengue epidemics less likely. This would also seem 
to validate the point made in Chapter 5 that considering if Quam et al. (2015) 
approximation of 572 apparent and 1747 inapparent dengue infections being imported 
through Rome’s airport in a year is reliable, then it may be the case that stochasticity 
294 
 
plays a role in preventing imported dengue from causing regular epidemics from taking 
place in Italy or other countries where Ae. albopictus has recently become established. 
As discussed in Chapter 5 and Chapter 6 the level of transmission from 
asymptomatic dengue infected individuals will be related to two features of 
asymptomatic dengue infection. The first is the level of viremia in asymptomatic 
dengue virus infections. Nguyet et al. (2013) reported that symptomatic dengue virus 
infections that where ambulatory had an infectious viremia, but it was lower than 
dengue virus infections in hospitalised patients.  This work would suggest that 
asymptomatic dengue virus infections may have a lower viremia leading them to being 
less infectious to blood feeding mosquitoes (Nguyet et al. 2013). However there have 
been very few studies that have detected viremia in asymptomatic dengue virus 
infections (Beckett et al. 2005; Reyes et al. 2010; Duong et al. 2011; Chastel 2012; 
Carrington & Simmons 2014). Duong et al. (2011) being the only study to quantify the 
level of viremia in asymptomatic dengue virus infections, found no significant 
difference in the levels of viremia in asymptomatic and symptomatic dengue virus 
infections. It should be pointed out that Duong et al. (2011) had a small sample size and 
to date there has been no study testing whether mosquitoes feeding on asymptomatically 
dengue infected humans can become infected (Carrington & Simmons 2014).  
It should also be noted that moving to a stochastic modelling approach from a 
deterministic one, allowed the occasional simulated epidemic of dengue virus to become 
endemic, when those same parameter settings did not lead to the dengue virus becoming 
endemic for the deterministic modelling approach seen Chapter 6. This happened for the 
mosquito dependent transmission version of Model A at a high transmission setting 
(βi=1 and b=1), when Model A resembled an SIR type mode in one of two ways. Firstly 
through infections being symptomatic (p=1) or Model A closely resembling an SIR 
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model, due to nearly all infections developing symptoms (p is close to 1) (see Figure 
7.13E, Figure 7.14E and Figure 7.19-20). This region of parameter space is excluded 
from the more conservative sample of parameter space for the proportion of infections 
developing symptoms (p), as p>0.7.  Secondly the level and duration of transmission 
from the asymptomatic class being similar to the symptomatic class (c and d are 1 or 
close to it) (see Figure 7.13E, Figure 7.14E and Figure 7.19-20). This would suggest 
that not only that parameter settings that allow a disease to become endemic when 
modelled deterministically, do not necessarily lead to a disease becoming endemic when 
modelled stochastically, but parameter settings that do not allow a disease to become 
endemic when modelled deterministically can lead to a disease becoming endemic when 
modelled stochastically. This would effectively happen through a run of “bad luck” 
where repeatedly a number of individuals remain in a disease transmitting state for 
much longer than average, or more mosquitoes are infected from biting dengue virus 
infected humans than average. 
The incorporation of stochasticity in to frequency dependent transmission and 
mosquito dependent transmission versions of Model A led to a similar pattern in the 
proportion of population resistant to the invading dengue serotype, provided an 
epidemic occurred. This is also true for the more conservative samples of parameter 
space for the proportion of infections developing symptoms (p), level and duration of 
transmission from the asymptomatic class (c and d respectively). Therefore there is no 
change to the two suggestions made in Chapter 5 and Chapter 6 regarding the 
proportion of population resistant to the invading dengue serotype. Firstly that should 
there be a second epidemic caused by a different dengue virus serotype a larger 
proportion of the population may be at risk of DHF then would be suggested from the 
number of reported DF cases in the first epidemic. Secondly that if in the first epidemic 
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dengue virus were to become endemic this at risk population would remain at a high 
proportion of the population through time.  
7.5 Conclusion 
The conclusions in Chapter 5 and Chapter 6 pointed to the need for a greater 
knowledge of the mosquito biting rate experienced by asymptomatic dengue virus 
infections, the level and duration of transmission from these infections, as well as the 
proportion of dengue virus infections that develop symptoms. In this chapter moving 
from a deterministic process to a stochastic process for frequency dependent 
transmission and mosquito dependent transmission versions of Model A, not only adds 
credence to these points but led to key additional insights being made. Where 
combinations of parameters led to R0 being only just over 1 epidemics often did not 
occur due to stochasticity. Such parameter settings occurred at a lower transmission 
level, with low rates of symptomatic dengue virus infection combined with lower 
transmission or durations of transmission in asymptomatic dengue virus infections. This 
would suggest that in countries where Ae. albopictus has recently become established, if 
it is the case that most dengue virus infections are asymptomatic and such infections 
have either a lower level or duration of transmission, then stochasticity could prevent 
many epidemics from occurring. Therefore the proportion of dengue virus infections 
that are symptomatic needs to be verified. As discussed in Chapter 5, Grange et al. 
(2014) review found a large degree of variation in the measure of the proportion of 
dengue virus infections that are symptomatic, especially between estimate using index 
cluster methods and cohort studies. Therefore the findings of this chapter along with 
Chapter 5 and Grange et al. (2014) highlight the need for comparative research between 
cohort studies and index cluster studies in order to assess which is the most accurate, 
followed by standardisation of methodologies in future studies assessing this.   
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In the higher transmission setting where the lower rates of progression to 
symptomatic dengue virus infection combined with higher durations or levels of 
asymptomatic dengue virus infection transmission led to dengue becoming endemic, the 
inclusion of stochasticity made this endemicity no longer guaranteed. Higher durations 
of asymptomatic dengue virus infection where less affected by this, suggesting that the 
duration of asymptomatic dengue virus infection may be more of a key determinant for 
a dengue epidemic becoming endemic than the transmission from such infections. As 
discussed in Chapter 5 and 6 direct research via screening mosquitoes fed on 
asymptomatic dengue virus infected humans for dengue virus, in order to ascertain the 
duration of transmission, has so far been completely lacking (possibly due to 
feasibility). There has been some related research on the viremia of asymptomatic 
dengue virus infected humans but this so far has been limited (Beckett et al. 2005; 
Reyes et al. 2010; Duong et al. 2011; Chastel 2012; Carrington & Simmons 2014), none 
of it looking into the duration of viremia. Such research could be furthered by studying 
how the level and duration viremia in asymptomatically dengue virus infected humans 
compares to symptomatically dengue virus infected humans. Hopefully such research 
would lead to a greater understanding of the transmission from asymptomatically 
dengue virus infected humans through the lifetime of infection. 
298 
 
Chapter 8: Discussion 
8.1 Summary of thesis findings 
The molecular analyses of some of the samples in Chapter 2 revealed a higher 
infection rate for Plodia interpunctella larvae raised on low quality food. This suggests 
that decreased food resource level, reduced the second generation of P. interpunctella’s 
ability to suppress or ultimately clear PiGV infection. Further experimentation would be 
needed to untie the effect of food resource on the processes involved in the infection of 
baculoviruses. Injection of PiGV into P. interpunctella may provide a possible solution, 
as the infection route would not be affected by any changes in P. interpunctella caused 
by food resource level. Within Chapter 2 none of the 995 larvae from PiGV treatments 
raised on low quality food showed overt signs of PiGV infection, suggesting that the 
lower quality food does not stress the larvae enough to cause the activation of PiGV. 
Then again neither did any of the1774 larval offspring from parents infected with PiGV. 
This would suggest therefore that a greater range of food resources (including 
starvation), differing nutrient ratios and unusual food resources need to be studied to 
ascertain whether or not food resource can affect the activation and vertical transmission 
of covert baculoviruses, not only in the offspring generation but the parental generation, 
as well. There is also a lack of research surrounding the effects of viral dose and 
parental host instar at the point of infection, on the vertical transmission of covert 
baculoviruses. The role of other infectious agents in causing activation of covert 
baculovirus infections also needs to be further explored. 
Chapter 3 found that inbreeding had no significant effect on the vertical 
transmission of PiGV in P. interpunctella. This could be due to the low rate of vertical 
transmission leading to a low sample in terms of PiGV infected larvae. Further study of 
299 
 
other insect baculovirus systems with much higher vertical transmission rates may be 
needed to verify the effect of inbreeding on the vertical transmission of baculoviruses.  
Other studies have found differing results regarding the effect of inbreeding on 
pathogen susceptibility and immunity. Therefore it may be the case that the effects of 
inbreeding on an insect’s immunity and susceptibility to a pathogen may be specific to 
that insect, its ecological niche or the pathogen. 
Chapter 4 overall concludes that vertical transmission of dengue virus is of little 
importance to the epidemiology and persistence of dengue virus; pointing to the low 
rates of vertical transmission seen in the field, the sheer sampling effort in obtaining 
such results, as well as the many field studies, which found no evidence of vertical 
transmission of dengue virus. A combination of asymptomatic dengue virus infection in 
humans and movement of dengue virus infected humans may well be more important. 
That being said vertical transmission may possibly lead to persistence of dengue viruses 
if combined with two other processes. The possibility of vertical transmission of dengue 
virus to larvae leading to the horizontal transmission of dengue virus between larvae via 
cannibalism needs to be further explored as a possible contributing factor in the 
persistence of dengue virus. Furthermore, there is a lack of work on vertical 
transmission of dengue virus into diapausing or desiccated eggs and the impact of 
dengue virus infection on survivorship. However, work on these two areas may be 
hampered logistically due to the low rate of vertical transmission and sampling effort 
required.  
Whilst Chapter 5 found that in two frequency dependent models asymptomatic 
infections did not lead to dengue becoming endemic. However, Chapter 5 demonstrated 
that asymptomatic dengue virus infections could lead to dengue virus persisting for 
several years in lower transmission settings with either a low level or duration of 
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transmission from asymptomatic dengue virus infections. Furthermore, Chapter 5 
reveals that a larger proportion of the population could also be left at risk of DHF than 
necessarily suggested by dengue fever cases (symptomatic dengue virus infections). 
This is despite one of the models making unrealistic assumptions about the length of 
time an infection progresses from an asymptomatic state to a symptomatic state.  
Lacking from Chapter 5’s two models was the explicit inclusion of mosquitoes 
in the transmission dynamics of dengue viruses; Chapter 6 included mosquitoes within 
these two models and broadly found the same results. Except for finding that the dengue 
virus could become endemic, provided the transmission setting was high and the 
probability of developing symptoms was less than 1 and there was either a high rate or 
duration of transmission in asymptomatic infections.  
With the inclusion of stochasticity into one of the models of asymptomatic 
dengue virus infections, Chapter 7 caused key additional insights to be made. Where 
combinations of parameters led to R0 being only just over 1, epidemics often did not 
occur due to stochasticity. Such parameter settings occurred at a lower transmission 
level with low rates of symptomatic dengue virus infection combined with lower 
transmission or durations of transmission in asymptomatic dengue virus infections. This 
would suggest that in countries where Ae. albopictus has recently become established, if 
it is the case that most dengue virus infections are asymptomatic and such infections 
have either a lower level or duration of transmission, then stochasticity could prevent 
many epidemics from occurring.  In the higher transmission setting were the lower rates 
of progression to symptoms combined with higher durations or levels of transmission 
from asymptomatic dengue virus infections led to dengue becoming endemic in Chapter 
6. The inclusion of stochasticity in Chapter 7 meant that the dengue virus did not always 
become endemic under these circumstances. Higher durations of asymptomatic dengue 
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virus infection were less affected by this, suggesting that the duration of asymptomatic 
dengue virus infection may be more of a key determinant for a dengue epidemic 
becoming endemic than the transmission from such infections.  
Chapter 5, 6 and 7 point to the need for a greater knowledge of the rate at which 
mosquitos bite asymptomatically dengue virus infected people, as well as the level and 
duration of viremia in asymptomatically dengue virus infected people. 
8.2 Future directions for studying vertical transmission in insect virus systems 
Recapping back to Chapter 2, the first repeat of the experiment that was 
analysed molecularly found a vertical infection rate from a parent infected with PiGV of 
2.5%-5.6%. An even lower vertical infection rate of 0.35-0.48% was obtained for PiGV 
in Chapter 4. This unfortunately suggests PiGV’s vertical infection rate is rather low. 
This means that further experimentation using the P. interpunctella PiGV model system 
to explore the ecology and evolution of vertical transmission or covert baculoviruses 
may be logistically unfeasible. Logistically, therefore, it may be better to use an insect 
baculovirus system with a higher rate of vertical infection. 
One such area of research is the circumstances that select for vertical 
transmission of viruses. Fuxa & Richter (1991) were able to select for an increased rate 
of vertical transmission of SfNPV through isolation SfNPV in the host pupae of 
Spodoptera frugiperda produced by parents who had survived SfNPV infection. Of 
interest regarding this PhD thesis is that both the wild type and selected strains of 
SfNPV produced overt and covert infections within the offspring of orally infected S. 
frugiperda (Fuxa & Richter 1991). It is of note that further experimentation by Fuxa & 
Richter (1992) followed transgenerational mortality of SfNPV overt infections up to the 
F5 and F7 generations for the wild-type and selected strains of SfNPV. This 
demonstrates that the vertical transmission of baculoviruses can be selected for. The 
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circumstances under which a covert vertically transmitted baculovirus would be selected 
for in nature were hypothesised by Sorrell et al. (2009). Through mathematical 
simulations Sorrell et al. (2009) suggested that vertically transmitted covert viral 
infection would be promoted in highly fecund hosts that go through fluctuating 
population densities, as found in many insect baculovirus systems. Therefore, the use of 
another insect baculovirus system with a higher vertical transmission rate could be used 
to test the suggestion made by Sorrell et al. (2009). An experimental setup within a 
microcosm where population densities of an insect host alternate across many 
generations with the baculovirus present in the host population would be one way to test 
this suggestion.  
Chapter 2 concluded that a greater range of food resources, different 
protein:carbohydrate levels and unusual food resources need to be studied to ascertain 
whether or not food resource can affect the activation of covert baculovirus infections. 
Furthermore, that the role of other infectious agents in causing activation of covert 
baculovirus infections also needs to be further explored. As suggested in Chapter 2, 
regarding food quality, if the possible causes of covert baculovirus activation were to be 
further explored, it may be logistically wiser to use an insect baculovirus system with a 
higher rate of vertical transmission than that found in PiGV infections. It was also 
suggested in Chapter 3 that the use of an insect baculovirus system with a higher rate of 
vertical transmission may be necessary to further explore the effect of inbreeding on 
vertically transmitted covert viruses in insects.   
8.3 Vertical transmission in other mosquito borne viral infections 
Vertical transmission has been demonstrated within many other mosquito borne 
viral pathogens (Rosen et al. 1978; Diallo et al. 2000; Nelms et al. 2013; Agarwal et al. 
2014; Lequime & Lambrechts 2014). There has been a recent systematic review by 
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Lequime & Lambrechts (2014) of studies researching vertical transmission of mosquito 
borne viral pathogens. Unfortunately this systematic review does not focus on the role 
of vertical transmission in the ecological dynamics of these diseases, but simply focuses 
on the trends of such studies, such as increases in there occurrence after major disease 
outbreaks and the development of different screening techniques. That being said 
Lequime & Lambrechts (2014) in their conclusion point out that in the field vertical 
transmission’s prevalence was typically <0.1%. Lequime & Lambrechts (2014) point 
out that vertical transmission’s prevalence in laboratory experiments may be 10 to 
10,000 fold higher due to 100% of the parental generation being infected. This leads on 
to Lequime & Lambrechts (2014) suggesting that even with an efficient form of vertical 
transmission, it is unlikely that vertical transmission can explain the persistence of 
arboviruses, through periods lacking in horizontal transmission (i.e. low numbers of or 
none existence of vectors).  
With many of the arbovirus pathogens of medical importance humans are not 
the main host. The yellow fever virus for instance is maintained within populations of 
monkeys and there is the occasional isolated case or spill-over outbreak in humans (M. 
Service 2012b; WHO 2014b). Similarly with both West Nile virus and Japanese 
encephalitis virus humans are dead end hosts, only being able to become infected but 
not developing a high enough viremia to be infectious to a biting mosquito (WHO 2011; 
M. Service 2012b; WHO 2014a). In the case of West Nile virus populations of multiple 
bird species (mostly corvids) maintain the virus (WHO 2011; M. Service 2012b). 
Likewise, for Japanese encephalitis virus, multiple water based bird species and pigs act 
as transmitting hosts (M. Service 2012b; WHO 2014a). Where there are multiple host 
species, transmission dynamics between these host species may be a more likely 
candidate for the persistence of an arbovirus through seasons of low vector abundance 
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than vertical transmission of the arbovirus. It may be the case that vertical transmission 
combined with transmission from an alternate host could lead to persistence of 
arbovirus where horizontal transmission between mosquitos and the main host would 
not allow an arbovirus to persist through seasons of low vector abundance. A recent 
theoretical study by Manore & Beechler (2015) on the persistence of Rift Valley fever 
virus demonstrates this. Rift Valley fever virus is a much more significant veterinary 
problem than a medical one, causing unexpected abortions in livestock and large 
mortalities in lambs (WHO 2010). Manore & Beechler (2015) modelled the zoological 
transmission cycle of Rift Valley fever virus with buffalo as the main host. Manore & 
Beechler (2015) found that one of the most realistic scenarios for the persistence of Rift 
Valley fever virus through seasons of low vector abundance was a combination of 
vertical transmission with in mosquito vectors (at levels seen in previous studies) and 
the involvement of an alternate mammalian host (possessing a lifespan of 7 years as 
opposed to a buffalo’s 15 years).  
Therefore Lequime & Lambrechts (2014) suggestion that, even with an efficient 
form of vertical transmission, it is unlikely that vertical transmission can explain the 
persistence of arboviruses through periods lacking in horizontal transmission and may 
be too broad a generalisation. Considering that most arboviruses have multiple hosts 
and that the review in Chapter 4 highlighted the many problems with research on 
vertical transmission of dengue viruses and pointed to the few possibilities where 
vertical transmission could cause the persistence of dengue viruses. Therefore I would 
hope that the large database of studies researching vertical transmission mosquito borne 
viral pathogens collected for Lequime & Lambrechts (2014) systematic review is used 
to conduct further reviews, looking at specific arboviruses and the role that vertical 
transmission plays in the ecological dynamics of that specific arbovirus. In order to 
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assess any problems with the research on vertical transmission of that specific arbovirus 
and point to the possible way in which vertical transmission could cause the persistence 
of that specific arbovirus. 
8.4 Possible future avenues for modelling work on the role of asymptomatic 
dengue infections 
The work on modelling asymptomatic dengue infections in this PhD is by its 
nature simplistic, but considering the paucity of models of dengue epidemiology that 
include asymptomatic dengue infections, this could be a vital first step in our 
understanding of asymptomatic dengue infections in dengue’s epidemiology. Future 
models on asymptomatic dengue virus infections, looking at how such infections 
interact with other aspects of dengue virus ecology, could reveal the extent to which 
transmission from asymptomatic dengue virus infections drive dengue virus 
epidemiology.   
For example work by Getis et al. (2003) showed that adult Ae. aegypti clustered 
within houses and weakly up to 30 meters beyond houses, suggesting that adult Ae. 
aegypti populations are heterogeneously spaced. Furthermore Boyer et al. (2014) found 
heterogeneous spacing of immature forms of Ae. ablopictus, suggesting that adult Ae. 
ablopictus may also be heterogeneously spaced. If both of these key vectors are 
dispersed in clusters it could be the case that asymptomatic dengue infections could 
cause greater transmission through their greater movement between these different 
clusters. Luz et al. (2003) modelled the effect of human movement between two patches 
of differing mosquito density, likewise Adams & Kapan (2009) modelled people 
regularly commuting through and between different patches of mosquito densities. Luz 
et al. (2003) found that human movement could lead to an increase chance of epidemics 
taking hold in a population and Adams & Kapan (2009) found that high degrees of 
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human movement to patches of high mosquito densities could lead to dengue becoming 
endemic. Incorporation of an ambulatory asymptomatic dengue virus infected class into 
either of these models could reveal a significant role for asymptomatic infection in 
spreading dengue virus.  
Getis et al. (2003) work on clustering of Ae. aegypti suggested that adult Ae. 
aegypti in urban settings do not fly far from the container where they developed as 
larvae and pupae. Whilst the maximum flight range of Ae. aegypti can be quite large 
and varies from less than 40m to greater than 1.2 km (Silver 2008), it has been argued 
that more epidemiologically relevant is the mean mosquito flight range, especially after 
the first blood meal or oviposition (Rodhain & Rosen 1997). Harrington et al. (2005) 
found a range of 28-199m mean Ae. aegypti dispersal across several different sites in 
Thailand and Puerto Rico. The key finding was that the majority of mosquitos were 
found in the house in which they were released or in an adjacent house (Harrington et 
al. 2005). Maciel-de-Freitas et al. (2010) found that most Ae. aegypti did not move 
much after the first 1-2 days after release. This suggests the mosquitoes did not move 
much after locating there first blood meal. Both the work by Harrington et al.( 2005) 
and Maciel-de-Freitas et al. (2010) would suggest Ae. aegypti move little. Stoddard et 
al. (2013) analysed dengue infection in Iquitos, Peru, finding that the risk of infection 
was characterised by visits to places where contact with infected mosquitoes was most 
likely and independent of proximity to the homes of other infected people.  Considering 
the lack of movement of Ae. aegypti (Rodhain & Rosen 1997; Harrington et al. 2005; 
Maciel-de-Freitas et al. 2010), Stoddard et al. (2013) and Reiner et al. (2014) point to 
human social movement as the main driver dengue of transmission. As with models that 
take into account mosquito spatial heterogeneity (Luz et al. 2003; Adams & Kapan 
2009), incorporation of an ambulatory asymptomatic infected class into models of 
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dengue transmission where mosquitoes move little, could reveal that through its greater 
host movement asymptomatic infection drives the spread of dengue.  
Reiner et al. (2014) through models of human social movement between groups 
was able to recreate the dengue infection dynamics seen by Stoddard et al. (2013). 
Asymptomatic infections do not lead to the decreased social movement seen in 
symptomatic infections.  Therefore the consideration of asymptomatic dengue virus 
infections in such a social structured agent-based models as Reiner et al. (2014), could 
also cast further light on the importance of asymptomatic infections in dengue virus 
transmission dynamics.  
8.5 Inapparent and vertically transmitted infections in two host-virus systems: 
the wider ecological context. 
The main aim of studying inapparent and vertically transmitted infections in 
these two host-virus systems was to determine the role of these two processes in the 
ecological persistence of pathogens. Inapparent infections whether in the form of covert 
or asymptomatic infections could allow a pathogen to persist by providing a reservoir of 
infected hosts, whose role would be at first sight hidden from researchers, medics, vets 
and conservationists. Similarly vertical transmission could provide a pathogen with a 
reservoir of infection that persists across generations. 
The introductory chapter (see Section 1.4) mentioned that several viruses are 
thought to persist in their host population with the majority of infections being 
inapparant infected in the form of asymptomatic infections. For example cowpox within 
wood mice and bank voles (Telfer et al. 2005) and squirrel parapoxvirus causing no 
signs of infection for the vast majority of grey squirrels (Sainsbury et al. 2000). 
Furthermore the polio virus being thought to persist, in the few countries where it is 
endemic, through the large proportion of asymptomatic infections (72%) acting as a 
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reservoir (Hamborsky et al. 2015). As discussed further research may be needed to 
prove that asymptomatic infections definitively can cause dengue viruses to persist for 
longer or indefinitely (see Section 5.4-5, 6.4-5, 7.4-5 and 8.4). However, the models in 
Chapter 5-7 demonstrate that inapparent (asymptomatic) infections can theoretically 
cause a pathogen to persist for longer or indefinitely under certain combinations of 
overall level of transmission, proportions of asymptomatic infection, levels and 
durations of transmission from asymptomatic infections. Taken all together this would 
suggest that under certain ecological conditions, asymptomatic infections could lead to 
a persisting reservoir of infection. Where asymptomatic infections are suspected to be a 
means of pathogen persistence, further research on the proportion of asymptomatic 
infections, the level and duration of transmission from such infections would verify 
such ecological conditions.  
As mentioned in section 1.5 of the introductory chapter, Sorrell et al. (2009) 
predicted that highly fecund hosts that go through fluctuating population densities 
would select for an infectious agent using a covert strategy for persistence. Sorrell et al. 
(2009) pointed to a few studies which found insects covertly infected with 
baculoviruses as examples, of which there are many dating back to the 1950s (Steinhaus 
1958; Steinhaus & Dineen 1960; Jaques 1962; Longworth & Cunningham 1968; Etzel 
1976; Biever & Wilkinson 1978; Jurkovíčová 1979; Fuxa & Richter 1992; Hughes et al. 
1997; Fuxa et al. 1999; Cooper et al. 2003; Burden et al. 2003; Burden et al. 2006; 
Vilaplana et al. 2008; Vilaplana et al. 2010; Murillo et al. 2011). A key feature of covert 
infections is that at some point the infection may switch to an overt form (activation), 
leading to the horizontal transmission of the infectious agent (Sorrell et al. 2009). The 
covert inapparent form of PiGV infection was not demonstrated to be activated into an 
overt form by low quality food (see Chapter 2), neither was this activation seen to be 
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affected by host inbreeding (see Chapter 3). Chapter 2 pointed to the many studies 
definitely showing that covert baculoviruses could be activated by infection from other 
baculoviruses (Longworth & Cunningham 1968; Jurkovíčová 1979; Hughes et al. 1993; 
Cooper et al. 2003; Burden et al. 2003). Whilst there is some evidence hinting at lack of 
food (Jaques 1962; Myers et al. 2011) and unusual diet (David & Gardiner 1965; 
Ilyinykh et al. 2013) as means of activation of overt infection Chapter 2 highlights the 
further research needed in these areas. Sorrell et al. (2009) models also found that such 
covert infection would be selected for in long-lived slow reproducing hosts when there 
was even a small variation in transmission. Viruses of the family Herpesviridae, such as 
varicella-zoster virus, herpes simplex 1 and 2 (Goering et al. 2008d) (see section 1.5) do 
persist by activating from a covert form to an overt form within long lived hosts. Within 
humans many covert infections as these have been demonstrated to be activated by old 
age, pregnancy and other infections leading to host immunosuppression (Goering et al. 
2008d). Therefore there is empirical support for Sorrell et al. (2009) suggestion that 
covert infections could provide a pathogen with a persisting reservoir of infection 
provided there is variation in horizontal transmission in a long lived slow reproducing 
host, or fluctuating host density in a short lived highly fecund host. However 
particularly in the case of covert infections of highly fecund hosts with fluctuating 
population densities there is need for further research into the means of activation to 
overt forms of infection.  
 Chapters 2 and 3 found extremely low rates of vertical transmission for PiGV 
suggesting that vertical transmission was not a means of persistence for strain of PiGV 
available. Likewise, Chapter 4 concluded that due to the low rates of vertical 
transmission seen in the field and the many field studies which found no evidence of 
vertical transmission of dengue virus, it is unlikely that vertical transmission of dengue 
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virus is of any importance to the persistence of dengue virus. However, there are many 
pathogens which are thought to persist through vertical transmission. As mentioned in 
the introductory chapter (see Section 1.3) Human T-cell Lymphotropic Virus type 1 
(HTLV-1)  is thought to persist through vertical transmission being transmitted through 
breast milk with some horizontal transmission through sexual intercourse (Goering et al. 
2008g; Goering et al. 2008c). The protozoan pathogen Ophryocystis elektroscirrha 
persist through being vertically transmitted. Vertical transmission occurring when adult 
monarch butterflies Danaus plexippus scatter O. elektroscirrha spores over their eggs 
and surrounding milkweed foliage, these spores are then eaten by host larvae shortly 
after hatching (McLaughlin & Myers 1970; Lefèvre et al. 2012). Vilaplana et al. (2010) 
found extremely high rates of covert infection of African armyworm’s (Spodoptera 
exemta) NPV in the field and nearly 100% of S. exemta were covertly infected within a 
lab colony. Due to the very rare occurrence of overt infection over the 5 years that this 
lab colony was maintained Vilaplana et al. (2010) point to these findings as evidence 
that S. exemta’s NPV was persisting through vertical transmission in the lab and in the 
field.  Lipsitch et al. (1996) used mathematical models to explore the circumstances 
which led to vertical and horizontal transmission being evolutionary stable strategies 
(ESSs), under the constraining influence of virulence on these transmission routes. 
Lipsitch et al. (1996) found that low virulence selected for high rates of vertical 
transmission and lower rates of horizontal transmission, but horizontally transmitting 
strains would outcompete vertically transmitting strains under high virulence. This first 
scenario does as such have vertical transmission providing a pathogen with a persisting 
reservoir of infection. However, Lipsitch et al. (1996) warns evolutionary trajectories 
depend on the constraints in the associations of vertical and horizontal transmission to 
virulence that are caused by the biology of host and pathogen. Therefore vertical 
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transmissions can provide a pathogen with a persisting reservoir of infection and 
Lipsitch et al. (1996) research provides a theoretical framework for understanding the 
circumstance for its evolution. However, further research needs to add to Lipsitch et al. 
(1996) findings and demonstrate more of the ecological conditions under which vertical 
transmission provides a pathogen with a persisting reservoir of infection.  
Over all inapparent and vertically transmitted infections may provide pathogens 
with a method of persistence in host populations. However, in the research outlined in 
Chapters 2-4 inapparent or vertically transmitted infections do not provide pathogens 
with a method of persistence. It is therefore difficult to see if there are broad trends or 
parallels in pathogens using inapparent and vertically transmitted infections as means of 
persistence, from looking at the findings of Chapters 2-4. There are other host pathogen 
systems in nature where pathogens do persist through inapparent, vertically transmitted 
infections or a combination of both. Chapters 5-7 firstly demonstrate that dengue 
viruses could be persisting through inapparent (asymptomatic) infections. Secondly 
Chapters 5-7 demonstrate that in theory that inapparent (asymptomatic) infections can 
provide a pathogen a persisting reservoir of infection under certain combinations of 
overall level of transmission, proportions of asymptomatic infection, level and durations 
of transmission from asymptomatic infections. Similarly Sorrell et al. (2009) theoretical 
work demonstrated that the ESS for covert infections was produced in short lived, 
fecund hosts with fluctuating population densities or long lived, slow reproducing hosts 
with variable horizontal transmission rates. Likewise, Lipsitch et al. (1996) found that 
under low virulence the ESS was for high rates of vertical transmission and lower rates 
of horizontal transmission, but under high virulence horizontally transmitting strains 
would outcompete vertically transmitting strains. The work in Chapter 5-7, Sorrell et al. 
(2009) and Lipsitch et al. (1996) are all theoretical; as such further investigations are 
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needed either to clarify these studies or provide evidence from the field to confirm their 
findings. Further investigation into asymptomatic dengue virus infections may shed 
further light on the role of inapparant (asymptomatic) infections in the persistence of 
pathogens. However, for vertically transmitted or inapparant (covert) infections 
investigation of other pathogen host systems where these process occur at higher rates 
may be more likely to demonstrate their effect on pathogen persistence.  
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